FeatureID,Name,Formula,MW,KEGG Pathways,Metabolika Pathways,name4plot,C,H,O,N,S,P,H_to_C,O_to_C,NOSC,GFE,DBE,DBE_O,AI,AI_mod,DBE_AI,Class,control_means,treatment_means,ratio,log2FC,pval,pval.adj,Comment
Feature1694,α-Lactose,C12 H22 O11,342.11629,Metabolic pathways;Biosynthesis of secondary metabolites;ABC transporters;Other,Other,α-Lactose-peak2,12,22,11,0,0,0,1.8333333333333333,0.9166666666666666,0,60.3,2,-9,-9,-0.5384615384615384,-9,Carbohydrate,4264435167.507026,4041925091.58202,0.9478219114173836,-0.0773120818090161,0.6012641773101142,0.7865713119297694,Downregulated
Feature1693,Phenacetin,C10 H13 N O2,179.09462,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",NA,Phenacetin-peak6,10,13,2,1,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Lignin,3610087.0006556,5316634.64742079,1.472716487568105,0.5584797240958399,0.13554446192575972,0.45384777576550756,Upregulated
Feature1692,"4-({4-[(2,4-Dihydroxy-3,6-dimethylbenzoyl)oxy]-2-methoxy-3,5,6-trimethylbenzoyl}oxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C31 H34 O10,566.21535,Biosynthesis of secondary metabolites;Other,NA,"4-({4-[(2,4-Dihydroxy-3,6-dimethylbenzoyl)oxy]-2-methoxy-3,5,6-trimethylbenzoyl}oxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak2",31,34,10,0,0,0,1.096774193548387,0.3225806451612903,-0.4516129032258061,73.17096774193547,15,5,0.23809523809523808,0.38461538461538464,5,Lignin,4308209579.537097,5454848382.97093,1.2661520481454933,0.3404506637977598,0.14011185666340806,0.45798070948295916,Upregulated
Feature1691,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",C10 H13 N O3,195.08956,Other,NA,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime-peak5",10,13,3,1,0,0,1.3,0.3,-0.4000000000000003,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Lignin,2337698.76892055,2546355.631211453,1.0892573778388273,0.12334488505518419,0.482138179445133,0.6986673019504323,Upregulated
Feature1690,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,NA,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole-peak13",11,12,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Lignin,2984707797.84593,4002931461.977647,1.341146850243287,0.4234672152575996,0.0753874234291606,0.39590936857023457,Upregulated
Feature1689,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",C10 H13 N O3,195.08956,Other,NA,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime-peak4",10,13,3,1,0,0,1.3,0.3,-0.4000000000000003,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Lignin,3226858.1322234636,1250923.5983226034,0.3876599302060595,-1.3671364737537541,0.4422288702296975,0.6668537167127339,Downregulated
Feature1688,Betaine,C5 H11 N O2,117.07895,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Biosynthesis of alkaloids derived from shikimate pathway;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Superpathway of indole-3-acetate conjugate biosynthesis;Other,Betaine-peak2,5,11,2,1,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,2181414587.50264,1938049693.2345033,0.8884371198109805,-0.17065842346975346,0.30369213143335455,0.5756097246483725,Downregulated
Feature1687,NA,C30 H32 O10,552.19968,NA,NA,Feature1687,30,32,10,0,0,0,1.0666666666666669,0.3333333333333333,-0.4000000000000003,71.7,15,5,0.25,0.4,5,Lignin,2465608333.7825403,2884186900.5743165,1.1697668526897076,0.2262210135810847,0.3934351785112211,0.6416841185496238,Upregulated
Feature1686,Phenacetin,C10 H13 N O2,179.09467,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",NA,Phenacetin-peak5,10,13,2,1,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Lignin,7956695.957244647,7722395.302767177,0.9705530215385274,-0.04312106502805689,0.892632285550405,0.9441529932099071,Downregulated
Feature1685,Choline O-Sulfate,C5 H13 N O4 S,183.05656,ABC transporters,NA,Choline O-Sulfate,5,13,4,1,1,0,2.6,0.8,0,60.3,0,-4,6,-4,-6,Other,1809189147.0819066,1575699897.44456,0.8709425987802613,-0.1993504566418202,0.32123265754143077,0.5861484461709393,Downregulated
Feature1684,NA,C30 H32 O10,552.19968,NA,NA,Feature1684,30,32,10,0,0,0,1.0666666666666669,0.3333333333333333,-0.4000000000000003,71.7,15,5,0.25,0.4,5,Lignin,2092961381.58248,2596830250.81709,1.2407444655541788,0.31120601938591125,0.1676713070401966,0.47405832082810595,Upregulated
Feature1683,NA,C9 H16 O7,236.0896,NA,NA,Feature1683,9,16,7,0,0,0,1.7777777777777777,0.7777777777777778,-0.22222222222222232,66.63333333333333,2,-5,-2.5,-0.2727272727272727,-5,Carbohydrate,1735609416.3424234,1545879440.6235766,0.8906839442490012,-0.16701450708517562,0.29455285942602133,0.5702543358487773,Downregulated
Feature1682,Citric acid,C6 H8 O7,192.02697,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Other,Other,Citric acid,6,8,7,0,0,0,1.3333333333333333,1.1666666666666667,1,31.799999999999997,3,-4,4,-0.2,-4,Other,1625148795.4360867,1450709291.0415766,0.8926624411965296,-0.16381336912454902,0.22541261965077497,0.5155824363504518,Downregulated
Feature1681,L-Phenylalanine,C9 H11 N O2,165.07901,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;ABC transporters;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various plant secondary metabolites;Phenylalanine metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of scopolin and esculin biosynthesis;Superpathway of aromatic amino acid biosynthesis;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of indole-3-acetate conjugate biosynthesis;Other,L-Phenylalanine-peak2,9,11,2,1,0,0,1.2222222222222223,0.2222222222222222,-0.44444444444444464,72.96666666666667,5,3,0.3333333333333333,0.42857142857142855,2,Lignin,221982435.38587135,491542526.266926,2.2143307213135093,1.1468707118964625,0.17391403792446014,0.4774884606872536,Upregulated
Feature1680,L-alpha-Glycerylphosphorylcholine,C8 H20 N O6 P,257.10283,NA,NA,L-alpha-Glycerylphosphorylcholine-peak2,8,20,6,1,0,1,2.5,0.75,-1.25,95.925,0,-6,-Inf,-1.6666666666666667,-8,Carbohydrate,1253396481.4328,1363376679.3775134,1.0877457369427042,0.12134136272659524,0.6104977362008759,0.7912648547240121,Upregulated
Feature1679,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,NA,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole-peak12",11,12,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Lignin,1512103819.3244133,1863508734.33217,1.2323947010230816,0.30146438428951455,0.3645615333405264,0.6199876837031111,Upregulated
Feature1678,L-Glutamic acid,C5 H9 N O4,147.05318,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Biosynthesis of various antibiotics;Other,Superpathway of L-lysine degradation;Superpathway of chorismate metabolism;Superpathway of branched chain amino acid biosynthesis;Superpathway of aromatic amino acid biosynthesis;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of butirocin biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Superpathway of indole-3-acetate conjugate biosynthesis;Superpathway of 4-hydroxybenzoate biosynthesis (yeast);Superpathway of purine nucleotide salvage;Other,L-Glutamic acid,5,9,4,1,0,0,1.8,0.8,0.3999999999999999,48.9,2,-2,-Inf,-0.5,-3,Carbohydrate,1009700446.9954487,730026204.1976724,0.7230126582294788,-0.46790718933609676,0.2858499922936529,0.5643704976054172,Downregulated
Feature1677,Meglutol,C6 H10 O5,162.05285,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Superpathway of butirocin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Other,Meglutol-peak5,6,10,5,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,2,-3,-3,-0.14285714285714285,-3,Carbohydrate,318649491.41439134,284371357.4054353,0.8924268359669885,-0.1641941976944011,0.19872327105692938,0.4953078558039763,Downregulated
Feature1676,Adenosine,C10 H13 N5 O4,267.09675,Metabolic pathways;ABC transporters;Other,Superpathway of purine nucleotide salvage;Other,Adenosine,10,13,4,5,0,0,1.3,0.4,1,31.799999999999997,7,3,-2,0,-2,Lignin,954825681.839454,963373907.3848274,1.0089526556605655,0.012858478660092805,0.938347314005616,0.9667510316338038,Upregulated
Feature1675,N-(3-Carboxypropanoyl)-5-hydroxynorvaline,C9 H15 N O6,233.08991,NA,NA,N-(3-Carboxypropanoyl)-5-hydroxynorvaline-peak2,9,15,6,1,0,0,1.6666666666666667,0.6666666666666666,0,60.3,3,-3,-2,-0.2,-4,Amino Sugar,821297050.7775843,1189053589.3582532,1.4477753064283938,0.5338377146758179,0.32491663704651236,0.5880435717487094,Upregulated
Feature1674,methoxyresorcinol,C7 H8 O3,140.04735,Microbial metabolism in diverse environments;Other,NA,methoxyresorcinol-peak3,7,8,3,0,0,0,1.1428571428571428,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,1,0.25,0.4545454545454546,1,Lignin,1169694783.1039567,1050657626.9921666,0.8982322928756615,-0.15483950466244745,0.02494441258990858,0.29968677253407894,Downregulated
Feature1673,Choline,C5 H13 N O,103.09967,NA,NA,Choline,5,13,1,1,0,0,2.6,0.2,-1.5999999999999996,105.89999999999998,0,-1,-0.6666666666666666,-0.42857142857142855,-2,Other,324930652.237669,392510133.860025,1.2079812450963392,0.27259805580823315,0.3745795912232396,0.6276338551257843,Upregulated
Feature1672,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose,C10 H19 N O7,265.11614,NA,NA,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose-peak3,10,19,7,1,0,0,1.9,0.7,-0.20000000000000015,66,2,-5,-3,-0.4545454545454546,-6,Amino Sugar,1191194959.91741,1371199311.0768135,1.1511124183835397,0.20302873488162207,0.1824971612607155,0.48456142817500325,Upregulated
Feature1671,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose,C10 H19 N O7,265.11614,NA,NA,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose-peak2,10,19,7,1,0,0,1.9,0.7,-0.20000000000000015,66,2,-5,-3,-0.4545454545454546,-6,Amino Sugar,579914559.2449133,999198021.089966,1.72300902807301,0.7849302608907991,0.4786359416504519,0.6977704691530684,Upregulated
Feature1670,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,NA,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole-peak11",11,12,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Lignin,1284359472.5261,1673774877.6011534,1.3031981414900493,0.382056451529014,0.08307672555994577,0.402486084203436,Upregulated
Feature1669,Meglutol,C6 H10 O5,162.05285,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Superpathway of butirocin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Other,Meglutol-peak4,6,10,5,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,2,-3,-3,-0.14285714285714285,-3,Carbohydrate,824087092.9013267,570560911.3303323,0.6923551117899249,-0.5304159029635038,0.11427658420330325,0.44645621006294445,Downregulated
Feature1668,DL-Carbidopa,C10 H14 N2 O4,226.09535,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Other,DL-Carbidopa,10,14,4,2,0,0,1.4,0.4,0,60.3,5,1,-0.25,0.16666666666666666,-1,Lignin,990215042.709026,757550872.2343533,0.7650367239037784,-0.3863990920203536,0.0036425191932811635,0.20435156612062716,Downregulated
Feature1667,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride",C12 H20 O10,324.1057,NA,NA,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride-peak3",12,20,10,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,3,-7,-3.5,-0.2857142857142857,-7,Carbohydrate,219093265.217099,185517785.123358,0.8467525687726132,-0.2399876364925372,0.09189863051543143,0.41723968591020827,Downregulated
Feature1666,Maltotriose,C18 H32 O16,504.16909,Metabolic pathways;ABC transporters;Other,NA,Maltotriose-peak2,18,32,16,0,0,0,1.7777777777777777,0.8888888888888888,0,60.3,3,-13,-6.5,-0.5,-13,Carbohydrate,411321757.535178,438738929.28809565,1.0666562642278237,0.09309533474762706,0.5450961479300516,0.7482924429444954,Upregulated
Feature1665,Meglutol,C6 H10 O5,162.05285,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Superpathway of butirocin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Other,Meglutol-peak3,6,10,5,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,2,-3,-3,-0.14285714285714285,-3,Carbohydrate,386636751.96488434,393513176.733027,1.0177852331243646,0.02543316475866221,0.8382618483647015,0.9202952502461467,Upregulated
Feature1664,L-Iditol,C6 H14 O6,182.07905,Metabolic pathways;ABC transporters;Other,Other,L-Iditol,6,14,6,0,0,0,2.3333333333333335,1,-0.33333333333333304,69.79999999999998,0,-6,-Inf,-1,-6,Carbohydrate,79789773.0517169,133196748.59895714,1.6693461267601768,0.7392831180246575,0.49759049746370476,0.7101249390931053,Upregulated
Feature1663,NA,C32 H36 O10,580.23111,NA,NA,Feature1663,32,36,10,0,0,0,1.125,0.3125,-0.5,74.55,15,5,0.2272727272727273,0.3703703703703703,5,Lignin,383638450.48901033,728380118.7173587,1.8986108347297264,0.9249442212628234,0.179478465865292,0.4841345878595616,Upregulated
Feature1662,Maltotriose,C18 H32 O16,504.16908,Metabolic pathways;ABC transporters;Other,NA,Maltotriose-peak1,18,32,16,0,0,0,1.7777777777777777,0.8888888888888888,0,60.3,3,-13,-6.5,-0.5,-13,Carbohydrate,279341583.563232,215295554.83632034,0.7707250459815119,-0.3757118204109293,0.023402842210851527,0.2919627558710051,Downregulated
Feature1661,Isoleucine,C6 H13 N O2,131.0946,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Superpathway of indole-3-acetate conjugate biosynthesis,Isoleucine-peak2,6,13,2,1,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,183534236.43487763,397268604.9161023,2.164547675861352,1.1140655773907622,0.2047119887388453,0.5004070835838441,Upregulated
Feature1660,DL-Carnitine,C7 H15 N O3,161.10522,Other,NA,DL-Carnitine-peak2,7,15,3,1,0,0,2.142857142857143,0.42857142857142855,-0.8571428571428568,84.72857142857141,1,-2,-1,-0.3333333333333333,-3,Protein,402860829.981521,443718823.700925,1.1014196235491003,0.1393642177459442,0.47773333828991715,0.6970545004850299,Upregulated
Feature1659,Dambonitol,C8 H16 O6,208.09467,NA,NA,Dambonitol,8,16,6,0,0,0,2,0.75,-0.5,74.55,1,-5,-2.5,-0.4,-5,Carbohydrate,89243943.9586035,131606319.36232594,1.4746806732720437,0.5604025877204637,0.39395010820047743,0.6416841185496238,Upregulated
Feature1658,NA,C6 H11 N O7,209.05352,NA,NA,Feature1658,6,11,7,1,0,0,1.8333333333333333,1.1666666666666667,1,31.799999999999997,2,-5,3,-1.6666666666666667,-6,Carbohydrate,886021424.782761,732477009.0201284,0.8267034955726049,-0.27455810789558277,0.09421011326706506,0.41723968591020827,Downregulated
Feature1657,"3',4'-Dimethoxyacetophenone",C10 H12 O3,180.07864,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of various plant secondary metabolites;Other,NA,"3',4'-Dimethoxyacetophenone-peak2",10,12,3,0,0,0,1.2,0.3,-0.5999999999999996,77.39999999999999,5,2,0.2857142857142857,0.4117647058823529,2,Lignin,335927.4559296743,1269785.6136344622,3.7799399579303485,1.9183633182865332,0.19910837149130084,0.4953078558039763,Upregulated
Feature1656,D-Gluconic acid,C6 H12 O7,196.05831,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Other,D-Gluconic acid,6,12,7,0,0,0,2,1.1666666666666667,0.3333333333333335,50.8,1,-6,6,-1,-6,Carbohydrate,20913829.393011667,16850001.67868053,0.8056870581678811,-0.31170851332880334,0.2383604399748713,0.5231694095424109,Downregulated
Feature1655,Proline,C5 H9 N O2,115.06328,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;ABC transporters;Other,Other,Proline,5,9,2,1,0,0,1.8,0.4,-0.4000000000000003,71.7,2,0,-0.5,0,-1,Protein,182100018.71534568,238608553.4401093,1.3103159193689946,0.38991468989895234,0.26190757733422304,0.5437149951031542,Upregulated
Feature1654,N-Acetylneuraminic acid,C11 H19 N O9,309.10605,Metabolic pathways;Other,Other,N-Acetylneuraminic acid,11,19,9,1,0,0,1.7272727272727273,0.8181818181818182,0.18181818181818168,55.11818181818182,3,-6,-7,-0.4545454545454546,-7,Carbohydrate,125335875.91209133,75847192.92776516,0.6051514969342315,-0.7246317351196266,0.01892005038449532,0.2716149606045345,Downregulated
Feature1653,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C22 H26 O7,402.16789,NA,NA,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak3",22,26,7,0,0,0,1.181818181818182,0.3181818181818182,-0.5454545454545459,75.84545454545456,10,3,0.2,0.35135135135135137,3,Lignin,684056494.344384,927958069.306079,1.3565518008793356,0.43994413899084395,0.07729419329452666,0.39590936857023457,Upregulated
Feature1652,L-Pyroglutamic acid,C5 H7 N O3,129.04257,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of butirocin biosynthesis;Other,L-Pyroglutamic acid-peak2,5,7,3,1,0,0,1.4,0.6,0.3999999999999999,48.9,3,0,-1,0.2,-1,Lignin,619458343.03382,498540882.95593166,0.8048013051439574,-0.3132954501276347,0.21549938981874495,0.5069722111991797,Downregulated
Feature1651,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,NA,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole-peak10",11,12,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Lignin,243337705.12569633,477884622.42914236,1.963874123750327,0.973702461800781,0.21183858452552548,0.5042851084128842,Upregulated
Feature1650,"(2S)-4-Methyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)pentanoic acid (non-preferred name)",C12 H23 N O7,293.14748,NA,NA,"(2S)-4-Methyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)pentanoic acid (non-preferred name)-peak2",12,23,7,1,0,0,1.9166666666666667,0.5833333333333334,-0.5,74.55,2,-5,-1.5,-0.3333333333333333,-6,Amino Sugar,48701528.1471337,23491027.6047445,0.4823468276760234,-1.051857216828815,0.2211078680072978,0.5089827335113032,Downregulated
Feature1649,NP-013538,C12 H16 O8,288.08457,NA,NA,NP-013538-peak3,12,16,8,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,5,-3,-0.75,0.125,-3,Tannin,117052135.41474803,75006825.63854077,0.640798438856078,-0.6420574618993814,0.5751968954607218,0.7678357296378745,Downregulated
Feature1648,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13223,NA,NA,6-(alpha-D-glucosaminyl)-1D-myo-inositol-peak8,12,23,10,1,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,64904585.010210164,47110819.827086836,0.7258473314277538,-0.4622619589991942,0.1383503799884156,0.45798070948295916,Downregulated
Feature1647,NA,C16 H29 N O12,427.16894,NA,NA,Feature1647,16,29,12,1,0,0,1.8125,0.75,-0.125,63.8625,3,-9,-3.3333333333333335,-0.4444444444444444,-10,Carbohydrate,106889210.38604704,32600289.590204034,0.3049913969095946,-1.7131595466738518,0.24516594085904983,0.5297335507847326,Downregulated
Feature1646,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13226,NA,NA,6-(alpha-D-glucosaminyl)-1D-myo-inositol-peak7,12,23,10,1,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,103076080.81969963,102691423.81175153,0.9962682224150436,-0.005393887681477769,0.9927631991387684,0.9957021073659407,Downregulated
Feature1645,NP-019445,C10 H10 O4,194.05792,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Superpathway of scopolin and esculin biosynthesis;Other,NP-019445,10,10,4,0,0,0,1,0.4,-0.20000000000000015,66,6,2,0.3333333333333333,0.5,2,Lignin,1578848.8442405257,2432595.2120016865,1.5407397743460607,0.6236232161922386,0.2877251027789053,0.5646020478032001,Upregulated
Feature1644,DL-Tryptophan,C11 H12 N2 O2,204.08987,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic amino acid biosynthesis;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,DL-Tryptophan,11,12,2,2,0,0,1.0909090909090908,0.18181818181818185,-0.18181818181818168,65.48181818181817,7,5,0.42857142857142855,0.5,3,Lignin,125034453.1721596,221293106.426083,1.7698570338959705,0.8236328265118873,0.21907248621056116,0.5083682077269734,Upregulated
Feature1643,Beauvericin,C45 H57 N3 O9,783.40966,NA,NA,Beauvericin,45,57,9,3,0,0,1.2666666666666666,0.2,-0.666666666666667,79.30000000000001,19,10,0.21212121212121213,0.30666666666666664,7,Lignin,736886.3635698897,833020.9675576023,1.1304605550331843,0.17691065325633662,0.44453101023091013,0.6681770464340389,Upregulated
Feature1642,NA,C11 H15 N O7,273.08486,NA,NA,Feature1642,11,15,7,1,0,0,1.3636363636363635,0.6363636363636364,0.18181818181818168,55.11818181818182,5,-2,-1,0.07692307692307693,-3,Lignin,548226061.29801,452004094.31078035,0.8244848726100156,-0.2784350710981467,0.10992041354627469,0.44011899692530887,Downregulated
Feature1641,1-Linoleoyl glycerol,C21 H38 O4,354.27701,NA,NA,1-Linoleoyl glycerol,21,38,4,0,0,0,1.8095238095238095,0.1904761904761905,-1.4285714285714288,101.01428571428572,3,-1,-0.0588235294117647,0.05263157894736842,-1,Lipid,77064666.01631586,48366404.35681437,0.6276080447370577,-0.6720642498664474,0.14795598574649857,0.4658688473133245,Downregulated
Feature1640,α-Lactose,C12 H22 O11,342.11628,Metabolic pathways;Biosynthesis of secondary metabolites;ABC transporters;Other,Other,α-Lactose-peak1,12,22,11,0,0,0,1.8333333333333333,0.9166666666666666,0,60.3,2,-9,-9,-0.5384615384615384,-9,Carbohydrate,462011666.37091833,369326283.06644636,0.7993873530672685,-0.3230333465116192,0.5426883814332192,0.7461965244706764,Downregulated
Feature1639,g-Butyrobetaine,C7 H15 N O2,145.1103,NA,NA,g-Butyrobetaine,7,15,2,1,0,0,2.142857142857143,0.2857142857142857,-1.1428571428571432,92.87142857142858,1,-1,-0.5,-0.2,-2,Lipid,217441041.69717667,230118797.25130835,1.058304335994617,0.0817545621338337,0.8906812879426421,0.9435985627109666,Upregulated
Feature1638,NA,C12 H21 N O9,323.12168,NA,NA,Feature1638,12,21,9,1,0,0,1.75,0.75,0,60.3,3,-6,-3.5,-0.38461538461538464,-7,Carbohydrate,80136579.10893986,17596832.18779088,0.21958551741857196,-2.187145189166345,0.22637294463386595,0.5161181267964589,Downregulated
Feature1637,DL-Stachydrine,C7 H13 N O2,143.09464,ABC transporters,NA,DL-Stachydrine,7,13,2,1,0,0,1.8571428571428572,0.2857142857142857,-0.8571428571428568,84.72857142857141,2,0,-0.25,0,-1,Lipid,20184325.37502583,72028296.06989004,3.5685263060122394,1.835328407600785,0.42762102460876017,0.6594697741371865,Upregulated
Feature1636,trans-3-Indoleacrylic acid,C11 H9 N O2,187.06331,Microbial metabolism in diverse environments;Other,NA,trans-3-Indoleacrylic acid,11,9,2,1,0,0,0.8181818181818182,0.18181818181818185,-0.18181818181818168,65.48181818181817,8,6,0.625,0.6666666666666666,5,Lignin,114210819.11995593,201955964.62546033,1.7682734979191896,0.822341432860483,0.21903960186544938,0.5083682077269734,Upregulated
Feature1635,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",C10 H13 N O3,195.08956,Other,NA,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime-peak3",10,13,3,1,0,0,1.3,0.3,-0.4000000000000003,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Lignin,5149864.59363185,3980395.3606399265,0.7729126248410396,-0.37162276331595423,0.23308222679344331,0.5201446342203138,Downregulated
Feature1634,Υ-Aminobutyric acid (GABA),C4 H9 N O2,103.06332,Metabolic pathways;Microbial metabolism in diverse environments;Other,Other,Υ-Aminobutyric acid (GABA),4,9,2,1,0,0,2.25,0.5,-0.5,74.55,1,-1,-2,-0.5,-2,Protein,119449955.52814914,81039269.4610308,0.6784369998524895,-0.5597132427219558,0.08518003794281437,0.406464744436979,Downregulated
Feature1633,Isoleucine,C6 H13 N O2,131.0946,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Superpathway of indole-3-acetate conjugate biosynthesis,Isoleucine-peak1,6,13,2,1,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,55412697.3602394,143368070.1488847,2.5872783130704704,1.3714352528205056,0.20957757357098236,0.5028674357354733,Upregulated
Feature1632,Crotonic acid,C4 H6 O2,86.03675,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,Other,Crotonic acid-peak7,4,6,2,0,0,0,1.5,0.5,-0.5,74.55,2,0,0,0.3333333333333333,0,Protein,112641611.3721064,76771393.12852323,0.681554464583363,-0.5530991441743354,0.07644659594657449,0.39590936857023457,Downregulated
Feature1631,L-Glutathione oxidized,C20 H32 N6 O12 S2,612.15209,Metabolic pathways;Biosynthesis of cofactors;Other,Other,L-Glutathione oxidized,20,32,12,6,2,0,1.6,0.6,0.7000000000000002,40.349999999999994,8,-4,-Inf,-1,-12,Amino Sugar,350684474.81934935,354127067.5189187,1.0098167810289942,0.014093557255221845,0.9446648484980162,0.9698580096209922,Upregulated
Feature1630,4-Hydroxy-3-nitrosobenzamide,C7 H6 N2 O3,166.03787,NA,NA,4-Hydroxy-3-nitrosobenzamide,7,6,3,2,0,0,0.8571428571428571,0.42857142857142855,0.8571428571428572,35.87142857142857,6,3,0.5,0.7142857142857143,1,Lignin,858737.556512895,671830.160593583,0.7823463123258597,-0.35412072459569377,0.0025008185005739774,0.1765161058321799,Downregulated
Feature1629,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,NA,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole-peak9",11,12,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Lignin,177960431.95002332,568667541.4435817,3.195471797929108,1.6760289547346563,0.0010520490647896777,0.1464780426635451,Upregulated
Feature1628,L-Saccharopine,C11 H20 N2 O6,276.13215,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Lysine degradation;Other,Superpathway of L-lysine degradation,L-Saccharopine,11,20,6,2,0,0,1.818181818181818,0.5454545454545454,-0.18181818181818168,65.48181818181817,3,-3,-1.6666666666666667,-0.3333333333333333,-5,Protein,19323962.706341233,64843913.0226309,3.3556219295202903,1.746580179683633,0.004025257366676626,0.20435156612062716,Upregulated
Feature1627,"4-[(1E,3Z)-5-Hydroxy-3-methyl-1,3-pentadien-1-yl]-3,4a,8,8-tetramethyldecahydro-1,2,3-naphthalenetriol",C20 H34 O4,338.24575,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"4-[(1E,3Z)-5-Hydroxy-3-methyl-1,3-pentadien-1-yl]-3,4a,8,8-tetramethyldecahydro-1,2,3-naphthalenetriol",20,34,4,0,0,0,1.7,0.2,-1.2999999999999998,97.35,4,0,0,0.1111111111111111,0,Lipid,3499649.100935153,3605206.2898323736,1.0301622207977976,0.04287153810039332,0.8442040646574706,0.9226333455030679,Upregulated
Feature1626,L-Tyrosine,C9 H11 N O3,181.07392,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various plant secondary metabolites;Biosynthesis of various antibiotics;Phenylalanine metabolism;Tyrosine metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of aromatic amino acid biosynthesis;Superpathway of 4-hydroxybenzoate biosynthesis (yeast);Other,L-Tyrosine,9,11,3,1,0,0,1.2222222222222223,0.3333333333333333,-0.22222222222222232,66.63333333333333,5,2,0.2,0.38461538461538464,1,Lignin,104038488.31742549,188306642.4168133,1.8099709584618568,0.8559665490105851,0.13405458855776628,0.45384777576550756,Upregulated
Feature1625,NA,C9 H17 N O6,235.10555,NA,NA,Feature1625,9,17,6,1,0,0,1.8888888888888888,0.6666666666666666,-0.22222222222222232,66.63333333333333,2,-4,-2.5,-0.4,-5,Amino Sugar,41387680.481832266,79034916.07554157,1.9096241962686242,0.9332887515991464,0.015376740310088415,0.26272560535949285,Upregulated
Feature1624,NA,C74 H117 N10 O14 P3,1462.79612,Other,NA,Feature1624,74,117,14,10,0,3,1.5810810810810811,0.1891891891891892,-1,88.8,23,9,-0.0851063829787234,0.05555555555555555,-4,Lipid,196552.81949924,249643.803167927,1.2701105168775881,0.3449540365361913,0.07878184396591835,0.39590936857023457,Upregulated
Feature1623,Homovanillic acid,C9 H10 O4,182.05795,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of various antibiotics;Phenylalanine metabolism;Tyrosine metabolism;Other,Superpathway of 4-hydroxybenzoate biosynthesis (yeast);Other,Homovanillic acid,9,10,4,0,0,0,1.1111111111111112,0.4444444444444444,-0.22222222222222232,66.63333333333333,5,1,0.2,0.42857142857142855,1,Lignin,457191405.4150083,293009258.567778,0.6408896910513955,-0.6418520311291258,0.002756864150204368,0.18680511481784798,Downregulated
Feature1622,L-Glutamine,C5 H10 N2 O3,146.06916,Metabolic pathways;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Superpathway of chorismate metabolism;Superpathway of aromatic amino acid biosynthesis;Superpathway of butirocin biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Superpathway of indole-3-acetate conjugate biosynthesis;Superpathway of purine nucleotide salvage;Other,L-Glutamine,5,10,3,2,0,0,2,0.6,0.3999999999999999,48.9,2,-1,-Inf,-1,-3,Amino Sugar,103360301.26903023,205403177.30357268,1.987254049975544,0.9907763180889253,0.2141115637508451,0.5058646987363062,Upregulated
Feature1621,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid,C18 H28 O3,292.20378,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of lipoxygenase,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid-peak3,18,28,3,0,0,0,1.5555555555555556,0.16666666666666666,-1.2222222222222223,95.13333333333333,5,2,0.13333333333333333,0.21212121212121213,2,Lipid,12233152.4411385,17486560.7585379,1.4294402724626296,0.5154503398555639,0.4747056681800144,0.6942757851074962,Upregulated
Feature1620,Acetylagmatine,C7 H16 N4 O,172.13243,NA,NA,Acetylagmatine,7,16,1,4,0,0,2.2857142857142856,0.14285714285714285,-0.2857142857142856,68.44285714285714,2,1,-1.5,-1,-3,Lipid,492715741.28228235,343776207.06667966,0.6977171181338946,-0.519285865023442,0.1464941648322835,0.4658688473133245,Downregulated
Feature1619,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C22 H26 O7,402.16788,NA,NA,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak2",22,26,7,0,0,0,1.181818181818182,0.3181818181818182,-0.5454545454545459,75.84545454545456,10,3,0.2,0.35135135135135137,3,Lignin,211401615.93310368,534787093.67185235,2.5297209357239794,1.3389782438710467,0.014188093928402474,0.2584368937065999,Upregulated
Feature1618,NA,C29 H30 O10,538.18407,NA,NA,Feature1618,29,30,10,0,0,0,1.0344827586206895,0.3448275862068966,-0.3448275862068968,70.12758620689655,15,5,0.2631578947368421,0.4166666666666667,5,Lignin,486872271.6731477,447869170.32815164,0.9198904854224682,-0.12046597887248986,0.629889716950935,0.8108154867134375,Downregulated
Feature1617,Tris(hydroxymethyl)aminomethane,C4 H11 N O3,121.07387,NA,NA,Tris(hydroxymethyl)aminomethane,4,11,3,1,0,0,2.75,0.75,-0.5,74.55,0,-3,-Inf,-1.6666666666666667,-4,Other,99489594.1194727,65444287.93567533,0.6578003309279375,-0.6042783609190117,0.0934309887177947,0.41723968591020827,Downregulated
Feature1616,Muramic acid,C9 H17 N O7,251.10051,Metabolic pathways;ABC transporters;Other,NA,Muramic acid-peak3,9,17,7,1,0,0,1.8888888888888888,0.7777777777777778,0,60.3,2,-5,-6,-0.5555555555555556,-6,Carbohydrate,47779993.782468304,30804915.345437367,0.6447241388453356,-0.6332460950510194,0.5260031352577,0.7333739186226698,Downregulated
Feature1615,L-Pyroglutamic acid,C5 H7 N O3,129.0426,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of butirocin biosynthesis;Other,L-Pyroglutamic acid-peak1,5,7,3,1,0,0,1.4,0.6,0.3999999999999999,48.9,3,0,-1,0.2,-1,Lignin,99640051.65523897,200434339.53914434,2.0115840589149845,1.0083320257318484,0.16564367314913467,0.4734778652324074,Upregulated
Feature1614,2-Hydroxy-N-(2-hydroxyethyl)propionamide,C5 H11 N O3,133.07387,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,2-Hydroxy-N-(2-hydroxyethyl)propionamide,5,11,3,1,0,0,2.2,0.6,-0.4000000000000003,71.7,1,-2,-3,-0.6,-3,Amino Sugar,45544447.197535634,41701971.90164533,0.9156324089471392,-0.12715956668157788,0.7517897991419146,0.876484459563939,Downregulated
Feature1613,Valine,C5 H11 N O2,117.07893,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Biosynthesis of alkaloids derived from shikimate pathway;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Superpathway of indole-3-acetate conjugate biosynthesis;Other,Valine,5,11,2,1,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,78348909.9125062,173855150.5855433,2.218986208993729,1.1499007012085687,0.17625441283870832,0.4787739794294037,Upregulated
Feature1612,Diethylpyrocarbonate,C6 H10 O5,162.05285,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Superpathway of butirocin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Other,Diethylpyrocarbonate,6,10,5,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,2,-3,-3,-0.14285714285714285,-3,Carbohydrate,327602361.38773066,249378359.494802,0.7612227165836959,-0.3936094793952017,0.12374409544950164,0.45317690246982556,Downregulated
Feature1611,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",C6 H8 O4,144.04227,Microbial metabolism in diverse environments;Other,Other,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one-peak7",6,8,4,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Tannin,69131383.0655701,53851633.9371425,0.7789752142824196,-0.3603506700673195,0.06843522928801656,0.3925920914282487,Downregulated
Feature1610,Ectoine,C6 H10 N2 O2,142.07426,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,Ectoine-peak2,6,10,2,2,0,0,1.6666666666666667,0.3333333333333333,0,60.3,3,1,-0.5,0,-1,Protein,6517507.781692537,5211422.227410447,0.7996035297493866,-0.32264325419464684,0.044736876662020246,0.35607946299980225,Downregulated
Feature1609,N~2~-Acetyl-L-ornithine,C7 H14 N2 O3,174.10046,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Other,N~2~-Acetyl-L-ornithine-peak3,7,14,3,2,0,0,2,0.42857142857142855,-0.2857142857142856,68.44285714285714,2,-1,-1.5,-0.42857142857142855,-3,Protein,6594968.87583739,7783918.183686504,1.180281261402943,0.23913069524753172,0.8217463454889866,0.9136000023320247,Upregulated
Feature1608,NA,C9 H19 N O7,253.11617,NA,NA,Feature1608,9,19,7,1,0,0,2.111111111111111,0.7777777777777778,-0.22222222222222232,66.63333333333333,1,-6,-7,-0.7777777777777778,-7,Carbohydrate,326292379.44386333,212906365.76722667,0.6525018026167416,-0.6159462075762709,0.0837228335325061,0.40291613637518564,Downregulated
Feature1607,3-Butynoic acid,C4 H4 O2,84.02115,Metabolic pathways;Other,NA,3-Butynoic acid-peak8,4,4,2,0,0,0,1,0.5,0,60.3,3,1,0.5,0.6666666666666666,1,Lignin,69883308.90119956,73091003.7628732,1.0459007295462877,0.06474592635760786,0.7758840719004187,0.8874730707625317,Upregulated
Feature1606,hercynine,C9 H15 N3 O2,197.1165,NA,NA,hercynine,9,15,2,3,0,0,1.6666666666666667,0.2222222222222222,-0.22222222222222232,66.63333333333333,4,2,-0.25,0,-1,Lipid,14585954.891723366,13785655.78944,0.9451322105255182,-0.0814119389631444,0.6640861134875027,0.8275141791352959,Downregulated
Feature1605,Meglutol,C6 H10 O5,162.05285,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Superpathway of butirocin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Other,Meglutol-peak2,6,10,5,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,2,-3,-3,-0.14285714285714285,-3,Carbohydrate,172604507.957066,136475007.09363902,0.7906804330254578,-0.33883337218041415,0.31328986810742515,0.582824705135905,Downregulated
Feature1604,NA,C6 H14 O4,150.08923,NA,NA,Feature1604,6,14,4,0,0,0,2.3333333333333335,0.6666666666666666,-1,88.8,0,-4,-2,-0.5,-4,Other,72674008.8474091,130333941.45855834,1.7934051461536358,0.8427014426511161,0.042444542272065795,0.35607946299980225,Upregulated
Feature1603,NA,C75 H119 N10 O14 P3,1476.81198,NA,NA,Feature1603,75,119,14,10,0,3,1.586666666666667,0.18666666666666668,-1.0133333333333336,89.18,23,9,-0.08333333333333333,0.05454545454545454,-4,Lipid,213620.94137175634,272080.8729832993,1.2736619885491816,0.34898245801381955,0.1861454445903555,0.4854964193043512,Upregulated
Feature1602,"(2S)-3-Phenyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",C15 H21 N O7,327.13187,NA,NA,"(2S)-3-Phenyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",15,21,7,1,0,0,1.4,0.4666666666666667,-0.2666666666666666,67.89999999999999,6,-1,-0.2857142857142857,0.14285714285714285,-2,Lignin,15328520.554401867,12984870.684075033,0.847105279207535,-0.23938681440667825,0.43139163434853195,0.6620361130263338,Downregulated
Feature1601,NA,C23 H33 N3 O5,431.24199,NA,NA,Feature1601,23,33,5,3,0,0,1.434782608695652,0.21739130434782608,-0.6086956521739131,77.64782608695651,9,4,0.06666666666666667,0.2,1,Lignin,994667.40107017,1398130.3397517235,1.4056259793449195,0.4912127611755716,0.0015979586505896054,0.15098679741337404,Upregulated
Feature1600,8-hydroxy-deoxyguanosine,C10 H13 N5 O5,283.09171,Metabolic pathways;ABC transporters;Other,Superpathway of purine nucleotide salvage;Other,8-hydroxy-deoxyguanosine,10,13,5,5,0,0,1.3,0.5,1.2000000000000002,26.09999999999999,7,2,-Inf,-0.2,-3,Lignin,126377148.085503,170822429.53860867,1.3516876439009,0.43476180349966304,0.2110514093425351,0.5042610541978201,Upregulated
Feature1599,L-glycero-Î±-D-manno-Heptopyranose,C7 H14 O7,210.07395,Metabolic pathways;Other,NA,L-glycero-Î±-D-manno-Heptopyranose,7,14,7,0,0,0,2,1,0,60.3,1,-6,-Inf,-0.7142857142857143,-6,Carbohydrate,2565389.8214984564,2275241.140345067,0.886898794591805,-0.173158609155644,0.35936614022033764,0.6167210416120837,Downregulated
Feature1598,"1-Pentofuranosyl-2,4(1H,3H)-pyrimidinedione",C9 H12 N2 O6,244.06954,Metabolic pathways;ABC transporters;Other,Other,"1-Pentofuranosyl-2,4(1H,3H)-pyrimidinedione",9,12,6,2,0,0,1.3333333333333333,0.6666666666666666,0.6666666666666665,41.3,5,-1,-3,0,-3,Tannin,66232518.2260106,63582298.138885766,0.9599861192340404,-0.05891454932126874,0.8629984424371937,0.9299622642827367,Downregulated
Feature1597,N-(Carboxymethyl)norleucine,C8 H15 N O4,189.10013,NA,NA,N-(Carboxymethyl)norleucine-peak2,8,15,4,1,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,186769376.55427834,277325402.36533135,1.4848547844498259,0.5703218455053887,0.032276279739671745,0.32345137828340564,Upregulated
Feature1596,Hypoxanthine,C5 H4 N4 O,136.03851,Metabolic pathways;Other,Superpathway of purine nucleotide salvage;Other,Hypoxanthine-peak4,5,4,1,4,0,0,0.8,0.2,2,3.299999999999997,6,5,Inf,3,1,Condensed HC,785387.901278829,804693.364612433,1.0245808005218433,0.03503376269523098,0.8371210092177064,0.9202752342914452,Upregulated
Feature1595,"7,8-Dihydroxy-3,7-dimethyl-6-oxo-7,8-dihydro-6H-isochromene-5-carbaldehyde",C12 H12 O5,236.06846,NA,NA,"7,8-Dihydroxy-3,7-dimethyl-6-oxo-7,8-dihydro-6H-isochromene-5-carbaldehyde",12,12,5,0,0,0,1,0.4166666666666667,-0.16666666666666696,65.05000000000001,7,2,0.2857142857142857,0.47368421052631576,2,Lignin,596165.765228705,865002.7087500397,1.4509432765200827,0.5369911194854369,0.07511628421191532,0.39590936857023457,Upregulated
Feature1594,2-Acetamido-2-deoxy-D-gluconolactone,C8 H13 N O6,219.07432,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,Other,2-Acetamido-2-deoxy-D-gluconolactone,8,13,6,1,0,0,1.625,0.75,0.25,53.175,3,-3,-4,-0.25,-4,Carbohydrate,97512979.32240187,66914695.045510866,0.6862132150046861,-0.5432711854911433,0.04253632479617739,0.35607946299980225,Downregulated
Feature1593,NA,C6 H15 N O7,213.0849,NA,NA,Feature1593,6,15,7,1,0,0,2.5,1.1666666666666667,0.3333333333333335,50.8,0,-7,4,-3,-8,Carbohydrate,17148773.533771,7962449.252178457,0.4643159603512194,-1.1068212220728046,0.024317845491347422,0.29653705466967917,Downregulated
Feature1592,NA,C6 H15 N O7,213.08492,NA,NA,Feature1592,6,15,7,1,0,0,2.5,1.1666666666666667,0.3333333333333335,50.8,0,-7,4,-3,-8,Carbohydrate,11572040.570396133,10844252.978856923,0.9371081023167985,-0.09371261191163305,0.790348377594013,0.8958806083516503,Downregulated
Feature1591,NA,C10 H20 O7,252.12091,NA,NA,Feature1591,10,20,7,0,0,0,2,0.7,-0.5999999999999996,77.39999999999999,1,-6,-2,-0.38461538461538464,-6,Amino Sugar,17780759.66678011,13163087.289219517,0.7402994886552673,-0.4338190628096898,0.5290747839101061,0.7346333474948522,Downregulated
Feature1590,"pentane-1,2,3,4,5-pentol",C5 H12 O5,152.06848,Metabolic pathways;ABC transporters;Other,Other,"pentane-1,2,3,4,5-pentol",5,12,5,0,0,0,2.4,1,-0.4000000000000003,71.7,0,-5,-Inf,-1,-5,Carbohydrate,5568629.592659957,11400397.739299601,2.047253736238182,1.0336899207915287,0.24333761063597673,0.5271028486779921,Upregulated
Feature1589,NA,C12 H18 O9,306.09515,NA,NA,Feature1589,12,18,9,0,0,0,1.5,0.75,0,60.3,4,-5,-1.6666666666666667,-0.06666666666666667,-5,Carbohydrate,21213310.05762992,3820444.874599958,0.1800965933284813,-2.4731572031189604,0.3936063895268464,0.6416841185496238,Downregulated
Feature1588,Cyclo(leucylprolyl),C11 H18 N2 O2,210.13681,NA,NA,Cyclo(leucylprolyl),11,18,2,2,0,0,1.6363636363636365,0.18181818181818185,-0.7272727272727275,81.02727272727273,4,2,0,0.125,0,Lipid,222531852.26003033,189039965.23920566,0.8494962106292581,-0.2353205829323346,0.17294511279508276,0.47637239199165887,Downregulated
Feature1587,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid,C18 H28 O3,292.20378,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of lipoxygenase,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid-peak2,18,28,3,0,0,0,1.5555555555555556,0.16666666666666666,-1.2222222222222223,95.13333333333333,5,2,0.13333333333333333,0.21212121212121213,2,Lipid,1821168.1015763034,3168750.173652733,1.7399547965451605,0.7990498258169633,0.32870235960834293,0.5910382735546541,Upregulated
Feature1586,Acetyl-L-carnitine,C9 H17 N O4,203.11568,NA,NA,Acetyl-L-carnitine,9,17,4,1,0,0,1.8888888888888888,0.4444444444444444,-0.666666666666667,79.30000000000001,2,-2,-0.75,-0.16666666666666666,-3,Protein,120463351.81306534,155961828.696961,1.294682792314978,0.372598669331495,0.2703444338373765,0.5504368640871584,Upregulated
Feature1585,3-Deoxy-D-glycero-hexitol,C6 H14 O5,166.08414,NA,NA,3-Deoxy-D-glycero-hexitol,6,14,5,0,0,0,2.3333333333333335,0.8333333333333334,-0.666666666666667,79.30000000000001,0,-5,-5,-0.7142857142857143,-5,Carbohydrate,16414931.131065432,27717890.7744167,1.6885779509583378,0.7558087809830655,0.509658447861177,0.7170775836186327,Upregulated
Feature1584,"(2E)-3-[7-Methoxy-2-(7-methoxy-1,3-benzodioxol-5-yl)-3-methyl-2,3-dihydro-1-benzofuran-5-yl]-2-propen-1-ol",C21 H22 O6,370.14172,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites,NA,"(2E)-3-[7-Methoxy-2-(7-methoxy-1,3-benzodioxol-5-yl)-3-methyl-2,3-dihydro-1-benzofuran-5-yl]-2-propen-1-ol",21,22,6,0,0,0,1.0476190476190477,0.2857142857142857,-0.4761904761904763,73.87142857142857,11,5,0.3333333333333333,0.4444444444444444,5,Lignin,100720794.83421406,193955202.48478234,1.9256718814027596,0.945361900792808,0.17642965568110747,0.4787739794294037,Upregulated
Feature1583,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",C6 H8 O4,144.04226,Microbial metabolism in diverse environments;Other,Other,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one-peak6",6,8,4,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Tannin,162431182.548831,130245441.837194,0.8018499883668511,-0.31859573511762657,0.04342927318267596,0.35607946299980225,Downregulated
Feature1582,Leucylproline,C11 H20 N2 O3,228.14739,NA,NA,Leucylproline-peak2,11,20,3,2,0,0,1.818181818181818,0.2727272727272727,-0.7272727272727275,81.02727272727273,3,0,-0.3333333333333333,-0.06666666666666667,-2,Lipid,76113694.56717573,74278673.8050463,0.9758910564969371,-0.03520799323058807,0.9507623745953553,0.9731670468667866,Downregulated
Feature1581,Cytarabine,C9 H13 N3 O5,243.08555,Metabolic pathways;ABC transporters;Other,Other,Cytarabine,9,13,5,3,0,0,1.4444444444444444,0.5555555555555556,0.6666666666666665,41.3,5,0,-3,-0.14285714285714285,-3,Lignin,28422408.6018883,29377045.420473497,1.0335874707860535,0.047660486808190086,0.8877923496456145,0.941126558385276,Upregulated
Feature1580,1-Monopropionin,C6 H12 O4,148.07358,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,1-Monopropionin-peak2,6,12,4,0,0,0,2,0.6666666666666666,-0.666666666666667,79.30000000000001,1,-3,-1.5,-0.25,-3,Amino Sugar,38231264.053544,36548262.924541466,0.9559784074456591,-0.06495006227011685,0.737971741195408,0.8689572839593829,Downregulated
Feature1579,(+)-Piperitol,C20 H20 O6,356.12609,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites;Other,Other,(+)-Piperitol,20,20,6,0,0,0,1,0.3,-0.4000000000000003,71.7,11,5,0.35714285714285715,0.4705882352941176,5,Lignin,250153419.41851166,334447900.533751,1.3369711327999598,0.4189683158307087,0.03456216575075764,0.334561764467334,Upregulated
Feature1578,5-Aminolevulinic acid,C5 H9 N O3,131.05823,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Other,5-Aminolevulinic acid,5,9,3,1,0,0,1.8,0.6,0,60.3,2,-1,-2,-0.2,-2,Amino Sugar,158606823.18712634,198112334.94600534,1.249078261357457,0.3208638722501967,0.2827590385403065,0.5619987758948393,Upregulated
Feature1577,"4-(2-Aminopropoxy)-3,5-dimethylphenol",C11 H17 N O2,195.12595,NA,NA,"4-(2-Aminopropoxy)-3,5-dimethylphenol-peak2",11,17,2,1,0,0,1.5454545454545454,0.18181818181818185,-0.9090909090909092,86.2090909090909,4,2,0.125,0.2222222222222222,1,Lipid,339623.10821499367,407078.9894488953,1.1986198218031727,0.2613741373395874,0.41008524612383973,0.6572227123309219,Upregulated
Feature1576,.alpha.-Glucoheptitol,C7 H16 O7,212.08964,NA,NA,.alpha.-Glucoheptitol,7,16,7,0,0,0,2.2857142857142856,1,-0.2857142857142856,68.44285714285714,0,-7,-Inf,-1,-7,Carbohydrate,5157151.610958953,3622927.96681134,0.7025056155247819,-0.5094183372301334,0.3714749877879466,0.6242377295699064,Downregulated
Feature1575,NA,C9 H17 N O6,235.10557,NA,NA,Feature1575,9,17,6,1,0,0,1.8888888888888888,0.6666666666666666,-0.22222222222222232,66.63333333333333,2,-4,-2.5,-0.4,-5,Amino Sugar,28216025.155476566,41308060.036383435,1.4639928837873815,0.5499085409514591,0.24272878698768657,0.5266694014404963,Upregulated
Feature1574,diphthinate,C13 H22 N4 O4,298.16416,NA,NA,diphthinate,13,22,4,4,0,0,1.6923076923076923,0.3076923076923077,-0.1538461538461542,64.6846153846154,5,1,-0.6,-0.14285714285714285,-3,Protein,145910.373230328,146736.37895026468,1.0056610486399948,0.008144136311826776,0.9719832170214421,0.9830086982891479,Upregulated
Feature1573,Linamarin,C10 H17 N O6,247.10556,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,Linamarin-peak2,10,17,6,1,0,0,1.7,0.6,-0.20000000000000015,66,3,-3,-1.3333333333333333,-0.16666666666666666,-4,Amino Sugar,182809154.56945464,260753245.04875135,1.4263686392668231,0.5123468887320194,0.3467395706197387,0.6049194980739828,Upregulated
Feature1572,NA,C62 H107 N2 O15 P3,1212.68834,NA,NA,Feature1572,62,107,15,2,0,3,1.7258064516129032,0.24193548387096775,-1.387096774193548,99.83225806451613,12,-3,-0.1904761904761905,-0.0101010101010101,-8,Lipid,101157.95727149973,130476.80953381267,1.289832387417863,0.3671836008794543,0.05205691439223891,0.36591042730478307,Upregulated
Feature1571,Inosine,C10 H12 N4 O5,268.08079,Metabolic pathways;ABC transporters;Other,Superpathway of purine nucleotide salvage;Other,Inosine,10,12,5,4,0,0,1.2,0.5,1,31.799999999999997,7,2,-2,0.14285714285714285,-2,Lignin,5112759.716652507,1857880.0389129834,0.36338105873854737,-1.4604448739288458,0.2740225447198581,0.5539310152212883,Downregulated
Feature1570,3-Butynoic acid,C4 H4 O2,84.02115,Metabolic pathways;Other,NA,3-Butynoic acid-peak7,4,4,2,0,0,0,1,0.5,0,60.3,3,1,0.5,0.6666666666666666,1,Lignin,128793966.07530634,103259873.28047824,0.8017446502121208,-0.3187852728349626,0.12063918795320153,0.4526122839818135,Downregulated
Feature1569,Adenine,C5 H5 N5,135.05448,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of purine nucleotide salvage;Other,Adenine,5,5,0,5,0,0,1,0,2,3.299999999999997,6,6,Inf,Inf,1,Unsaturated HC,925137.237889273,4372040.6783808,4.7258293140980205,2.240567523482046,0.32991647126663515,0.591405822566857,Upregulated
Feature1568,Penicillic acid,C8 H10 O4,170.05795,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Tyrosine metabolism;Other,NA,Penicillic acid-peak2,8,10,4,0,0,0,1.25,0.5,-0.25,67.425,4,0,0,0.3333333333333333,0,Lignin,630748.6051568337,759242.9695200523,1.2037172390278517,0.2674965334911821,0.637336036883713,0.8131443267876828,Upregulated
Feature1567,"(2S)-3-Methyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",C11 H21 N O7,279.13182,NA,NA,"(2S)-3-Methyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)-peak2",11,21,7,1,0,0,1.9090909090909092,0.6363636363636364,-0.3636363636363633,70.66363636363636,2,-5,-2,-0.38461538461538464,-6,Amino Sugar,11976904.05879869,7596647.24924279,0.6342747017049037,-0.6568202940262621,0.3632902033689001,0.6191283747554495,Downregulated
Feature1566,2'-Deoxyadenosine,C10 H13 N5 O3,251.10191,Metabolic pathways;ABC transporters;Other,Superpathway of butirocin biosynthesis;Other,2'-Deoxyadenosine-peak2,10,13,3,5,0,0,1.3,0.3,0.7999999999999998,37.5,7,4,-0.5,0.14285714285714285,-1,Lignin,102332539.10244617,130430737.38556834,1.2745773585759732,0.350018938245963,0.22139858904506662,0.5089827335113032,Upregulated
Feature1565,"(2Z)-3-[4,5-Dihydroxy-2-(2-hydroxy-2-propanyl)-2,3-dihydro-1-benzofuran-7-yl]acrylic acid",C14 H16 O6,280.09473,NA,NA,"(2Z)-3-[4,5-Dihydroxy-2-(2-hydroxy-2-propanyl)-2,3-dihydro-1-benzofuran-7-yl]acrylic acid-peak2",14,16,6,0,0,0,1.1428571428571428,0.42857142857142855,-0.2857142857142856,68.44285714285714,7,1,0.125,0.3636363636363637,1,Lignin,545379.8385350846,689801.173640543,1.2648087166063577,0.33891921537804937,0.36492571415653874,0.6199876837031111,Upregulated
Feature1564,NA,C22 H33 N O6,407.23081,NA,NA,Feature1564,22,33,6,1,0,0,1.5,0.2727272727272727,-0.8181818181818183,83.61818181818182,7,1,0,0.16666666666666666,0,Lipid,1088018.2710433467,128766710.29850113,118.34976831319321,6.886913071565593,0.42256784714607426,0.6594697741371865,Upregulated
Feature1563,NA,C8 H19 N O6,225.12125,NA,NA,Feature1563,8,19,6,1,0,0,2.375,0.75,-0.5,74.55,0,-6,-7,-1,-7,Carbohydrate,11294798.545857932,16983795.691751007,1.5036829229662856,0.5885003823807131,0.48170915642215584,0.6986673019504323,Upregulated
Feature1562,NA,C15 H27 N O12,413.15342,NA,NA,Feature1562,15,27,12,1,0,0,1.8,0.8,0,60.3,3,-9,-5,-0.5,-10,Carbohydrate,19218225.744980235,8159681.07293847,0.4245803531093272,-1.2358904808921494,0.1708090464439705,0.4760067902771642,Downregulated
Feature1561,N-Caffeoylputrescine,C13 H18 N2 O3,250.1317,NA,NA,N-Caffeoylputrescine,13,18,3,2,0,0,1.3846153846153846,0.2307692307692308,-0.4615384615384617,73.45384615384616,6,3,0.125,0.2631578947368421,1,Lignin,285449.3425009123,358285.147597488,1.255161929813669,0.32787349984857234,0.11970541973222487,0.4526122839818135,Upregulated
Feature1560,NA,C21 H31 N O12,489.18471,NA,NA,Feature1560,21,31,12,1,0,0,1.4761904761904765,0.5714285714285714,-0.1904761904761907,65.72857142857143,7,-5,-0.75,0,-6,Lignin,5039990.72145541,2334528.5806814465,0.46320096795878607,-1.1102898267331804,0.03734994465030993,0.3383465574204546,Downregulated
Feature1559,Succinyl proline,C9 H13 N O5,215.07946,Other,NA,Succinyl proline-peak2,9,13,5,1,0,0,1.4444444444444444,0.5555555555555556,0,60.3,4,-1,-0.6666666666666666,0.09090909090909093,-2,Lignin,107609180.7049847,178532605.90821037,1.659083404766972,0.730386414695895,0.5159377952946208,0.7241082230564106,Upregulated
Feature1558,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13231,NA,NA,6-(alpha-D-glucosaminyl)-1D-myo-inositol-peak6,12,23,10,1,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,92995039.1907103,74958181.8764264,0.8060449517388268,-0.311067797272682,0.2042670487291886,0.5000410123515109,Downregulated
Feature1557,2-Deoxyhexopyranose,C6 H12 O5,164.0685,Metabolic pathways;Microbial metabolism in diverse environments;ABC transporters;Other,Other,2-Deoxyhexopyranose,6,12,5,0,0,0,2,0.8333333333333334,-0.33333333333333304,69.79999999999998,1,-4,-4,-0.42857142857142855,-4,Carbohydrate,30039348.849692468,32085638.637797933,1.0681203110741335,0.09507415864927399,0.3014509083363044,0.5743234421814979,Upregulated
Feature1556,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride",C12 H20 O10,324.10572,NA,NA,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride-peak2",12,20,10,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,3,-7,-3.5,-0.2857142857142857,-7,Carbohydrate,89312402.96484476,71042097.15337403,0.7954337224734362,-0.3301863682812109,0.16705142251955785,0.47405832082810595,Downregulated
Feature1555,Glutarylcarnitine,C12 H21 N O6,275.13695,NA,NA,Glutarylcarnitine,12,21,6,1,0,0,1.75,0.5,-0.5,74.55,3,-3,-0.8,-0.125,-4,Protein,17032169.689397965,6809181.621237794,0.39978357105473844,-1.3227089085598505,0.18227793932576267,0.48456142817500325,Downregulated
Feature1554,NA,C10 H15 N O8,277.07983,NA,NA,Feature1554,10,15,8,1,0,0,1.5,0.8,0.3999999999999999,48.9,4,-4,-5,-0.2,-5,Carbohydrate,132962860.17501901,66967549.65584843,0.5036560552901693,-0.9894892356019721,0.012521570855983889,0.25835889181660304,Downregulated
Feature1553,NA,C6 H11 N3 O2,157.08515,NA,NA,Feature1553,6,11,2,3,0,0,1.8333333333333333,0.3333333333333333,0.3333333333333335,50.8,3,1,-2,-0.5,-2,Protein,203355794.021132,165956422.12175265,0.8160889780426274,-0.2932016373197438,0.10321435564798424,0.42914157342056886,Downregulated
Feature1552,Pinolenic acid,C18 H30 O2,278.22458,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Superpathway of lipoxygenase,Pinolenic acid,18,30,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666668,4,2,0.125,0.17647058823529413,2,Lipid,8084541.927429623,12230655.8991222,1.5128446371989788,0.5972638364301586,0.09735057905023745,0.4196231066440261,Upregulated
Feature1551,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,NA,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole-peak8",11,12,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Lignin,251833989.02058,243083441.79446933,0.9652527156475468,-0.05102138682798637,0.822634486971553,0.9136000023320247,Downregulated
Feature1550,NA,C22 H14 N3 O4 P,415.07208,NA,NA,Feature1550,22,14,4,3,0,1,0.6363636363636364,0.18181818181818185,-0.09090909090909084,62.89090909090909,18,14,0.7142857142857143,0.75,10,Condensed HC,683582.7346307503,837139.3833034927,1.224635060093624,0.29235189173141857,0.06618243173554726,0.3871937356331548,Upregulated
Feature1549,4-Acetamidobutanoic acid,C6 H11 N O3,145.07391,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Lysine degradation;Other,Superpathway of L-lysine degradation;Other,4-Acetamidobutanoic acid-peak2,6,11,3,1,0,0,1.8333333333333333,0.5,-0.33333333333333304,69.79999999999998,2,-1,-1,-0.14285714285714285,-2,Protein,95217043.95281152,110856487.37341583,1.164250461591257,0.21940145414474335,0.23043682908223234,0.5170330973050352,Upregulated
Feature1548,Valylproline,C10 H18 N2 O3,214.13174,Metabolic pathways;Biosynthesis of cofactors;Other,Other,Valylproline,10,18,3,2,0,0,1.8,0.3,-0.5999999999999996,77.39999999999999,3,0,-0.4,-0.07692307692307693,-2,Lipid,75044090.84650481,90635881.63094896,1.207768401330034,0.27234383356514485,0.6651856614409295,0.8275141791352959,Upregulated
Feature1547,D-Glucose 6-phosphate,C6 H13 O9 P,260.02974,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;ABC transporters;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various antibiotics;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of butirocin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Other,D-Glucose 6-phosphate,6,13,9,0,0,1,2.1666666666666665,1.5,0,60.3,1,-8,2.25,-9,-9,Carbohydrate,163593921.269809,154065180.14502466,0.9417536968927532,-0.08657830334503863,0.6196010841327113,0.8012246080311549,Downregulated
Feature1546,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C22 H26 O7,402.1679,NA,NA,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak1",22,26,7,0,0,0,1.181818181818182,0.3181818181818182,-0.5454545454545459,75.84545454545456,10,3,0.2,0.35135135135135137,3,Lignin,233791110.23392868,273648410.4044973,1.170482530882752,0.22710340279944102,0.3098477262014024,0.5799801637405255,Upregulated
Feature1545,Leucylproline,C11 H20 N2 O3,228.14739,NA,NA,Leucylproline-peak1,11,20,3,2,0,0,1.818181818181818,0.2727272727272727,-0.7272727272727275,81.02727272727273,3,0,-0.3333333333333333,-0.06666666666666667,-2,Lipid,79677282.33891153,29895521.723394364,0.37520759802313763,-1.4142390518973111,0.316127728070241,0.5833555243474817,Downregulated
Feature1544,1-linoleoyl-sn-glycerol,C21 H38 O4,354.27689,NA,NA,1-linoleoyl-sn-glycerol,21,38,4,0,0,0,1.8095238095238095,0.1904761904761905,-1.4285714285714288,101.01428571428572,3,-1,-0.0588235294117647,0.05263157894736842,-1,Lipid,37394667.50258666,22944049.456380397,0.6135647403414755,-0.7047125168641636,0.2161655382707037,0.5069722111991797,Downregulated
Feature1543,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,NA,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole-peak7",11,12,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Lignin,29714214.7452173,45785508.07163787,1.5408621248861152,0.6237377764263321,0.014805822964964419,0.25983697563097224,Upregulated
Feature1542,Pyrone,C5 H4 O2,96.02112,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,Pyrone-peak3,5,4,2,0,0,0,0.8,0.4,0,60.3,4,2,0.6666666666666666,0.75,2,Condensed HC,74737947.0967613,63162911.1492842,0.8451250482905129,-0.24276327041434292,0.08974370094010639,0.41723968591020827,Downregulated
Feature1541,NA,C10 H17 N O9,295.09039,NA,NA,Feature1541,10,17,9,1,0,0,1.7,0.9,0.3999999999999999,48.9,3,-6,-Inf,-0.5555555555555556,-7,Carbohydrate,135752362.21373168,65062344.41743393,0.4792722819437813,-1.061082588810256,0.013586058200742284,0.25835889181660304,Downregulated
Feature1540,(5S)-5-(Carboxymethyl)-L-proline,C7 H11 N O4,173.06883,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Other,(5S)-5-(Carboxymethyl)-L-proline,7,11,4,1,0,0,1.5714285714285714,0.5714285714285714,0,60.3,3,-1,-1,0,-2,Amino Sugar,202433118.39303398,165058413.445583,0.8153725771546623,-0.29446865838008535,0.12736048568788985,0.45384777576550756,Downregulated
Feature1539,Guanine,C5 H5 N5 O,151.04943,Metabolic pathways;Other,Superpathway of purine nucleotide salvage;Other,Guanine-peak3,5,5,1,5,0,0,1,0.2,2.4,-8.099999999999994,6,5,-0,-1,0,Lignin,1006927.095604799,1248544.1865647133,1.2399549004238384,0.31028764793623964,0.15783607522573695,0.46825623718458564,Upregulated
Feature1538,L-Alanyl-L-proline,C8 H14 N2 O3,186.10045,NA,NA,L-Alanyl-L-proline-peak2,8,14,3,2,0,0,1.75,0.375,-0.25,67.425,3,0,-0.6666666666666666,-0.1111111111111111,-2,Protein,86888794.66022363,99485433.8658999,1.1449742657259212,0.19531517288394984,0.6901927725603412,0.8394586943835308,Upregulated
Feature1537,triacetic acid,C6 H8 O4,144.04226,Microbial metabolism in diverse environments;Other,Other,triacetic acid,6,8,4,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Tannin,63562189.742625564,45290902.0947357,0.712544710591729,-0.48894755198551604,0.6571475322098375,0.8228257792439163,Downregulated
Feature1536,N-Acetyl-α-D-glucosamine,C8 H15 N O6,221.08991,Metabolic pathways;ABC transporters;Other,Other,N-Acetyl-α-D-glucosamine,8,15,6,1,0,0,1.875,0.75,0,60.3,2,-4,-5,-0.5,-5,Carbohydrate,22753551.782058734,47690856.50566767,2.095974156582978,1.067620928516855,0.1334875305903001,0.45384777576550756,Upregulated
Feature1535,Cyclo(phenylalanyl-prolyl),C14 H16 N2 O2,244.12119,NA,NA,Cyclo(phenylalanyl-prolyl)-peak2,14,16,2,2,0,0,1.1428571428571428,0.14285714285714285,-0.4285714285714288,72.51428571428572,8,6,0.4,0.4545454545454546,4,Lignin,174673731.79247,145949712.392905,0.8355561588751533,-0.25919129783023775,0.009742718743691932,0.2324530359410441,Downregulated
Feature1534,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13225,NA,NA,6-(alpha-D-glucosaminyl)-1D-myo-inositol-peak5,12,23,10,1,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,79298891.76415624,78421243.24106967,0.9889323986305283,-0.016056190175807037,0.8796692871428318,0.9372827292086907,Downregulated
Feature1533,NA,C12 H25 N O12,375.13771,NA,NA,Feature1533,12,25,12,1,0,0,2.0833333333333335,1,0.16666666666666652,55.55,1,-11,12,-1.2,-12,Carbohydrate,5429103.192107887,5794057.936657287,1.0672219207547802,0.0938602049179533,0.9141742653879545,0.9541658691110259,Upregulated
Feature1532,NA,C7 H15 N O5,193.09509,NA,NA,Feature1532,7,15,5,1,0,0,2.142857142857143,0.7142857142857143,-0.2857142857142856,68.44285714285714,1,-4,-5,-0.7142857142857143,-5,Carbohydrate,64126965.064168066,51907109.681195766,0.8094427925796175,-0.3049989733195295,0.17976675657999402,0.484141312633561,Downregulated
Feature1531,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",C9 H17 N O8,267.09546,Metabolic pathways;ABC transporters;Other,Superpathway of purine nucleotide salvage;Other,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)-peak2",9,17,8,1,0,0,1.8888888888888888,0.8888888888888888,0.22222222222222232,53.96666666666666,2,-6,-Inf,-0.75,-7,Carbohydrate,50091253.17985444,40458302.496658,0.8076919607379559,-0.3081229150901979,0.07899199582798165,0.39590936857023457,Downregulated
Feature1530,"8-Azabicyclo[3.2.1]octane-1,2,7-triol",C7 H13 N O3,159.08956,Metabolic pathways;Lysine degradation;Other,Superpathway of L-lysine degradation,"8-Azabicyclo[3.2.1]octane-1,2,7-triol",7,13,3,1,0,0,1.8571428571428572,0.42857142857142855,-0.5714285714285712,76.58571428571427,2,-1,-0.6666666666666666,-0.1111111111111111,-2,Protein,41517856.984181464,32565541.4751079,0.7843743353014476,-0.35038576351215883,0.008419763501635457,0.23030609530252863,Downregulated
Feature1529,Proacacipetalin,C11 H17 N O6,259.1056,NA,NA,Proacacipetalin-peak2,11,17,6,1,0,0,1.5454545454545454,0.5454545454545454,-0.18181818181818168,65.48181818181817,4,-2,-0.75,0,-3,Protein,114860014.00576037,73295325.5255524,0.6381274298110093,-0.6480835455067261,0.518706712513673,0.72558973657982,Downregulated
Feature1528,"N-(4-Hydroxy-3,5-dimethoxybenzoyl)glycine",C11 H13 N O6,255.07427,NA,NA,"N-(4-Hydroxy-3,5-dimethoxybenzoyl)glycine-peak2",11,13,6,1,0,0,1.181818181818182,0.5454545454545454,0.18181818181818168,55.11818181818182,6,0,-0.25,0.2857142857142857,-1,Lignin,168039897.52743033,142934506.99034065,0.850598632190956,-0.23344955985421867,0.22135543066340005,0.5089827335113032,Downregulated
Feature1527,NA,C6 H14 O4,150.08924,NA,NA,Feature1527,6,14,4,0,0,0,2.3333333333333335,0.6666666666666666,-1,88.8,0,-4,-2,-0.5,-4,Other,10518112.17100306,14018189.016757267,1.3327666399492697,0.41442419463505803,0.1329607070483163,0.45384777576550756,Upregulated
Feature1526,"3-Morpholino-4-tetrahydro-1H-pyrrol-1-ylcyclobut-3-ene-1,2-dione",C12 H16 N2 O3,236.11602,NA,Other,"3-Morpholino-4-tetrahydro-1H-pyrrol-1-ylcyclobut-3-ene-1,2-dione",12,16,3,2,0,0,1.3333333333333333,0.25,-0.33333333333333304,69.79999999999998,6,3,0.14285714285714285,0.29411764705882354,1,Lignin,1036202.787694905,2180516.8353277934,2.10433407555145,1.0733637592317364,0.06877442633361741,0.3925920914282487,Upregulated
Feature1525,Lactamide,C3 H7 N O2,89.04769,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Superpathway of L-lysine degradation;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Superpathway of indole-3-acetate conjugate biosynthesis;Other,Lactamide,3,7,2,1,0,0,2.3333333333333335,0.6666666666666666,0,60.3,1,-1,-Inf,-1,-2,Other,39295636.88760743,84016414.1805207,2.1380596125931923,1.0963020783126658,0.2950519594917906,0.57033619612451,Upregulated
Feature1524,cis-acetylacrylic acid,C5 H6 O3,114.03168,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylalanine metabolism;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,cis-acetylacrylic acid-peak2,5,6,3,0,0,0,1.2,0.6,0,60.3,3,0,0,0.42857142857142855,0,Lignin,33230832.958886832,25966610.498025,0.7814011322000528,-0.355864748991809,0.1197568468745094,0.4526122839818135,Downregulated
Feature1523,Buphedrine,C11 H17 N O,179.13104,NA,NA,Buphedrine,11,17,1,1,0,0,1.5454545454545454,0.09090909090909093,-1.0909090909090908,91.39090909090908,4,3,0.2222222222222222,0.2631578947368421,2,Lipid,247987.549770469,321125.65930126567,1.2949265380398793,0.37287025527727424,0.03523371401826402,0.33805559870221996,Upregulated
Feature1522,Glycerylphosphorylethanolamine,C5 H14 N O6 P,215.05587,Metabolic pathways;Other,NA,Glycerylphosphorylethanolamine,5,14,6,1,0,1,2.8,1.2,-0.7999999999999998,83.1,0,-6,2.6666666666666665,-Inf,-8,Other,43661367.86052933,36489591.165609166,0.8357409067478259,-0.25887234215648297,0.37305355603901186,0.625695766267412,Downregulated
Feature1521,NA,C8 H9 N,119.07346,NA,NA,Feature1521,8,9,0,1,0,0,1.125,0,-0.75,81.675,5,5,0.5714285714285714,0.5714285714285714,4,Unsaturated HC,27741838.982360333,59790139.647023365,2.1552334610925024,1.1078441546588975,0.1846808784858483,0.4854964193043512,Upregulated
Feature1520,Linolenelaidic acid,C18 H30 O2,278.22466,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Superpathway of lipoxygenase,Linolenelaidic acid,18,30,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666668,4,2,0.125,0.17647058823529413,2,Lipid,10096626.98284912,12524720.880323863,1.2404856494747487,0.31090504554766163,0.690794226665078,0.8394586943835308,Upregulated
Feature1519,Glutaric acid,C5 H8 O4,132.04225,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Phenylalanine metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,Glutaric acid,5,8,4,0,0,0,1.6,0.8,0,60.3,2,-2,-2,0,-2,Carbohydrate,29774568.321959168,23415834.851413067,0.7864374253293055,-0.346596115970513,0.3375271388897325,0.5981373757723136,Downregulated
Feature1518,"DL-2,6-Diaminopimelic acid",C7 H14 N2 O4,190.09538,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Other,Other,"DL-2,6-Diaminopimelic acid",7,14,4,2,0,0,2,0.5714285714285714,0,60.3,2,-2,-4,-0.6666666666666666,-4,Amino Sugar,184282144.91823798,159083202.86253932,0.863258906244667,-0.2121347814429522,0.17664329229243053,0.4787739794294037,Downregulated
Feature1517,NA,C17 H31 N O12,441.1847,NA,NA,Feature1517,17,31,12,1,0,0,1.8235294117647056,0.7058823529411765,-0.23529411764705888,67.00588235294117,3,-9,-2.5,-0.4,-10,Carbohydrate,5548490.898481146,1258664.72080175,0.22684811849403935,-2.140201401037699,0.29585358772775433,0.57033619612451,Downregulated
Feature1516,fructosylglycine,C8 H15 N O7,237.08487,NA,NA,fructosylglycine-peak2,8,15,7,1,0,0,1.875,0.875,0.25,53.175,2,-5,-Inf,-0.7142857142857143,-6,Carbohydrate,143490891.41041434,83680705.9698571,0.5831778250684397,-0.7779922316560115,0.022199677265852116,0.2912553665556471,Downregulated
Feature1515,Methionine,C5 H11 N O2 S,149.05106,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Biosynthesis of various plant secondary metabolites;Other,Superpathway of butirocin biosynthesis;Other,Methionine,5,11,2,1,1,0,2.2,0.4,-0.4000000000000003,71.7,1,-1,-3,-1,-3,Protein,7284171.588215946,48120129.4985825,6.60612245549369,2.7238037126292007,0.13391385032980227,0.45384777576550756,Upregulated
Feature1514,L-Aspartic acid,C4 H7 N O4,133.03749,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Biosynthesis of various plant secondary metabolites;Other,Superpathway of L-isoleucine biosynthesis I;Superpathway of indole-3-acetate conjugate biosynthesis;Superpathway of purine nucleotide salvage;Other,L-Aspartic acid,4,7,4,1,0,0,1.75,1,1,31.799999999999997,2,-2,3,-1,-3,Carbohydrate,45889173.82037417,52960413.40145057,1.154093852479359,0.20676055067396776,0.5912946770928036,0.7815760310467212,Upregulated
Feature1513,3-Butynoic acid,C4 H4 O2,84.0211,Metabolic pathways;Other,NA,3-Butynoic acid-peak6,4,4,2,0,0,0,1,0.5,0,60.3,3,1,0.5,0.6666666666666666,1,Lignin,12374220.29265207,9755655.787036581,0.788385494707055,-0.3430268620203088,0.2083262735311275,0.5028674357354733,Downregulated
Feature1512,UQ1000000,C6 H6 O3,126.03168,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,NA,UQ1000000,6,6,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Lignin,41938918.6343925,42207255.830373496,1.006398286000654,0.009201370274531447,0.9917495360328821,0.9952747121088282,Upregulated
Feature1511,Hordenine,C10 H15 N O,165.11539,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of alkaloids derived from shikimate pathway;Tyrosine metabolism;Other,NA,Hordenine,10,15,1,1,0,0,1.5,0.1,-1,88.8,4,3,0.25,0.29411764705882354,2,Lipid,63212246.31012973,52667176.0892656,0.8331799479308444,-0.2632999763067427,0.6630036151235811,0.8270457467005496,Downregulated
Feature1510,Pyrogallol,C6 H6 O3,126.03165,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,NA,Pyrogallol-peak3,6,6,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Lignin,25035591.507792436,20320829.69423847,0.81167763453535835,-0.301021233732393,0.12025584284831539,0.4526122839818135,Downregulated
Feature1509,Methylhippuric acid,C10 H11 N O3,193.07397,Phenylalanine metabolism;Other,NA,Methylhippuric acid-peak5,10,11,3,1,0,0,1.1,0.3,-0.20000000000000015,66,6,3,0.3333333333333333,0.4666666666666667,2,Lignin,1039708.7705427603,880664.8160709003,0.8470302848471365,-0.23951454207405956,0.4323303995969005,0.6624661519943489,Downregulated
Feature1508,L-alpha-Glycerylphosphorylcholine,C8 H20 N O6 P,257.1028,NA,NA,L-alpha-Glycerylphosphorylcholine-peak1,8,20,6,1,0,1,2.5,0.75,-1.25,95.925,0,-6,-Inf,-1.6666666666666667,-8,Carbohydrate,75304096.11804387,65002627.15319267,0.86320174471382,-0.21223031406579743,0.6007708413218998,0.7865713119297694,Downregulated
Feature1507,Muramic acid,C9 H17 N O7,251.10051,Metabolic pathways;ABC transporters;Other,NA,Muramic acid-peak2,9,17,7,1,0,0,1.8888888888888888,0.7777777777777778,0,60.3,2,-5,-6,-0.5555555555555556,-6,Carbohydrate,72656725.79675807,63023136.554415934,0.8674095324734274,-0.20521479697505515,0.4268303964553044,0.6594697741371865,Downregulated
Feature1506,Thymidine,C10 H14 N2 O5,242.09029,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Other,Thymidine,10,14,5,2,0,0,1.4,0.5,0.20000000000000015,54.599999999999994,5,0,-0.6666666666666666,0.09090909090909093,-2,Lignin,28870763.695301034,33764315.98631324,1.1694985398605398,0.2258900604613766,0.31836945480794265,0.5849434451677384,Upregulated
Feature1505,(Z)-dehydrobutyrine,C4 H7 N O2,101.04767,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,(Z)-dehydrobutyrine-peak2,4,7,2,1,0,0,1.75,0.5,0,60.3,2,0,-1,0,-1,Protein,44402707.9294881,35871162.90554673,0.8078598035622165,-0.307823146284974,0.3614704838023202,0.6171436750022657,Downregulated
Feature1504,Pyrogallol,C6 H6 O3,126.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,NA,Pyrogallol-peak2,6,6,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Lignin,971934.838209832,1320653.3612325918,1.3587879653177681,0.4423203455454837,0.5656111112952363,0.7622475915148212,Upregulated
Feature1503,Î²-Glycerophosphate,C3 H9 O6 P,172.01368,Metabolic pathways;Biosynthesis of secondary metabolites;ABC transporters;Other,Other,Î²-Glycerophosphate,3,9,6,0,0,1,3,2,-0.666666666666667,79.30000000000001,0,-6,1.75,4,-7,Other,10478587.927980384,10690429.274038494,1.0202165928762637,0.028875470134525558,0.8980452085825756,0.9454870002106172,Upregulated
Feature1502,"6-Methoxy-1,2,4-benzenetriol",C7 H8 O4,156.04228,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,"6-Methoxy-1,2,4-benzenetriol",7,8,4,0,0,0,1.1428571428571428,0.5714285714285714,0,60.3,4,0,0,0.4,0,Lignin,135842761.16512766,163924505.421705,1.2067224194776323,0.27109385331033015,0.432519223202922,0.6624661519943489,Upregulated
Feature1501,N-Acetylglucosaminitol,C8 H17 N O6,223.10558,NA,NA,N-Acetylglucosaminitol-peak2,8,17,6,1,0,0,2.125,0.75,-0.25,67.425,1,-5,-6,-0.75,-6,Carbohydrate,142410563.96863198,132734709.06987932,0.9320566211584984,-0.10151049560508539,0.6005897732500307,0.7865713119297694,Downregulated
Feature1500,pseudouridine,C9 H12 N2 O6,244.06948,Metabolic pathways;ABC transporters;Other,Other,pseudouridine-peak2,9,12,6,2,0,0,1.3333333333333333,0.6666666666666666,0.6666666666666665,41.3,5,-1,-3,0,-3,Tannin,3610334.4758327133,4597625.965620167,1.2734626102917341,0.34875660174907397,0.21348746391990667,0.5058010683640866,Upregulated
Feature1499,NA,C18 H31 N O11,437.18971,NA,NA,Feature1499,18,31,11,1,0,0,1.7222222222222223,0.6111111111111112,-0.33333333333333304,69.79999999999998,4,-7,-1.3333333333333333,-0.21739130434782608,-8,Amino Sugar,10403385.785266306,2735283.31330959,0.2629224148529999,-1.9272909540010752,0.2857695097997045,0.5643704976054172,Downregulated
Feature1498,3-Hydroxy-5-methyl-L-tyrosine,C10 H13 N O4,211.08446,NA,NA,3-Hydroxy-5-methyl-L-tyrosine,10,13,4,1,0,0,1.3,0.4,-0.20000000000000015,66,5,1,0,0.2857142857142857,0,Lignin,45314881.00191167,33004998.8663476,0.7283479099273203,-0.4573003477191885,0.005120229943085275,0.228254461147012,Downregulated
Feature1497,Mephedrone,C11 H15 N O,177.11538,NA,NA,Mephedrone,11,15,1,1,0,0,1.3636363636363635,0.09090909090909093,-0.9090909090909092,86.2090909090909,5,4,0.3333333333333333,0.3684210526315789,3,Unsaturated HC,321752.32418745535,335041.26771545166,1.0413017794403066,0.0583882363681742,0.8755276425901992,0.9357374299986103,Upregulated
Feature1496,2908,C5 H11 N,85.08916,Other,NA,2908-peak2,5,11,0,1,0,0,2.2,0,-1.5999999999999996,105.89999999999998,1,1,0,0,0,Lipid,30093598.467038833,64083039.040679865,2.1294575027599065,1.0904859385431869,0.19665379786424908,0.4913444448112654,Upregulated
Feature1495,NP-011220,C11 H18 N2 O2,210.13681,NA,NA,NP-011220-peak2,11,18,2,2,0,0,1.6363636363636365,0.18181818181818185,-0.7272727272727275,81.02727272727273,4,2,0,0.125,0,Lipid,129320288.845322,112434188.50011767,0.8694241986622724,-0.20186784421706266,0.06202834687971506,0.3794192923980171,Downregulated
Feature1494,Anhydroecgonine,C9 H13 N O2,167.09466,Metabolic pathways;Biosynthesis of alkaloids derived from shikimate pathway;Tyrosine metabolism;Other,Other,Anhydroecgonine-peak3,9,13,2,1,0,0,1.4444444444444444,0.2222222222222222,-0.666666666666667,79.30000000000001,4,2,0.16666666666666666,0.2857142857142857,1,Lignin,6799944.94758041,6632999.952320203,0.9754490666399277,-0.03586155083254069,0.652188023394713,0.8222902365534117,Downregulated
Feature1493,NA,C17 H31 N O13,457.17959,NA,NA,Feature1493,17,31,13,1,0,0,1.8235294117647056,0.7647058823529411,-0.117647058823529,63.65294117647058,3,-10,-3.6666666666666665,-0.47368421052631576,-11,Carbohydrate,11119051.766168546,10034628.454411637,0.9024716014852601,-0.1480465601628943,0.528385243169856,0.7346333474948522,Downregulated
Feature1492,3-oxovaleric acid,C5 H8 O3,116.04731,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Other,3-oxovaleric acid-peak5,5,8,3,0,0,0,1.6,0.6,-0.4000000000000003,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,54253017.6576144,72196492.93754044,1.3307369074503024,0.41222537227546785,0.20768859606832699,0.5026064024853513,Upregulated
Feature1491,NA,C75 H89 N10 O16 P3 S,1510.53954,NA,NA,Feature1491,75,89,16,10,1,3,1.1866666666666668,0.21333333333333335,-0.5333333333333332,75.5,38,22,0.17777777777777778,0.3018867924528302,8,Lignin,140423918.66664732,121417359.03363,0.8646487022048072,-0.20981399512067775,0.14310303982629946,0.46161586781018427,Downregulated
Feature1490,Linoleamide,C18 H33 N O,279.25629,NA,NA,Linoleamide,18,33,1,1,0,0,1.8333333333333333,0.05555555555555555,-1.5555555555555554,104.63333333333333,3,2,0.0625,0.09090909090909093,1,Lipid,17503098.055903368,12933876.544598324,0.738947842449871,-0.43645555743673264,0.33571561458395527,0.5980044701421874,Downregulated
Feature1489,Acrylic acid,C3 H4 O2,72.02113,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Superpathway of L-threonine metabolism;Other,Acrylic acid,3,4,2,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,2,0,0,0.5,0,Tannin,100668971.9522212,82662773.57711673,0.8211345757692803,-0.28430941017499645,0.04662074145180668,0.35607946299980225,Downregulated
Feature1488,"5-[(5-Hydroxytetrahydro-2-furanyl)methyl]-1,3-benzenediol",C11 H14 O4,210.08921,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Other,"5-[(5-Hydroxytetrahydro-2-furanyl)methyl]-1,3-benzenediol-peak3",11,14,4,0,0,0,1.2727272727272727,0.3636363636363637,-0.5454545454545459,75.84545454545456,5,1,0.14285714285714285,0.3333333333333333,1,Lignin,88918950.53252077,93985047.13667636,1.0569743184531033,0.07994032365488118,0.7415418849096542,0.8705280339826433,Upregulated
Feature1487,NP-011220,C11 H18 N2 O2,210.13681,NA,NA,NP-011220-peak1,11,18,2,2,0,0,1.6363636363636365,0.18181818181818185,-0.7272727272727275,81.02727272727273,4,2,0,0.125,0,Lipid,123233175.12916033,106508495.002886,0.8642842715953294,-0.21042218786012512,0.05969543197839725,0.3794192923980171,Downregulated
Feature1486,dihydropyranone,C5 H6 O2,98.03676,Microbial metabolism in diverse environments;Other,NA,dihydropyranone-peak3,5,6,2,0,0,0,1.2,0.4,-0.4000000000000003,71.7,3,1,0.3333333333333333,0.5,1,Lignin,35600789.829170235,19366469.413628,0.5439898807458392,-0.8783482800543563,0.4706000863146225,0.690213459928113,Downregulated
Feature1485,Isoferulic acid,C10 H10 O4,194.05792,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Superpathway of scopolin and esculin biosynthesis;Other,Isoferulic acid,10,10,4,0,0,0,1,0.4,-0.20000000000000015,66,6,2,0.3333333333333333,0.5,2,Lignin,919023.0304387526,1168271.0071736034,1.271209717797667,0.34620205856316255,0.24266711731217153,0.5266694014404963,Upregulated
Feature1484,NA,C11 H19 N5 O2,253.15388,NA,NA,Feature1484,11,19,2,5,0,0,1.7272727272727273,0.18181818181818185,0,60.3,5,3,-0.5,-0.2,-2,Lipid,143002624.91280234,113509321.17672637,0.7937569065318915,-0.3332308550746162,0.05839269431874675,0.3790841191943452,Downregulated
Feature1483,NP-019811,C6 H7 N O2,125.04764,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,Other,NP-019811-peak3,6,7,2,1,0,0,1.1666666666666667,0.3333333333333333,0,60.3,4,2,0.3333333333333333,0.5,1,Lignin,2383219.7702588416,2478268.9052487165,1.039882656302214,0.0564207392104101,0.9446668924879795,0.9698580096209922,Upregulated
Feature1482,Glucosamine,C6 H13 N O5,179.07942,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,Other,Glucosamine-peak3,6,13,5,1,0,0,2.1666666666666665,0.8333333333333334,0,60.3,1,-4,-Inf,-1,-5,Carbohydrate,23671650.176023033,29165357.439851236,1.232079606743799,0.30109547400696224,0.5418730953579136,0.7456807664795334,Upregulated
Feature1481,Methylhippuric acid,C10 H11 N O3,193.07394,Phenylalanine metabolism;Other,NA,Methylhippuric acid-peak4,10,11,3,1,0,0,1.1,0.3,-0.20000000000000015,66,6,3,0.3333333333333333,0.4666666666666667,2,Lignin,1474647.1239099132,1331362.4867271467,0.9028346274443892,-0.14746634197097072,0.4427763888052897,0.6668537167127339,Downregulated
Feature1480,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",C10 H19 N O8,281.11106,NA,NA,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",10,19,8,1,0,0,1.9,0.8,0,60.3,2,-6,-7,-0.6,-7,Carbohydrate,36260633.83357556,23995074.245762,0.6617389634139198,-0.5956658664599018,0.11893803519099799,0.4526122839818135,Downregulated
Feature1479,Methylglutaric acid,C6 H10 O4,146.05791,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Aminobenzoate degradation;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,Methylglutaric acid,6,10,4,0,0,0,1.6666666666666667,0.6666666666666666,-0.33333333333333304,69.79999999999998,2,-2,-1,0,-2,Amino Sugar,10816429.938672956,13033861.672234492,1.2050058795863277,0.26904018581568767,0.7709019852848147,0.8847614925965286,Upregulated
Feature1478,NA,C2 H5 N2 O5 P S,199.96575,NA,NA,Feature1478,2,5,5,2,1,1,2.5,2.5,4,-53.7,2,-3,1,1,-7,Other,91329264.6769915,72221815.97969127,0.7907850373603855,-0.33864252115229904,0.03158103586825071,0.32345137828340564,Downregulated
Feature1477,NA,C11 H20 N4 O3,256.15356,NA,NA,Feature1477,11,20,3,4,0,0,1.818181818181818,0.2727272727272727,-0.18181818181818168,65.48181818181817,4,1,-0.75,-0.2727272727272727,-3,Lipid,1403187.4436475134,1266378.5869507666,0.9025013676425729,-0.14799897663862,0.563319414856336,0.7614512866361725,Downregulated
Feature1476,Mevalonolactone,C6 H10 O3,130.06297,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I,Mevalonolactone-peak2,6,10,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,14171026.454905467,16533819.876401767,1.1667341056073177,0.222475813633582,0.31537437418703207,0.5832360151450134,Upregulated
Feature1475,α-Aspartylphenylalanine,C13 H16 N2 O5,280.10595,NA,NA,α-Aspartylphenylalanine-peak3,13,16,5,2,0,0,1.2307692307692308,0.38461538461538464,0,60.3,7,2,0,0.29411764705882354,0,Lignin,50678910.85732193,10568177.01969523,0.20853204697804534,-2.2616589823755873,0.41837780345592046,0.6592855805156551,Downregulated
Feature1474,MFCD00025555,C9 H18 N2 O3,202.1317,NA,NA,MFCD00025555-peak4,9,18,3,2,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,70431714.6803347,56117161.12000296,0.7967598314864182,-0.32778317887709224,0.16056963930970308,0.47167290218904195,Downregulated
Feature1473,NA,C43 H79 N O9,753.57577,NA,NA,Feature1473,43,79,9,1,0,0,1.837209302325581,0.20930232558139536,-1.348837209302325,98.74186046511628,5,-4,-0.15151515151515152,-0.01333333333333333,-5,Lipid,26133285.528227575,138987410.91281843,5.3184055545825935,2.4109937939831876,0.1574815438190494,0.46825623718458564,Upregulated
Feature1472,NA,C77 H123 N10 O14 P3,1504.84348,NA,NA,Feature1472,77,123,14,10,0,3,1.5974025974025974,0.18181818181818185,-1.0389610389610393,89.91038961038961,23,9,-0.08,0.05263157894736842,-4,Lipid,170752.01333096132,212440.81835079266,1.2441482487180267,0.31515840262873973,0.17506221776400402,0.47831515627777876,Upregulated
Feature1471,NA,C8 H16 N2 O2,172.12119,NA,NA,Feature1471,8,16,2,2,0,0,2,0.25,-0.75,81.675,2,0,-0.5,-0.2,-2,Lipid,9990763.965454899,13625592.545830704,1.3638188824141944,0.44765206460220613,0.4513291238878099,0.6730207181918573,Upregulated
Feature1470,Crotonic acid,C4 H6 O2,86.03679,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,Other,Crotonic acid-peak6,4,6,2,0,0,0,1.5,0.5,-0.5,74.55,2,0,0,0.3333333333333333,0,Protein,23294329.726495434,24428275.000292066,1.0486790256302958,0.06857317268069926,0.9029908120778307,0.9478425405251708,Upregulated
Feature1469,arg-leu,C12 H25 N5 O3,287.19576,NA,NA,arg-leu-peak2,12,25,3,5,0,0,2.0833333333333335,0.25,-0.33333333333333304,69.79999999999998,3,0,-1.25,-0.6363636363636364,-5,Lipid,50544280.50628237,78690041.53801107,1.5568535302076434,0.6386332211138602,0.12357882049503689,0.45317690246982556,Upregulated
Feature1468,"7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione",C11 H14 N4 O2,234.11167,NA,NA,"7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione-peak2",11,14,2,4,0,0,1.2727272727272727,0.18181818181818185,0.18181818181818168,55.11818181818182,7,5,0.2,0.3333333333333333,1,Lignin,121312971.24135067,109321874.384599,0.901155690656562,-0.1501517161138363,0.016312627069929548,0.2637533176745511,Downregulated
Feature1467,NA,C16 H29 N O13,443.16396,NA,NA,Feature1467,16,29,13,1,0,0,1.8125,0.8125,0,60.3,3,-10,-5.5,-0.5294117647058824,-11,Carbohydrate,7432785.724522534,2465949.6483469466,0.33176654618351104,-1.591759676008922,0.2752363332688097,0.5546259239675787,Downregulated
Feature1466,DL-Mevalonic acid,C6 H12 O4,148.07354,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,DL-Mevalonic acid,6,12,4,0,0,0,2,0.6666666666666666,-0.666666666666667,79.30000000000001,1,-3,-1.5,-0.25,-3,Amino Sugar,12385210.836392567,11286470.84499019,0.9112861294073532,-0.1340239863437649,0.7928275412177046,0.8965619858630117,Downregulated
Feature1465,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",C21 H24 O7,388.1523,NA,NA,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol-peak2",21,24,7,0,0,0,1.1428571428571428,0.3333333333333333,-0.4761904761904763,73.87142857142857,10,3,0.21428571428571427,0.37142857142857144,3,Lignin,140531523.028927,152921918.00739798,1.0881680829426472,0.12190141844363761,0.6712079806383908,0.8299462183952073,Upregulated
Feature1464,NA,C12 H18 N6,246.15928,NA,NA,Feature1464,12,18,0,6,0,0,1.5,0,0,60.3,7,7,0.16666666666666666,0.16666666666666666,1,Lipid,82278329.88970096,599227.2070615747,0.007282928662563699,-7.101265570870499,0.1863376607060288,0.4854964193043512,Downregulated
Feature1463,NA,C11 H23 N O7,281.14745,NA,NA,Feature1463,11,23,7,1,0,0,2.090909090909091,0.6363636363636364,-0.5454545454545459,75.84545454545456,1,-6,-2.3333333333333335,-0.5384615384615384,-7,Amino Sugar,114406216.1810269,62730052.92453527,0.5483098298197052,-0.8669367571180122,0.32091417882848006,0.5861484461709393,Downregulated
Feature1462,4-Guanidinobutyric acid,C5 H11 N3 O2,145.08514,Metabolic pathways;Other,NA,4-Guanidinobutyric acid,5,11,2,3,0,0,2.2,0.4,0.3999999999999999,48.9,2,0,-Inf,-2,-3,Protein,111266268.58031513,88210111.85538161,0.7927839495373125,-0.33500034043224175,0.30124632528962836,0.5743234421814979,Downregulated
Feature1461,Meconin,C10 H10 O4,194.05788,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Superpathway of scopolin and esculin biosynthesis;Other,Meconin-peak2,10,10,4,0,0,0,1,0.4,-0.20000000000000015,66,6,2,0.3333333333333333,0.5,2,Lignin,475764.21833698265,599078.867054869,1.2591927765163349,0.3324991698192561,0.5037964286814585,0.713571195808019,Upregulated
Feature1460,Phenacetin,C10 H13 N O2,179.0946,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",NA,Phenacetin-peak4,10,13,2,1,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Lignin,21808601.939636968,5663854.40177722,0.2597073584750615,-1.9450412033774631,0.0019560082452585127,0.15520563728364625,Downregulated
Feature1459,L-Threonine,C4 H9 N O3,119.05821,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,L-Threonine,4,9,3,1,0,0,2.25,0.75,0,60.3,1,-2,-Inf,-1,-3,Carbohydrate,45069443.2675445,67554832.07805987,1.4989054042011563,0.5839093377913184,0.22560793399634027,0.5155824363504518,Upregulated
Feature1458,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",C21 H24 O7,388.15227,NA,NA,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol-peak1",21,24,7,0,0,0,1.1428571428571428,0.3333333333333333,-0.4761904761904763,73.87142857142857,10,3,0.21428571428571427,0.37142857142857144,3,Lignin,67343774.37234947,119115153.42822744,1.768762659034072,0.8227404733496497,0.18657507022853168,0.4854964193043512,Upregulated
Feature1457,NA,C18 H31 N O14,485.17458,NA,NA,Feature1457,18,31,14,1,0,0,1.7222222222222223,0.7777777777777778,0,60.3,4,-10,-3.6666666666666665,-0.4,-11,Carbohydrate,12707401.21704156,2076091.9087439843,0.1633765923719944,-2.6137267973763154,0.14025356022899596,0.45798070948295916,Downregulated
Feature1456,4-Phenylbutyric acid,C10 H12 O2,164.08376,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylpropanoid biosynthesis;Other,Other,4-Phenylbutyric acid,10,12,2,0,0,0,1.2,0.2,-0.7999999999999998,83.1,5,3,0.375,0.4444444444444444,3,Lignin,1893611.3779727332,2648691.482194363,1.3987513557454463,0.48413952954038897,0.283813326207856,0.5623155258434013,Upregulated
Feature1455,Cantharidin,C10 H12 O4,196.07357,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylpropanoid biosynthesis;Other,Other,Cantharidin,10,12,4,0,0,0,1.2,0.4,-0.4000000000000003,71.7,5,1,0.16666666666666666,0.375,1,Lignin,1237616.7812699943,1377150.581132458,1.112743946247464,0.1541216519988815,0.7136932502825839,0.8526067461062744,Upregulated
Feature1454,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",C6 H8 O4,144.04228,Microbial metabolism in diverse environments;Other,Other,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one-peak5",6,8,4,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Tannin,77813002.32362154,59450545.1865418,0.7640181385019572,-0.38832120529624653,0.31717859885068744,0.584022333101157,Downregulated
Feature1453,NA,C6 H14 O4,150.08923,NA,NA,Feature1453,6,14,4,0,0,0,2.3333333333333335,0.6666666666666666,-1,88.8,0,-4,-2,-0.5,-4,Other,17751209.009597134,21620752.262610365,1.2179875889535847,0.2844994325493839,0.09840268328644712,0.4217100532363531,Upregulated
Feature1452,NA,C9 H15 N O7,249.08484,NA,NA,Feature1452,9,15,7,1,0,0,1.6666666666666667,0.7777777777777778,0.22222222222222232,53.96666666666666,3,-4,-5,-0.3333333333333333,-5,Carbohydrate,37912979.221631035,30490099.500616536,0.8042127030529055,-0.3143509702801885,0.17225039105070936,0.4760067902771642,Downregulated
Feature1451,Val-Leu,C11 H22 N2 O3,230.16304,NA,NA,Val-Leu-peak2,11,22,3,2,0,0,2,0.2727272727272727,-0.9090909090909092,86.2090909090909,2,-1,-0.5,-0.2,-3,Lipid,76888279.39917737,49390562.97417467,0.6423679052272185,-0.6385282819297592,0.1584759430976894,0.46933260071238786,Downregulated
Feature1450,Furan,C4 H4 O,68.02623,Other,NA,Furan-peak3,4,4,1,0,0,0,1,0.25,-0.5,74.55,3,2,0.6666666666666666,0.7142857142857143,2,Lignin,43772321.019382134,32973958.952699468,0.7533061575167281,-0.4086917729342773,0.15432911422580908,0.46816691236933006,Downregulated
Feature1449,NA,C23 H35 N O6,421.24649,NA,NA,Feature1449,23,35,6,1,0,0,1.5217391304347827,0.2608695652173913,-0.8695652173913047,85.08260869565218,7,1,0,0.15789473684210523,0,Lipid,2282637.5278271167,66352260.867362425,29.068242354941184,4.861371934766333,0.4159073507014013,0.6580333694263849,Upregulated
Feature1448,Phloroglucinol,C6 H6 O3,126.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,NA,Phloroglucinol-peak2,6,6,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Lignin,71406768.10476036,63904646.731687665,0.8949382310362178,-0.16013998441325195,0.19184573692993262,0.4862119877973694,Downregulated
Feature1447,NA,C11 H19 N3 O2,225.14773,NA,NA,Feature1447,11,19,2,3,0,0,1.7272727272727273,0.18181818181818185,-0.5454545454545459,75.84545454545456,4,2,-0.16666666666666666,0,-1,Lipid,114598060.068601,91221228.84553483,0.7960102360452501,-0.3291411121124441,0.008191355983309641,0.23030609530252863,Downregulated
Feature1446,3-oxovaleric acid,C5 H8 O3,116.04731,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Other,3-oxovaleric acid-peak4,5,8,3,0,0,0,1.6,0.6,-0.4000000000000003,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,36373792.80068607,60520219.32976547,1.663841317329546,0.7345178483719748,0.2909282567815732,0.5677030523083425,Upregulated
Feature1445,N-Acetyltyramine,C10 H13 N O2,179.09456,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",NA,N-Acetyltyramine-peak2,10,13,2,1,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Lignin,82204694.2377494,67003431.422994636,0.8150803557423347,-0.29498579859114504,0.004347659583418887,0.20458153706421098,Downregulated
Feature1444,D-PANTOTHENIC ACID,C9 H17 N O5,219.11067,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,Other,D-PANTOTHENIC ACID-peak3,9,17,5,1,0,0,1.8888888888888888,0.5555555555555556,-0.44444444444444464,72.96666666666667,2,-3,-1.3333333333333333,-0.2727272727272727,-4,Amino Sugar,35023512.54081157,33332585.860649534,0.9517202428456694,-0.07139053771224876,0.7100647408115432,0.8500704388231478,Downregulated
Feature1443,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13229,NA,NA,6-(alpha-D-glucosaminyl)-1D-myo-inositol-peak4,12,23,10,1,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,82541734.09188,56046584.304549664,0.6790090482247721,-0.5584972954659091,0.09236644323336855,0.41723968591020827,Downregulated
Feature1442,3-Butynoic acid,C4 H4 O2,84.02112,Metabolic pathways;Other,NA,3-Butynoic acid-peak5,4,4,2,0,0,0,1,0.5,0,60.3,3,1,0.5,0.6666666666666666,1,Lignin,27367229.275184866,20750636.297663935,0.7582293438992561,-0.3992938041942285,0.4815342614101215,0.6986673019504323,Downregulated
Feature1441,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid,C18 H28 O3,292.20371,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of lipoxygenase,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid-peak1,18,28,3,0,0,0,1.5555555555555556,0.16666666666666666,-1.2222222222222223,95.13333333333333,5,2,0.13333333333333333,0.21212121212121213,2,Lipid,2373482.016859142,6839039.85414292,2.8814374010691286,1.5267886776638202,0.07908310298636217,0.39590936857023457,Upregulated
Feature1440,"9(Z),11(E),13(E)-Octadecatrienoic Acid methyl ester",C19 H32 O2,292.24009,Other,NA,"9(Z),11(E),13(E)-Octadecatrienoic Acid methyl ester",19,32,2,0,0,0,1.6842105263157894,0.10526315789473684,-1.473684210526316,102.3,4,2,0.1176470588235294,0.16666666666666666,2,Lipid,26534485.247962248,39983825.77624843,1.5068626884073075,0.5915479585552785,0.6442324598373357,0.8156425911542949,Upregulated
Feature1439,NA,C18 H30 O15,486.1586,Metabolic pathways;ABC transporters;Other,NA,Feature1439,18,30,15,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,4,-11,-3.6666666666666665,-0.3333333333333333,-11,Carbohydrate,20110598.254793067,18764440.518891335,0.9330622729942459,-0.09995472448353206,0.5083707091113159,0.7164558912101241,Downregulated
Feature1438,"5-[(Z)-(4-Ethyl-3-methyl-5-oxo-1,5-dihydro-2H-pyrrol-2-ylidene)methyl]-5-methoxy-3-methyl-4-vinyl-1,5-dihydro-2H-pyrrol-2-one",C16 H20 N2 O3,288.14735,NA,Superpathway of indole-3-acetate conjugate biosynthesis,"5-[(Z)-(4-Ethyl-3-methyl-5-oxo-1,5-dihydro-2H-pyrrol-2-ylidene)methyl]-5-methoxy-3-methyl-4-vinyl-1,5-dihydro-2H-pyrrol-2-one-peak2",16,20,3,2,0,0,1.25,0.1875,-0.5,74.55,8,5,0.2727272727272727,0.36,3,Lignin,2340662.1229186677,3220367.4738452528,1.3758361116339355,0.46030862773278874,0.6383947445589637,0.8131443267876828,Upregulated
Feature1437,L-Lysine,C6 H14 N2 O2,146.10554,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Lysine degradation;Other,Superpathway of L-lysine degradation;Other,L-Lysine,6,14,2,2,0,0,2.3333333333333335,0.3333333333333333,-0.666666666666667,79.30000000000001,1,-1,-1.5,-0.6666666666666666,-3,Other,18719213.229464002,29464912.351922665,1.5740465152426895,0.6544781751010457,0.25612736248569734,0.5396514328989693,Upregulated
Feature1436,Veronal,C8 H12 N2 O3,184.08481,NA,NA,Veronal-peak2,8,12,3,2,0,0,1.5,0.375,0,60.3,4,1,-0.3333333333333333,0.1111111111111111,-1,Protein,84508869.29001656,79003971.5116047,0.9348601179419379,-0.09717758255961212,0.32901363161867697,0.5910382735546541,Downregulated
Feature1435,NA,C22 H46 O6,406.32947,NA,NA,Feature1435,22,46,6,0,0,0,2.090909090909091,0.2727272727272727,-1.545454545454546,104.34545454545454,0,-6,-0.375,-0.15789473684210523,-6,Lipid,2136054.0559871066,20321747.671849657,9.513686048763702,3.250004417210706,0.18055827383199688,0.48423459758942683,Upregulated
Feature1434,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose,C10 H19 N O7,265.11624,NA,NA,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose-peak1,10,19,7,1,0,0,1.9,0.7,-0.20000000000000015,66,2,-5,-3,-0.4545454545454546,-6,Amino Sugar,29657785.364054933,28335218.774305165,0.9554057535478454,-0.06581452999994392,0.9165335905486436,0.954276522673265,Downregulated
Feature1433,NA,C75 H89 N10 O16 P3 S,1510.53964,NA,NA,Feature1433,75,89,16,10,1,3,1.1866666666666668,0.21333333333333335,-0.5333333333333332,75.5,38,22,0.17777777777777778,0.3018867924528302,8,Lignin,14790816.968180401,13887102.071346434,0.9389002717849774,-0.09095616921509884,0.8398529460941832,0.92084847293433425,Downregulated
Feature1432,Misoprostol,C22 H38 O5,382.2719,NA,NA,Misoprostol,22,38,5,0,0,0,1.7272727272727273,0.2272727272727273,-1.2727272727272725,96.57272727272726,4,-1,-0.0588235294117647,0.07692307692307693,-1,Lipid,1030494.6806125153,1232624.1178343366,1.196147967597152,0.2583958668892481,0.43765589046328507,0.6649229403092421,Upregulated
Feature1431,NA,C15 H18 O11,374.08496,NA,NA,Feature1431,15,18,11,0,0,0,1.2,0.7333333333333333,0.2666666666666666,52.7,7,-4,-1,0.15789473684210523,-4,Tannin,130558.67815364033,2906885.327162351,22.264972105045008,4.476703899170382,0.23447733618370406,0.5205827096922604,Upregulated
Feature1430,"Norspermidine-2,3-dihydroxybenzoate",C13 H21 N3 O3,267.15832,NA,Other,"Norspermidine-2,3-dihydroxybenzoate",13,21,3,3,0,0,1.6153846153846154,0.2307692307692308,-0.4615384615384617,73.45384615384616,5,2,-0.14285714285714285,0.0588235294117647,-1,Lipid,3364851.200439417,3109461.3778563566,0.9241007083612764,-0.11387800998176413,0.6723827507911233,0.8307923995916577,Downregulated
Feature1429,Mevalonolactone,C6 H10 O3,130.06295,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I,Mevalonolactone-peak1,6,10,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,14746345.520600967,14514886.7921501,0.9843039939537892,-0.02282414635718109,0.8539579671392251,0.92558845302131,Downregulated
Feature1428,acetoacetic acid,C4 H6 O3,102.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Tyrosine metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,acetoacetic acid-peak3,4,6,3,0,0,0,1.5,0.75,0,60.3,2,-1,-1,0.2,-1,Carbohydrate,35241798.78556697,54050468.22584604,1.533703445579572,0.6170195526243977,0.23843887117656412,0.5231694095424109,Upregulated
Feature1427,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride",C12 H20 O10,324.10574,NA,NA,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride-peak1",12,20,10,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,3,-7,-3.5,-0.2857142857142857,-7,Carbohydrate,51924794.68972483,8523810.804230653,0.16415685136868519,-2.606853130359651,0.1355152466562522,0.45384777576550756,Downregulated
Feature1426,Inosine-5'-monophosphate (IMP),C10 H13 N4 O8 P,348.04716,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Other,Superpathway of purine nucleotide salvage;Other,Inosine-5'-monophosphate (IMP),10,13,8,4,0,1,1.3,0.8,1,31.799999999999997,7,-1,2,-2,-6,Tannin,354253.99623447633,186368.08411631236,0.5260860458803621,-0.9266293109355263,0.2139978937430521,0.5058646987363062,Downregulated
Feature1425,N6-acetyl-N6-hydroxy-L-lysine,C8 H16 N2 O4,204.111,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,NA,N6-acetyl-N6-hydroxy-L-lysine-peak3,8,16,4,2,0,0,2,0.5,-0.25,67.425,2,-2,-2,-0.5,-4,Protein,22591675.918817267,26141001.870878264,1.1571076871328816,0.21052313623711924,0.3400424492980866,0.6000332386572487,Upregulated
Feature1424,NA,C10 H21 N O9,299.12162,NA,NA,Feature1424,10,21,9,1,0,0,2.1,0.9,0,60.3,1,-8,-Inf,-1,-9,Carbohydrate,26337187.821981166,22727386.522290435,0.8629390000143459,-0.2126695140314277,0.4411333050803575,0.6668537167127339,Downregulated
Feature1423,NA,C5 H14 N O4 P,183.06609,NA,NA,Feature1423,5,14,4,1,0,1,2.8,0.8,-1.5999999999999996,105.89999999999998,0,-4,6,-4,-6,Other,36118426.25086673,27231285.07832167,0.7539443963915289,-0.40746996662977913,0.5608646345495714,0.7594761718041357,Downregulated
Feature1422,6-Aminocaproic acid,C6 H13 N O2,131.0946,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Superpathway of indole-3-acetate conjugate biosynthesis,6-Aminocaproic acid-peak4,6,13,2,1,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,9934853.989395307,15370494.654667463,1.5471283897150663,0.6295929249830695,0.43084785060402786,0.6620361130263338,Upregulated
Feature1421,NA,C16 H27 N O14,457.14329,NA,NA,Feature1421,16,27,14,1,0,0,1.6875,0.875,0.25,53.175,4,-10,-11,-0.5,-11,Carbohydrate,9237183.460863419,3661254.7080950034,0.3963605057328566,-1.3351148786343419,0.04212895881989767,0.35607946299980225,Downregulated
Feature1420,PYRIDOXAMINE,C8 H12 N2 O2,168.08991,Metabolic pathways;Microbial metabolism in diverse environments;Other,Other,PYRIDOXAMINE-peak2,8,12,2,2,0,0,1.5,0.25,-0.25,67.425,4,2,0,0.2,0,Lipid,85273317.46667966,78580712.38108967,0.9215158353818578,-0.11791913746264313,0.20925789849244175,0.5028674357354733,Downregulated
Feature1419,"1-(Methylnitrosoamino)-4-(3-pyridinyl)-1,4-butanediol",C10 H15 N3 O3,225.11134,Other,NA,"1-(Methylnitrosoamino)-4-(3-pyridinyl)-1,4-butanediol",10,15,3,3,0,0,1.5,0.3,0,60.3,5,2,-0.25,0.09090909090909093,-1,Lipid,82054640.50662114,84887069.4559646,1.0345188149244882,0.04895988391364484,0.6970970297191559,0.8446941118342275,Upregulated
Feature1418,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",C6 H8 O4,144.04225,Microbial metabolism in diverse environments;Other,Other,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one-peak4",6,8,4,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Tannin,47304120.72693407,25210440.700836703,0.5329438601420269,-0.9079445261813266,0.053166535411998464,0.36911520896690736,Downregulated
Feature1417,MFCD00025555,C9 H18 N2 O3,202.1317,NA,NA,MFCD00025555-peak3,9,18,3,2,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,54602942.9003883,53001547.05646447,0.9706719865475888,-0.04294423830460946,0.9203559603184953,0.9559061905453898,Downregulated
Feature1416,Pyrone,C5 H4 O2,96.02111,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,Pyrone-peak2,5,4,2,0,0,0,0.8,0.4,0,60.3,4,2,0.6666666666666666,0.75,2,Condensed HC,31448890.609342903,30267629.1119344,0.9624386910151428,-0.055233453398246805,0.8560605781442406,0.9259629890260237,Downregulated
Feature1415,"9S,13R-12-Oxophytodienoic acid",C18 H28 O3,292.20376,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of lipoxygenase,"9S,13R-12-Oxophytodienoic acid",18,28,3,0,0,0,1.5555555555555556,0.16666666666666666,-1.2222222222222223,95.13333333333333,5,2,0.13333333333333333,0.21212121212121213,2,Lipid,8395365.018234182,7567631.43544259,0.9014058851528421,-0.14975122564937382,0.7589156787174121,0.8780106829437524,Downregulated
Feature1414,NA,C14 H25 N O12,399.13775,NA,NA,Feature1414,14,25,12,1,0,0,1.7857142857142858,0.8571428571428571,0.1428571428571428,56.22857142857143,3,-9,-10,-0.5714285714285714,-10,Carbohydrate,7315035.839900037,5059017.8271961035,0.6915916665235692,-0.5320076098538921,0.264531553980723,0.5456763303919344,Downregulated
Feature1413,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",C9 H17 N O8,267.0954,Metabolic pathways;ABC transporters;Other,NA,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)-peak1",9,17,8,1,0,0,1.8888888888888888,0.8888888888888888,0.22222222222222232,53.96666666666666,2,-6,-Inf,-0.75,-7,Carbohydrate,16408816.489399433,19332759.5128473,1.1781934136040109,0.23657639310944878,0.32059410290541246,0.5861484461709393,Upregulated
Feature1412,NA,C23 H41 N,331.32396,NA,NA,Feature1412,23,41,0,1,0,0,1.7826086956521738,0,-1.6521739130434785,107.38695652173914,4,4,0.13636363636363635,0.13636363636363635,3,Lipid,106726663.3998677,47803759.53182147,0.4479083109036905,-1.1587246593517087,0.33414401398892996,0.5961118026223778,Downregulated
Feature1411,NA,C21 H31 N O13,505.17965,NA,NA,Feature1411,21,31,13,1,0,0,1.4761904761904765,0.6190476190476191,-0.0952380952380949,63.014285714285705,7,-6,-1,-0.03703703703703703,-7,Lignin,863663.1465215567,791522.0417658164,0.9164707848814762,-0.125839203405789,0.7543813015983926,0.8766653050016304,Downregulated
Feature1410,Leu-Leu,C12 H24 N2 O3,244.17868000000001,Microbial metabolism in diverse environments;Other,NA,Leu-Leu-peak3,12,24,3,2,0,0,2,0.25,-1,88.8,2,-1,-0.42857142857142855,-0.17647058823529413,-3,Lipid,62930424.32866176,49628901.0549295,0.7886312794545378,-0.3425771617444456,0.3758057515682071,0.62821390206306,Downregulated
Feature1409,Caffeic acid,C9 H8 O4,180.04227,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various antibiotics;Phenylalanine metabolism;Tyrosine metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of scopolin and esculin biosynthesis;Superpathway of aromatic amino acid biosynthesis;Superpathway of 4-hydroxybenzoate biosynthesis (yeast);Other,Caffeic acid-peak2,9,8,4,0,0,0,0.8888888888888888,0.4444444444444444,0,60.3,6,2,0.4,0.5714285714285714,2,Lignin,429027.96696806396,379296.64337952965,0.8840837254969995,-0.17774509106304912,0.7222097207209441,0.8568018164604311,Downregulated
Feature1408,Isoamylamine,C5 H13 N,87.10481,NA,NA,Isoamylamine,5,13,0,1,0,0,2.6,0,-2,117.3,0,0,-0.25,-0.25,-1,Other,1395865.3956329466,814662.541441518,0.5836254297801503,-0.7768853490228738,0.10400033489062627,0.4293543275989352,Downregulated
Feature1407,4-guanidinobutanal,C5 H11 N3 O,129.09017,Metabolic pathways;Other,NA,4-guanidinobutanal,5,11,1,3,0,0,2.2,0.2,0,60.3,2,1,-2,-1,-2,Lipid,56293807.88681517,37976554.10220147,0.6746133460816413,-0.5678672349728574,0.3057073526072465,0.5763754381762052,Downregulated
Feature1406,NA,C9 H15 N O7,249.08488,NA,NA,Feature1406,9,15,7,1,0,0,1.6666666666666667,0.7777777777777778,0.22222222222222232,53.96666666666666,3,-4,-5,-0.3333333333333333,-5,Carbohydrate,21552155.2274204,19679959.7599482,0.9131318678936462,-0.13110487605941984,0.5000392093027971,0.7117038087448558,Downregulated
Feature1405,2'-Deoxyguanosine,C10 H13 N5 O4,267.09677,Metabolic pathways;ABC transporters;Other,Superpathway of purine nucleotide salvage;Other,2'-Deoxyguanosine,10,13,4,5,0,0,1.3,0.4,1,31.799999999999997,7,3,-2,0,-2,Lignin,45376327.6574439,70183823.5756987,1.546705676702887,0.6291986918360468,0.18376975726745576,0.4854964193043512,Upregulated
Feature1404,NP-007065,C8 H10 O3,154.063,Microbial metabolism in diverse environments;Aminobenzoate degradation,NA,NP-007065-peak3,8,10,3,0,0,0,1.25,0.375,-0.5,74.55,4,1,0.2,0.38461538461538464,1,Lignin,84752376.386509,69252766.94154106,0.8171188808407832,-0.2913821066967839,0.03275276349372688,0.32345137828340564,Downregulated
Feature1403,"3-(1-hydroxyethyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione",C9 H14 N2 O3,198.10045,NA,NA,"3-(1-hydroxyethyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione-peak2",9,14,3,2,0,0,1.5555555555555556,0.3333333333333333,-0.22222222222222232,66.63333333333333,4,1,-0.25,0.09090909090909093,-1,Protein,79212931.6764584,72811077.16331834,0.9191816995324936,-0.12157801998486482,0.16817787370742643,0.47405832082810595,Downregulated
Feature1402,NP-016455,C11 H18 N2 O4,242.12665,NA,NA,NP-016455-peak3,11,18,4,2,0,0,1.6363636363636365,0.3636363636363637,-0.3636363636363633,70.66363636363636,4,0,-0.4,0,-2,Protein,629994.4700657347,533150.9046722293,0.8462787056156215,-0.2407952294234484,0.36787209008517574,0.6231744047749879,Downregulated
Feature1401,Hypoxanthine,C5 H4 N4 O,136.0385,Metabolic pathways;Other,Superpathway of purine nucleotide salvage;Other,Hypoxanthine-peak3,5,4,1,4,0,0,0.8,0.2,2,3.299999999999997,6,5,Inf,3,1,Condensed HC,1557666.8633774472,241096.6192758664,0.15478060485481668,-2.6917033923509686,0.23597790867005825,0.5231694095424109,Downregulated
Feature1400,"3-(propan-2-yl)-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",C10 H16 N2 O2,196.12119,NA,NA,"3-(propan-2-yl)-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",10,16,2,2,0,0,1.6,0.2,-0.5999999999999996,77.39999999999999,4,2,0,0.14285714285714285,0,Lipid,64146887.55225107,56921505.136953235,0.8873619174521542,-0.17240545595263734,0.055299392221189285,0.3747086816907786,Downregulated
Feature1399,Isoprenaline,C11 H17 N O3,211.12084,Biosynthesis of alkaloids derived from shikimate pathway;Other,NA,Isoprenaline,11,17,3,1,0,0,1.5454545454545454,0.2727272727272727,-0.7272727272727275,81.02727272727273,4,1,0,0.17647058823529413,0,Lipid,1982186.82354146,1635826.1096017633,0.825263335510992,-0.2770735486008574,0.2497054225314018,0.5310276106497658,Downregulated
Feature1398,2908,C5 H11 N,85.08916,Other,NA,2908-peak1,5,11,0,1,0,0,2.2,0,-1.5999999999999996,105.89999999999998,1,1,0,0,0,Lipid,10823715.88182662,27982982.6688307,2.585339727534336,1.370353870878785,0.1882949164207781,0.4862119877973694,Upregulated
Feature1397,Glycyl-L-leucine,C8 H16 N2 O3,188.11611,Metabolic pathways;Lysine degradation,Superpathway of L-lysine degradation,Glycyl-L-leucine-peak4,8,16,3,2,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,40133954.87587987,61988575.07767113,1.5445419039658532,0.6271790123210992,0.17447993041910226,0.4782669937377981,Upregulated
Feature1396,NA,C20 H29 N5 O7,451.2068,NA,NA,Feature1396,20,29,7,5,0,0,1.45,0.35,0,60.3,9,2,-0.375,0.04347826086956521,-3,Lignin,1969828.3504612267,1185983.3919485798,0.6020744861707809,-0.7319861125840776,0.3456199079270255,0.60358775673029,Downregulated
Feature1395,NL8513000,C11 H13 N O2,191.09464,NA,Other,NL8513000-peak3,11,13,2,1,0,0,1.181818181818182,0.18181818181818185,-0.5454545454545459,75.84545454545456,6,4,0.375,0.4444444444444444,3,Lignin,13137641.363693118,11910041.870157199,0.9065586082347715,-0.1415278029086233,0.728039555344288,0.8612423231516927,Downregulated
Feature1394,"4-({4-[(2,4-Dihydroxy-3,6-dimethylbenzoyl)oxy]-2-methoxy-3,5,6-trimethylbenzoyl}oxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C31 H34 O10,566.21537,Biosynthesis of secondary metabolites;Other,NA,"4-({4-[(2,4-Dihydroxy-3,6-dimethylbenzoyl)oxy]-2-methoxy-3,5,6-trimethylbenzoyl}oxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak1",31,34,10,0,0,0,1.096774193548387,0.3225806451612903,-0.4516129032258061,73.17096774193547,15,5,0.23809523809523808,0.38461538461538464,5,Lignin,97061904.36262034,117605596.15136597,1.2116555606821293,0.27697963980150136,0.3421033229236879,0.6017631473175763,Upregulated
Feature1393,(4S)-4-Hydroxy-4-methyltetrahydro-2H-pyran-2-one,C6 H10 O3,130.06296,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I,(4S)-4-Hydroxy-4-methyltetrahydro-2H-pyran-2-one-peak6,6,10,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,18916477.8713444,19707788.0046042,1.0418317901800587,0.059122364888312455,0.7464024182916795,0.8738118151942675,Upregulated
Feature1392,Methionine sulfoxide,C5 H11 N O3 S,165.04597,Metabolic pathways;Other,Other,Methionine sulfoxide,5,11,3,1,1,0,2.2,0.6,0,60.3,1,-2,-Inf,-1.6666666666666667,-4,Amino Sugar,2736624.380076263,3929447.923970337,1.4358740470845446,0.5219292034673507,0.44658023945808234,0.6687322960777052,Upregulated
Feature1391,3-Buten-1-amine,C4 H9 N,71.07352,NA,NA,3-Buten-1-amine-peak2,4,9,0,1,0,0,2.25,0,-1.5,103.05,1,1,0,0,0,Lipid,19384615.214249384,41667595.067269064,2.149518812044293,1.1040137364781113,0.20100412606620313,0.4974607521671786,Upregulated
Feature1390,3-Butynoic acid,C4 H4 O2,84.02115,Metabolic pathways;Other,NA,3-Butynoic acid-peak4,4,4,2,0,0,0,1,0.5,0,60.3,3,1,0.5,0.6666666666666666,1,Lignin,47836282.9947407,40009400.5926489,0.8363818860476196,-0.25776627780952927,0.23873078723511432,0.5231694095424109,Downregulated
Feature1389,"(1R,4aS,5R,8aS)-5-(5-hydroxy-3-methylpentyl)-1,4a-dimethyl-6-methylidene-decahydronaphthalene-1-carboxylic acid",C20 H34 O3,322.2507,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"(1R,4aS,5R,8aS)-5-(5-hydroxy-3-methylpentyl)-1,4a-dimethyl-6-methylidene-decahydronaphthalene-1-carboxylic acid",20,34,3,0,0,0,1.7,0.15,-1.4000000000000004,100.20000000000002,4,1,0.0588235294117647,0.13513513513513514,1,Lipid,1941916.0946569734,2446005.6753005767,1.2595836050952796,0.33294688440108455,0.6420088695228748,0.8140441803680764,Upregulated
Feature1388,lys-leu,C12 H25 N3 O3,259.18959,NA,NA,lys-leu-peak4,12,25,3,3,0,0,2.0833333333333335,0.25,-0.833333333333333,84.04999999999998,2,-1,-0.6666666666666666,-0.3333333333333333,-4,Lipid,32106689.6434948,43115698.79278877,1.3428883286173516,0.425339338683123,0.28103882084957693,0.5605282439044939,Upregulated
Feature1387,Phloroglucinol,C6 H6 O3,126.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,NA,Phloroglucinol-peak1,6,6,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Lignin,19394294.866307065,7473117.286915514,0.38532554745768366,-1.3758502536377666,0.10718522232069802,0.43283090716191397,Downregulated
Feature1386,"4-(2-Aminopropoxy)-3,5-dimethylphenol",C11 H17 N O2,195.12596,NA,NA,"4-(2-Aminopropoxy)-3,5-dimethylphenol-peak1",11,17,2,1,0,0,1.5454545454545454,0.18181818181818185,-0.9090909090909092,86.2090909090909,4,2,0.125,0.2222222222222222,1,Lipid,216169.834013575,380541.74584099365,1.7603832078489567,0.8158895151610588,0.013878783444693552,0.25835889181660304,Upregulated
Feature1385,Ne-Acetyllysine,C8 H16 N2 O3,188.11611,Metabolic pathways;Lysine degradation,Superpathway of L-lysine degradation,Ne-Acetyllysine-peak2,8,16,3,2,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,65920867.123869404,43657835.275804564,0.6622764108028005,-0.5944946221671797,0.10684499050465932,0.43283090716191397,Downregulated
Feature1384,Uracil,C4 H4 N2 O2,112.02723,Metabolic pathways;Other,Other,Uracil-peak2,4,4,2,2,0,0,1,0.5,1.5,17.549999999999997,4,2,NA,1,0,Lignin,22396270.07659127,20339154.898786567,0.9081492065076134,-0.13899874692585043,0.5989295316580927,0.7865713119297694,Downregulated
Feature1383,"1,4-Anhydro-1-(2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinyl)-5-O-phosphonopentitol",C9 H13 N2 O9 P,324.03593,Metabolic pathways;Biosynthesis of cofactors;Other,Other,"1,4-Anhydro-1-(2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinyl)-5-O-phosphonopentitol",9,13,9,2,0,1,1.4444444444444444,1,0.6666666666666665,41.3,5,-4,2.3333333333333335,-1.6666666666666667,-7,Tannin,14813115.2830608,17493163.5465368,1.1809240130967391,0.2399161370844456,0.30059979368444795,0.5743234421814979,Upregulated
Feature1382,Phenyl D-glucopyranosiduronic acid,C12 H14 O7,270.07398,NA,NA,Phenyl D-glucopyranosiduronic acid-peak7,12,14,7,0,0,0,1.1666666666666667,0.5833333333333334,0,60.3,6,-1,-0.2,0.29411764705882354,-1,Lignin,602912.6008054317,613311.138772977,1.017247173062321,0.024670271156634553,0.9436491915074157,0.9698580096209922,Upregulated
Feature1381,"(5R)-3-[(1S,2R,4aS,6R,8aR)-1,6-dimethyl-2-[(1E)-prop-1-en-1-yl]-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl]-4-hydroxy-5-(hydroxymethyl)-1-methyl-2,5-dihydro-1H-pyrrol-2-one",C22 H31 N O4,373.22538,NA,NA,"(5R)-3-[(1S,2R,4aS,6R,8aR)-1,6-dimethyl-2-[(1E)-prop-1-en-1-yl]-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl]-4-hydroxy-5-(hydroxymethyl)-1-methyl-2,5-dihydro-1H-pyrrol-2-one",22,31,4,1,0,0,1.4090909090909092,0.18181818181818185,-0.9090909090909092,86.2090909090909,8,4,0.17647058823529413,0.2631578947368421,3,Lignin,1545697.4321256967,49060061.63030397,31.739757478172734,4.988219199545201,0.42251744568063504,0.6594697741371865,Upregulated
Feature1380,Anhydroecgonine,C9 H13 N O2,167.09467,Metabolic pathways;Biosynthesis of alkaloids derived from shikimate pathway;Tyrosine metabolism;Other,Other,Anhydroecgonine-peak2,9,13,2,1,0,0,1.4444444444444444,0.2222222222222222,-0.666666666666667,79.30000000000001,4,2,0.16666666666666666,0.2857142857142857,1,Lignin,792679.4449067273,856881.2892564443,1.0809934517190256,0.11235778375609523,0.4058242715584153,0.6534850912737219,Upregulated
Feature1379,NA,C5 H13 O6 P,200.04503,NA,NA,Feature1379,5,13,6,0,0,1,2.6,1.2,-1.2000000000000002,94.5,0,-6,3.5,-4,-7,Other,4121094.1950536566,5526535.658022563,1.3410359958905544,0.4233479623697737,0.4171947100141307,0.6580333694263849,Upregulated
Feature1378,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13214,NA,NA,6-(alpha-D-glucosaminyl)-1D-myo-inositol-peak3,12,23,10,1,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,56299837.51555407,26107669.871776566,0.46372549236156757,-1.1086570567824157,0.08335150402671834,0.402486084203436,Downregulated
Feature1377,"16?,17-isopropylidenedioxy-6?-methylprogesterone",C25 H36 O4,400.26153,NA,NA,"16?,17-isopropylidenedioxy-6?-methylprogesterone",25,36,4,0,0,0,1.44,0.16,-1.12,92.22,8,4,0.1904761904761905,0.2608695652173913,4,Lignin,2459311.6387120667,3953139.16782318,1.6074169314684437,0.6847441834909488,0.04510747427214587,0.35607946299980225,Upregulated
Feature1376,Acetonedicarboxylic Acid,C5 H6 O5,146.02149,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various antibiotics;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of chorismate metabolism;Superpathway of branched chain amino acid biosynthesis;Superpathway of scopolin and esculin biosynthesis;Superpathway of aromatic amino acid biosynthesis;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of butirocin biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Superpathway of 4-hydroxybenzoate biosynthesis (yeast);Other,Acetonedicarboxylic Acid,5,6,5,0,0,0,1.2,1,0.7999999999999998,37.5,3,-2,-Inf,0.2,-2,Tannin,88329265.4684845,71735934.65624137,0.8121423208464972,-0.3001955256202007,0.09798881367327625,0.4213021582805329,Downregulated
Feature1375,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",C10 H18 N2 O5,246.12156,Metabolic pathways;Other,NA,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose-peak6",10,18,5,2,0,0,1.8,0.5,-0.20000000000000015,66,3,-2,-1.3333333333333333,-0.2727272727272727,-4,Protein,35652411.0725043,47901859.62199647,1.3435798079569194,0.42608201924763134,0.30536067244904896,0.5763754381762052,Upregulated
Feature1374,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,NA,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole-peak6",11,12,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Lignin,46588996.01728234,85343571.91485623,1.831839687706465,0.8732932524136673,0.11737435617418986,0.45214600181013836,Upregulated
Feature1373,NP-021733,C7 H13 N O2,143.09463,ABC transporters,NA,NP-021733-peak2,7,13,2,1,0,0,1.8571428571428572,0.2857142857142857,-0.8571428571428568,84.72857142857141,2,0,-0.25,0,-1,Lipid,297278.77590261266,484932.518399236,1.631238277696952,0.7059675343144057,0.1431025681072352,0.46161586781018427,Upregulated
Feature1372,D-lysopine,C9 H18 N2 O4,218.12665,Lysine degradation,NA,D-lysopine-peak6,9,18,4,2,0,0,2,0.4444444444444444,-0.44444444444444464,72.96666666666667,2,-2,-1.3333333333333333,-0.4,-4,Protein,69382693.04927574,50524377.64447027,0.7281985668758597,-0.4575961933841499,0.2927474488922052,0.568708920210316,Downregulated
Feature1371,3-O-beta-D-galactosyl-sn-glycerol,C9 H18 O8,254.10017,Other,NA,3-O-beta-D-galactosyl-sn-glycerol-peak2,9,18,8,0,0,0,2,0.8888888888888888,-0.22222222222222232,66.63333333333333,1,-7,-7,-0.6,-7,Carbohydrate,39861047.436089866,49960231.9593385,1.2533597377098755,0.3258005545821585,0.33321000255146993,0.5954195615212976,Upregulated
Feature1370,NA,C16 H28 N2 O13,456.15926,NA,NA,Feature1370,16,28,13,2,0,0,1.75,0.8125,0.25,53.175,4,-9,-11,-0.6,-11,Carbohydrate,4089968.6789791267,2428206.5159562635,0.5936980711946073,-0.7521986687986271,0.18419282895351471,0.4854964193043512,Downregulated
Feature1369,"1,2-dihydroxyheptadec-16-yn-4-yl acetate",C19 H34 O4,326.24576,NA,NA,"1,2-dihydroxyheptadec-16-yn-4-yl acetate",19,34,4,0,0,0,1.7894736842105263,0.21052631578947367,-1.3684210526315788,99.29999999999998,3,-1,-0.06666666666666667,0.0588235294117647,-1,Lipid,8640623.511227988,12266140.869516123,1.4195897846465577,0.5054740979302202,0.275893709441681,0.5550640662639045,Upregulated
Feature1368,Glucosamine,C6 H13 N O5,179.0794,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,Other,Glucosamine-peak2,6,13,5,1,0,0,2.1666666666666665,0.8333333333333334,0,60.3,1,-4,-Inf,-1,-5,Carbohydrate,41867128.96641847,42224597.09458573,1.0085381571889964,0.012265668131297359,0.9836406889876717,0.9918376947292356,Upregulated
Feature1367,4-Methoxycinnamaldehyde,C10 H10 O2,162.0681,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Other,4-Methoxycinnamaldehyde-peak2,10,10,2,0,0,0,1,0.2,-0.5999999999999996,77.39999999999999,6,4,0.5,0.5555555555555556,4,Lignin,611108.8686461584,614454.6184352963,1.005474883381336,0.007877043777758217,0.9553778254068886,0.9749458049634153,Upregulated
Feature1366,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",C6 H8 O4,144.04225,Microbial metabolism in diverse environments;Other,Other,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one-peak3",6,8,4,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Tannin,47304120.72693407,31537678.958312735,0.6667004580925606,-0.5848893764905269,0.25830730125942414,0.5415502083334957,Downregulated
Feature1365,L-Alanyl-L-proline,C8 H14 N2 O3,186.10045,NA,NA,L-Alanyl-L-proline-peak1,8,14,3,2,0,0,1.75,0.375,-0.25,67.425,3,0,-0.6666666666666666,-0.1111111111111111,-2,Protein,35049049.42442877,42771499.738359265,1.2203326606783247,0.28727447769897557,0.5624249891147495,0.7609807760066978,Upregulated
Feature1364,"5,6,7,4'-Tetramethoxyisoflavone",C19 H18 O6,342.11042,Biosynthesis of secondary metabolites;Other,NA,"5,6,7,4'-Tetramethoxyisoflavone",19,18,6,0,0,0,0.9473684210526316,0.3157894736842105,-0.3157894736842106,69.3,11,5,0.38461538461538464,0.5,5,Lignin,89560661.08880466,111878795.43266557,1.2491957302741565,0.32099954337696157,0.16558273671941523,0.4734778652324074,Upregulated
Feature1363,Zalcitabine,C9 H13 N3 O3,211.0957,Other,NA,Zalcitabine-peak2,9,13,3,3,0,0,1.4444444444444444,0.3333333333333333,0.22222222222222232,53.96666666666666,5,2,-0.3333333333333333,0.1111111111111111,-1,Lignin,69168269.68442394,69157701.63410553,0.999847212452088,-2.2044267855930415e-4,0.9980527420184955,0.9986422592908042,Downregulated
Feature1362,5-Ethyl-4-hydroxy-3(2H)-furanone,C6 H8 O3,128.04731,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Aminobenzoate degradation;Other,Other,5-Ethyl-4-hydroxy-3(2H)-furanone-peak3,6,8,3,0,0,0,1.3333333333333333,0.5,-0.33333333333333304,69.79999999999998,3,0,0,0.3333333333333333,0,Lignin,3371938.481855177,6760550.881919767,2.0049449058157904,1.0035625931897174,0.427837828675778,0.6594697741371865,Upregulated
Feature1361,ile-his,C12 H20 N4 O3,268.15355,NA,NA,ile-his-peak4,12,20,3,4,0,0,1.6666666666666667,0.25,-0.16666666666666696,65.05000000000001,5,2,-0.4,-0.07692307692307693,-2,Lipid,25204892.86766623,34646629.9562118,1.3745993739436908,0.45901120740629725,0.42319723008602733,0.6594697741371865,Upregulated
Feature1360,glu-thr,C9 H16 N2 O6,248.10093,NA,NA,glu-thr,9,16,6,2,0,0,1.7777777777777777,0.6666666666666666,0.22222222222222232,53.96666666666666,3,-3,-5,-0.5,-5,Amino Sugar,1871760.793824437,3790786.736293461,2.0252517035299227,1.0181012210184974,0.5914878818193015,0.7815760310467212,Upregulated
Feature1359,NA,C17 H30 N2 O8,390.20035,NA,NA,Feature1359,17,30,8,2,0,0,1.7647058823529411,0.4705882352941176,-0.47058823529411775,73.71176470588236,4,-4,-0.8571428571428571,-0.18181818181818185,-6,Protein,32670626.585923165,38910414.8880572,1.1909907753291327,0.2521622390303617,0.192590462698958,0.4862119877973694,Upregulated
Feature1358,anticapsin,C9 H13 N O4,199.0845,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics,NA,anticapsin-peak2,9,13,4,1,0,0,1.4444444444444444,0.4444444444444444,-0.22222222222222232,66.63333333333333,4,0,-0.25,0.16666666666666666,-1,Lignin,853608.8098689624,1165791.062260124,1.3657205136379562,0.44966227510435647,0.5517617121270588,0.7556057723065784,Upregulated
Feature1357,Leu-Glu,C11 H20 N2 O5,260.13724,NA,NA,Leu-Glu-peak2,11,20,5,2,0,0,1.818181818181818,0.4545454545454546,-0.3636363636363633,70.66363636363636,3,-2,-1,-0.2307692307692308,-4,Protein,59096940.55956403,48186510.06611776,0.8153807897644109,-0.294454127315367,0.3586027307951773,0.6165116688402364,Downregulated
Feature1356,mycosporine,C11 H19 N O6,261.12123,Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,mycosporine-peak3,11,19,6,1,0,0,1.7272727272727273,0.5454545454545454,-0.3636363636363633,70.66363636363636,3,-3,-1,-0.14285714285714285,-4,Protein,1104770.169381171,1133901.266073611,1.0263684678495235,0.03754875366191409,0.9607846928915811,0.9777049000724726,Upregulated
Feature1355,tert-Butyl N-[1-(aminocarbonyl)-3-methylbutyl]carbamate,C11 H22 N2 O3,230.16304,NA,NA,tert-Butyl N-[1-(aminocarbonyl)-3-methylbutyl]carbamate-peak2,11,22,3,2,0,0,2,0.2727272727272727,-0.9090909090909092,86.2090909090909,2,-1,-0.5,-0.2,-3,Lipid,38684719.86719537,44984654.75667746,1.1628533154979477,0.21766912402500882,0.584916318205793,0.7765268362387253,Upregulated
Feature1354,"4-(Î²-D-Glucopyranosyloxy)-2,5-dimethyl-3(2H)-furanone",C12 H18 O8,290.10021,NA,NA,"4-(Î²-D-Glucopyranosyloxy)-2,5-dimethyl-3(2H)-furanone",12,18,8,0,0,0,1.5,0.6666666666666666,-0.16666666666666696,65.05000000000001,4,-4,-1,0,-4,Amino Sugar,3148115.266269827,1525882.5489698742,0.4846971663708739,-1.0448444466199747,0.36596396943131143,0.620563527744386,Downregulated
Feature1353,NA,C12 H18 O9,306.09516,NA,NA,Feature1353,12,18,9,0,0,0,1.5,0.75,0,60.3,4,-5,-1.6666666666666667,-0.06666666666666667,-5,Carbohydrate,22578127.019839767,18294192.734468233,0.8102617510474995,-0.30354005610448337,0.3770887115098162,0.62821390206306,Downregulated
Feature1352,Asparagine,C4 H8 N2 O3,132.05347,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Other,Other,Asparagine,4,8,3,2,0,0,2,0.75,1,31.799999999999997,2,-1,3,-3,-3,Carbohydrate,38004468.73605997,67234414.07461683,1.7691186407987456,0.8230308014215945,0.17204029281022384,0.4760067902771642,Upregulated
Feature1351,"(3S,9S,14aR)-3,6-Dimethyl-9-{6-[(2S)-2-oxiranyl]-6-oxohexyl}decahydropyrrolo[1,2-a][1,4,7,10]tetraazacyclododecine-1,4,7,10-tetrone",C21 H32 N4 O6,436.23229,NA,NA,"(3S,9S,14aR)-3,6-Dimethyl-9-{6-[(2S)-2-oxiranyl]-6-oxohexyl}decahydropyrrolo[1,2-a][1,4,7,10]tetraazacyclododecine-1,4,7,10-tetrone",21,32,6,4,0,0,1.5238095238095235,0.2857142857142857,-0.3809523809523814,71.15714285714287,8,2,-0.18181818181818185,0.07142857142857142,-2,Lipid,460047.6687150173,676022.084001563,1.4694609493181323,0.555287020116393,0.008675523407084836,0.23146778150390945,Upregulated
Feature1350,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,NA,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole-peak5",11,12,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Lignin,16342494.940269733,42480197.44579027,2.599370389958899,1.3781622212222129,0.014939744999863547,0.25983697563097224,Upregulated
Feature1349,Veronal,C8 H12 N2 O3,184.0848,NA,NA,Veronal-peak1,8,12,3,2,0,0,1.5,0.375,0,60.3,4,1,-0.3333333333333333,0.1111111111111111,-1,Protein,8738577.316388879,8963408.147587603,1.0257285394473838,0.03664897011470917,0.7792362132403234,0.8895054886988598,Upregulated
Feature1348,NA,C10 H15 N O5,229.09503,NA,NA,Feature1348,10,15,5,1,0,0,1.5,0.5,-0.20000000000000015,66,4,-1,-0.5,0.07692307692307693,-2,Protein,68141143.47730628,47709531.83081857,0.7001574877695992,-0.5142486281593991,0.0041015072302841345,0.20435156612062716,Downregulated
Feature1347,Imidazoleacetic acid riboside,C10 H14 N2 O6,258.08518,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,Imidazoleacetic acid riboside,10,14,6,2,0,0,1.4,0.6,0.3999999999999999,48.9,5,-1,-1.5,0,-3,Lignin,7896563.896818613,2998209.23240951,0.3796853000350489,-1.3971239504920376,0.03268518969889358,0.32345137828340564,Downregulated
Feature1346,2-Methylhippuric Acid,C10 H11 N O3,193.07391,Phenylalanine metabolism;Other,NA,2-Methylhippuric Acid,10,11,3,1,0,0,1.1,0.3,-0.20000000000000015,66,6,3,0.3333333333333333,0.4666666666666667,2,Lignin,21230596.560034066,16257060.962148134,0.7657373600491068,-0.3850784472909799,0.006949188529226411,0.23030609530252863,Downregulated
Feature1345,NA,C14 H27 N O11,385.1585,NA,NA,Feature1345,14,27,11,1,0,0,1.9285714285714288,0.7857142857142857,-0.14285714285714324,64.37142857142858,2,-9,-5,-0.6,-10,Carbohydrate,14350781.025378225,5792392.531079007,0.40362907920033186,-1.3088979786520667,0.26011900146551836,0.5433311818527596,Downregulated
Feature1344,N-(2-Cyanoethyl)-L-glutamine,C8 H13 N3 O3,199.09574,Other,NA,N-(2-Cyanoethyl)-L-glutamine-peak2,8,13,3,3,0,0,1.625,0.375,0.25,53.175,4,1,-1,-0.14285714285714285,-2,Protein,9144193.889410213,7451279.43783273,0.8148645498934545,-0.29536782626424873,0.11197728833456566,0.44353045445343764,Downregulated
Feature1343,AC-LYS-OH,C8 H16 N2 O3,188.1161,Metabolic pathways;Lysine degradation,Superpathway of L-lysine degradation,AC-LYS-OH-peak2,8,16,3,2,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,44520952.9233204,42596250.710504435,0.9567686204711088,-0.06375802123041611,0.6657787724246311,0.8275141791352959,Downregulated
Feature1342,Sorbic acid,C6 H8 O2,112.05238,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Aminobenzoate degradation;Other,NA,Sorbic acid-peak2,6,8,2,0,0,0,1.3333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,3,1,0.25,0.4,1,Lignin,10404383.8865876,10491797.315316917,1.0084015958736396,0.012070306487555258,0.8932393606984181,0.9441529932099071,Upregulated
Feature1341,L-(+)-Valine,C5 H11 N O2,117.07893,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Biosynthesis of alkaloids derived from shikimate pathway;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Superpathway of indole-3-acetate conjugate biosynthesis;Other,L-(+)-Valine,5,11,2,1,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,35215281.9076873,49582877.13865996,1.4079931908151584,0.4936403569858939,0.26113583581294625,0.5437149951031542,Upregulated
Feature1340,NA,C37 H71 N O5,609.53331,NA,NA,Feature1340,37,71,5,1,0,0,1.9189189189189189,0.13513513513513514,-1.5675675675675675,104.97567567567567,3,-2,-0.0967741935483871,-0.01492537313432835,-3,Lipid,1914814.72959398,2244331.326804557,1.172087979122893,0.22908086522132923,0.2934308472022706,0.5693835683398011,Upregulated
Feature1339,"(3E,5E,7E,9Z,11E,13E,15Z,17E)-18-(4-Hydroxy-2,2,6-trimethyl-7-oxabicyclo[4.1.0]hept-1-yl)-3,7,12,16-tetramethyl-3,5,7,9,11,13,15,17-octadecaoctaen-2-one",C31 H42 O3,462.31357,NA,NA,"(3E,5E,7E,9Z,11E,13E,15Z,17E)-18-(4-Hydroxy-2,2,6-trimethyl-7-oxabicyclo[4.1.0]hept-1-yl)-3,7,12,16-tetramethyl-3,5,7,9,11,13,15,17-octadecaoctaen-2-one",31,42,3,0,0,0,1.3548387096774193,0.0967741935483871,-1.161290322580645,93.39677419354838,11,8,0.2857142857142857,0.3220338983050847,8,Unsaturated HC,720764.3639605823,815227.364009534,1.1310594762619504,0.17767479480261295,0.5637540013886844,0.7614512866361725,Upregulated
Feature1338,Phenyl D-glucopyranosiduronic acid,C12 H14 O7,270.07397,NA,NA,Phenyl D-glucopyranosiduronic acid-peak6,12,14,7,0,0,0,1.1666666666666667,0.5833333333333334,0,60.3,6,-1,-0.2,0.29411764705882354,-1,Lignin,640306.288229423,793038.178299495,1.2385294239299238,0.30862814331462557,0.5596070454435647,0.7588768357008283,Upregulated
Feature1337,Pyridoxine,C8 H11 N O3,169.07391,Metabolic pathways;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Tyrosine metabolism;Other,Other,Pyridoxine-peak2,8,11,3,1,0,0,1.375,0.375,-0.25,67.425,4,1,0,0.2727272727272727,0,Lignin,66857119.48952117,56186319.00825947,0.8403939541108381,-0.25086231175037593,0.07651360842984217,0.39590936857023457,Downregulated
Feature1336,4-Hydroxyprolyllysine,C11 H21 N3 O4,259.15318,NA,NA,4-Hydroxyprolyllysine-peak4,11,21,4,3,0,0,1.9090909090909092,0.3636363636363637,-0.3636363636363633,70.66363636363636,3,-1,-1,-0.3333333333333333,-4,Protein,40037001.69338637,31581522.0392329,0.7888083698447825,-0.3422532350205522,0.2957508664648,0.57033619612451,Downregulated
Feature1335,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,NA,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole-peak4",11,12,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Lignin,9781920.854344727,43242209.84194965,4.420625609820103,2.1442505552086177,0.4192696736214421,0.6594640920285264,Upregulated
Feature1334,ALA-GLU,C8 H14 N2 O5,218.09029,NA,NA,ALA-GLU,8,14,5,2,0,0,1.75,0.625,0.25,53.175,3,-2,-4,-0.42857142857142855,-4,Amino Sugar,40120392.3898158,33281788.6494851,0.8295479347787581,-0.26960274629269715,0.26478509066243805,0.5456763303919344,Downregulated
Feature1333,MFCD01318772,C8 H13 N3 O2,183.10077,NA,NA,MFCD01318772,8,13,2,3,0,0,1.625,0.25,0,60.3,4,2,-0.3333333333333333,0,-1,Lipid,17211832.3599113,13085436.5496621,0.7602581919249842,-0.39543863823717307,0.016572212926288497,0.2637533176745511,Downregulated
Feature1332,NP-008177,C28 H41 N O5,471.29851,NA,NA,NP-008177,28,41,5,1,0,0,1.4642857142857142,0.17857142857142858,-1,88.8,9,4,0.13636363636363635,0.22448979591836735,3,Lignin,1658814.8698818665,2236106.32452919,1.3480143957766884,0.4308359034965819,0.017959547571940293,0.2637533176745511,Upregulated
Feature1331,Leu-Leu,C12 H24 N2 O3,244.17868000000001,Microbial metabolism in diverse environments;Other,NA,Leu-Leu-peak2,12,24,3,2,0,0,2,0.25,-1,88.8,2,-1,-0.42857142857142855,-0.17647058823529413,-3,Lipid,25795167.869299967,34586326.97480793,1.3408064312684986,0.42310097415058645,0.3683345324780308,0.6231744047749879,Upregulated
Feature1330,Valylvaline,C10 H20 N2 O3,216.14739,NA,NA,Valylvaline,10,20,3,2,0,0,2,0.3,-0.7999999999999998,83.1,2,-1,-0.6,-0.2307692307692308,-3,Lipid,35653132.569426164,30398048.0245121,0.8526052504732645,-0.23005015522189862,0.6127053407374068,0.7929127938954676,Downregulated
Feature1329,NA,C6 H15 N O6,197.08997,NA,NA,Feature1329,6,15,6,1,0,0,2.5,1,0,60.3,0,-6,7,-2,-7,Carbohydrate,24246257.297860768,29628234.483887635,1.221971462230656,0.2892105930297507,0.12875293619016934,0.45384777576550756,Upregulated
Feature1328,"(2Z,4E)-2,4-Hexadienedial",C6 H6 O2,110.03674,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Tyrosine metabolism;Aminobenzoate degradation;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,"(2Z,4E)-2,4-Hexadienedial-peak3",6,6,2,0,0,0,1,0.3333333333333333,-0.33333333333333304,69.79999999999998,4,2,0.5,0.6,2,Lignin,2000288.0026699933,1368921.0000537003,0.6843619509922864,-0.5471685434771586,0.19580373283800992,0.4903287788808408,Downregulated
Feature1327,3-oxovaleric acid,C5 H8 O3,116.0473,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Other,3-oxovaleric acid-peak3,5,8,3,0,0,0,1.6,0.6,-0.4000000000000003,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,9356898.45276677,8180668.57411564,0.8742927600861877,-0.19381164261956235,0.0929981197122749,0.41723968591020827,Downregulated
Feature1326,"hexahydro-2-oxo-1h-thieno(3,4-d)imidazole-4-pentanoic acid",C10 H16 N2 O3 S,244.08813,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;ABC transporters;Other,Other,"hexahydro-2-oxo-1h-thieno(3,4-d)imidazole-4-pentanoic acid",10,16,3,2,1,0,1.6,0.3,-0.20000000000000015,66,4,1,-0.5,-0.09090909090909093,-2,Lipid,56556247.78367557,48407276.996284865,0.8559138714689833,-0.2244624658499789,0.09606285031436101,0.41723968591020827,Downregulated
Feature1325,L-Cystathionine,C7 H14 N2 O4 S,222.06742,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of amino acids;Other,Other,L-Cystathionine,7,14,4,2,1,0,2,0.5714285714285714,0.2857142857142856,52.15714285714286,2,-2,-Inf,-1.5,-5,Amino Sugar,7409475.207153689,40768755.46713731,5.502246019768843,2.460020647753977,0.11907790742985147,0.4526122839818135,Upregulated
Feature1324,Leu-Leu,C12 H24 N2 O3,244.17868000000001,Microbial metabolism in diverse environments;Other,NA,Leu-Leu-peak1,12,24,3,2,0,0,2,0.25,-1,88.8,2,-1,-0.42857142857142855,-0.17647058823529413,-3,Lipid,41519803.91638157,31632148.795600966,0.7618568926603373,-0.3924080678233554,0.31355489300152223,0.582824705135905,Downregulated
Feature1323,Pyrogallol,C6 H6 O3,126.03167,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,NA,Pyrogallol-peak1,6,6,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Lignin,47200047.61086723,33536044.472662564,0.7105087001001521,-0.4930757796705411,0.1320831851102725,0.45384777576550756,Downregulated
Feature1322,NA,C14 H25 N O9,351.15307,Biosynthesis of secondary metabolites;Other,NA,Feature1322,14,25,9,1,0,0,1.7857142857142858,0.6428571428571429,-0.2857142857142856,68.44285714285714,3,-6,-1.75,-0.29411764705882354,-7,Amino Sugar,12000444.675449254,2380313.0435071667,0.19835207010094033,-2.3338646406419996,0.09364203179556763,0.41723968591020827,Downregulated
Feature1321,"3-[(4-hydroxyphenyl)methyl]-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",C14 H16 N2 O3,260.11612,NA,NA,"3-[(4-hydroxyphenyl)methyl]-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",14,16,3,2,0,0,1.1428571428571428,0.21428571428571427,-0.2857142857142856,68.44285714285714,8,5,0.3333333333333333,0.42857142857142855,3,Lignin,56356001.57520547,45795653.6429739,0.812613605701975,-0.29935857487356476,0.05850100894232329,0.3790841191943452,Downregulated
Feature1320,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",C6 H8 O4,144.04227,Microbial metabolism in diverse environments;Other,Other,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one-peak2",6,8,4,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Tannin,4705321.1621362,3962893.7563872235,0.842215359979399,-0.24773890785810948,0.36134123798538936,0.6171436750022657,Downregulated
Feature1319,afegostat,C6 H13 N O3,147.08955,Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,afegostat-peak4,6,13,3,1,0,0,2.1666666666666665,0.5,-0.666666666666667,79.30000000000001,1,-2,-1.5,-0.42857142857142855,-3,Protein,1563682.4271529894,2570361.1197673487,1.6437871751537352,0.7170235221180777,0.5166590322160443,0.7245201991506448,Upregulated
Feature1318,"8-Hydroxy-3-(methylamino)-2,3,4,4a,9,9a-hexahydro-1H-carbazole-6-carboxamide",C14 H19 N3 O2,261.14775,NA,NA,"8-Hydroxy-3-(methylamino)-2,3,4,4a,9,9a-hexahydro-1H-carbazole-6-carboxamide",14,19,2,3,0,0,1.3571428571428572,0.14285714285714285,-0.4285714285714288,72.51428571428572,7,5,0.2222222222222222,0.3,2,Lignin,33816473.173058204,32896403.644341502,0.972792268312305,-0.03979633250370785,0.93878715881795,0.9667510316338038,Downregulated
Feature1317,Nojirimycin,C6 H13 N O5,179.0794,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,Other,Nojirimycin-peak2,6,13,5,1,0,0,2.1666666666666665,0.8333333333333334,0,60.3,1,-4,-Inf,-1,-5,Carbohydrate,53946669.433540665,37568818.55468957,0.6964066354637943,-0.5219981456245061,0.16602470599058444,0.4734778652324074,Downregulated
Feature1316,NA,C11 H21 N O8 S,327.09883,NA,NA,Feature1316,11,21,8,1,1,0,1.9090909090909092,0.7272727272727273,0,60.3,2,-6,-8,-0.8,-8,Carbohydrate,15983008.024867734,7637537.645808023,0.4778535826250533,-1.065359459901839,0.025463014940517344,0.3037630092199745,Downregulated
Feature1315,Maraniol,C12 H12 O3,204.07864,NA,NA,Maraniol,12,12,3,0,0,0,1,0.25,-0.5,74.55,7,4,0.4444444444444444,0.5238095238095238,4,Lignin,762944.4486147229,762887.4451884266,0.9999252849582957,-1.0779504715248894e-4,0.9997722105632261,0.9997722105632261,Downregulated
Feature1314,NA,C30 H46 O11,582.30426,NA,NA,Feature1314,30,46,11,0,0,0,1.5333333333333334,0.36666666666666664,-0.7999999999999998,83.1,8,-3,-0.15789473684210523,0.1020408163265306,-3,Protein,1477785.53844688,1515019.9700675467,1.0251960996044116,0.03589989496717971,0.8877047661482206,0.941126558385276,Upregulated
Feature1313,2-Pyrrolidone,C4 H7 N O,85.05278,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,2-Pyrrolidone-peak2,4,7,1,1,0,0,1.75,0.25,-0.5,74.55,2,1,0,0.2,0,Lipid,49776508.11345667,49857375.90392247,1.0016246175863015,0.0023419258827958233,0.9679924871432802,0.9807292303951655,Upregulated
Feature1312,4-O-(beta-L-Araf)-cis-L-Hyp,C10 H17 N O7,263.10053,NA,Other,4-O-(beta-L-Araf)-cis-L-Hyp,10,17,7,1,0,0,1.7,0.7,0,60.3,3,-4,-2.5,-0.2727272727272727,-5,Amino Sugar,17500792.900086932,15523035.090081634,0.8869903883043223,-0.1730096237554094,0.6555813250295569,0.8228154163778454,Downregulated
Feature1311,NA,C15 H21 N3 O5,323.14822,NA,NA,Feature1311,15,21,5,3,0,0,1.4,0.3333333333333333,-0.13333333333333375,64.10000000000001,7,2,-0.14285714285714285,0.15789473684210523,-1,Lignin,42696039.865504965,33648804.5472048,0.7881013005702756,-0.34354701287403105,0.06159035609919462,0.3794192923980171,Downregulated
Feature1310,Guanosine monophosphate,C10 H14 N5 O8 P,363.05806,Metabolic pathways;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Other,Superpathway of purine nucleotide salvage;Other,Guanosine monophosphate,10,14,8,5,0,1,1.4,0.8,1.2000000000000002,26.09999999999999,7,-1,1.75,-Inf,-7,Tannin,17191071.9549592,17537688.43734216,1.0201625869108744,0.028799097919757245,0.9643675025050471,0.9788536492904287,Upregulated
Feature1309,1-alpha-linolenoyl-sn-glycerol,C21 H36 O4,352.26144,NA,NA,1-alpha-linolenoyl-sn-glycerol-peak2,21,36,4,0,0,0,1.7142857142857142,0.1904761904761905,-1.333333333333333,98.29999999999998,4,0,0,0.10526315789473684,0,Lipid,5561516.547654377,3683908.6017285897,0.6623928150105592,-0.5942410709101084,0.23914139435419735,0.5233921473333467,Downregulated
Feature1308,dihydropyranone,C5 H6 O2,98.03676,Microbial metabolism in diverse environments;Other,NA,dihydropyranone-peak2,5,6,2,0,0,0,1.2,0.4,-0.4000000000000003,71.7,3,1,0.3333333333333333,0.5,1,Lignin,9421579.07948492,9148144.616426101,0.9709778519341614,-0.04248970683215505,0.9061010812032679,0.9498361581425345,Downregulated
Feature1307,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,NA,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole-peak3",11,12,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Lignin,41127105.61247593,47364236.19480577,1.1516549849410702,0.20370857609811327,0.7161502416990755,0.8543369784776295,Upregulated
Feature1306,NA,C18 H34 N2 O12,470.2114,NA,NA,Feature1306,18,34,12,2,0,0,1.8888888888888888,0.6666666666666666,-0.22222222222222232,66.63333333333333,3,-9,-2.75,-0.5,-11,Amino Sugar,11237515.5071151,7853721.59615838,0.6988841609327034,-0.5168747441466713,0.3118050969100503,0.5817156763938603,Downregulated
Feature1305,RV0540000,C5 H12 O4,136.07356,NA,NA,RV0540000,5,12,4,0,0,0,2.4,0.8,-0.7999999999999998,83.1,0,-4,-4,-0.6666666666666666,-4,Carbohydrate,5959130.46413711,6116325.09386298,1.0263787864138718,0.03756325767996462,0.886049688493145,0.941126558385276,Upregulated
Feature1304,Azobenzene,C12 H10 N2,182.08443,Biosynthesis of secondary metabolites;Biosynthesis of alkaloids derived from shikimate pathway;Other,NA,Azobenzene-peak2,12,10,0,2,0,0,0.8333333333333334,0,-0.33333333333333304,69.79999999999998,9,9,0.7,0.7,7,Unsaturated HC,43324625.06704456,70418332.87832484,1.6253650843914504,0.7007638081614999,0.02144975006455753,0.29068701287488363,Upregulated
Feature1303,"N-Acetyl-1,6-anhydro-Î²-muramic acid",C11 H17 N O7,275.10045,Metabolic pathways;Other,NA,"N-Acetyl-1,6-anhydro-Î²-muramic acid",11,17,7,1,0,0,1.5454545454545454,0.6363636363636364,0,60.3,4,-3,-1.3333333333333333,-0.07692307692307693,-4,Amino Sugar,2083940.3968538768,1704412.18927522,0.8178795285356385,-0.2900397411873013,0.3228018869849173,0.5861484461709393,Downregulated
Feature1302,(+)-castanospermine,C8 H15 N O4,189.10013,NA,NA,(+)-castanospermine-peak2,8,15,4,1,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,629383.6671311536,432263.7354994923,0.6868048188632377,-0.542027933057935,0.3017401791862651,0.5743234421814979,Downregulated
Feature1301,Agmatine,C5 H14 N4,130.12182,Metabolic pathways;Other,Other,Agmatine,5,14,0,4,0,0,2.8,0,-0.4000000000000003,71.7,1,1,-3,-3,-3,Other,1118781.5610117423,887040.5836769487,0.7928630704949906,-0.33485636461426294,0.7545324762056536,0.8766653050016304,Downregulated
Feature1300,Crotonic acid,C4 H6 O2,86.03679,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,Other,Crotonic acid-peak5,4,6,2,0,0,0,1.5,0.5,-0.5,74.55,2,0,0,0.3333333333333333,0,Protein,27828156.275225267,20672089.58554027,0.7428479767430417,-0.4288611003274521,0.038449839458102,0.34143592688945573,Downregulated
Feature1299,Val-Leu,C11 H22 N2 O3,230.16304,NA,NA,Val-Leu-peak1,11,22,3,2,0,0,2,0.2727272727272727,-0.9090909090909092,86.2090909090909,2,-1,-0.5,-0.2,-3,Lipid,36215459.232841,25254775.7071895,0.6973479348920667,-0.5200494406623594,0.4934791337654437,0.7080575663806328,Downregulated
Feature1298,N-(3-Hydroxy-4-methoxybenzoyl)glycine,C10 H11 N O5,225.0637,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,Superpathway of chorismate metabolism;Other,N-(3-Hydroxy-4-methoxybenzoyl)glycine,10,11,5,1,0,0,1.1,0.5,0.20000000000000015,54.599999999999994,6,1,0,0.38461538461538464,0,Lignin,37085581.7959017,27443670.843400765,0.740009176462038,-0.43438493393740885,0.02919509372105315,0.31473439619293775,Downregulated
Feature1297,α-Linolenic acid,C18 H30 O2,278.22444,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Superpathway of lipoxygenase,α-Linolenic acid,18,30,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666668,4,2,0.125,0.17647058823529413,2,Lipid,2939592.42046757,5409815.2317428235,1.8403283373830244,0.8799631839211836,0.04895210627798439,0.35641545489778387,Upregulated
Feature1296,Propionylcarnitine,C10 H19 N O4,217.13141,NA,NA,Propionylcarnitine,10,19,4,1,0,0,1.9,0.4,-0.7999999999999998,83.1,2,-2,-0.6,-0.14285714285714285,-3,Protein,18432850.9317903,16432585.235149499,0.8914836503564929,-0.16571975555184512,0.8037781458401971,0.9047911092281152,Downregulated
Feature1295,Glu-Gly,C7 H12 N2 O5,204.07472,NA,NA,Glu-Gly,7,12,5,2,0,0,1.7142857142857142,0.7142857142857143,0.5714285714285716,44.014285714285705,3,-2,-Inf,-0.6,-4,Carbohydrate,4455166.292866903,2488718.81815935,0.5586141244927263,-0.840076042433141,0.16445016336672588,0.4734778652324074,Downregulated
Feature1294,Glycyl-L-leucine,C8 H16 N2 O3,188.11611,Metabolic pathways;Lysine degradation,Superpathway of L-lysine degradation,Glycyl-L-leucine-peak3,8,16,3,2,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,20770120.118308745,26543733.13798873,1.2779768719098825,0.35386172745639227,0.587277200687341,0.777832351809504,Upregulated
Feature1293,NA,C15 H22 N4 O6,354.15406,NA,NA,Feature1293,15,22,6,4,0,0,1.4666666666666666,0.4,0.1333333333333333,56.5,7,1,-0.6,0,-3,Lignin,913346.785007025,2663032.9437142676,2.9156865578650772,1.5438356353990523,0.4892753905782758,0.7053893716081695,Upregulated
Feature1292,arg-leu,C12 H25 N5 O3,287.19577,NA,NA,arg-leu-peak1,12,25,3,5,0,0,2.0833333333333335,0.25,-0.33333333333333304,69.79999999999998,3,0,-1.25,-0.6363636363636364,-5,Lipid,20510591.5347722,35635144.17004017,1.7374020690542678,0.7969316607302311,0.056494485478967446,0.3769401647878184,Upregulated
Feature1291,Tridemorph,C19 H39 N O,297.30319,NA,NA,Tridemorph,19,39,1,1,0,0,2.0526315789473686,0.05263157894736842,-1.7894736842105263,111.3,1,0,-0.0588235294117647,-0.02857142857142857,-1,Lipid,293918.6197649203,451084.94952004065,1.534727367326452,0.6179823945272357,7.552078074866595e-4,0.13209075561330955,Upregulated
Feature1290,NA,C15 H22 N4 O6,354.15401,NA,NA,Feature1290,15,22,6,4,0,0,1.4666666666666666,0.4,0.1333333333333333,56.5,7,1,-0.6,0,-3,Lignin,194630.424802021,235595.340808446,1.2104753974004563,0.2755737572310618,0.06906283544605556,0.3925920914282487,Upregulated
Feature1289,ornithinoalanine,C8 H17 N3 O4,219.12181,NA,NA,ornithinoalanine,8,17,4,3,0,0,2.125,0.5,0,60.3,2,-2,-5,-1,-5,Protein,254928.86706833934,802562.0056518454,3.14818017622422,1.6545181113367016,0.12501230878514902,0.453719825968702,Upregulated
Feature1288,N-Acetyl-D-galactosamine,C8 H15 N O6,221.08991,Metabolic pathways;ABC transporters;Other,Other,N-Acetyl-D-galactosamine,8,15,6,1,0,0,1.875,0.75,0,60.3,2,-4,-5,-0.5,-5,Carbohydrate,11644255.95913993,17723967.84730093,1.522121113576935,0.6060831571365337,0.060326177427098,0.3794192923980171,Upregulated
Feature1287,Indole-3-acetic acid,C10 H9 N O2,175.06333,Metabolic pathways;Other,Superpathway of indole-3-acetate conjugate biosynthesis,Indole-3-acetic acid,10,9,2,1,0,0,0.9,0.2,-0.20000000000000015,66,7,5,0.5714285714285714,0.625,4,Lignin,1629472.32799373,1076804.8352703871,0.6608303907782167,-0.5976480588309327,0.1399325884355787,0.45798070948295916,Downregulated
Feature1286,NA,C11 H18 N3 O6 P S,351.06552,NA,NA,Feature1286,11,18,6,3,1,1,1.6363636363636365,0.5454545454545454,0,60.3,5,-1,-Inf,-1,-6,Protein,1232180.9683143566,1050862.0479779437,0.8528471669348536,-0.22964086595856606,0.39790801627069766,0.644110748404211,Downregulated
Feature1285,Atagabalin,C10 H19 N O2,185.14156,NA,NA,Atagabalin-peak2,10,19,2,1,0,0,1.9,0.2,-1.2000000000000002,94.5,2,0,-0.14285714285714285,0,-1,Lipid,509337.33730904065,635442.04091428,1.247585822534595,0.319139063246914,0.07394967511793674,0.39590936857023457,Upregulated
Feature1284,6-[2-Formyl-5-(hydroxymethyl)-1H-pyrrol-1-yl]norleucine,C12 H18 N2 O4,254.12666,NA,NA,6-[2-Formyl-5-(hydroxymethyl)-1H-pyrrol-1-yl]norleucine-peak2,12,18,4,2,0,0,1.5,0.3333333333333333,-0.33333333333333304,69.79999999999998,5,1,-0.16666666666666666,0.125,-1,Protein,24957570.8782368,19576710.258762065,0.7843996659079154,-0.35033917383090607,0.21804988814802864,0.5080832331812387,Downregulated
Feature1283,Pyrone,C5 H4 O2,96.02112,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,Pyrone-peak1,5,4,2,0,0,0,0.8,0.4,0,60.3,4,2,0.6666666666666666,0.75,2,Condensed HC,29721809.0306393,20321836.1744755,0.6837348343610694,-0.5484911664479438,0.125530282509347,0.453719825968702,Downregulated
Feature1282,NA,C22 H33 N6 O10 P S,604.17155,NA,NA,Feature1282,22,33,10,6,1,1,1.5,0.4545454545454546,0.09090909090909084,57.70909090909091,10,0,-2,-0.3333333333333333,-8,Protein,43900520.364301436,63721991.04126473,1.4515087865127336,0.53755330515092,0.06865420348574762,0.3925920914282487,Upregulated
Feature1281,"(2S)-4-Methyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)pentanoic acid (non-preferred name)",C12 H23 N O7,293.14749,NA,NA,"(2S)-4-Methyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)pentanoic acid (non-preferred name)-peak1",12,23,7,1,0,0,1.9166666666666667,0.5833333333333334,-0.5,74.55,2,-5,-1.5,-0.3333333333333333,-6,Amino Sugar,51110520.39538284,32431755.435270067,0.6345416791764822,-0.6562131658621504,0.04328374142368261,0.35607946299980225,Downregulated
Feature1280,(3Z)-4-Hydroxy-5-methylene-3-tetradecylidenedihydro-2(3H)-furanone,C19 H32 O3,308.23512,NA,NA,(3Z)-4-Hydroxy-5-methylene-3-tetradecylidenedihydro-2(3H)-furanone,19,32,3,0,0,0,1.6842105263157894,0.15789473684210523,-1.3684210526315788,99.29999999999998,4,1,0.0625,0.14285714285714285,1,Lipid,4059860.9010285735,5977946.48474644,1.4724510594025317,0.5582196832709196,0.5709508387308816,0.7634736581619005,Upregulated
Feature1279,"(2Z,5E)-6-Hydroxy-4-oxo-2,5-hexadienoic acid",C6 H6 O4,142.02662,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,"(2Z,5E)-6-Hydroxy-4-oxo-2,5-hexadienoic acid",6,6,4,0,0,0,1,0.6666666666666666,0.3333333333333335,50.8,4,0,0,0.5,0,Tannin,48272942.84180883,38123025.96983283,0.7897390075173698,-0.3405521438402504,0.0030565604805252913,0.19914667130807093,Downregulated
Feature1278,N-Methyltyramine,C9 H13 N O,151.09973,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of alkaloids derived from shikimate pathway;Tyrosine metabolism;Other,NA,N-Methyltyramine,9,13,1,1,0,0,1.4444444444444444,0.1111111111111111,-0.8888888888888893,85.63333333333334,4,3,0.2857142857142857,0.3333333333333333,2,Unsaturated HC,16969160.32199777,15109922.404732648,0.8904343006969578,-0.167418926632169,0.8219743024291227,0.9136000023320247,Downregulated
Feature1277,NP-013538,C12 H16 O8,288.08462,NA,NA,NP-013538-peak2,12,16,8,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,5,-3,-0.75,0.125,-3,Tannin,24252527.280066468,18364136.092486102,0.757205048381901,-0.40124406518323275,0.09306130062155735,0.41723968591020827,Downregulated
Feature1276,N1-Acetyl-5-methoxykynuramine,C12 H16 N2 O3,236.11608,NA,Other,N1-Acetyl-5-methoxykynuramine-peak2,12,16,3,2,0,0,1.3333333333333333,0.25,-0.33333333333333304,69.79999999999998,6,3,0.14285714285714285,0.29411764705882354,1,Lignin,27341001.978248864,21094443.366503734,0.7715314670356785,-0.3742030963408097,0.20150157929446125,0.4974607521671786,Downregulated
Feature1275,(4S)-4-Hydroxy-4-methyltetrahydro-2H-pyran-2-one,C6 H10 O3,130.06297,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I,(4S)-4-Hydroxy-4-methyltetrahydro-2H-pyran-2-one-peak5,6,10,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,4019144.149418333,4891947.012884826,1.2171613734214557,0.28352045580909946,0.7393247902653806,0.8691299061135008,Upregulated
Feature1274,Phenyl D-glucopyranosiduronic acid,C12 H14 O7,270.07398,NA,NA,Phenyl D-glucopyranosiduronic acid-peak5,12,14,7,0,0,0,1.1666666666666667,0.5833333333333334,0,60.3,6,-1,-0.2,0.29411764705882354,-1,Lignin,1112492.34138236,807013.4582645966,0.7254103495776145,-0.46313076620753274,0.10782470963983129,0.43326919821836624,Downregulated
Feature1273,Ne-Acetyllysine,C8 H16 N2 O3,188.11612,Metabolic pathways;Lysine degradation,Superpathway of L-lysine degradation,Ne-Acetyllysine-peak1,8,16,3,2,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,5881316.95653889,4520134.99749738,0.7685583060562416,-0.3797733819233702,0.26424004490047787,0.5456763303919344,Downregulated
Feature1272,α-Eleostearic acid,C18 H30 O2,278.22457000000003,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Superpathway of lipoxygenase,α-Eleostearic acid,18,30,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666668,4,2,0.125,0.17647058823529413,2,Lipid,32307280.195246264,8036442.751997843,0.2487502105850537,-2.0072303478848084,0.005824920196591949,0.23030609530252863,Downregulated
Feature1271,imazamethabenz-methyl,C16 H20 N2 O3,288.14736,NA,Superpathway of indole-3-acetate conjugate biosynthesis,imazamethabenz-methyl,16,20,3,2,0,0,1.25,0.1875,-0.5,74.55,8,5,0.2727272727272727,0.36,3,Lignin,129370.015315701,220510.37392450534,1.7044936833809208,0.7693432530584363,0.16648271138880413,0.47398607242459534,Upregulated
Feature1270,N-(tert-Butoxycarbonyl)-L-leucine,C11 H21 N O4,231.14706,NA,NA,N-(tert-Butoxycarbonyl)-L-leucine-peak2,11,21,4,1,0,0,1.9090909090909092,0.3636363636363637,-0.9090909090909092,86.2090909090909,2,-2,-0.5,-0.125,-3,Protein,16309935.282564979,18999752.094239566,1.1649189138444929,0.22022953714073468,0.7542589339380154,0.8766653050016304,Upregulated
Feature1269,Isobutyraldehyde,C4 H8 O,72.05754,Metabolic pathways;Microbial metabolism in diverse environments;Other,Other,Isobutyraldehyde,4,8,1,0,0,0,2,0.25,-1.5,103.05,1,0,0,0.14285714285714285,0,Lipid,2009997.224152644,1915914.3201365466,0.953192520424619,-0.06916046395154814,0.8940582508683396,0.9441867904517578,Downregulated
Feature1268,4-Hydroxy-5-(4-hydroxy-3-methoxyphenyl)pentanoic acid,C12 H16 O5,240.09978,NA,NA,4-Hydroxy-5-(4-hydroxy-3-methoxyphenyl)pentanoic acid,12,16,5,0,0,0,1.3333333333333333,0.4166666666666667,-0.5,74.55,5,0,0,0.2631578947368421,0,Lignin,2153949.4612722234,6624694.1752417,3.0756033483389373,1.6208694550931941,0.4347298872465168,0.6634526387347742,Upregulated
Feature1267,MFCD00025555,C9 H18 N2 O3,202.1317,NA,NA,MFCD00025555-peak2,9,18,3,2,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,42084743.32837397,22670965.6818576,0.538697967217317,-0.8924514737256299,0.09607197743902689,0.41723968591020827,Downregulated
Feature1266,"3,4,5-Trimethoxyphenyl acetate",C11 H14 O5,226.08413,NA,NA,"3,4,5-Trimethoxyphenyl acetate",11,14,5,0,0,0,1.2727272727272727,0.4545454545454546,-0.3636363636363633,70.66363636363636,5,0,0,0.29411764705882354,0,Lignin,42482449.72177587,30569552.6116893,0.719580740091356,-0.47477152217587193,0.6041998265213193,0.7867481750107239,Downregulated
Feature1265,L-gamma-Glutamyl-L-leucine,C11 H20 N2 O5,260.13723,NA,NA,L-gamma-Glutamyl-L-leucine-peak3,11,20,5,2,0,0,1.818181818181818,0.4545454545454546,-0.3636363636363633,70.66363636363636,3,-2,-1,-0.2307692307692308,-4,Protein,28676342.394327536,29530052.9180109,1.0297705513466124,0.04232291866063006,0.9367048060854176,0.965780853018075,Upregulated
Feature1264,NA,C18 H33 N O15,503.18514,NA,NA,Feature1264,18,33,15,1,0,0,1.8333333333333333,0.8333333333333334,0,60.3,3,-12,-6.5,-0.5789473684210527,-13,Carbohydrate,9091283.528115354,7548810.42141708,0.8303349464431418,-0.2682346763845659,0.20721600309835145,0.5026064024853513,Downregulated
Feature1263,pentobarbital,C11 H18 N2 O3,226.13174,NA,NA,pentobarbital,11,18,3,2,0,0,1.6363636363636365,0.2727272727272727,-0.5454545454545459,75.84545454545456,4,1,-0.16666666666666666,0.06666666666666667,-1,Lipid,24087375.828691434,21615423.84534053,0.8973756211165825,-0.15621610384385462,0.43459071403509597,0.6634526387347742,Downregulated
Feature1262,NA,C11 H23 N O7,281.14745,NA,NA,Feature1262,11,23,7,1,0,0,2.090909090909091,0.6363636363636364,-0.5454545454545459,75.84545454545456,1,-6,-2.3333333333333335,-0.5384615384615384,-7,Amino Sugar,21658323.034277793,22929280.445247166,1.0586821707736964,0.08226953978352444,0.9230364453893869,0.9575160676605153,Upregulated
Feature1261,NA,C5 H16 N5 O7 P,289.07872,Metabolic pathways;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Other,Other,Feature1261,5,16,7,5,0,1,3.2,1.4,1.6,14.699999999999996,1,-6,1.5,1.8888888888888888,-12,Other,25814600.4406921,41292743.11011703,1.599588698069733,0.6777009929021208,0.18889835232777788,0.4862119877973694,Upregulated
Feature1260,5-Hydroxy-2-furoic acid,C5 H4 O4,128.01093,NA,NA,5-Hydroxy-2-furoic acid,5,4,4,0,0,0,0.8,0.8,0.7999999999999998,37.5,4,0,0,0.6666666666666666,0,Condensed HC,53094653.5770703,42586543.9784907,0.8020872368377655,-0.31816893886953856,0.08685018122969546,0.4119191293266186,Downregulated
Feature1259,Pipecolic acid,C6 H11 N O2,129.07898,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Lysine degradation;Other,Superpathway of L-lysine degradation,Pipecolic acid-peak2,6,11,2,1,0,0,1.8333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,2,0,-0.3333333333333333,0,-1,Protein,1453957.2994146133,589837.5126835296,0.40567732829637276,-1.3015954166181207,0.001124093597772188,0.1464780426635451,Downregulated
Feature1258,mebutamate,C10 H20 N2 O4,232.1423,Other,NA,mebutamate-peak4,10,20,4,2,0,0,2,0.4,-0.5999999999999996,77.39999999999999,2,-2,-1,-0.3333333333333333,-4,Protein,33995454.72172527,27142494.6080199,0.7984154008292794,-0.32478854544749114,0.2941422970080005,0.5701110424846142,Downregulated
Feature1257,Trigonelline,C7 H7 N O2,137.04767,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various antibiotics;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminobenzoate degradation;Other",Superpathway of chorismate metabolism;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic amino acid biosynthesis;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of aromatic compound degradation via 3-oxoadipate;Other,Trigonelline-peak3,7,7,2,1,0,0,1,0.2857142857142857,0,60.3,5,3,0.5,0.6,2,Lignin,50958592.50240523,48171520.797485866,0.9453071294151655,-0.08114495910291782,0.564140478221428,0.7614512866361725,Downregulated
Feature1256,NA,C7 H11 N O6,205.0586,NA,NA,Feature1256,7,11,6,1,0,0,1.5714285714285714,0.8571428571428571,0.5714285714285716,44.014285714285705,3,-3,-Inf,-0.3333333333333333,-4,Carbohydrate,48803066.2921622,40182025.88800126,0.8233504355535651,-0.280421491665781,0.04634939288338755,0.35607946299980225,Downregulated
Feature1255,DL-2-(acetylamino)-3-phenylpropanoic acid,C11 H13 N O3,207.08953,Metabolic pathways;Phenylalanine metabolism;Other,NA,DL-2-(acetylamino)-3-phenylpropanoic acid,11,13,3,1,0,0,1.181818181818182,0.2727272727272727,-0.3636363636363633,70.66363636363636,6,3,0.2857142857142857,0.4117647058823529,2,Lignin,2730793.4487714935,1547748.4750226233,0.5667761052081444,-0.8191491581282142,0.007940908508681503,0.23030609530252863,Downregulated
Feature1254,NA,C16 H21 N8 O2 P,388.15237,NA,NA,Feature1254,16,21,2,8,0,1,1.3125,0.125,0.125,56.7375,11,9,0,0.16666666666666666,0,Unsaturated HC,37574911.82542027,41965477.007480636,1.1168483163037006,0.159433260865022,0.7367808754392786,0.8685503152360042,Upregulated
Feature1253,N-Phenyl-beta-D-glucopyranosylamine,C12 H17 N O5,255.11068,NA,NA,N-Phenyl-beta-D-glucopyranosylamine-peak3,12,17,5,1,0,0,1.4166666666666667,0.4166666666666667,-0.33333333333333304,69.79999999999998,5,0,-0.16666666666666666,0.17647058823529413,-1,Lignin,49014510.7300193,42725792.52989387,0.871696807609387,-0.19810166885299513,0.05778208973029258,0.3790841191943452,Downregulated
Feature1252,NA,C14 H31 N O,229.24056,NA,NA,Feature1252,14,31,1,1,0,0,2.2142857142857144,0.07142857142857142,-1.8571428571428568,113.2285714285714,0,-1,-0.16666666666666666,-0.12,-2,Lipid,51726723.22834403,15508181.52356059,0.29980985756822054,-1.737880275874479,0.15114586888640202,0.46695517742640485,Downregulated
Feature1251,11-Aminoundecanoic acid,C11 H23 N O2,201.1728,NA,NA,11-Aminoundecanoic acid,11,23,2,1,0,0,2.090909090909091,0.18181818181818185,-1.454545454545454,101.75454545454544,1,-1,-0.25,-0.1111111111111111,-2,Lipid,6336771.611673516,16749199.680304566,2.6431755327033426,1.4022722372199778,0.05754137674700964,0.3790841191943452,Upregulated
Feature1250,2-Pyrrolidone,C4 H7 N O,85.05278,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,2-Pyrrolidone-peak1,4,7,1,1,0,0,1.75,0.25,-0.5,74.55,2,1,0,0.2,0,Lipid,19179987.700378865,21784099.362879466,1.1357723322444655,0.18367367281846295,0.38210898898328766,0.6339790669321149,Upregulated
Feature1249,3-Butynoic acid,C4 H4 O2,84.02114,Metabolic pathways;Other,NA,3-Butynoic acid-peak3,4,4,2,0,0,0,1,0.5,0,60.3,3,1,0.5,0.6666666666666666,1,Lignin,21332638.387400832,15980158.275579933,0.7490943213577322,-0.4167807094640793,0.047981778615059784,0.35641545489778387,Downregulated
Feature1248,NA,C12 H19 N O7,289.11624,NA,NA,Feature1248,12,19,7,1,0,0,1.5833333333333333,0.5833333333333334,-0.16666666666666696,65.05000000000001,4,-3,-1,-0.06666666666666667,-4,Amino Sugar,45425843.385639496,45890482.03447194,1.0102285090204692,0.014681660841460914,0.9549464364522642,0.9749458049634153,Upregulated
Feature1247,"1D-myo-Inositol 1,2-cyclic phosphate",C6 H11 O8 P,242.01913,"Metabolic pathways;Biosynthesis of secondary metabolites;Phenylalanine, tyrosine and tryptophan biosynthesis",Other,"1D-myo-Inositol 1,2-cyclic phosphate",6,11,8,0,0,1,1.8333333333333333,1.3333333333333333,0,60.3,2,-6,2.3333333333333335,-3,-7,Carbohydrate,27778345.865033735,34270442.096019596,1.2337106846652757,0.3030041102604431,0.35969326393904294,0.6167210416120837,Upregulated
Feature1246,APM,C7 H13 N O4,175.08447,NA,NA,APM-peak4,7,13,4,1,0,0,1.8571428571428572,0.5714285714285714,-0.2857142857142856,68.44285714285714,2,-2,-1.5,-0.25,-3,Amino Sugar,31401188.749651533,37487287.69522493,1.1938174695899353,0.25558227056592625,0.3784282739964457,0.6297224913064627,Upregulated
Feature1245,NA,C16 H23 N5 O9,429.1496,NA,NA,Feature1245,16,23,9,5,0,0,1.4375,0.5625,0.625,42.4875,8,-1,-3,-0.2307692307692308,-6,Lignin,30152105.618552968,24076717.140196234,0.798508649604276,-0.3246200596070118,0.6964437209635254,0.8445065592786056,Downregulated
Feature1244,6-Aminocaproic acid,C6 H13 N O2,131.09459,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Superpathway of indole-3-acetate conjugate biosynthesis,6-Aminocaproic acid-peak3,6,13,2,1,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,215757.71452575398,273961.0948855106,1.2697626849064958,0.3445588865243385,0.51064041076588,0.7178629509024071,Upregulated
Feature1243,Etilevodopa,C11 H15 N O4,225.1001,NA,NA,Etilevodopa-peak2,11,15,4,1,0,0,1.3636363636363635,0.3636363636363637,-0.3636363636363633,70.66363636363636,5,1,0,0.25,0,Lignin,37019978.720674396,28346733.133636698,0.7657144631962204,-0.38512158697792553,2.660090045729466e-4,0.13209075561330955,Downregulated
Feature1242,NA,C11 H20 N2 O8,308.12197,NA,NA,Feature1242,11,20,8,2,0,0,1.818181818181818,0.7272727272727273,0.18181818181818168,55.11818181818182,3,-5,-7,-0.6,-7,Carbohydrate,3155051.0013554767,4861598.616651803,1.5408938285191451,0.6237674599410838,0.017194495573890575,0.2637533176745511,Upregulated
Feature1241,(-)-Caryophyllene oxide,C15 H24 O,220.1827,Biosynthesis of secondary metabolites;Other,Other,(-)-Caryophyllene oxide-peak2,15,24,1,0,0,0,1.6,0.06666666666666667,-1.4666666666666668,102.1,4,3,0.21428571428571427,0.2413793103448276,3,Lipid,660462.6199810617,768473.249908794,1.1635378394780758,0.21851812947096627,0.5544081131282846,0.7562901141909594,Upregulated
Feature1240,cis-4-Decenedioic acid,C10 H16 O4,200.10487,NA,NA,cis-4-Decenedioic acid,10,16,4,0,0,0,1.6,0.4,-0.7999999999999998,83.1,3,-1,-0.16666666666666666,0.125,-1,Protein,30372270.24001157,19577323.996660367,0.6445788820510939,-0.633571171862596,0.03623687691981138,0.33805559870221996,Downregulated
Feature1239,EDDA,C6 H12 N2 O4,176.07974,Other,NA,EDDA,6,12,4,2,0,0,2,0.6666666666666666,0.3333333333333335,50.8,2,-2,-Inf,-1,-4,Amino Sugar,30633963.125178333,33677940.1246076,1.0993660855107381,0.13667187928532687,0.5929117242721089,0.7816283742544378,Upregulated
Feature1238,Leucylasparagine,C10 H19 N3 O4,245.13753,NA,NA,Leucylasparagine-peak4,10,19,4,3,0,0,1.9,0.4,-0.20000000000000015,66,3,-1,-1.3333333333333333,-0.4,-4,Protein,24763046.9981734,25616650.768129833,1.0344708698416394,0.0488930202325133,0.8550073234951432,0.9259629890260237,Upregulated
Feature1237,Neolinustatin,C17 H29 N O11,423.17418,NA,NA,Neolinustatin,17,29,11,1,0,0,1.7058823529411764,0.6470588235294118,-0.23529411764705888,67.00588235294117,4,-7,-1.6,-0.23809523809523808,-8,Amino Sugar,1399381.7244334642,633718.2128542647,0.4528558589764517,-1.1428761718369351,0.20897680108029046,0.5028674357354733,Downregulated
Feature1236,NA,C12 H19 N3 O4 S,301.10964,NA,NA,Feature1236,12,19,4,3,1,0,1.5833333333333333,0.3333333333333333,0,60.3,5,1,-0.75,-0.16666666666666666,-3,Protein,349083.02414393297,348611.12731662137,0.9986481816797914,-0.0019515809756022538,0.9849127865111557,0.9925296016358702,Downregulated
Feature1235,ARG-PHE,C15 H23 N5 O3,321.18018,NA,NA,ARG-PHE-peak2,15,23,3,5,0,0,1.5333333333333334,0.2,-0.13333333333333375,64.10000000000001,7,4,-0.14285714285714285,0.0588235294117647,-1,Lipid,17754797.7976727,28106369.9706794,1.5830295726805508,0.6626882068086797,0.08079029108124822,0.39590936857023457,Upregulated
Feature1234,Gly-Phe,C11 H14 N2 O3,222.10044,NA,NA,Gly-Phe-peak2,11,14,3,2,0,0,1.2727272727272727,0.2727272727272727,-0.18181818181818168,65.48181818181817,6,3,0.16666666666666666,0.3333333333333333,1,Lignin,21602102.8545864,34480297.3022477,1.5961546676427891,0.6746004557142832,0.2163306166910473,0.5069722111991797,Upregulated
Feature1233,"tert-Butyl 3-amino-1-methyl-2,3-dioxopropylcarbamate",C9 H16 N2 O4,216.11101,Metabolic pathways;Other,Other,"tert-Butyl 3-amino-1-methyl-2,3-dioxopropylcarbamate",9,16,4,2,0,0,1.7777777777777777,0.4444444444444444,-0.22222222222222232,66.63333333333333,3,-1,-1,-0.2,-3,Protein,27515495.4735636,27618160.87506487,1.0037311849099686,0.005372944463392935,0.9914688102169418,0.9952747121088282,Upregulated
Feature1232,N-Acetyl-6-oxo-L-norleucine,C8 H13 N O4,187.08446,Metabolic pathways;Lysine degradation;Other,Superpathway of L-lysine degradation,N-Acetyl-6-oxo-L-norleucine,8,13,4,1,0,0,1.625,0.5,-0.25,67.425,3,-1,-0.6666666666666666,0,-2,Protein,1106833.7852921314,1226318.5953028947,1.1079518999135243,0.14789525028374703,0.638684165519941,0.8131443267876828,Upregulated
Feature1231,Hymexazol N-glucoside,C10 H15 N O7,261.08485,NA,NA,Hymexazol N-glucoside,10,15,7,1,0,0,1.5,0.7,0.20000000000000015,54.599999999999994,4,-3,-2,-0.09090909090909093,-4,Amino Sugar,458439.212852273,303297.33224058733,0.6615868009055359,-0.595997642811789,0.3275729869679372,0.5903535715724065,Downregulated
Feature1230,"(2Z,4E)-2,4-Pentadecadienal",C15 H26 O,222.19833,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"(2Z,4E)-2,4-Pentadecadienal",15,26,1,0,0,0,1.7333333333333334,0.06666666666666667,-1.5999999999999996,105.89999999999998,3,2,0.14285714285714285,0.1724137931034483,2,Lipid,733518.1747389063,937870.082748627,1.2785914719597224,0.3545553763965753,0.43897348441690975,0.6660955963052084,Upregulated
Feature1229,pro-his,C11 H16 N4 O3,252.12227,NA,NA,pro-his,11,16,3,4,0,0,1.4545454545454546,0.2727272727272727,0.18181818181818168,55.11818181818182,6,3,-0.25,0.09090909090909093,-1,Lignin,16534284.20455678,16583456.850680467,1.0029739809425882,0.004284180175427163,0.9943038652480757,0.9966572471776568,Upregulated
Feature1228,N-[(2S)-2-Hydroxypropanoyl]-L-tryptophan,C14 H16 N2 O4,276.11103,NA,NA,N-[(2S)-2-Hydroxypropanoyl]-L-tryptophan,14,16,4,2,0,0,1.1428571428571428,0.2857142857142857,-0.14285714285714324,64.37142857142858,8,4,0.25,0.4,2,Lignin,7953015.526402573,3867440.03871825,0.4862859912543926,-1.0401230633332073,0.09914776658772498,0.42200079547639724,Downregulated
Feature1227,NA,C21 H35 N O16,557.19585,NA,NA,Feature1227,21,35,16,1,0,0,1.6666666666666667,0.7619047619047619,0,60.3,5,-11,-3,-0.3333333333333333,-12,Carbohydrate,5367431.672408007,1461555.1445848919,0.27230065211602217,-1.8767276574802227,0.12301534157954272,0.45317690246982556,Downregulated
Feature1226,N-{3-[(4-Acetamidobutyl)amino]propyl}acetamide,C11 H23 N3 O2,229.17901,NA,NA,N-{3-[(4-Acetamidobutyl)amino]propyl}acetamide,11,23,2,3,0,0,2.090909090909091,0.18181818181818185,-0.9090909090909092,86.2090909090909,2,0,-0.5,-0.2857142857142857,-3,Lipid,1275398.65063168,788866.375153696,0.6185253330501691,-0.6930954097626928,0.04709417705329519,0.35607946299980225,Downregulated
Feature1225,NA,C12 H19 N O8,305.11113,NA,NA,Feature1225,12,19,8,1,0,0,1.5833333333333333,0.6666666666666666,0,60.3,4,-4,-1.6666666666666667,-0.14285714285714285,-5,Amino Sugar,937069.1513973504,968978.874574828,1.0340526877124212,0.04830969664402681,0.836384369448686,0.9202752342914452,Upregulated
Feature1224,NA,C18 H33 N O15,503.18519,NA,NA,Feature1224,18,33,15,1,0,0,1.8333333333333333,0.8333333333333334,0,60.3,3,-12,-6.5,-0.5789473684210527,-13,Carbohydrate,18627570.5189434,16176330.339828966,0.8684079506438248,-0.20355516038765625,0.13367521938056118,0.45384777576550756,Downregulated
Feature1223,"(2S)-3-Methyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",C11 H21 N O7,279.13182,NA,NA,"(2S)-3-Methyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)-peak1",11,21,7,1,0,0,1.9090909090909092,0.6363636363636364,-0.3636363636363633,70.66363636363636,2,-5,-2,-0.38461538461538464,-6,Amino Sugar,32541249.163534466,33096663.50823153,1.017068009341186,0.024416152606182982,0.9280544703372323,0.9614238318542533,Upregulated
Feature1222,2762577,C15 H23 N3 O4,309.16894,NA,NA,2762577-peak2,15,23,4,3,0,0,1.5333333333333334,0.26666666666666666,-0.4000000000000003,71.7,6,2,-0.125,0.1,-1,Lipid,8832823.0452224109,21302174.458904512,2.4117062404444582,1.2700541894668929,0.32284413696170894,0.5861484461709393,Upregulated
Feature1221,N-(Carboxymethyl)norleucine,C8 H15 N O4,189.10012,NA,NA,N-(Carboxymethyl)norleucine-peak1,8,15,4,1,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,9500409.92551376,7995344.22385591,0.841578867284881,-0.24882961702293757,0.6098640150043083,0.7912648547240121,Downregulated
Feature1220,2'-Deoxycytidine,C9 H13 N3 O4,227.0906,Metabolic pathways;ABC transporters;Other,Other,2'-Deoxycytidine,9,13,4,3,0,0,1.4444444444444444,0.4444444444444444,0.44444444444444464,47.633333333333326,5,1,-1,0,-2,Lignin,5439837.938036436,9735207.598425154,1.789613534321424,0.8396480722296994,0.2258336291452392,0.5155824363504518,Upregulated
Feature1219,NA,C7 H17 N O6,211.10558,NA,NA,Feature1219,7,17,6,1,0,0,2.4285714285714284,0.8571428571428571,-0.2857142857142856,68.44285714285714,0,-6,-Inf,-1.3333333333333333,-7,Carbohydrate,40848741.8283583,42971028.461263,1.0519547613442368,0.07307266376742187,0.8499537729917629,0.92558845302131,Upregulated
Feature1218,NA,C20 H42 O5,362.30324,NA,NA,Feature1218,20,42,5,0,0,0,2.1,0.25,-1.5999999999999996,105.89999999999998,0,-5,-0.3333333333333333,-0.14285714285714285,-5,Lipid,868885.8407190354,8773238.05564539,10.097112468060486,3.3358708706747087,0.17787138449505271,0.48056479319715995,Upregulated
Feature1217,leu-phe,C15 H22 N2 O3,278.16307,NA,NA,leu-phe-peak2,15,22,3,2,0,0,1.4666666666666666,0.2,-0.666666666666667,79.30000000000001,6,3,0.1,0.21739130434782608,1,Lignin,20822376.396337368,18606401.0504715,0.8935772121449281,-0.1623356999621722,0.6372348630081947,0.8131443267876828,Downregulated
Feature1216,D-ribosylnicotinate,C11 H13 N O6,255.07429,NA,NA,D-ribosylnicotinate-peak2,11,13,6,1,0,0,1.181818181818182,0.5454545454545454,0.18181818181818168,55.11818181818182,6,0,-0.25,0.2857142857142857,-1,Lignin,3508260.3910164735,10011705.655948674,2.853752156363716,1.5128600445854352,0.23822575133577192,0.5231694095424109,Upregulated
Feature1215,Tiglic acid,C5 H8 O2,100.05241,NA,NA,Tiglic acid-peak2,5,8,2,0,0,0,1.6,0.4,-0.7999999999999998,83.1,2,0,0,0.25,0,Protein,6258123.88854298,5251826.14203595,0.8392013701823157,-0.25291106145071113,0.23990210824903313,0.5243795759662737,Downregulated
Feature1214,NP-013538,C12 H16 O8,288.08457,NA,NA,NP-013538-peak1,12,16,8,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,5,-3,-0.75,0.125,-3,Tannin,7787749.249521471,6649443.5435537305,0.8538338010770332,-0.22797281859723534,0.8472040037050481,0.924718803013113,Downregulated
Feature1213,"(2E,4E,7E)-2,4,7-Decatrienoic acid",C10 H14 O2,166.0994,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"(2E,4E,7E)-2,4,7-Decatrienoic acid",10,14,2,0,0,0,1.4,0.2,-1,88.8,4,2,0.25,0.3333333333333333,2,Lignin,1447971.7915533881,2828084.93426858,1.9531353792704778,0.9657919513922035,0.06161413362274422,0.3794192923980171,Upregulated
Feature1212,NA,C32 H36 O10,580.23105,NA,NA,Feature1212,32,36,10,0,0,0,1.125,0.3125,-0.5,74.55,15,5,0.2272727272727273,0.3703703703703703,5,Lignin,36416225.98042907,54308906.70416427,1.4913381395796244,0.5766074051639284,0.03678071813875521,0.33805559870221996,Upregulated
Feature1211,"5-[(5-Hydroxytetrahydro-2-furanyl)methyl]-1,3-benzenediol",C11 H14 O4,210.08922,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Other,"5-[(5-Hydroxytetrahydro-2-furanyl)methyl]-1,3-benzenediol-peak2",11,14,4,0,0,0,1.2727272727272727,0.3636363636363637,-0.5454545454545459,75.84545454545456,5,1,0.14285714285714285,0.3333333333333333,1,Lignin,36630982.04861837,49325575.20768223,1.3465534487231328,0.4292714958458367,0.25872396595705116,0.541753273586211,Upregulated
Feature1210,4-Nitrophenyl 2-acetamido-2-deoxy-α-D-glucopyranoside,C14 H18 N2 O8,342.10633,Biosynthesis of secondary metabolites;Other,NA,4-Nitrophenyl 2-acetamido-2-deoxy-α-D-glucopyranoside,14,18,8,2,0,0,1.2857142857142858,0.5714285714285714,0.2857142857142856,52.15714285714286,7,-1,-0.75,0.125,-3,Lignin,973217.7670786887,325435.9919524377,0.3343917496793139,-1.5803888420964785,0.42563916478963715,0.6594697741371865,Downregulated
Feature1209,10-Deoxymethymycin,C25 H43 N O6,453.30918,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,10-Deoxymethymycin,25,43,6,1,0,0,1.72,0.24,-1.12,92.22,5,-1,-0.1111111111111111,0.04761904761904761,-2,Lipid,2133626.4916980797,2281091.77265024,1.069114852822622,0.09641684716226982,0.7639855728495806,0.8813077766218278,Upregulated
Feature1208,NA,C12 H22 N4 O7,334.14893,NA,NA,Feature1208,12,22,7,4,0,0,1.8333333333333333,0.5833333333333334,0.3333333333333335,50.8,4,-3,-7,-0.7777777777777778,-7,Amino Sugar,8373420.517074403,8658787.478266288,1.0340800943425672,0.0483479334630014,0.9164160899666052,0.954276522673265,Upregulated
Feature1207,NA,C46 H84 N10 O13 P2 S,1078.54184,NA,NA,Feature1207,46,84,13,10,1,2,1.826086956521739,0.2826086956521739,-0.7826086956521738,82.60434782608695,11,-2,-0.75,-0.32075471698113206,-15,Lipid,432071.476058832,487131.34918826236,1.127432325854191,0.17304083828357206,0.4476856233449076,0.6693345092486654,Upregulated
Feature1206,Diethyl tartrate,C8 H14 O6,206.07905,NA,NA,Diethyl tartrate,8,14,6,0,0,0,1.75,0.75,-0.25,67.425,2,-4,-2,-0.2,-4,Carbohydrate,195626.425039691,255381.63002967866,1.3054556917750955,0.3845534922419983,0.45993561775971276,0.6804636999868588,Upregulated
Feature1205,NA,C9 H19 N O3,189.13649,NA,NA,Feature1205,9,19,3,1,0,0,2.111111111111111,0.3333333333333333,-1.1111111111111107,91.96666666666664,1,-2,-0.6,-0.2307692307692308,-3,Protein,1623994.0651297267,1589679.0551086634,0.9788699905018913,-0.030810835174207202,0.8875332864335599,0.941126558385276,Downregulated
Feature1204,NA,C16 H5 O13 P3,497.89406,NA,NA,Feature1204,16,5,13,0,0,3,0.3125,0.8125,0.375,49.6125,16,3,NA,1,0,Condensed HC,26415655.4257068,35401892.92058544,1.340186050660456,0.4224332960062466,0.153738851798969,0.46778235597057083,Upregulated
Feature1203,5-guanidino-2-oxopentanoic acid,C6 H11 N3 O3,173.08005,Metabolic pathways;Other,NA,5-guanidino-2-oxopentanoic acid,6,11,3,3,0,0,1.8333333333333333,0.5,0.6666666666666665,41.3,3,0,-Inf,-1,-3,Protein,12711168.333207559,4892951.037725884,0.38493322639298155,-1.3773198888373686,0.19236032648052626,0.4862119877973694,Downregulated
Feature1202,"(E,E)-alpha-Farnesene",C15 H24,204.18778,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,Other,"(E,E)-alpha-Farnesene",15,24,0,0,0,0,1.6,0,-1.5999999999999996,105.89999999999998,4,4,0.26666666666666666,0.26666666666666666,4,Lipid,532299.729630849,585334.8079564027,1.0996338629785396,0.13702324011826725,0.816165581457319,0.9127191231804745,Upregulated
Feature1201,Nicotinamide,C6 H6 N2 O,122.04796,Metabolic pathways;Biosynthesis of cofactors;Other,Other,Nicotinamide,6,6,1,2,0,0,1,0.16666666666666666,0.3333333333333335,50.8,5,4,0.6666666666666666,0.7142857142857143,2,Lignin,24841849.5068594,22923247.775791943,0.9227673555248901,-0.11596112777088247,0.8770661722763622,0.9367907287743742,Downregulated
Feature1200,δ-Valerolactam,C5 H9 N O,99.06839,Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,δ-Valerolactam-peak2,5,9,1,1,0,0,1.8,0.2,-0.7999999999999998,83.1,2,1,0,0.14285714285714285,0,Lipid,9353341.204029826,9664252.599027567,1.0332406771244254,0.04717634641069868,0.7504505897968116,0.8761290827813912,Upregulated
Feature1199,NA,C11 H17 N O5,243.11065,NA,NA,Feature1199,11,17,5,1,0,0,1.5454545454545454,0.4545454545454546,-0.3636363636363633,70.66363636363636,4,-1,-0.4,0.06666666666666667,-2,Protein,12360298.649827776,8456863.974794604,0.684195763741715,-0.5475189233272088,0.32282934980426664,0.5861484461709393,Downregulated
Feature1198,8722455,C11 H17 N O8,291.09546,NA,NA,8722455,11,17,8,1,0,0,1.5454545454545454,0.7272727272727273,0.18181818181818168,55.11818181818182,4,-4,-2.5,-0.16666666666666666,-5,Carbohydrate,19581332.376859665,9532272.492224494,0.48680407996594266,-1.038586835377286,0.06552496043734372,0.38614481760703634,Downregulated
Feature1197,Fluoranthene,C16 H10,202.07833,Microbial metabolism in diverse environments;Other,NA,Fluoranthene-peak4,16,10,0,0,0,0,0.625,0,-0.625,78.1125,12,12,0.75,0.75,12,Condensed HC,16398828.092547633,16680876.282591533,1.0171992893914215,0.024602359283961664,0.8695177773641051,0.9340286080245999,Upregulated
Feature1196,Nicotinic acid,C6 H5 N O2,123.03199,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Aminobenzoate degradation;Other,Other,Nicotinic acid,6,5,2,1,0,0,0.8333333333333334,0.3333333333333333,0.3333333333333335,50.8,5,3,0.6666666666666666,0.75,2,Lignin,15142733.251348166,18306278.717567034,1.208915089086524,0.2737129171629325,0.5699681214704819,0.7634736581619005,Upregulated
Feature1195,"2-oxa-4-azatetracyclo[6.3.1.1~6,10~.0~1,5~]tridecan-3-one",C11 H15 N O2,193.11027,NA,NA,"2-oxa-4-azatetracyclo[6.3.1.1~6,10~.0~1,5~]tridecan-3-one",11,15,2,1,0,0,1.3636363636363635,0.18181818181818185,-0.7272727272727275,81.02727272727273,5,3,0.25,0.3333333333333333,2,Lignin,16844605.20846103,14493939.546731833,0.8604499403436027,-0.21683683396277886,0.06416023783872786,0.38541646418015957,Downregulated
Feature1194,2-methylbutyrylcarnitine,C12 H23 N O4,245.1627,NA,NA,2-methylbutyrylcarnitine,12,23,4,1,0,0,1.9166666666666667,0.3333333333333333,-1,88.8,2,-2,-0.42857142857142855,-0.1111111111111111,-3,Protein,7112239.3898064,5234378.849786211,0.7359677540225055,-0.4422855380221287,0.5839626775535806,0.7764778459778379,Downregulated
Feature1193,dihydropyranone,C5 H6 O2,98.03675,Microbial metabolism in diverse environments;Other,NA,dihydropyranone-peak1,5,6,2,0,0,0,1.2,0.4,-0.4000000000000003,71.7,3,1,0.3333333333333333,0.5,1,Lignin,30260799.023958035,37618029.73516376,1.2431274437063236,0.31397420707271795,0.209454359823987,0.5028674357354733,Upregulated
Feature1192,"2,5-Furandicarboxylic acid",C6 H4 O5,156.00587,Microbial metabolism in diverse environments;Other,NA,"2,5-Furandicarboxylic acid",6,4,5,0,0,0,0.6666666666666666,0.8333333333333334,1,31.799999999999997,5,0,0,0.7142857142857143,0,Condensed HC,42568205.873623036,34126246.20130193,0.801683921155059,-0.3188945555446103,0.11017024897564077,0.44011899692530887,Downregulated
Feature1191,"3-Hydroxy-2,4,5-pyridinetrimethanol",C8 H11 N O4,185.06883,NA,NA,"3-Hydroxy-2,4,5-pyridinetrimethanol-peak5",8,11,4,1,0,0,1.375,0.5,0,60.3,4,0,-0.3333333333333333,0.2,-1,Lignin,7840013.03843341,11858636.341942191,1.5125786505467065,0.5970101611003501,0.3375556855007862,0.5981373757723136,Upregulated
Feature1190,MFCD00025555,C9 H18 N2 O3,202.13171,NA,NA,MFCD00025555-peak1,9,18,3,2,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,20849202.699899666,21373766.25874927,1.0251598857951594,0.03584893261391291,0.9199032641119702,0.9559061905453898,Upregulated
Feature1189,5-Ethyl-4-hydroxy-3(2H)-furanone,C6 H8 O3,128.04732,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Aminobenzoate degradation;Other,Other,5-Ethyl-4-hydroxy-3(2H)-furanone-peak2,6,8,3,0,0,0,1.3333333333333333,0.5,-0.33333333333333304,69.79999999999998,3,0,0,0.3333333333333333,0,Lignin,554200.764918868,672116.5774226009,1.212767321822436,0.27830278553467774,0.5304828601423577,0.7346581985645525,Upregulated
Feature1188,UNII:74D1OHC38H,C19 H32 O4,324.23008,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,UNII:74D1OHC38H-peak2,19,32,4,0,0,0,1.6842105263157894,0.21052631578947367,-1.2631578947368425,96.3,4,0,0,0.1176470588235294,0,Lipid,2287950.0826353934,3341856.9616336413,1.4606336855847384,0.5465944079470979,0.6609762713151375,0.8257328935161082,Upregulated
Feature1187,Meglutol,C6 H10 O5,162.05283,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Superpathway of butirocin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Other,Meglutol-peak1,6,10,5,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,2,-3,-3,-0.14285714285714285,-3,Carbohydrate,36187708.7250491,25927857.187923033,0.7164824218333501,-0.4809967850195384,0.1946080461109379,0.4891187390384701,Downregulated
Feature1186,NA,C7 H17 N O6,211.10569,NA,NA,Feature1186,7,17,6,1,0,0,2.4285714285714284,0.8571428571428571,-0.2857142857142856,68.44285714285714,0,-6,-Inf,-1.3333333333333333,-7,Carbohydrate,20425314.5356051,17447882.561034173,0.8542283415327234,-0.22730633047039484,0.6515486055001244,0.8222902365534117,Downregulated
Feature1185,"1-{[(3S,4S,5R)-2,3,4-Trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}-2-pyrrolidinecarboxylic acid (non-preferred name)",C11 H19 N O7,277.11616,NA,NA,"1-{[(3S,4S,5R)-2,3,4-Trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}-2-pyrrolidinecarboxylic acid (non-preferred name)",11,19,7,1,0,0,1.7272727272727273,0.6363636363636364,-0.18181818181818168,65.48181818181817,3,-4,-1.6666666666666667,-0.2307692307692308,-5,Amino Sugar,35377544.189667135,34364889.9786246,0.9713757912190437,-0.04189856315146565,0.8605962856120077,0.9285182374020331,Downregulated
Feature1184,NP-019722,C8 H13 N O4,187.08445,Metabolic pathways;Lysine degradation;Other,Superpathway of L-lysine degradation,NP-019722-peak2,8,13,4,1,0,0,1.625,0.5,-0.25,67.425,3,-1,-0.6666666666666666,0,-2,Protein,23753528.12068023,19250917.854997266,0.8104445687896394,-0.30321458041791116,0.18370426944912513,0.4854964193043512,Downregulated
Feature1183,Tolycaine,C15 H22 N2 O3,278.16307,NA,NA,Tolycaine-peak2,15,22,3,2,0,0,1.4666666666666666,0.2,-0.666666666666667,79.30000000000001,6,3,0.1,0.21739130434782608,1,Lignin,29584451.25724373,22459116.47903517,0.7591527145035712,-0.3975379611633912,0.27803896660579136,0.5571101578849338,Downregulated
Feature1182,Thymine,C5 H6 N2 O2,126.04289,Metabolic pathways;Other,Other,Thymine,5,6,2,2,0,0,1.2,0.4,0.7999999999999998,37.5,4,2,0,0.5,0,Lignin,5383833.036538834,5620100.808454843,1.043884676644412,0.061962338705593624,0.8355464114120071,0.9202752342914452,Upregulated
Feature1181,Quinestrol,C25 H32 O2,364.24025,NA,NA,Quinestrol-peak2,25,32,2,0,0,0,1.28,0.08,-1.12,92.22,10,8,0.34782608695652173,0.375,8,Unsaturated HC,2483086.94685852,3901626.86708518,1.5712808091643053,0.6519410328193972,0.12170529318531728,0.45317690246982556,Upregulated
Feature1180,1-Monopropionin,C6 H12 O4,148.07358,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,1-Monopropionin-peak1,6,12,4,0,0,0,2,0.6666666666666666,-0.666666666666667,79.30000000000001,1,-3,-1.5,-0.25,-3,Amino Sugar,584081.9449473947,561786.7614643637,0.9618286720281364,-0.05614816142041281,0.8170231668241303,0.9127191231804745,Downregulated
Feature1179,pyroglutamine,C5 H8 N2 O2,128.05857,Metabolic pathways;Other,NA,pyroglutamine,5,8,2,2,0,0,1.6,0.4,0.3999999999999999,48.9,3,1,-1,0,-1,Protein,19655702.2509909,20208344.7862026,1.0281161429978334,0.040003250390111406,0.8488859830269146,0.9253621977140241,Upregulated
Feature1178,pyr-gln-OH,C10 H15 N3 O5,257.10118,NA,NA,pyr-gln-OH,10,15,5,3,0,0,1.5,0.5,0.3999999999999999,48.9,5,0,-1.5,-0.1111111111111111,-3,Protein,3364678.09625509,2208194.8238150897,0.6562870980950082,-0.6076010233546303,0.22920041124259605,0.5170330973050352,Downregulated
Feature1177,NA,C9 H17 N5 O2,227.1382,NA,NA,Feature1177,9,17,2,5,0,0,1.8888888888888888,0.2222222222222222,0.22222222222222232,53.96666666666666,4,2,-1.5,-0.6666666666666666,-3,Lipid,40341859.97530803,31773230.737069163,0.7875995493642719,-0.34446580910512803,0.07970000838301873,0.39590936857023457,Downregulated
Feature1176,NA,C5 H10 N6 O,170.09157,NA,NA,Feature1176,5,10,1,6,0,0,2,0.2,2,3.299999999999997,4,3,1.5,1.6666666666666667,-3,Lipid,17257141.116603334,48487124.45119597,2.8096846472760104,1.4904082146662017,0.01373571709201443,0.25835889181660304,Upregulated
Feature1175,NA,C15 H27 N O5,301.18898,NA,NA,Feature1175,15,27,5,1,0,0,1.8,0.3333333333333333,-0.9333333333333336,86.9,3,-2,-0.3333333333333333,-0.04347826086956521,-3,Protein,2398045.5186026767,13976249.720486334,5.828183665433587,2.5430463422334277,0.020266812394616373,0.28009922407994764,Upregulated
Feature1174,"3-Hydroxy-2,4,5-pyridinetrimethanol",C8 H11 N O4,185.06883,NA,NA,"3-Hydroxy-2,4,5-pyridinetrimethanol-peak4",8,11,4,1,0,0,1.375,0.5,0,60.3,4,0,-0.3333333333333333,0.2,-1,Lignin,6971483.675767303,7751087.798298493,1.1118275762792178,0.15293307031454473,0.7647712111181151,0.8813077766218278,Upregulated
Feature1173,Bis(4-ethylbenzylidene)sorbitol,C24 H30 O6,414.20433,NA,NA,Bis(4-ethylbenzylidene)sorbitol,24,30,6,0,0,0,1.25,0.25,-0.75,81.675,10,4,0.2222222222222222,0.3333333333333333,4,Lignin,32175095.383958258,9372334.302551923,0.2912915778712733,-1.7794641055237628,0.21788640428748735,0.5080832331812387,Downregulated
Feature1172,NA,C31 H40 O6,508.28264,NA,NA,Feature1172,31,40,6,0,0,0,1.2903225806451613,0.1935483870967742,-0.903225806451613,86.04193548387097,12,6,0.24,0.32142857142857145,6,Lignin,173241.252401292,206582.912121306,1.1924579697841375,0.25393841687849905,0.3711347533422759,0.6242377295699064,Upregulated
Feature1171,2-(2-amino-3-methylbutanamido)-3-phenylpropanoic acid,C14 H20 N2 O3,264.14741,Metabolic pathways;Other,NA,2-(2-amino-3-methylbutanamido)-3-phenylpropanoic acid,14,20,3,2,0,0,1.4285714285714286,0.21428571428571427,-0.5714285714285712,76.58571428571427,6,3,0.1111111111111111,0.23809523809523808,1,Lignin,27689907.617268566,19230771.37058817,0.6945047140061625,-0.5259436082397547,0.19205814942127275,0.4862119877973694,Downregulated
Feature1170,Troxipide,C15 H22 N2 O4,294.15799,NA,NA,Troxipide-peak4,15,22,4,2,0,0,1.4666666666666666,0.26666666666666666,-0.5333333333333332,75.5,6,2,0,0.18181818181818185,0,Lignin,21598277.746302266,20433887.219553366,0.9460887326097911,-0.07995259621405207,0.8196402591847409,0.9136000023320247,Downregulated
Feature1169,N6-Acetyl-L-lysine,C8 H16 N2 O3,188.11611,Metabolic pathways;Lysine degradation,Superpathway of L-lysine degradation,N6-Acetyl-L-lysine,8,16,3,2,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,12858921.66363965,18432124.29094229,1.4334113522957082,0.5194526854937193,0.5003773531376171,0.7117038087448558,Upregulated
Feature1168,Apocynin,C9 H10 O3,166.06303,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylpropanoid biosynthesis;Biosynthesis of various plant secondary metabolites;Phenylalanine metabolism;Tyrosine metabolism;Other,Other,Apocynin-peak2,9,10,3,0,0,0,1.1111111111111112,0.3333333333333333,-0.44444444444444464,72.96666666666667,5,2,0.3333333333333333,0.4666666666666667,2,Lignin,3972980.346914993,14638429.884594966,3.6844959215470725,1.8814672567074517,0.05160065490515712,0.36591042730478307,Upregulated
Feature1167,NA,C6 H9 O7 P,224.00856,NA,NA,Feature1167,6,9,7,0,0,1,1.5,1.1666666666666667,0,60.3,3,-4,2.5,-1,-5,Carbohydrate,19330289.093688633,26204750.757098734,1.3556316012704963,0.4389651731420091,0.3325099350367965,0.5947960189570572,Upregulated
Feature1166,R-Palmitoyl-(2-methyl) ethanolamide,C19 H39 N O2,313.2981,NA,NA,R-Palmitoyl-(2-methyl) ethanolamide-peak2,19,39,2,1,0,0,2.0526315789473686,0.10526315789473684,-1.6842105263157894,108.3,1,-1,-0.125,-0.0588235294117647,-2,Lipid,148540.07960053734,185662.07149490766,1.2499122929932511,0.32182686376489905,0.084020283515612,0.4032021537548066,Upregulated
Feature1165,Glycylproline,C7 H12 N2 O3,172.08476,NA,NA,Glycylproline,7,12,3,2,0,0,1.7142857142857142,0.42857142857142855,0,60.3,3,0,-1,-0.14285714285714285,-2,Protein,16318950.510720767,20492387.886211567,1.2557417753518556,0.32853982591720904,0.48141441998399714,0.6986673019504323,Upregulated
Feature1164,Phosphoric acid,H3 O4 P,97.97687,ABC transporters;Other,Superpathway of L-lysine degradation;Superpathway of chorismate metabolism;Superpathway of aromatic amino acid biosynthesis;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of butirocin biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Superpathway of purine nucleotide salvage;Other,Phosphoric acid,0,3,4,0,0,1,Inf,Inf,NA,NA,0,-4,1,1,-5,Other,19987509.001344234,20587768.014101032,1.0300317069383897,0.04268874783443636,0.6042911871961004,0.7867481750107239,Upregulated
Feature1163,arg-val,C11 H23 N5 O3,273.18012,NA,NA,arg-val,11,23,3,5,0,0,2.090909090909091,0.2727272727272727,-0.18181818181818168,65.48181818181817,3,0,-1.6666666666666667,-0.7777777777777778,-5,Lipid,16397260.203170836,24020206.65872257,1.4648914733985643,0.5507937864295489,0.4635620787189511,0.6840367259145498,Upregulated
Feature1162,NA,C52 H85 N10 O8 P3,1070.57651,NA,NA,Feature1162,52,85,8,10,0,3,1.6346153846153846,0.15384615384615383,-1.0384615384615383,89.89615384615384,17,9,-0.12903225806451613,0,-4,Lipid,160306.88351548434,214437.04412801066,1.3376658533025363,0.4197177781701729,0.06455681321645641,0.38614481760703634,Upregulated
Feature1161,Glycylglutamic acid,C7 H12 N2 O5,204.07457,NA,NA,Glycylglutamic acid,7,12,5,2,0,0,1.7142857142857142,0.7142857142857143,0.5714285714285716,44.014285714285705,3,-2,-Inf,-0.6,-4,Carbohydrate,14453783.23441355,18421228.725641236,1.2744918355895534,0.34992213146745843,0.3833043333956067,0.6347363154654443,Upregulated
Feature1160,NA,C12 H22 N4 O6,318.15394,NA,NA,Feature1160,12,22,6,4,0,0,1.8333333333333333,0.5,0.16666666666666652,55.55,4,-2,-3,-0.6,-6,Protein,5019617.39603143,4343603.674809706,0.8653256477762253,-0.20868493090224696,0.703278331447269,0.8470526718656479,Downregulated
Feature1159,NA,C12 H22 N4 O6,318.1539,NA,NA,Feature1159,12,22,6,4,0,0,1.8333333333333333,0.5,0.16666666666666652,55.55,4,-2,-3,-0.6,-6,Protein,4467961.686825033,2017533.03127431,0.4515555800810781,-1.1470245209745467,0.30275260141844473,0.5749584156982571,Downregulated
Feature1158,AC-LYS-OH,C8 H16 N2 O3,188.11612,Metabolic pathways;Lysine degradation,Superpathway of L-lysine degradation,AC-LYS-OH-peak1,8,16,3,2,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,26101569.274183866,22966942.555391733,0.8799065801038836,-0.1845777342910832,0.32089229057761504,0.5861484461709393,Downregulated
Feature1157,Cytidine 5'-monophosphate (hydrate),C9 H14 N3 O8 P,323.05194,Metabolic pathways;Other,Other,Cytidine 5'-monophosphate (hydrate)-peak2,9,14,8,3,0,1,1.5555555555555556,0.8888888888888888,0.6666666666666665,41.3,5,-3,2.3333333333333335,-3,-7,Carbohydrate,10457750.719428763,10613978.013744483,1.014938900200162,0.02139287910359521,0.8934340307647468,0.9441529932099071,Upregulated
Feature1156,Trachelogenin,C21 H24 O7,388.1523,NA,NA,Trachelogenin,21,24,7,0,0,0,1.1428571428571428,0.3333333333333333,-0.4761904761904763,73.87142857142857,10,3,0.21428571428571427,0.37142857142857144,3,Lignin,30041924.767751236,42655067.1114272,1.419851339126435,0.5057398849887714,0.13404801769234678,0.45384777576550756,Upregulated
Feature1155,"(2R,5R)-2-Benzyl-5-(hydroxymethyl)-2,5-dihydro-2,3,5,6-pyrazinetetrol",C12 H14 N2 O5,266.0903,NA,NA,"(2R,5R)-2-Benzyl-5-(hydroxymethyl)-2,5-dihydro-2,3,5,6-pyrazinetetrol",12,14,5,2,0,0,1.1666666666666667,0.4166666666666667,0.16666666666666652,55.55,7,2,0,0.3333333333333333,0,Lignin,25290208.6178643,13012124.082894893,0.5145123268656429,-0.9587224527634647,0.008744945700265764,0.23146778150390945,Downregulated
Feature1154,Leu-arg,C12 H25 N5 O3,287.19576,NA,NA,Leu-arg-peak2,12,25,3,5,0,0,2.0833333333333335,0.25,-0.33333333333333304,69.79999999999998,3,0,-1.25,-0.6363636363636364,-5,Lipid,15672532.2396385,17795671.136769768,1.1354687847928933,0.18328804541644023,0.5435626207330009,0.7467924408124116,Upregulated
Feature1153,L-gamma-Glutamyl-L-leucine,C11 H20 N2 O5,260.13724,NA,NA,L-gamma-Glutamyl-L-leucine-peak2,11,20,5,2,0,0,1.818181818181818,0.4545454545454546,-0.3636363636363633,70.66363636363636,3,-2,-1,-0.2307692307692308,-4,Protein,14154304.27520007,9397858.961041164,0.663957675228677,-0.5908368166944991,0.2719662346836371,0.5517494629390195,Downregulated
Feature1152,Pipecolic acid,C6 H11 N O2,129.07895,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Lysine degradation;Other,Superpathway of L-lysine degradation,Pipecolic acid-peak1,6,11,2,1,0,0,1.8333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,2,0,-0.3333333333333333,0,-1,Protein,2555511.895622417,4045187.90595046,1.5829266586001236,0.6625944129450405,0.37614643404570847,0.62821390206306,Upregulated
Feature1151,Atagabalin,C10 H19 N O2,185.14156,NA,NA,Atagabalin-peak1,10,19,2,1,0,0,1.9,0.2,-1.2000000000000002,94.5,2,0,-0.14285714285714285,0,-1,Lipid,379451.9206672153,580737.8548718434,1.530464923858321,0.6139699806665783,0.18403352171399232,0.4854964193043512,Upregulated
Feature1150,NA,C11 H14 N O P S,239.05347,NA,NA,Feature1150,11,14,1,1,1,1,1.2727272727272727,0.09090909090909093,-1.0909090909090908,91.39090909090908,6,5,0.2857142857142857,0.3333333333333333,2,Unsaturated HC,186229.55556932933,202527.87263892833,1.087517349326066,0.1210384166735729,0.329732516847435,0.591405822566857,Upregulated
Feature1149,"4-Methyl-6-[(1-methyl-2-piperidinyl)methyl]-5,6-dihydro-2H-pyran-2-one",C13 H21 N O2,223.15721,NA,NA,"4-Methyl-6-[(1-methyl-2-piperidinyl)methyl]-5,6-dihydro-2H-pyran-2-one",13,21,2,1,0,0,1.6153846153846154,0.15384615384615383,-1.0769230769230766,90.99230769230768,4,2,0.1,0.18181818181818185,1,Lipid,41509381.25187653,38596886.04960036,0.9298352537561734,-0.10495296968112901,0.7477830359771028,0.8748111485860584,Downregulated
Feature1148,NA,C16 H21 N5 O9,427.13398,NA,NA,Feature1148,16,21,9,5,0,0,1.3125,0.5625,0.75,38.925,9,0,-2.5,-0.07692307692307693,-5,Lignin,21106477.329973098,22626765.7688602,1.072029472996337,0.10034456993854714,0.409275275136045,0.6571680721141803,Upregulated
Feature1147,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",C10 H18 N2 O5,246.12155,Metabolic pathways;Other,NA,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose-peak5",10,18,5,2,0,0,1.8,0.5,-0.20000000000000015,66,3,-2,-1.3333333333333333,-0.2727272727272727,-4,Protein,24205794.910262767,18994159.1910058,0.7846947089084301,-0.3497966225535071,0.4558450961408355,0.6767761550066392,Downregulated
Feature1146,NA,C4 H11 O6 P,186.02935,NA,NA,Feature1146,4,11,6,0,0,1,2.75,1.5,-1,88.8,0,-6,2.3333333333333335,-Inf,-7,Other,734237.0390450847,537977.4274571344,0.7327026543863863,-0.44870025270101843,0.5265484628197545,0.7335305065926515,Downregulated
Feature1145,NA,C13 H19 N O6,285.1213,NA,NA,Feature1145,13,19,6,1,0,0,1.4615384615384617,0.4615384615384616,-0.3076923076923075,69.06923076923076,5,-1,-0.3333333333333333,0.1111111111111111,-2,Lignin,581402.7527873497,378837.63957984064,0.6515924421816454,-0.6179582247413895,0.017989546670433166,0.2637533176745511,Downregulated
Feature1144,Kanosamine,C6 H13 N O5,179.07944,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,Other,Kanosamine-peak2,6,13,5,1,0,0,2.1666666666666665,0.8333333333333334,0,60.3,1,-4,-Inf,-1,-5,Carbohydrate,28726448.281587232,26331445.7469628,0.9166272658858577,-0.12559289430140855,0.7482888750302235,0.8748111485860584,Downregulated
Feature1143,asn-leu,C10 H19 N3 O4,245.13755,NA,NA,asn-leu-peak3,10,19,4,3,0,0,1.9,0.4,-0.20000000000000015,66,3,-1,-1.3333333333333333,-0.4,-4,Protein,23256459.104510702,26365006.0919178,1.1336638124246603,0.18099287303470885,0.3506892960803239,0.6093000912850749,Upregulated
Feature1142,NA,C15 H29 N O12,415.16907,NA,NA,Feature1142,15,29,12,1,0,0,1.9333333333333331,0.8,-0.13333333333333375,64.10000000000001,2,-10,-5.5,-0.625,-11,Carbohydrate,4765205.762004817,2564565.37509047,0.5381856530811182,-0.8938241626689843,0.24898757437824148,0.5310276106497658,Downregulated
Feature1141,mebutamate,C10 H20 N2 O4,232.14229,Other,NA,mebutamate-peak3,10,20,4,2,0,0,2,0.4,-0.5999999999999996,77.39999999999999,2,-2,-1,-0.3333333333333333,-4,Protein,15079555.003090417,22797788.183178898,1.5118342801565894,0.5963000070858712,0.19002665299991348,0.4862119877973694,Upregulated
Feature1140,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",C10 H18 N2 O5,246.12155,Metabolic pathways;Other,NA,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose-peak4",10,18,5,2,0,0,1.8,0.5,-0.20000000000000015,66,3,-2,-1.3333333333333333,-0.2727272727272727,-4,Protein,19523531.63500921,21665141.273911767,1.1096937623243464,0.1501615968165416,0.7306186238342967,0.8636901247559654,Upregulated
Feature1139,Ser-Glu,C8 H14 N2 O6,234.08519,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,NA,Ser-Glu,8,14,6,2,0,0,1.75,0.75,0.5,46.05,3,-3,-Inf,-0.6666666666666666,-5,Carbohydrate,15874107.071237465,21594702.3339254,1.3603727275503368,0.44400198861922935,0.18929249077338783,0.4862119877973694,Upregulated
Feature1138,Apocynin,C9 H10 O3,166.06304,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylpropanoid biosynthesis;Biosynthesis of various plant secondary metabolites;Phenylalanine metabolism;Tyrosine metabolism;Other,Other,Apocynin-peak1,9,10,3,0,0,0,1.1111111111111112,0.3333333333333333,-0.44444444444444464,72.96666666666667,5,2,0.3333333333333333,0.4666666666666667,2,Lignin,2665635.6511629634,11043331.321593223,4.142850999451197,2.0506239337087595,0.05236102553958645,0.36652717877710517,Upregulated
Feature1137,Adenosine 5'-monophosphate,C10 H14 N5 O7 P,347.06316,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Other,Superpathway of chorismate metabolism;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of indole-3-acetate conjugate biosynthesis;Superpathway of 4-hydroxybenzoate biosynthesis (yeast);Superpathway of purine nucleotide salvage;Other,Adenosine 5'-monophosphate,10,14,7,5,0,1,1.4,0.7,1,31.799999999999997,7,0,2,-5,-6,Tannin,32931621.1023398,32554809.64526707,0.9885577616752684,-0.016602829440874087,0.9763241470835123,0.9868097286154355,Downregulated
Feature1136,Ethyl lactate,C5 H10 O3,118.06297000000001,Metabolic pathways;Other,NA,Ethyl lactate,5,10,3,0,0,0,2,0.6,-0.7999999999999998,83.1,1,-2,-1,-0.14285714285714285,-2,Amino Sugar,2709500.5888027768,2507473.1007570834,0.9254373706798265,-0.11179273641438081,0.22148853269323143,0.5089827335113032,Downregulated
Feature1135,Furan,C4 H4 O,68.02622,Other,NA,Furan-peak2,4,4,1,0,0,0,1,0.25,-0.5,74.55,3,2,0.6666666666666666,0.7142857142857143,2,Lignin,18900397.624582484,14698478.214598134,0.7776808989182749,-0.362749790556013,0.7493334090366568,0.875428134419377,Downregulated
Feature1134,Glycyl-L-leucine,C8 H16 N2 O3,188.11612,Metabolic pathways;Lysine degradation,Superpathway of L-lysine degradation,Glycyl-L-leucine-peak2,8,16,3,2,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,10823953.988141917,21007578.69041297,1.940841462688,0.9566822765600351,0.17496949715329085,0.47831515627777876,Upregulated
Feature1133,Acetylcholine,C7 H15 N O2,145.11029,NA,NA,Acetylcholine,7,15,2,1,0,0,2.142857142857143,0.2857142857142857,-1.1428571428571432,92.87142857142858,1,-1,-0.5,-0.2,-2,Lipid,2999657.8258281667,2265367.4690559465,0.7552086273141864,-0.40505284910670336,0.30622071685866864,0.5763754381762052,Downregulated
Feature1132,3-Methylhippuric acid,C10 H11 N O3,193.0739,Phenylalanine metabolism;Other,NA,3-Methylhippuric acid,10,11,3,1,0,0,1.1,0.3,-0.20000000000000015,66,6,3,0.3333333333333333,0.4666666666666667,2,Lignin,10888010.271796381,2863522.7012674334,0.26299779572075926,-1.9268773870658156,0.2492140133117716,0.5310276106497658,Downregulated
Feature1131,glycidyl oleate,C21 H38 O3,338.28215,NA,NA,glycidyl oleate,21,38,3,0,0,0,1.8095238095238095,0.14285714285714285,-1.5238095238095235,103.72857142857144,3,0,0,0.07692307692307693,0,Lipid,1569558.0598642034,2463113.1048462335,1.569303594324723,0.6501244801946433,0.1515042519565483,0.46695517742640485,Upregulated
Feature1130,Lys-phe,C15 H23 N3 O3,293.17394,NA,NA,Lys-phe-peak2,15,23,3,3,0,0,1.5333333333333334,0.2,-0.5333333333333332,75.5,6,3,0,0.14285714285714285,0,Lipid,14639214.617631,18901755.346257135,1.2911727739473446,0.36868206295287465,0.2465376906917518,0.5299934619693243,Upregulated
Feature1129,2805789,C9 H11 N O3,181.07391,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various plant secondary metabolites;Biosynthesis of various antibiotics;Phenylalanine metabolism;Tyrosine metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of aromatic amino acid biosynthesis;Superpathway of 4-hydroxybenzoate biosynthesis (yeast);Other,2805789,9,11,3,1,0,0,1.2222222222222223,0.3333333333333333,-0.22222222222222232,66.63333333333333,5,2,0.2,0.38461538461538464,1,Lignin,29072231.107877433,23608400.034181934,0.8120601389889538,-0.30034152140750187,0.008367511102792723,0.23030609530252863,Downregulated
Feature1128,Muramic acid,C9 H17 N O7,251.10052,Metabolic pathways;ABC transporters;Other,NA,Muramic acid-peak1,9,17,7,1,0,0,1.8888888888888888,0.7777777777777778,0,60.3,2,-5,-6,-0.5555555555555556,-6,Carbohydrate,15389871.859152267,22552752.258706465,1.4654282027237593,0.5513222862725712,0.1812095873089047,0.48423459758942683,Upregulated
Feature1127,val-arg,C11 H23 N5 O3,273.18012,NA,NA,val-arg,11,23,3,5,0,0,2.090909090909091,0.2727272727272727,-0.18181818181818168,65.48181818181817,3,0,-1.6666666666666667,-0.7777777777777778,-5,Lipid,19693279.12878227,29196237.3797339,1.4825482942077837,0.5680791015195042,0.16818716104940476,0.47405832082810595,Upregulated
Feature1126,NP-001346,C11 H15 N5 O3 S,297.08963,Metabolic pathways;Biosynthesis of plant secondary metabolites;Other,Other,NP-001346,11,15,3,5,1,0,1.3636363636363635,0.2727272727272727,0.7272727272727271,39.57272727272728,7,4,-1,-0.14285714285714285,-2,Lignin,20215214.594067767,19141299.555631865,0.9468759021360551,-0.07875273688599649,0.35884327359886253,0.6165116688402364,Downregulated
Feature1125,"8-Methyl-8-azabicyclo[3.2.1]octane-1,2,3,4,6-pentol",C8 H15 N O5,205.09502,NA,NA,"8-Methyl-8-azabicyclo[3.2.1]octane-1,2,3,4,6-pentol",8,15,5,1,0,0,1.875,0.625,-0.25,67.425,2,-3,-2,-0.3333333333333333,-4,Amino Sugar,25343866.557171065,19327639.65844457,0.7626160599782593,-0.39097118170030226,0.40903550352919205,0.6571680721141803,Downregulated
Feature1124,"3,6-Dideoxy-3-[(Z)-(1-hydroxyethylidene)amino]-alpha-D-glucopyranose",C8 H15 N O5,205.09504,NA,NA,"3,6-Dideoxy-3-[(Z)-(1-hydroxyethylidene)amino]-alpha-D-glucopyranose-peak2",8,15,5,1,0,0,1.875,0.625,-0.25,67.425,2,-3,-2,-0.3333333333333333,-4,Amino Sugar,4166381.32611328,2239101.8414607,0.5374212454887095,-0.8958747393804456,0.1513943764889495,0.46695517742640485,Downregulated
Feature1123,4-hydroxy-4-(indol-3-ylmethyl)glutamic acid,C14 H16 N2 O5,292.10594,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,4-hydroxy-4-(indol-3-ylmethyl)glutamic acid,14,16,5,2,0,0,1.1428571428571428,0.35714285714285715,0,60.3,8,3,0.14285714285714285,0.3684210526315789,1,Lignin,490248.346427311,706124.7988188637,1.4403410107647565,0.5264104202060655,0.48191902738382414,0.6986673019504323,Upregulated
Feature1122,DL-Carnitine,C7 H15 N O3,161.10522,Other,NA,DL-Carnitine-peak1,7,15,3,1,0,0,2.142857142857143,0.42857142857142855,-0.8571428571428568,84.72857142857141,1,-2,-1,-0.3333333333333333,-3,Protein,356687.2877992387,423122.92261631467,1.1862573662969151,0.2464170459709646,0.3798115917940229,0.6314041575064522,Upregulated
Feature1121,L-Theanine,C7 H14 N2 O3,174.10045,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Other,L-Theanine,7,14,3,2,0,0,2,0.42857142857142855,-0.2857142857142856,68.44285714285714,2,-1,-1.5,-0.42857142857142855,-3,Protein,10684674.543869717,13694645.901935562,1.28170922246694,0.35806899917422125,0.5185587984613048,0.72558973657982,Upregulated
Feature1120,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",C10 H13 N O3,195.08948,Other,NA,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime-peak2",10,13,3,1,0,0,1.3,0.3,-0.4000000000000003,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Lignin,295366.359006408,342530.848940311,1.1596813194724038,0.2137284070926003,0.759836872016258,0.8780106829437524,Upregulated
Feature1119,Fluoranthene,C16 H10,202.07831,Microbial metabolism in diverse environments;Other,NA,Fluoranthene-peak3,16,10,0,0,0,0,0.625,0,-0.625,78.1125,12,12,0.75,0.75,12,Condensed HC,24778453.217921566,26328150.262064934,1.062542122000679,0.08752003465923301,0.6293681613775347,0.8108154867134375,Upregulated
Feature1118,Icacine,C22 H31 N O6,405.21526,NA,NA,Icacine-peak2,22,31,6,1,0,0,1.4090909090909092,0.2727272727272727,-0.7272727272727275,81.02727272727273,8,2,0.06666666666666667,0.2222222222222222,1,Lignin,578092.8645458753,18644503.107370615,32.2517440550264,5.011305273144329,0.42069142830738127,0.6594697741371865,Upregulated
Feature1117,NA,C5 H13 N O5,167.07939,NA,NA,Feature1117,5,13,5,1,0,0,2.6,1,0,60.3,0,-5,6,-2.3333333333333335,-6,Other,24659386.708977565,25718185.725244198,1.0429369565740727,0.06065195250117253,0.784486663636714,0.892491879248216,Upregulated
Feature1116,5-Deoxy-5-aminoshikimic acid,C7 H11 N O4,173.06882,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Other,5-Deoxy-5-aminoshikimic acid-peak3,7,11,4,1,0,0,1.5714285714285714,0.5714285714285714,0,60.3,3,-1,-1,0,-2,Amino Sugar,11721332.469346367,12292720.299964316,1.0487476856502658,0.0686676269658675,0.8718244549399359,0.935214143108896,Upregulated
Feature1115,leu-gln,C11 H21 N3 O4,259.1532,NA,NA,leu-gln-peak3,11,21,4,3,0,0,1.9090909090909092,0.3636363636363637,-0.3636363636363633,70.66363636363636,3,-1,-1,-0.3333333333333333,-4,Protein,17871953.463939466,18059228.885308232,1.010478732598909,0.015038957841381104,0.9609673309449038,0.9777049000724726,Upregulated
Feature1114,NA,C42 H55 N10 O17 P3,1064.29584,NA,NA,Feature1114,42,55,17,10,0,3,1.3095238095238095,0.4047619047619048,-0.14285714285714324,64.37142857142858,22,5,-0.6666666666666666,0.02439024390243902,-8,Lignin,29550317.8779399,35756026.5514527,1.2100048026266927,0.27501277370810323,0.13487355129827447,0.45384777576550756,Upregulated
Feature1113,NA,C29 H44 N4 O7,560.32104,NA,NA,Feature1113,29,44,7,4,0,0,1.5172413793103448,0.2413793103448276,-0.6206896551724137,77.98965517241379,10,3,-0.05555555555555555,0.11627906976744186,-1,Lipid,104792.44776460294,136564.76773625065,1.3031928411770513,0.3820505838481263,0.06192251649293502,0.3794192923980171,Upregulated
Feature1112,Cytidine 5'-diphosphocholine,C14 H26 N4 O11 P2,488.10744,Metabolic pathways;Other,NA,Cytidine 5'-diphosphocholine,14,26,11,4,0,2,1.8571428571428572,0.7857142857142857,-0.14285714285714324,64.37142857142858,5,-6,4,-2.6,-12,Carbohydrate,3504313.0160261565,2447609.0459047435,0.6984561695006055,-0.5177585104310781,0.04687683249790363,0.35607946299980225,Downregulated
Feature1111,Pro-tyr,C14 H18 N2 O4,278.1267,Metabolic pathways;Biosynthesis of cofactors;Other,NA,Pro-tyr,14,18,4,2,0,0,1.2857142857142858,0.2857142857142857,-0.2857142857142856,68.44285714285714,7,3,0.125,0.3,1,Lignin,10011842.160846973,8251858.996458037,0.8242098570758883,-0.27891637736277985,0.6030482689702721,0.7867481750107239,Downregulated
Feature1110,NA,C18 H28 O,260.21405,NA,NA,Feature1110,18,28,1,0,0,0,1.5555555555555556,0.05555555555555555,-1.4444444444444446,101.46666666666668,5,4,0.2352941176470588,0.2571428571428571,4,Lipid,2212954.03941317,3304377.8916067397,1.4931977044055524,0.5784051958020593,0.1499567094274948,0.46695517742640485,Upregulated
Feature1109,Pogostone,C12 H16 O4,224.10484,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites,NA,Pogostone,12,16,4,0,0,0,1.3333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,5,1,0.125,0.3,1,Lignin,119902.08605654801,138316.22544998332,1.153576472262133,0.206113645543586,0.17642984745262516,0.4787739794294037,Upregulated
Feature1108,NA,C13 H18 O9,318.09513,NA,NA,Feature1108,13,18,9,0,0,0,1.3846153846153846,0.6923076923076923,0,60.3,5,-4,-1,0.0588235294117647,-4,Tannin,1188201.7443499274,558457.3755313699,0.4700021508863425,-1.0892607358290884,0.3105777221661929,0.5800646762398355,Downregulated
Feature1107,D-lysopine,C9 H18 N2 O4,218.12664,Lysine degradation,NA,D-lysopine-peak5,9,18,4,2,0,0,2,0.4444444444444444,-0.44444444444444464,72.96666666666667,2,-2,-1.3333333333333333,-0.4,-4,Protein,16524219.195246983,17635610.519441366,1.0672583261612787,0.09390941774107306,0.7874384567653825,0.8940944250138846,Upregulated
Feature1106,Acetylarginine,C8 H16 N4 O3,216.12223,NA,NA,Acetylarginine,8,16,3,4,0,0,2,0.375,0.25,53.175,3,0,-4,-1,-4,Protein,3353929.5857902034,2772325.1998217935,0.8265901620497554,-0.27475590180942705,0.427396118924882,0.6594697741371865,Downregulated
Feature1105,N6-acetyl-N6-hydroxy-L-lysine,C8 H16 N2 O4,204.11096,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,NA,N6-acetyl-N6-hydroxy-L-lysine-peak2,8,16,4,2,0,0,2,0.5,-0.25,67.425,2,-2,-2,-0.5,-4,Protein,17259304.5444362,18905878.330822133,1.0954020935285442,0.13146054275529978,0.711283348492292,0.8509279606962872,Upregulated
Feature1104,"(1R,2R,3S,5R,7R)-2-Acetamido-7-(1,2-dihydroxyethyl)-3-hydroxy-6,8-dioxabicyclo[3.2.1]octane-5-carboxylic acid",C11 H17 N O8,291.09544,NA,NA,"(1R,2R,3S,5R,7R)-2-Acetamido-7-(1,2-dihydroxyethyl)-3-hydroxy-6,8-dioxabicyclo[3.2.1]octane-5-carboxylic acid",11,17,8,1,0,0,1.5454545454545454,0.7272727272727273,0.18181818181818168,55.11818181818182,4,-4,-2.5,-0.16666666666666666,-5,Carbohydrate,33189433.517544765,25952024.044226367,0.7819363361687833,-0.3548769441737969,0.10182444377116379,0.42858214338366585,Downregulated
Feature1103,NA,C6 H15 N O4 S,197.07221,NA,NA,Feature1103,6,15,4,1,1,0,2.5,0.6666666666666666,-0.33333333333333304,69.79999999999998,0,-4,-Inf,-2,-6,Other,415611.60077071865,575322.7666092523,1.3842798553802684,0.46913563745044723,0.5566013499553524,0.7562901141909594,Upregulated
Feature1102,NA,C10 H25 N10 O4 P,380.1797,NA,NA,Feature1102,10,25,4,10,0,1,2.5,0.4,0.7999999999999998,37.5,4,0,2.2,3,-11,Other,953152.938562652,868999.6967878017,0.9117106621926249,-0.1333520473059124,0.2108373495172514,0.5042610541978201,Downregulated
Feature1101,4149853,C21 H41 N O4,371.30356,NA,NA,4149853,21,41,4,1,0,0,1.9523809523809523,0.1904761904761905,-1.4285714285714288,101.01428571428572,2,-2,-0.1875,-0.05555555555555555,-3,Lipid,2286678.209363343,1592352.0589514116,0.6963603590707038,-0.5220940162519815,0.420778518140992,0.6594697741371865,Downregulated
Feature1100,Terpendole I,C27 H35 N O5,453.2516,Biosynthesis of secondary metabolites;Other,NA,Terpendole I,27,35,5,1,0,0,1.2962962962962965,0.18518518518518515,-0.8148148148148149,83.52222222222223,11,6,0.23809523809523808,0.3191489361702128,5,Lignin,677706.705104067,1431300.5793932704,2.1119764178421154,1.078593725770147,0.09393008819123624,0.41723968591020827,Upregulated
Feature1099,mycosporine,C11 H19 N O6,261.12118,Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,mycosporine-peak2,11,19,6,1,0,0,1.7272727272727273,0.5454545454545454,-0.3636363636363633,70.66363636363636,3,-3,-1,-0.14285714285714285,-4,Protein,11710088.258761033,7996405.701350126,0.6828646825413571,-0.5503283745974326,0.3877297808564452,0.6370652267418218,Downregulated
Feature1098,N-Benzylformamide,C8 H9 N O,135.06844,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;2-Oxocarboxylic acid metabolism;Phenylalanine metabolism;Other,NA,N-Benzylformamide,8,9,1,1,0,0,1.125,0.125,-0.5,74.55,5,4,0.5,0.5384615384615384,3,Unsaturated HC,15828146.190928767,12441374.822165733,0.7860285514229065,-0.34734637750764735,0.10150098962358166,0.42858214338366585,Downregulated
Feature1097,Arg-Glu,C11 H21 N5 O5,303.15426,NA,NA,Arg-Glu,11,21,5,5,0,0,1.9090909090909092,0.4545454545454546,0.36363636363636376,49.93636363636363,4,-1,-6,-1,-6,Protein,14041436.96176463,25038924.834105633,1.78321669657369,0.8344820299826738,0.3140467098660442,0.582824705135905,Upregulated
Feature1096,Mesalazine,C7 H7 N O3,153.04261,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Aminobenzoate degradation;Other,Other,Mesalazine,7,7,3,1,0,0,1,0.42857142857142855,0.2857142857142856,52.15714285714286,5,2,0.3333333333333333,0.5555555555555556,1,Lignin,17497888.954541035,18228052.9245611,1.0417286892102817,0.05897958692779655,0.8744859519979287,0.935214143108896,Upregulated
Feature1095,Fluoranthene,C16 H10,202.07828,Microbial metabolism in diverse environments;Other,NA,Fluoranthene-peak2,16,10,0,0,0,0,0.625,0,-0.625,78.1125,12,12,0.75,0.75,12,Condensed HC,24989041.5125542,16500383.602261966,0.6603047817569301,-0.5987960012735061,0.03811942239558121,0.34143592688945573,Downregulated
Feature1094,Pivagabine,C9 H17 N O3,187.12085,Metabolic pathways;Biosynthesis of cofactors;Other,Other,Pivagabine-peak3,9,17,3,1,0,0,1.8888888888888888,0.3333333333333333,-0.8888888888888893,85.63333333333334,2,-1,-0.4,-0.07692307692307693,-2,Protein,935811.912823788,1512119.9559724333,1.6158374725212152,0.6922820932755935,0.2656604084952683,0.5468149841931768,Upregulated
Feature1093,tert-Butyl N-[1-(aminocarbonyl)-3-methylbutyl]carbamate,C11 H22 N2 O3,230.16305,NA,NA,tert-Butyl N-[1-(aminocarbonyl)-3-methylbutyl]carbamate-peak1,11,22,3,2,0,0,2,0.2727272727272727,-0.9090909090909092,86.2090909090909,2,-1,-0.5,-0.2,-3,Lipid,17425409.461225398,11878741.659636626,0.6816908197232849,-0.5528105403741451,0.2626256271750317,0.5442389980100781,Downregulated
Feature1092,1726033,C6 H13 N O6,195.07432,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,1726033-peak2,6,13,6,1,0,0,2.1666666666666665,1,0.3333333333333335,50.8,1,-5,6,-1.5,-6,Carbohydrate,21376068.622189235,18369574.8505017,0.8593523521642015,-0.21867830753825554,0.298880972350385,0.5730571519090011,Downregulated
Feature1091,Hydrocotarnine,C12 H15 N O3,221.10517,NA,NA,Hydrocotarnine,12,15,3,1,0,0,1.25,0.25,-0.5,74.55,6,3,0.25,0.3684210526315789,2,Lignin,23089909.5212477,18689946.982394867,0.8094421922786696,-0.30500004325495866,0.029534782446263726,0.31473439619293775,Downregulated
Feature1090,Norharman,C11 H8 N2,168.06878,NA,NA,Norharman,11,8,0,2,0,0,0.7272727272727273,0,-0.18181818181818168,65.48181818181817,9,9,0.7777777777777778,0.7777777777777778,7,Condensed HC,14656755.109553933,19869399.612808265,1.3556479223601474,0.4389825423250067,0.08495675155772556,0.406464744436979,Upregulated
Feature1089,N1-Acetyl-5-methoxykynuramine,C12 H16 N2 O3,236.11607,NA,Other,N1-Acetyl-5-methoxykynuramine-peak1,12,16,3,2,0,0,1.3333333333333333,0.25,-0.33333333333333304,69.79999999999998,6,3,0.14285714285714285,0.29411764705882354,1,Lignin,17953083.028389167,15032673.217259366,0.837331014037435,-0.25613003256007744,0.42771689998738716,0.6594697741371865,Downregulated
Feature1088,NA,C17 H32 N2 O8,392.21598,NA,NA,Feature1088,17,32,8,2,0,0,1.8823529411764703,0.4705882352941176,-0.5882352941176467,77.06470588235292,3,-5,-1,-0.2727272727272727,-7,Protein,7878973.978857074,4058782.88906737,0.5151410450090277,-0.9569606003088726,0.026748162205364048,0.30466056797140506,Downregulated
Feature1087,4-Acetamidobutanoic acid,C6 H11 N O3,145.07388,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Lysine degradation;Other,Superpathway of L-lysine degradation;Other,4-Acetamidobutanoic acid-peak1,6,11,3,1,0,0,1.8333333333333333,0.5,-0.33333333333333304,69.79999999999998,2,-1,-1,-0.14285714285714285,-2,Protein,25233282.588122133,28774010.9183802,1.1403197668750702,0.18943843965023585,0.22905192889799886,0.5170330973050352,Upregulated
Feature1086,Crotonic acid,C4 H6 O2,86.03679,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,Other,Crotonic acid-peak4,4,6,2,0,0,0,1.5,0.5,-0.5,74.55,2,0,0,0.3333333333333333,0,Protein,8998623.27783337,13654254.72332904,1.5173715247046793,0.6015743691873815,0.267746004977429,0.5485236753179552,Upregulated
Feature1085,NP-016455,C11 H18 N2 O4,242.12664,NA,NA,NP-016455-peak2,11,18,4,2,0,0,1.6363636363636365,0.3636363636363637,-0.3636363636363633,70.66363636363636,4,0,-0.4,0,-2,Protein,1198719.5535277857,2068503.36684687,1.7255940814174122,0.7870931333469852,0.07527237456922736,0.39590936857023457,Upregulated
Feature1084,N-Acetylglucosaminitol,C8 H17 N O6,223.10552,NA,NA,N-Acetylglucosaminitol-peak1,8,17,6,1,0,0,2.125,0.75,-0.25,67.425,1,-5,-6,-0.75,-6,Carbohydrate,900035.1076173519,945148.9096868277,1.050124491464455,0.07056036843622518,0.7798835038011224,0.8896448858175767,Upregulated
Feature1083,D-Alanyl-D-alanine,C6 H12 N2 O3,160.08481,Metabolic pathways;Microbial metabolism in diverse environments;Other,Other,D-Alanyl-D-alanine,6,12,3,2,0,0,2,0.5,0,60.3,2,-1,-3,-0.6,-3,Protein,23486056.9832982,22486783.3509518,0.9574524734800302,-0.06272721931337817,0.7926671154650342,0.8965619858630117,Downregulated
Feature1082,3-O-beta-D-galactosyl-sn-glycerol,C9 H18 O8,254.10017,Other,NA,3-O-beta-D-galactosyl-sn-glycerol-peak1,9,18,8,0,0,0,2,0.8888888888888888,-0.22222222222222232,66.63333333333333,1,-7,-7,-0.6,-7,Carbohydrate,14805845.165053066,13036524.9339152,0.8804985320720443,-0.18360749602582174,0.4267549236985798,0.6594697741371865,Downregulated
Feature1081,"5-[(5-Hydroxytetrahydro-2-furanyl)methyl]-1,3-benzenediol",C11 H14 O4,210.08924,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Other,"5-[(5-Hydroxytetrahydro-2-furanyl)methyl]-1,3-benzenediol-peak1",11,14,4,0,0,0,1.2727272727272727,0.3636363636363637,-0.5454545454545459,75.84545454545456,5,1,0.14285714285714285,0.3333333333333333,1,Lignin,32075364.8491652,19987073.710546266,0.6231284914305957,-0.6823984118371195,0.0016576405661462995,0.15098679741337404,Downregulated
Feature1080,NA,C23 H26 N4 O5,438.1904,NA,NA,Feature1080,23,26,5,4,0,0,1.1304347826086956,0.21739130434782608,-0.17391304347826075,65.25652173913043,13,8,0.2857142857142857,0.3939393939393939,4,Lignin,14157141.140642533,9067699.399786029,0.6405035670481762,-0.6427214897406051,0.06390755421631052,0.3852647574463702,Downregulated
Feature1079,cys-val,C8 H16 N2 O3 S,220.08814,NA,NA,cys-val-peak2,8,16,3,2,1,0,2,0.375,-0.25,67.425,2,-1,-2,-0.7142857142857143,-4,Protein,574215.9962984247,364476.098969601,0.6347369305611957,-0.6557693102665172,0.014999185135740051,0.25983697563097224,Downregulated
Feature1078,"Methyl (3,5-dihydroxy-2-oxo-2,3-dihydro-1H-indol-3-yl)acetate",C11 H11 N O5,237.06372,NA,NA,"Methyl (3,5-dihydroxy-2-oxo-2,3-dihydro-1H-indol-3-yl)acetate",11,11,5,1,0,0,1,0.4545454545454546,0.18181818181818168,55.11818181818182,7,2,0.2,0.4666666666666667,1,Lignin,23613867.005378768,16845922.659329,0.7133911042817271,-0.487234868834044,5.614848774462235e-4,0.13209075561330955,Downregulated
Feature1077,NA,C29 H30 O10,538.18408,NA,NA,Feature1077,29,30,10,0,0,0,1.0344827586206895,0.3448275862068966,-0.3448275862068968,70.12758620689655,15,5,0.2631578947368421,0.4166666666666667,5,Lignin,30795009.815588832,36860962.160229,1.196978418937522,0.25939714127683067,0.045778839912185294,0.35607946299980225,Upregulated
Feature1076,2'-O-Methyladenosine,C11 H15 N5 O4,281.11245,NA,NA,2'-O-Methyladenosine,11,15,4,5,0,0,1.3636363636363635,0.3636363636363637,0.7272727272727271,39.57272727272728,7,3,-1,0,-2,Lignin,5523932.908335891,9461851.351143952,1.712883104873621,0.7764266985476989,0.22147375206872993,0.5089827335113032,Upregulated
Feature1075,Kanosamine,C6 H13 N O5,179.07942,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,Other,Kanosamine-peak1,6,13,5,1,0,0,2.1666666666666665,0.8333333333333334,0,60.3,1,-4,-Inf,-1,-5,Carbohydrate,23385855.669417534,26520162.902091336,1.134025766556519,0.1814534205808425,0.6797849647061318,0.8353437703403417,Upregulated
Feature1074,NA,C4 H N4 O7 P3,309.90566,NA,NA,Feature1074,4,1,7,4,0,3,0.25,1.75,2.5,-10.950000000000005,8,1,0.6,0.38461538461538464,-6,Other,28111368.586642932,28307546.178208165,1.0069785855839992,0.010033003304710943,0.9336287046269748,0.9640795504757004,Upregulated
Feature1073,Sorbic acid,C6 H8 O2,112.05238,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Aminobenzoate degradation;Other,NA,Sorbic acid-peak1,6,8,2,0,0,0,1.3333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,3,1,0.25,0.4,1,Lignin,2292702.5445033233,3181071.8029813003,1.3874768929828303,0.4724637450435215,0.6010757490965923,0.7865713119297694,Upregulated
Feature1072,Imidazoleacetic acid,C5 H6 N2 O2,126.04288,Metabolic pathways;Other,Other,Imidazoleacetic acid,5,6,2,2,0,0,1.2,0.4,0.7999999999999998,37.5,4,2,0,0.5,0,Lignin,10124843.2362331,8738822.9427742,0.8631069873261009,-0.212388693631341,0.31384095113230653,0.582824705135905,Downregulated
Feature1071,α-Aspartylphenylalanine,C13 H16 N2 O5,280.10594,NA,NA,α-Aspartylphenylalanine-peak2,13,16,5,2,0,0,1.2307692307692308,0.38461538461538464,0,60.3,7,2,0,0.29411764705882354,0,Lignin,16822350.604053833,23696395.777258866,1.4086257227065837,0.49428833292181,0.15045192650768657,0.46695517742640485,Upregulated
Feature1070,Indole-3-lactic acid,C11 H11 N O3,205.07389,Metabolic pathways;Other,Other,Indole-3-lactic acid,11,11,3,1,0,0,1,0.2727272727272727,-0.18181818181818168,65.48181818181817,7,4,0.42857142857142855,0.5294117647058824,3,Lignin,24228333.3766261,19144958.36002657,0.7901888281963448,-0.3397306454582207,0.008186202586512327,0.23030609530252863,Downregulated
Feature1069,L-Alanyl-L-glutamine,C8 H15 N3 O4,217.10622,Metabolic pathways;Biosynthesis of amino acids;Other,NA,L-Alanyl-L-glutamine-peak3,8,15,4,3,0,0,1.875,0.5,0.25,53.175,3,-1,-4,-0.6666666666666666,-4,Protein,18188898.637502767,19736932.36928103,1.0851087117823863,0.11783958653395332,0.539822347924993,0.7440675812733426,Upregulated
Feature1068,Dicyclomine,C19 H35 N O2,309.26682,NA,NA,Dicyclomine,19,35,2,1,0,0,1.8421052631578947,0.10526315789473684,-1.473684210526316,102.3,3,1,0,0.0588235294117647,0,Lipid,5551812.007697555,9107089.54834573,1.640381471079857,0.7140313529156747,0.6296448223586637,0.8108154867134375,Upregulated
Feature1067,Maltol,C6 H6 O3,126.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,NA,Maltol,6,6,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Lignin,8854794.420303829,3475259.199087469,0.3924720365182938,-1.3493382286883282,0.2680191196440075,0.5485236753179552,Downregulated
Feature1066,Proacaciberin,C16 H25 N O10,391.14794,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics,NA,Proacaciberin,16,25,10,1,0,0,1.5625,0.625,-0.125,63.8625,5,-5,-1.2,-0.1,-6,Amino Sugar,606162.024077565,351347.0447381673,0.5796256294228169,-0.7868067066458818,0.2504927705028048,0.5311095604794577,Downregulated
Feature1065,N-Acetylvaline,C7 H13 N O3,159.08955,Metabolic pathways;Lysine degradation;Other,Superpathway of L-lysine degradation,N-Acetylvaline,7,13,3,1,0,0,1.8571428571428572,0.42857142857142855,-0.5714285714285712,76.58571428571427,2,-1,-0.6666666666666666,-0.1111111111111111,-2,Protein,5811676.893536896,3003660.31189045,0.5168319517609088,-0.9522328313143478,0.026847406339034,0.30466056797140506,Downregulated
Feature1064,3-Methoxy-4-hydroxyhippuric acid,C10 H11 N O5,225.06372,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,Superpathway of chorismate metabolism;Other,3-Methoxy-4-hydroxyhippuric acid-peak2,10,11,5,1,0,0,1.1,0.5,0.20000000000000015,54.599999999999994,6,1,0,0.38461538461538464,0,Lignin,29832280.472190768,24187261.8044414,0.8107748191422518,-0.30262681227733434,0.0989917461017284,0.42200079547639724,Downregulated
Feature1063,N6-Me-Adenosine,C11 H15 N5 O4,281.11242,NA,NA,N6-Me-Adenosine,11,15,4,5,0,0,1.3636363636363635,0.3636363636363637,0.7272727272727271,39.57272727272728,7,3,-1,0,-2,Lignin,185241.93357676535,228171.80295822333,1.231750276800407,0.30070979585430185,0.7240969944689344,0.8577764396016607,Upregulated
Feature1062,Prolylglycine,C7 H12 N2 O3,172.08478,NA,NA,Prolylglycine,7,12,3,2,0,0,1.7142857142857142,0.42857142857142855,0,60.3,3,0,-1,-0.14285714285714285,-2,Protein,11311688.137893107,13884326.947710333,1.2274319074620812,0.29564299236758623,0.34463470980988115,0.6035784634978973,Upregulated
Feature1061,NA,C10 H22 N2 O6,266.14776,NA,NA,Feature1061,10,22,6,2,0,0,2.2,0.6,-0.4000000000000003,71.7,1,-5,-3.5,-0.8,-7,Amino Sugar,727180.3981663993,703934.7309608806,0.9680331493201232,-0.046871642903099246,0.9164945026648574,0.954276522673265,Downregulated
Feature1060,Acetyl-L-methionine,C7 H13 N O3 S,191.06162,NA,NA,Acetyl-L-methionine-peak2,7,13,3,1,1,0,1.8571428571428572,0.42857142857142855,-0.2857142857142856,68.44285714285714,2,-1,-1.5,-0.42857142857142855,-3,Protein,1159377.1310445932,480674.7694876857,0.4145974218540951,-1.270216949713253,0.032154265684269406,0.32345137828340564,Downregulated
Feature1059,NP-007735,C18 H24 O12,432.1269,NA,NA,NP-007735,18,24,12,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,7,-5,-0.8333333333333334,0.08333333333333333,-5,Tannin,123021.14288806901,205610.85668795765,1.6713456879118171,0.7410101598842224,0.0535397215183785,0.3701889316413599,Upregulated
Feature1058,NA,C16 H28 N2 O8,376.18453,NA,NA,Feature1058,16,28,8,2,0,0,1.75,0.5,-0.375,70.9875,4,-4,-1,-0.2,-6,Protein,5026413.607366,5667237.25059132,1.127491227997278,0.1731162092021148,0.6536638111618105,0.8228154163778454,Upregulated
Feature1057,HC blue 2,C12 H19 N3 O5,285.1325,NA,NA,HC blue 2-peak2,12,19,5,3,0,0,1.5833333333333333,0.4166666666666667,0,60.3,5,0,-0.75,-0.07692307692307693,-3,Protein,33545937.2375738,21261531.4330623,0.6338034702231511,-0.6578925360507357,0.17191304505330912,0.4760067902771642,Downregulated
Feature1056,Stavudine,C10 H12 N2 O4,224.07968,Metabolic pathways;Biosynthesis of cofactors;Other,Other,Stavudine,10,12,4,2,0,0,1.2,0.4,0.20000000000000015,54.599999999999994,6,2,0,0.3333333333333333,0,Lignin,24535684.868587535,24214542.9023231,0.9869112287680388,-0.019007772693833552,0.9164438736449751,0.954276522673265,Downregulated
Feature1055,val-his,C11 H18 N4 O3,254.1379,NA,NA,val-his,11,18,3,4,0,0,1.6363636363636365,0.2727272727272727,0,60.3,5,2,-0.5,-0.09090909090909093,-2,Lipid,17734443.116181333,20139864.27484653,1.135635561991255,0.18349993232316303,0.6335346684154672,0.8130361577998497,Upregulated
Feature1054,NA,C23 H32 N2 O12,528.19573,NA,NA,Feature1054,23,32,12,2,0,0,1.391304347826087,0.5217391304347826,-0.08695652173913082,62.77826086956522,9,-3,-0.5555555555555556,0.06666666666666667,-5,Lignin,1183904.2470000666,265655.895635553,0.22438968042281046,-2.1559217662899273,6.397314652854996e-4,0.13209075561330955,Downregulated
Feature1053,lamifiban,C24 H28 N4 O6,468.20096,NA,NA,lamifiban-peak3,24,28,6,4,0,0,1.1666666666666667,0.25,-0.16666666666666696,65.05000000000001,13,7,0.21428571428571427,0.35294117647058826,3,Lignin,9229883.185206817,8108987.105848161,0.8785579343891187,-0.18679067046358885,0.5074423339789843,0.7157429756539546,Downregulated
Feature1052,Oxepanone,C6 H10 O2,114.06804,Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,NA,Oxepanone-peak3,6,10,2,0,0,0,1.6666666666666667,0.3333333333333333,-1,88.8,2,0,0,0.2,0,Protein,7311651.74071899,8763661.941577543,1.1985885340753073,0.26133647799326987,0.019730251628705335,0.2785253854918903,Upregulated
Feature1051,NA,C6 H19 N4 O P,194.12956,NA,NA,Feature1051,6,19,1,4,0,1,3.1666666666666665,0.16666666666666666,-1.666666666666667,107.8,0,-1,-Inf,-11,-6,Other,1805837.1245278867,1972679.3967487707,1.0923905428428395,0.12748872942016193,0.817891162330555,0.9127191231804745,Upregulated
Feature1050,ascopyrone M,C6 H8 O4,144.04227,Microbial metabolism in diverse environments;Other,Other,ascopyrone M,6,8,4,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Tannin,24079617.323408134,18751847.6986497,0.7787435924249828,-0.36077970733143844,0.3612443928456769,0.6171436750022657,Downregulated
Feature1049,indospicine,C7 H15 N3 O2,173.11643,NA,NA,indospicine,7,15,2,3,0,0,2.142857142857143,0.2857142857142857,-0.2857142857142856,68.44285714285714,2,0,-1.5,-0.6666666666666666,-3,Lipid,1282288.4408543666,1186947.56038977,0.9256478671826187,-0.11146462374209509,0.6675920982603969,0.8278923971106239,Downregulated
Feature1048,Xanthine,C5 H4 N4 O2,152.03344,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of plant secondary metabolites;Other,Other,Xanthine,5,4,2,4,0,0,0.8,0.4,2.4,-8.099999999999994,6,4,-0,Inf,0,Condensed HC,78816.34809170307,104363.11594924163,1.3241303165659848,0.40504511445001656,0.12503652052669337,0.453719825968702,Upregulated
Feature1047,ser-gln,C8 H15 N3 O5,233.10121,NA,NA,ser-gln,8,15,5,3,0,0,1.875,0.625,0.5,46.05,3,-2,-Inf,-1,-5,Amino Sugar,20182734.442305084,19320572.335374765,0.9572821953638185,-0.06298381820248312,0.9030802009490115,0.9478425405251708,Downregulated
Feature1046,Isovalerylglutamic acid,C10 H17 N O5,231.11068,NA,NA,Isovalerylglutamic acid-peak6,10,17,5,1,0,0,1.7,0.5,-0.4000000000000003,71.7,3,-2,-0.75,-0.07692307692307693,-3,Protein,306262.1573556757,370894.46864657133,1.211035904170933,0.276241637948421,0.4149980764552474,0.6580333694263849,Upregulated
Feature1045,Oxepanone,C6 H10 O2,114.06804,Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,NA,Oxepanone-peak2,6,10,2,0,0,0,1.6666666666666667,0.3333333333333333,-1,88.8,2,0,0,0.2,0,Protein,725992.3448538136,705044.7656413907,0.9711462808652053,-0.04223947402770693,0.874058468247146,0.935214143108896,Downregulated
Feature1044,"3-Hydroxy-2,4,5-pyridinetrimethanol",C8 H11 N O4,185.06883,NA,NA,"3-Hydroxy-2,4,5-pyridinetrimethanol-peak3",8,11,4,1,0,0,1.375,0.5,0,60.3,4,0,-0.3333333333333333,0.2,-1,Lignin,6434856.7014068365,7284425.44969165,1.132026055545118,0.17890716468315587,0.6673218736095134,0.8278923971106239,Upregulated
Feature1043,(4S)-4-Hydroxy-4-methyltetrahydro-2H-pyran-2-one,C6 H10 O3,130.06295,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I,(4S)-4-Hydroxy-4-methyltetrahydro-2H-pyran-2-one-peak4,6,10,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,1289196.8616356067,1349558.1194496967,1.0468208228008788,0.06601452710346127,0.6297501696794278,0.8108154867134375,Upregulated
Feature1042,"1-(3-Hydroxy-4-methoxyphenyl)-1,2-ethanediol",C9 H12 O4,184.07358,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylalanine metabolism;Tyrosine metabolism;Other,Other,"1-(3-Hydroxy-4-methoxyphenyl)-1,2-ethanediol",9,12,4,0,0,0,1.3333333333333333,0.4444444444444444,-0.44444444444444464,72.96666666666667,4,0,0,0.2857142857142857,0,Lignin,22460774.863225933,22696019.5754964,1.0104735795493691,0.015031600637579622,0.858502017542529,0.9273877754225012,Upregulated
Feature1041,NA,C26 H40 O3 S2,464.24195,Other,NA,Feature1041,26,40,3,0,2,0,1.5384615384615383,0.1153846153846154,-1.1538461538461542,93.1846153846154,7,4,0.09523809523809525,0.15555555555555556,2,Lipid,22876347.698215384,19526859.802320726,0.8535829259075322,-0.22839677645099868,0.8070831362034254,0.9072321385060402,Downregulated
Feature1040,3-Butynoic acid,C4 H4 O2,84.02114,Metabolic pathways;Other,NA,3-Butynoic acid-peak2,4,4,2,0,0,0,1,0.5,0,60.3,3,1,0.5,0.6666666666666666,1,Lignin,27590786.3357253,24465557.082879465,0.8867292430589699,-0.17343444056014226,0.5870462065724058,0.777832351809504,Downregulated
Feature1039,4-Oxo-4-(3-pyridyl)butyric acid,C9 H9 N O3,179.05826,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of alkaloids derived from shikimate pathway;Other,Other,4-Oxo-4-(3-pyridyl)butyric acid,9,9,3,1,0,0,1,0.3333333333333333,0,60.3,6,3,0.4,0.5384615384615384,2,Lignin,22417077.630899835,17923512.518389165,0.7995472386500231,-0.3227448217160292,0.04541087757987648,0.35607946299980225,Downregulated
Feature1038,"2-(2,4-Dihydroxy-5-methoxyphenyl)-5,7-dihydroxy-6-(3-methyl-2-buten-1-yl)-2,3-dihydro-4H-chromen-4-one",C21 H22 O7,386.13664,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites,NA,"2-(2,4-Dihydroxy-5-methoxyphenyl)-5,7-dihydroxy-6-(3-methyl-2-buten-1-yl)-2,3-dihydro-4H-chromen-4-one",21,22,7,0,0,0,1.0476190476190477,0.3333333333333333,-0.3809523809523814,71.15714285714287,11,4,0.2857142857142857,0.42857142857142855,4,Lignin,4948527.255884304,15136698.6000931,3.058828984339537,1.6129794497067889,0.036488186484675084,0.33805559870221996,Upregulated
Feature1037,Pyridoxal,C8 H9 N O3,167.05826,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Other,Pyridoxal-peak4,8,9,3,1,0,0,1.125,0.375,0,60.3,5,2,0.25,0.4545454545454546,1,Lignin,24894012.166858535,19815856.034400735,0.7960089318499505,-0.32914347584791803,0.12773822078824204,0.45384777576550756,Downregulated
Feature1036,nicotianamine,C12 H21 N3 O6,303.14313,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites;Other,NA,nicotianamine,12,21,6,3,0,0,1.75,0.5,0,60.3,4,-2,-1.6666666666666667,-0.3333333333333333,-5,Protein,31952433.354281865,8882396.067186827,0.27798809463744706,-1.8469049967418278,0.053808928437696024,0.3705379055831588,Downregulated
Feature1035,Alanylclavam,C8 H12 N2 O4,200.0797,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,Alanylclavam-peak2,8,12,4,2,0,0,1.5,0.5,0.25,53.175,4,0,-1,0,-2,Protein,16437200.095362667,16985289.950772032,1.0333444779055767,0.04732127426133082,0.8635363882625412,0.9299622642827367,Upregulated
Feature1034,N-(2-morpholinophenyl)-2-furamide,C15 H16 N2 O3,272.11607,NA,NA,N-(2-morpholinophenyl)-2-furamide,15,16,3,2,0,0,1.0666666666666669,0.2,-0.2666666666666666,67.89999999999999,9,6,0.4,0.4782608695652174,4,Lignin,24166005.7384126,27774411.972754966,1.1493174450673367,0.20077732989988192,0.09606164923075183,0.41723968591020827,Upregulated
Feature1033,17-Methyl-6Z-octadecenoic acid,C19 H36 O2,296.27159,NA,NA,17-Methyl-6Z-octadecenoic acid,19,36,2,0,0,0,1.894736842105263,0.10526315789473684,-1.6842105263157894,108.3,2,0,0,0.05555555555555555,0,Lipid,3880949.395376393,10716032.83862151,2.7611884997490974,1.4652893806352947,0.20203836923909024,0.4974607521671786,Upregulated
Feature1032,NA,C23 H33 N3 O5,431.24203,NA,NA,Feature1032,23,33,5,3,0,0,1.434782608695652,0.21739130434782608,-0.6086956521739131,77.64782608695651,9,4,0.06666666666666667,0.2,1,Lignin,108817.9734841909,141718.784243342,1.3023472107200282,0.3811141277696879,0.06252125863379422,0.3794192923980171,Upregulated
Feature1031,threonylphenylalanine,C13 H18 N2 O4,266.12655,Metabolic pathways;Biosynthesis of cofactors;Other,NA,threonylphenylalanine-peak5,13,18,4,2,0,0,1.3846153846153846,0.3076923076923077,-0.3076923076923075,69.06923076923076,6,2,0,0.2222222222222222,0,Lignin,137657.19412613,134244.656633946,0.9752098863132629,-0.03621534335210378,0.9082007345340795,0.9502730353926686,Downregulated
Feature1030,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,NA,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole-peak2",11,12,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Lignin,23519793.4328412,31942554.700390566,1.3581137432860477,0.4416043116908118,0.2883744972868867,0.5647472813918913,Upregulated
Feature1029,NA,C27 H33 N8 O7 P,612.22109,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Other,Feature1029,27,33,7,8,0,1,1.2222222222222223,0.25925925925925924,0,60.3,16,9,0,0.2413793103448276,0,Lignin,1003281.3025245407,7347142.95755102,7.323113606386885,2.8724571771183394,0.09107622165536604,0.41723968591020827,Upregulated
Feature1028,5-Ethyl-4-hydroxy-3(2H)-furanone,C6 H8 O3,128.04731,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Aminobenzoate degradation;Other,Other,5-Ethyl-4-hydroxy-3(2H)-furanone-peak1,6,8,3,0,0,0,1.3333333333333333,0.5,-0.33333333333333304,69.79999999999998,3,0,0,0.3333333333333333,0,Lignin,445641.32337293465,361041.6685053211,0.8101620060112414,-0.3037176660274652,0.7064196452469507,0.8478072560935465,Downregulated
Feature1027,Quinestrol,C25 H32 O2,364.24025,NA,NA,Quinestrol-peak1,25,32,2,0,0,0,1.28,0.08,-1.12,92.22,10,8,0.34782608695652173,0.375,8,Unsaturated HC,734527.9271824963,1070131.294388914,1.4568966744310536,0.5428985626654025,0.13072711354663766,0.45384777576550756,Upregulated
Feature1026,Phenacetin,C10 H13 N O2,179.09465,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",NA,Phenacetin-peak3,10,13,2,1,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Lignin,26542394.70940084,4502020.187113897,0.1696162021703099,-2.559654108510351,0.12933006998075983,0.45384777576550756,Downregulated
Feature1025,(DL)-3-O-Methyldopa,C10 H13 N O4,211.08446,NA,NA,(DL)-3-O-Methyldopa,10,13,4,1,0,0,1.3,0.4,-0.20000000000000015,66,5,1,0,0.2857142857142857,0,Lignin,23652518.655940834,17344609.450097434,0.7333091964707515,-0.44750646247807774,0.03613182086475928,0.33805559870221996,Downregulated
Feature1024,NA,C18 H29 N3 O12,479.17524,NA,NA,Feature1024,18,29,12,3,0,0,1.6111111111111112,0.6666666666666666,0.22222222222222232,53.96666666666666,6,-6,-3,-0.3333333333333333,-9,Amino Sugar,1278035.74967454,684043.3317077786,0.5352302014102303,-0.9017685697236788,0.012345598055105465,0.25835889181660304,Downregulated
Feature1023,2181,C11 H15 N O2,193.11028,NA,NA,2181,11,15,2,1,0,0,1.3636363636363635,0.18181818181818185,-0.7272727272727275,81.02727272727273,5,3,0.25,0.3333333333333333,2,Lignin,673102.442339749,437833.0970875803,0.6504702249566103,-0.62044507528569115,0.11310121134267404,0.4445323712633174,Downregulated
Feature1022,NA,C12 H23 N5 O2,269.18519,NA,NA,Feature1022,12,23,2,5,0,0,1.9166666666666667,0.16666666666666666,-0.33333333333333304,69.79999999999998,4,2,-0.6,-0.3333333333333333,-3,Lipid,25823758.818802234,21462343.877434067,0.8311084388616335,-0.2668913699958983,0.10251400838457284,0.42914157342056886,Downregulated
Feature1021,NA,C10 H23 N O7,269.14745,NA,NA,Feature1021,10,23,7,1,0,0,2.3,0.7,-0.5999999999999996,77.39999999999999,0,-7,-4,-0.8181818181818182,-8,Carbohydrate,3098183.44145277,2183384.3486360866,0.70473049446429,-0.5048564524628211,0.06135949919772513,0.3794192923980171,Downregulated
Feature1020,N-Acetyl-L-leucine,C8 H15 N O3,173.10517,Other,NA,N-Acetyl-L-leucine-peak4,8,15,3,1,0,0,1.875,0.375,-0.75,81.675,2,-1,-0.5,-0.09090909090909093,-2,Protein,15911669.470805533,9389666.489458714,0.590111961958908,-0.760939391872785,0.03684143729091856,0.33805559870221996,Downregulated
Feature1019,NA,C20 H30 N4 O6,422.21665,NA,NA,Feature1019,20,30,6,4,0,0,1.5,0.3,-0.2999999999999998,68.85,8,2,-0.2,0.07692307692307693,-2,Lipid,1198005.9754934134,1063410.3650819543,0.887650301279988,-0.1719366705352093,0.49628256429636697,0.7099241665400493,Downregulated
Feature1018,MFCD03548046,C12 H16 N2 O4,252.111,NA,NA,MFCD03548046,12,16,4,2,0,0,1.3333333333333333,0.3333333333333333,-0.16666666666666696,65.05000000000001,6,2,0,0.25,0,Lignin,20993273.8450513,18136558.175365668,0.863922335755219,-0.21102647099046423,0.48732484587582775,0.7043756731345155,Downregulated
Feature1017,1â€²-Acetoxyeugenol acetate,C14 H16 O5,264.09978,NA,NA,1â€²-Acetoxyeugenol acetate,14,16,5,0,0,0,1.1428571428571428,0.35714285714285715,-0.4285714285714288,72.51428571428572,7,2,0.2222222222222222,0.391304347826087,2,Lignin,240904.648596946,332978.361144957,1.3821998167501457,0.46696619300287706,0.34526250791813073,0.6035858497557415,Upregulated
Feature1016,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",C10 H18 N2 O5,246.12156,Metabolic pathways;Other,NA,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose-peak3",10,18,5,2,0,0,1.8,0.5,-0.20000000000000015,66,3,-2,-1.3333333333333333,-0.2727272727272727,-4,Protein,858264.1194944533,752504.7045805859,0.8767752111364469,-0.189721084996848,0.45423699274632057,0.6755956624903008,Downregulated
Feature1015,Guanine,C5 H5 N5 O,151.04939,Metabolic pathways;Other,Superpathway of purine nucleotide salvage;Other,Guanine-peak2,5,5,1,5,0,0,1,0.2,2.4,-8.099999999999994,6,5,-0,-1,0,Lignin,11728287.1711275,13217344.521018567,1.126962899881647,0.17244002213145251,0.39759830915229905,0.644110748404211,Upregulated
Feature1014,Val-lys,C11 H23 N3 O3,245.17392,NA,NA,Val-lys,11,23,3,3,0,0,2.090909090909091,0.2727272727272727,-0.7272727272727275,81.02727272727273,2,-1,-0.8,-0.38461538461538464,-4,Lipid,13403134.120925836,21774952.918332,1.624616505503406,0.7000992068160938,0.15221387947489665,0.46778235597057083,Upregulated
Feature1013,3-Hydroxy-2-methylpyridine,C6 H7 N O,109.05272,Metabolic pathways;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,NA,3-Hydroxy-2-methylpyridine,6,7,1,1,0,0,1.1666666666666667,0.16666666666666666,-0.33333333333333304,69.79999999999998,4,3,0.5,0.5555555555555556,2,Lignin,20055377.992601734,14448309.7869845,0.7204207166932662,-0.4730884263570807,0.10195903411075402,0.42858214338366585,Downregulated
Feature1012,Crotanecine,C8 H13 N O3,171.08958,Other,NA,Crotanecine-peak2,8,13,3,1,0,0,1.625,0.375,-0.5,74.55,3,0,-0.25,0.09090909090909093,-1,Protein,398403.0512115603,370738.273345544,0.9305608283322967,-0.10382763631161562,0.8060453767037888,0.9066672431183388,Downregulated
Feature1011,1-Hydroxy-3-methoxy-10-methyl-9(10H)-acridinone,C15 H13 N O3,255.08951,NA,NA,1-Hydroxy-3-methoxy-10-methyl-9(10H)-acridinone,15,13,3,1,0,0,0.8666666666666667,0.2,-0.2666666666666666,67.89999999999999,10,7,0.5454545454545454,0.6,6,Lignin,19776600.408365432,17213400.694008633,0.8703922989073201,-0.2002623029789926,0.04443711835678696,0.35607946299980225,Downregulated
Feature1010,NA,C10 H15 N O5,229.09503,NA,NA,Feature1010,10,15,5,1,0,0,1.5,0.5,-0.20000000000000015,66,4,-1,-0.5,0.07692307692307693,-2,Protein,25096564.10577,13565595.996645933,0.5405359849050827,-0.8875374297192887,0.06564917796388811,0.38614481760703634,Downregulated
Feature1009,thiodiglycol,C4 H10 O2 S,122.04011,NA,NA,thiodiglycol,4,10,2,0,1,0,2.5,0.5,-1,88.8,0,-2,-3,-1,-3,Other,6548399.69237003,8171428.34922476,1.2478511900771463,0.3194458988329535,0.5029168404692824,0.7129214458200539,Upregulated
Feature1008,lys-leu,C12 H25 N3 O3,259.18959,NA,NA,lys-leu-peak3,12,25,3,3,0,0,2.0833333333333335,0.25,-0.833333333333333,84.04999999999998,2,-1,-0.6666666666666666,-0.3333333333333333,-4,Lipid,8378297.740435207,16331962.5544202,1.9493175177577113,0.9629691054674088,0.12533244130606355,0.453719825968702,Upregulated
Feature1007,NA,C17 H29 N O12,439.16903,NA,NA,Feature1007,17,29,12,1,0,0,1.7058823529411764,0.7058823529411765,-0.117647058823529,63.65294117647058,4,-8,-2.25,-0.3,-9,Carbohydrate,2035938.7002566368,841796.3549889297,0.41346841871163337,-1.2741509563206013,0.3870336116093361,0.6365387748215682,Downregulated
Feature1006,NA,C17 H29 N3 O7,387.20043,NA,NA,Feature1006,17,29,7,3,0,0,1.7058823529411764,0.4117647058823529,-0.35294117647058787,70.35882352941175,5,-2,-0.7142857142857143,-0.14285714285714285,-5,Protein,24759438.2776019,18211763.2010707,0.7355483188625318,-0.4431079782968989,0.007112546581940924,0.23030609530252863,Downregulated
Feature1005,Pyridoxine,C8 H11 N O3,169.07393,Metabolic pathways;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Tyrosine metabolism;Other,Other,Pyridoxine-peak1,8,11,3,1,0,0,1.375,0.375,-0.25,67.425,4,1,0,0.2727272727272727,0,Lignin,14350254.500169333,11750797.327605134,0.8188563713254335,-0.28831767177339807,0.0038834703163422744,0.20435156612062716,Downregulated
Feature1004,Perillartine,C10 H15 N O,165.11539,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of alkaloids derived from shikimate pathway;Tyrosine metabolism;Other,NA,Perillartine,10,15,1,1,0,0,1.5,0.1,-1,88.8,4,3,0.25,0.29411764705882354,2,Lipid,594159.0844251093,394573.1748904277,0.6640867492116274,-0.5905563827086028,0.026977027860514025,0.30466056797140506,Downregulated
Feature1003,NA,C16 H22 N2 O8,370.13769,NA,NA,Feature1003,16,22,8,2,0,0,1.375,0.5,0,60.3,7,-1,-0.5,0.1,-3,Lignin,23942518.426506568,20481536.88998743,0.855446220198477,-0.22525093601345084,0.09448597311830452,0.41723968591020827,Downregulated
Feature1002,α-Aspartylphenylalanine,C13 H16 N2 O5,280.10596,NA,NA,α-Aspartylphenylalanine-peak1,13,16,5,2,0,0,1.2307692307692308,0.38461538461538464,0,60.3,7,2,0,0.29411764705882354,0,Lignin,2946136.5239853375,479205.592544017,0.16265559611466326,-2.620107636184995,0.31478227585446106,0.5829267059951295,Downregulated
Feature1001,2-Mercaptoethanol,C2 H6 O S,78.01397,Metabolic pathways;Other,Other,2-Mercaptoethanol,2,6,1,0,1,0,3,0.5,-1,88.8,0,-1,-Inf,-3,-2,Other,14105858.472359767,11567440.244134067,0.8200451086901449,-0.2862248238229257,0.1474076325032881,0.4658688473133245,Downregulated
Feature1000,N-Acetyl-L-leucine,C8 H15 N O3,173.10514,Other,NA,N-Acetyl-L-leucine-peak3,8,15,3,1,0,0,1.875,0.375,-0.75,81.675,2,-1,-0.5,-0.09090909090909093,-2,Protein,4009500.18329773,4120428.2153290836,1.0276662992792578,0.039371872965170085,0.8860248231239551,0.941126558385276,Upregulated
Feature0999,metharbital,C9 H14 N2 O3,198.10045,NA,NA,metharbital-peak2,9,14,3,2,0,0,1.5555555555555556,0.3333333333333333,-0.22222222222222232,66.63333333333333,4,1,-0.25,0.09090909090909093,-1,Protein,18489228.0000702,19130220.896638066,1.0346684510875972,0.049168544922126155,0.8301922202604357,0.9173813575480614,Upregulated
Feature0998,Furan,C4 H4 O,68.02622,Other,NA,Furan-peak1,4,4,1,0,0,0,1,0.25,-0.5,74.55,3,2,0.6666666666666666,0.7142857142857143,2,Lignin,14218840.4708209,8912534.51271693,0.6268116258148285,-0.6738961563821434,0.07446822951688742,0.39590936857023457,Downregulated
Feature0997,"(6R,7R)-1,2,3,13-Tetramethoxy-6,7-dimethyl-5,6,7,8-tetrahydrobenzo[3',4']cycloocta[1',2':4,5]benzo[1,2-d][1,3]dioxol-6-ol",C23 H28 O7,416.18357,NA,NA,"(6R,7R)-1,2,3,13-Tetramethoxy-6,7-dimethyl-5,6,7,8-tetrahydrobenzo[3',4']cycloocta[1',2':4,5]benzo[1,2-d][1,3]dioxol-6-ol",23,28,7,0,0,0,1.2173913043478262,0.30434782608695654,-0.6086956521739131,77.64782608695651,10,3,0.1875,0.3333333333333333,3,Lignin,19215360.992473867,28116846.777579833,1.463248428618772,0.5491747293599647,0.013181957692101393,0.25835889181660304,Upregulated
Feature0996,Benserazide,C10 H15 N3 O5,257.1012,NA,NA,Benserazide,10,15,5,3,0,0,1.5,0.5,0.3999999999999999,48.9,5,0,-1.5,-0.1111111111111111,-3,Protein,6392053.939519473,7410682.527072767,1.1593585719381256,0.21332683895063503,0.3700257323762868,0.6242377295699064,Upregulated
Feature0995,MFCD00672375,C5 H9 N O5,163.04806,Metabolic pathways;Other,NA,MFCD00672375,5,9,5,1,0,0,1.8,1,0.7999999999999998,37.5,2,-3,4,-1,-4,Carbohydrate,18073002.089560967,17478792.5224179,0.9671217009659793,-0.04823064744745332,0.8863867606716862,0.941126558385276,Downregulated
Feature0994,NA,C11 H18 N2 O4,242.12664,NA,NA,Feature0994,11,18,4,2,0,0,1.6363636363636365,0.3636363636363637,-0.3636363636363633,70.66363636363636,4,0,-0.4,0,-2,Protein,4640677.995772246,4450393.630344736,0.9589964299180286,-0.06040265039384438,0.8653064546639399,0.9312764512075694,Downregulated
Feature0993,Phe-his,C15 H18 N4 O3,302.13799,NA,NA,Phe-his,15,18,3,4,0,0,1.2,0.2,0,60.3,9,6,0.25,0.3684210526315789,2,Lignin,6887204.471859944,14192424.611280046,2.0606945342291065,1.0431306637251982,0.15893172395947427,0.46986097798839344,Upregulated
Feature0992,Cytidine 5'-monophosphate (hydrate),C9 H14 N3 O8 P,323.05194,Metabolic pathways;Other,Other,Cytidine 5'-monophosphate (hydrate)-peak1,9,14,8,3,0,1,1.5555555555555556,0.8888888888888888,0.6666666666666665,41.3,5,-3,2.3333333333333335,-3,-7,Carbohydrate,10621447.59953899,15088942.666048734,1.4206107524085183,0.5065113100364185,0.13039130308102453,0.45384777576550756,Upregulated
Feature0991,"4-Ethyl-2,6-dimethoxy-1,3-benzenediol",C10 H14 O4,198.08925,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Other,"4-Ethyl-2,6-dimethoxy-1,3-benzenediol",10,14,4,0,0,0,1.4,0.4,-0.5999999999999996,77.39999999999999,4,0,0,0.25,0,Lignin,19249145.592635933,21416495.391927034,1.112594597451653,0.15392800526767925,0.5094060019970101,0.7170775836186327,Upregulated
Feature0990,lamifiban,C24 H28 N4 O6,468.20102,NA,NA,lamifiban-peak2,24,28,6,4,0,0,1.1666666666666667,0.25,-0.16666666666666696,65.05000000000001,13,7,0.21428571428571427,0.35294117647058826,3,Lignin,3917786.1203954103,2709399.13033425,0.6915638187162699,-0.532065702951775,0.6557265714935604,0.8228154163778454,Downregulated
Feature0989,"(1R)-6-Hydroxy-7-methoxy-1-methyl-1,2,3,4-tetrahydro-1-isoquinoliniumcarboxylate",C12 H15 N O4,237.10008,NA,NA,"(1R)-6-Hydroxy-7-methoxy-1-methyl-1,2,3,4-tetrahydro-1-isoquinoliniumcarboxylate-peak3",12,15,4,1,0,0,1.25,0.3333333333333333,-0.33333333333333304,69.79999999999998,6,2,0.14285714285714285,0.3333333333333333,1,Lignin,24906026.8512695,22217748.53327453,0.8920631406185953,-0.16478226654283507,0.13652163450334023,0.4561492087744741,Downregulated
Feature0988,NA,C14 H27 N O9,353.16869,Biosynthesis of secondary metabolites;Other,NA,Feature0988,14,27,9,1,0,0,1.9285714285714288,0.6428571428571429,-0.4285714285714288,72.51428571428572,2,-7,-2,-0.4117647058823529,-8,Amino Sugar,126906.75671703297,1387331.3499081135,10.931895084211153,3.4504716140676144,0.29904517254283175,0.5730571519090011,Upregulated
Feature0987,"3',4'-Dimethoxyacetophenone",C10 H12 O3,180.07865,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of various plant secondary metabolites;Other,NA,"3',4'-Dimethoxyacetophenone-peak1",10,12,3,0,0,0,1.2,0.3,-0.5999999999999996,77.39999999999999,5,2,0.2857142857142857,0.4117647058823529,2,Lignin,570582.507394888,631907.7717224534,1.10747834630886,0.14727849112501096,0.7700652726731478,0.8847614925965286,Upregulated
Feature0986,met-pro,C10 H18 N2 O3 S,246.10387,NA,NA,met-pro,10,18,3,2,1,0,1.8,0.3,-0.4000000000000003,71.7,3,0,-0.75,-0.2727272727272727,-3,Lipid,5697694.275433376,4480069.64943758,0.7862951981741454,-0.3468570508667848,0.2490224619910682,0.5310276106497658,Downregulated
Feature0985,δ-Valerolactam,C5 H9 N O,99.06839,Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,δ-Valerolactam-peak1,5,9,1,1,0,0,1.8,0.2,-0.7999999999999998,83.1,2,1,0,0.14285714285714285,0,Lipid,7671181.909408467,7754657.449702933,1.0108817052287713,0.015614180955021139,0.918963296033956,0.9559061905453898,Upregulated
Feature0984,Valylglutamine,C10 H19 N3 O4,245.13752,NA,NA,Valylglutamine,10,19,4,3,0,0,1.9,0.4,-0.20000000000000015,66,3,-1,-1.3333333333333333,-0.4,-4,Protein,12225091.434163226,8471440.390773997,0.6929551763596968,-0.5291660598914166,0.4252199588172041,0.6594697741371865,Downregulated
Feature0983,Pivagabine,C9 H17 N O3,187.12085,Metabolic pathways;Biosynthesis of cofactors;Other,Other,Pivagabine-peak2,9,17,3,1,0,0,1.8888888888888888,0.3333333333333333,-0.8888888888888893,85.63333333333334,2,-1,-0.4,-0.07692307692307693,-2,Protein,1482608.7795034023,1082264.8789026693,0.7299733374472344,-0.4540843249154407,0.4581543513302928,0.6784208663929336,Downregulated
Feature0982,NA,C16 H25 N O9,375.15303,NA,NA,Feature0982,16,25,9,1,0,0,1.5625,0.5625,-0.25,67.425,5,-4,-0.8333333333333334,-0.04761904761904761,-5,Amino Sugar,16150848.796261033,7967209.049600041,0.4932997113714836,-1.0194636516722306,0.007506534573092215,0.23030609530252863,Downregulated
Feature0981,Drospirenone,C24 H30 O3,366.21955,NA,NA,Drospirenone-peak2,24,30,3,0,0,0,1.25,0.125,-1,88.8,10,7,0.3333333333333333,0.37777777777777777,7,Unsaturated HC,427839.085172634,476976.763696002,1.1148508404825634,0.156850700198438,0.6382054454708637,0.8131443267876828,Upregulated
Feature0980,NA,C18 H35 N5 O8,449.24869,NA,NA,Feature0980,18,35,8,5,0,0,1.9444444444444444,0.4444444444444444,-0.22222222222222232,66.63333333333333,4,-4,-1.8,-0.5555555555555556,-9,Protein,1156339.9118741348,691352.6484677376,0.5978801227635823,-0.7420718473060075,0.44616321010041116,0.6687322960777052,Downregulated
Feature0979,D-lysopine,C9 H18 N2 O4,218.12662,Lysine degradation,NA,D-lysopine-peak4,9,18,4,2,0,0,2,0.4444444444444444,-0.44444444444444464,72.96666666666667,2,-2,-1.3333333333333333,-0.4,-4,Protein,14072504.14343716,14011004.600724867,0.9956298081645281,-0.00631867106963259,0.9820596072546366,0.990833218993064,Downregulated
Feature0978,"(2S)-3-(1H-Imidazol-4-yl)-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",C12 H19 N3 O7,317.12236,NA,NA,"(2S)-3-(1H-Imidazol-4-yl)-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)-peak2",12,19,7,3,0,0,1.5833333333333333,0.5833333333333334,0.3333333333333335,50.8,5,-2,-2.5,-0.2727272727272727,-5,Amino Sugar,22170788.28417647,19729233.931493632,0.8898751672070496,-0.1683251276653606,0.12161615522165921,0.45317690246982556,Downregulated
Feature0977,Phenyl D-glucopyranosiduronic acid,C12 H14 O7,270.07395,NA,NA,Phenyl D-glucopyranosiduronic acid-peak4,12,14,7,0,0,0,1.1666666666666667,0.5833333333333334,0,60.3,6,-1,-0.2,0.29411764705882354,-1,Lignin,15395383.245194333,10085414.2909848,0.6550934218628797,-0.6102274330502528,0.4126234887913791,0.6580333694263849,Downregulated
Feature0976,gamma-Glu-gln,C10 H17 N3 O6,275.11175,NA,NA,gamma-Glu-gln,10,17,6,3,0,0,1.7,0.6,0.3999999999999999,48.9,4,-2,-5,-0.5,-5,Amino Sugar,12334607.9298071,11879926.86369669,0.9631377771634189,-0.054185904074445256,0.85371083445164,0.92558845302131,Downregulated
Feature0975,Borrelidin,C28 H43 N O6,489.30914,NA,NA,Borrelidin,28,43,6,1,0,0,1.5357142857142858,0.21428571428571427,-1,88.8,8,2,0.04761904761904761,0.16666666666666666,1,Lipid,1158562.931170851,1584961.5264377566,1.3680409443412664,0.4521114095470034,0.25050563094633216,0.5311095604794577,Upregulated
Feature0974,Tolycaine,C15 H22 N2 O3,278.16307,NA,NA,Tolycaine-peak1,15,22,3,2,0,0,1.4666666666666666,0.2,-0.666666666666667,79.30000000000001,6,3,0.1,0.21739130434782608,1,Lignin,12851636.6417238,9645211.038126126,0.7505044926972356,-0.414067386702129,0.2731491838700969,0.552825229959312,Downregulated
Feature0973,"2-(3-CARBOXYPROPIONYL)-6-HYDROXY-CYCLOHEXA-2,4-DIENE CARBOXYLIC ACID",C11 H12 O6,240.06344000000001,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,Superpathway of chorismate metabolism;Other,"2-(3-CARBOXYPROPIONYL)-6-HYDROXY-CYCLOHEXA-2,4-DIENE CARBOXYLIC ACID",11,12,6,0,0,0,1.0909090909090908,0.5454545454545454,0,60.3,6,0,0,0.375,0,Lignin,23365860.204285666,19594672.346827433,0.8386026525671613,-0.2539407013362138,0.018208039755292213,0.2637533176745511,Downregulated
Feature0972,L-Ergothioneine,C9 H15 N3 O2 S,229.08852,NA,NA,L-Ergothioneine,9,15,2,3,1,0,1.6666666666666667,0.2222222222222222,0,60.3,4,2,-0.6666666666666666,-0.25,-2,Lipid,2413385.4662412233,4650261.280631043,1.9268622214227915,0.946253416689973,0.13193461156119113,0.45384777576550756,Upregulated
Feature0971,Propoxur,C11 H15 N O3,209.10519,Biosynthesis of alkaloids derived from shikimate pathway;Other,NA,Propoxur,11,15,3,1,0,0,1.3636363636363635,0.2727272727272727,-0.5454545454545459,75.84545454545456,5,2,0.14285714285714285,0.29411764705882354,1,Lignin,16313975.143626567,14171076.793428967,0.8686464622305881,-0.20315897304541752,0.054877291668423055,0.3736903134868504,Downregulated
Feature0970,Nojirimycin,C6 H13 N O5,179.07941,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,Other,Nojirimycin-peak1,6,13,5,1,0,0,2.1666666666666665,0.8333333333333334,0,60.3,1,-4,-Inf,-1,-5,Carbohydrate,24244830.511565402,17426519.336451467,0.7187725782672959,-0.47639272492712637,0.13148725368549483,0.45384777576550756,Downregulated
Feature0969,Glycyl-L-leucine,C8 H16 N2 O3,188.11611,Metabolic pathways;Lysine degradation,Superpathway of L-lysine degradation,Glycyl-L-leucine-peak1,8,16,3,2,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,10120329.918186696,6464280.5367913,0.6387420755102748,-0.64669460737792,0.30909087006264596,0.5794265880107856,Downregulated
Feature0968,NA,C13 H12 N2 O6 S,324.04171,NA,NA,Feature0968,13,12,6,2,1,0,0.9230769230769232,0.4615384615384616,0.6153846153846154,42.76153846153846,9,3,0,0.42857142857142855,0,Lignin,238922.69430673867,264770.8991155457,1.1081864779894957,0.1482006686019744,0.42536222959292375,0.6594697741371865,Upregulated
Feature0967,Methoxyphenamine,C11 H17 N O,179.13104,NA,NA,Methoxyphenamine,11,17,1,1,0,0,1.5454545454545454,0.09090909090909093,-1.0909090909090908,91.39090909090908,4,3,0.2222222222222222,0.2631578947368421,2,Lipid,21900459.199005067,15130420.655939134,0.6908723017381528,-0.5335090220078503,7.797565266429135e-4,0.13209075561330955,Downregulated
Feature0966,Vorinostat,C14 H20 N2 O3,264.14742,Metabolic pathways;Other,NA,Vorinostat,14,20,3,2,0,0,1.4285714285714286,0.21428571428571427,-0.5714285714285712,76.58571428571427,6,3,0.1111111111111111,0.23809523809523808,1,Lignin,15426903.016240634,16781484.9873576,1.0878064748116285,0.12142191811096217,0.6835633029787322,0.8366735803800379,Upregulated
Feature0965,NA,C5 H10 N9 O2 P,259.06957,NA,NA,Feature0965,5,10,2,9,0,1,2,0.4,3.2,-30.90000000000001,6,4,0.8571428571428571,0.8333333333333334,-6,Protein,10088491.092159918,4908034.673815167,0.48649838999504635,-1.0394930642900317,0.0049857159650996,0.228254461147012,Downregulated
Feature0964,NA,C11 H19 N5 O2,253.15395,NA,NA,Feature0964,11,19,2,5,0,0,1.7272727272727273,0.18181818181818185,0,60.3,5,3,-0.5,-0.2,-2,Lipid,21364138.3154285,17490936.244277798,0.8187054392756108,-0.2885836146147583,0.22871796931676805,0.5170330973050352,Downregulated
Feature0963,pyroglutamylglycine,C7 H10 N2 O4,186.06407,NA,NA,pyroglutamylglycine,7,10,4,2,0,0,1.4285714285714286,0.5714285714285714,0.5714285714285716,44.014285714285705,4,0,-2,0,-2,Lignin,13653850.642516833,10682757.06713588,0.782398851930514,-0.3540238415647122,0.03303251974204792,0.32345137828340564,Downregulated
Feature0962,NA,C16 H30 N2 O9,394.19526,NA,NA,Feature0962,16,30,9,2,0,0,1.875,0.5625,-0.375,70.9875,3,-6,-1.6,-0.3684210526315789,-8,Amino Sugar,279791.31284773466,440001.026694668,1.572604317897894,0.6531557207117016,0.00965670969598355,0.2324530359410441,Upregulated
Feature0961,afegostat,C6 H13 N O3,147.08956,Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,afegostat-peak3,6,13,3,1,0,0,2.1666666666666665,0.5,-0.666666666666667,79.30000000000001,1,-2,-1.5,-0.42857142857142855,-3,Protein,4877104.28758682,3821634.177840017,0.7835867253375778,-0.3518351376237015,0.2596284577898531,0.5429760586370508,Downregulated
Feature0960,"3-Hydroxy-2,4,5-pyridinetrimethanol",C8 H11 N O4,185.06883,NA,NA,"3-Hydroxy-2,4,5-pyridinetrimethanol-peak2",8,11,4,1,0,0,1.375,0.5,0,60.3,4,0,-0.3333333333333333,0.2,-1,Lignin,8074997.27935922,9138639.540703453,1.1317204482610843,0.178517635100164,0.5205772770473466,0.7276055340909283,Upregulated
Feature0959,NA,C9 H19 N O9,285.106,NA,NA,Feature0959,9,19,9,1,0,0,2.111111111111111,1,0.22222222222222232,53.96666666666666,1,-8,9,-1.2857142857142858,-9,Carbohydrate,6111888.332601677,5756417.02794667,0.9418393652974855,-0.08644707183305847,0.5709082896220455,0.7634736581619005,Downregulated
Feature0958,NA,C13 H25 N3 O4,287.18454,NA,NA,Feature0958,13,25,4,3,0,0,1.9230769230769231,0.3076923076923077,-0.615384615384615,77.83846153846153,3,-1,-0.6666666666666666,-0.25,-4,Protein,10737758.102335447,14321361.295312466,1.333738491668721,0.4154758226267607,0.025663624865690397,0.3040152484089478,Upregulated
Feature0957,4-Methoxycinnamaldehyde,C10 H10 O2,162.0681,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Other,4-Methoxycinnamaldehyde-peak1,10,10,2,0,0,0,1,0.2,-0.5999999999999996,77.39999999999999,6,4,0.5,0.5555555555555556,4,Lignin,2196962.53171931,3223099.66738444,1.467070840239633,0.5529385359021652,0.04715668418203104,0.35607946299980225,Upregulated
Feature0956,NA,C13 H12 N2 O6 S,324.04171,NA,NA,Feature0956,13,12,6,2,1,0,0.9230769230769232,0.4615384615384616,0.6153846153846154,42.76153846153846,9,3,0,0.42857142857142855,0,Lignin,110817.57822860533,125674.637271456,1.1340677109203927,0.18150678074995516,0.23810295549483876,0.5231694095424109,Upregulated
Feature0955,Crotonic acid,C4 H6 O2,86.0368,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,Other,Crotonic acid-peak3,4,6,2,0,0,0,1.5,0.5,-0.5,74.55,2,0,0,0.3333333333333333,0,Protein,451513.0922787507,408121.15912345203,0.9038966224959214,-0.14577031200436713,0.8676626024122882,0.9326271881258987,Downregulated
Feature0954,N8-Acetylspermidine,C9 H21 N3 O,187.16849,NA,NA,N8-Acetylspermidine,9,21,1,3,0,0,2.3333333333333335,0.1111111111111111,-1.1111111111111107,91.96666666666664,1,0,-0.6,-0.4545454545454546,-3,Lipid,291698.32203520165,409899.812213049,1.4052182726083113,0.49079424172842834,0.1275949533252119,0.45384777576550756,Upregulated
Feature0953,NA,C7 H9 O5 P S,235.99087,NA,NA,Feature0953,7,9,5,0,1,1,1.2857142857142858,0.7142857142857143,-0.2857142857142856,68.44285714285714,4,-1,-Inf,-0.2,-3,Tannin,16367565.598187601,23665383.2613674,1.445870683664032,0.5319385257472942,0.1371968852948014,0.45750299938857,Upregulated
Feature0952,NA,C19 H41 N O2,315.3138,NA,NA,Feature0952,19,41,2,1,0,0,2.1578947368421053,0.10526315789473684,-1.7894736842105263,111.3,0,-2,-0.1875,-0.1176470588235294,-3,Lipid,134250.23674159366,163923.79015195568,1.22103166542252,0.28810061470342324,0.11580974560179633,0.44790344531836296,Upregulated
Feature0951,Guanine,C5 H5 N5 O,151.0494,Metabolic pathways;Other,Superpathway of purine nucleotide salvage;Other,Guanine-peak1,5,5,1,5,0,0,1,0.2,2.4,-8.099999999999994,6,5,-0,-1,0,Lignin,10007196.90732397,12698275.267754167,1.2689143009128439,0.343594636694359,0.26176090321158435,0.5437149951031542,Upregulated
Feature0950,NA,C18 H34 N2 O8,406.23161,NA,NA,Feature0950,18,34,8,2,0,0,1.8888888888888888,0.4444444444444444,-0.666666666666667,79.30000000000001,3,-5,-0.875,-0.25,-7,Protein,462763.0653733033,166787.729073803,0.3604171152666605,-1.4722605722929492,0.23022226994608766,0.5170330973050352,Downregulated
Feature0949,({5-[(2S)-2-Carboxy-2-(trimethylammonio)ethyl]-1H-imidazol-2-yl}sulfanyl)oxidanide,C9 H15 N3 O3 S,245.08343,NA,NA,({5-[(2S)-2-Carboxy-2-(trimethylammonio)ethyl]-1H-imidazol-2-yl}sulfanyl)oxidanide,9,15,3,3,1,0,1.6666666666666667,0.3333333333333333,0.22222222222222232,53.96666666666666,4,1,-1.5,-0.42857142857142855,-3,Protein,2739426.02083571,3770407.7579935165,1.3763495452391472,0.46084691127685706,0.3833147879109501,0.6347363154654443,Upregulated
Feature0948,Methylhippuric acid,C10 H11 N O3,193.0739,Phenylalanine metabolism;Other,NA,Methylhippuric acid-peak3,10,11,3,1,0,0,1.1,0.3,-0.20000000000000015,66,6,3,0.3333333333333333,0.4666666666666667,2,Lignin,185526.68372010367,345824.92468073434,1.86401717395254,0.8984151521928488,0.07797011403689218,0.39590936857023457,Upregulated
Feature0947,Cytosine,C4 H5 N3 O,111.04321,Metabolic pathways;Other,Other,Cytosine-peak2,4,5,1,3,0,0,1.25,0.25,1.5,17.549999999999997,4,3,NA,1,0,Lignin,11271942.952799024,8738571.171699293,0.7752497691207132,-0.3672669037024175,0.08564930758274435,0.40755597484598016,Downregulated
Feature0946,NA,C5 H11 N3,113.09524,NA,NA,Feature0946,5,11,0,3,0,0,2.2,0,-0.4000000000000003,71.7,2,2,-0.5,-0.5,-1,Lipid,15145537.927720433,11698744.247298067,0.7724218382422852,-0.3725391415277636,0.16226789970977196,0.4734778652324074,Downregulated
Feature0945,4-Hydroxyprolylthreonine,C9 H16 N2 O5,232.10593,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,Other,4-Hydroxyprolylthreonine-peak2,9,16,5,2,0,0,1.7777777777777777,0.5555555555555556,0,60.3,3,-2,-2,-0.3333333333333333,-4,Amino Sugar,13700142.475972414,13080383.4755361,0.9547625872122674,-0.06678605999347466,0.8462256629322847,0.9242464687345522,Downregulated
Feature0944,(4S)-4-Hydroxy-4-methyltetrahydro-2H-pyran-2-one,C6 H10 O3,130.06295,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I,(4S)-4-Hydroxy-4-methyltetrahydro-2H-pyran-2-one-peak3,6,10,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,1428408.81282161,1489274.6765758132,1.0426109550766296,0.06020092402574236,0.5070010214147236,0.7157429756539546,Upregulated
Feature0943,Phenyl D-glucopyranosiduronic acid,C12 H14 O7,270.07396,NA,NA,Phenyl D-glucopyranosiduronic acid-peak3,12,14,7,0,0,0,1.1666666666666667,0.5833333333333334,0,60.3,6,-1,-0.2,0.29411764705882354,-1,Lignin,351727.8042552826,204260.96475655868,0.5807359051100404,-0.784045860704098,0.2631133241258834,0.5442389980100781,Downregulated
Feature0942,Cytosine,C4 H5 N3 O,111.04321,Metabolic pathways;Other,Other,Cytosine-peak1,4,5,1,3,0,0,1.25,0.25,1.5,17.549999999999997,4,3,NA,1,0,Lignin,2975635.328444883,4399208.15610159,1.4784097076844056,0.5640461350688329,0.23325865533907916,0.5201446342203138,Upregulated
Feature0941,Glu-Glu,C10 H16 N2 O7,276.09576,Other,NA,Glu-Glu,10,16,7,2,0,0,1.6,0.7,0.3999999999999999,48.9,4,-3,-5,-0.3333333333333333,-5,Amino Sugar,21013003.180312134,16035296.477212267,0.7631130276626206,-0.3900313387820883,0.05893608965057848,0.3794192923980171,Downregulated
Feature0940,"(3S,5R,6S)-5,6-epoxy-3-hydroxy-5,6-dihydro-12'-apo-beta-caroten-12'-al",C25 H34 O3,382.25081,NA,NA,"(3S,5R,6S)-5,6-epoxy-3-hydroxy-5,6-dihydro-12'-apo-beta-caroten-12'-al",25,34,3,0,0,0,1.36,0.12,-1.12,92.22,9,6,0.2727272727272727,0.3191489361702128,6,Unsaturated HC,2028479.2753647,2460102.92008136,1.2127818854047983,0.2783201101125419,0.18981413245461062,0.4862119877973694,Upregulated
Feature0939,387122,C12 H18 O,178.13575,NA,NA,387122,12,18,1,0,0,0,1.5,0.08333333333333333,-1.333333333333333,98.29999999999998,4,3,0.2727272727272727,0.30434782608695654,3,Lipid,1303725.508108478,1823973.80221539,1.3990474151738572,0.4844448577685737,0.1207678585358794,0.4526122839818135,Upregulated
Feature0938,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,NA,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole-peak1",11,12,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Lignin,4911017.02811439,10460211.76832748,2.1299481774233904,1.0908183294728055,0.5158088003511729,0.7241082230564106,Upregulated
Feature0937,NA,C19 H41 N O2,315.31381,NA,NA,Feature0937,19,41,2,1,0,0,2.1578947368421053,0.10526315789473684,-1.7894736842105263,111.3,0,-2,-0.1875,-0.1176470588235294,-3,Lipid,179654.646310695,292141.23154343397,1.6261267801457497,0.7014397407815263,0.2375778874653487,0.5231694095424109,Upregulated
Feature0936,NA,C12 H21 N O8,307.12685,NA,NA,Feature0936,12,21,8,1,0,0,1.75,0.6666666666666666,-0.16666666666666696,65.05000000000001,3,-5,-2,-0.2857142857142857,-6,Amino Sugar,2889132.579326093,3099586.6527237836,1.0728433422902248,0.10143942763100137,0.8263371365199088,0.9149513021703188,Upregulated
Feature0935,Crotonic acid,C4 H6 O2,86.0368,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,Other,Crotonic acid-peak2,4,6,2,0,0,0,1.5,0.5,-0.5,74.55,2,0,0,0.3333333333333333,0,Protein,3837909.4300969234,5106380.758183657,1.3305110115781704,0.41198045044542375,0.34886540655042275,0.6073771826273547,Upregulated
Feature0934,NA,C62 H106 N2 O14 P2 S2,1228.65592,NA,NA,Feature0934,62,106,14,2,2,2,1.7096774193548387,0.2258064516129032,-1.258064516129032,96.1548387096774,12,-2,-0.1904761904761905,-0.02040816326530612,-8,Lipid,104162.0157289561,134438.77762531367,1.2906698923256426,0.36812005749806065,0.051319268844013596,0.36591042730478307,Upregulated
Feature0933,gamma glutamyl ornithine,C10 H19 N3 O5,261.13251,NA,NA,gamma glutamyl ornithine,10,19,5,3,0,0,1.9,0.5,0,60.3,3,-2,-2.5,-0.5555555555555556,-5,Protein,4550741.279121984,3667832.4025812265,0.8059857015841813,-0.3111738497278774,0.4410671350623561,0.6668537167127339,Downregulated
Feature0932,Crotonic acid,C4 H6 O2,86.0368,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,Other,Crotonic acid-peak1,4,6,2,0,0,0,1.5,0.5,-0.5,74.55,2,0,0,0.3333333333333333,0,Protein,4768779.144542307,4344271.1106261695,0.9109818213322017,-0.13450582959280666,0.6071355291175531,0.7893227830584304,Downregulated
Feature0931,NA,C9 H19 N O9,285.10601,NA,NA,Feature0931,9,19,9,1,0,0,2.111111111111111,1,0.22222222222222232,53.96666666666666,1,-8,9,-1.2857142857142858,-9,Carbohydrate,19631030.18772054,8731465.54451588,0.4447787742681748,-1.1688401534732205,0.2333588677729861,0.5201446342203138,Downregulated
Feature0930,5-Deoxy-5-aminoshikimic acid,C7 H11 N O4,173.06882,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Other,5-Deoxy-5-aminoshikimic acid-peak2,7,11,4,1,0,0,1.5714285714285714,0.5714285714285714,0,60.3,3,-1,-1,0,-2,Amino Sugar,878260.9703820127,898676.3579901883,1.0232452406478858,0.033151956485702065,0.9007230914160934,0.9477173396638895,Upregulated
Feature0929,NA,C20 H28 N2 O9,440.17967,NA,NA,Feature0929,20,28,9,2,0,0,1.4,0.45,-0.20000000000000015,66,8,-1,-0.3333333333333333,0.1111111111111111,-3,Lignin,6744772.465989657,7864325.973013927,1.165988328393521,0.22155334715499295,0.4634992130664519,0.6840367259145498,Upregulated
Feature0928,anticapsin,C9 H13 N O4,199.0845,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics,NA,anticapsin-peak1,9,13,4,1,0,0,1.4444444444444444,0.4444444444444444,-0.22222222222222232,66.63333333333333,4,0,-0.25,0.16666666666666666,-1,Lignin,12518908.188905757,15225723.409906566,1.216218154183732,0.2824020295468179,0.4143687380062188,0.6580333694263849,Upregulated
Feature0927,Anhalamine,C11 H15 N O3,209.10518,Biosynthesis of alkaloids derived from shikimate pathway;Other,NA,Anhalamine-peak3,11,15,3,1,0,0,1.3636363636363635,0.2727272727272727,-0.5454545454545459,75.84545454545456,5,2,0.14285714285714285,0.29411764705882354,1,Lignin,498417.9764545573,367766.6700831167,0.7378679892310172,-0.4385653657526463,0.4647951918831361,0.6852594038729614,Downregulated
Feature0926,NA,C24 H40 N8 O7,552.30201,NA,NA,Feature0926,24,40,7,8,0,0,1.6666666666666667,0.2916666666666667,-0.08333333333333304,62.67499999999999,9,2,-0.6666666666666666,-0.2,-6,Lipid,77284.33188146967,81523.2740116013,1.0548486611313774,0.07703603068904823,0.8038433408431602,0.9047911092281152,Upregulated
Feature0925,NA,C4 H5 N O,83.03712,NA,NA,Feature0925,4,5,1,1,0,0,1.25,0.25,0,60.3,3,2,0.5,0.6,1,Lignin,19499712.5935742,16017320.415563734,0.8214131535888365,-0.28382004498280694,0.1803514204611266,0.48423459758942683,Downregulated
Feature0924,MFCD02728197,C14 H20 N2 O4,280.14234,NA,NA,MFCD02728197-peak2,14,20,4,2,0,0,1.4285714285714286,0.2857142857142857,-0.4285714285714288,72.51428571428572,6,2,0,0.2,0,Lignin,9997749.954316176,14463507.014511367,1.4466762102074036,0.5327420592574551,0.12232986624843076,0.45317690246982556,Upregulated
Feature0923,3-Methylcrotonylglycine,C7 H11 N O3,157.07391,NA,NA,3-Methylcrotonylglycine-peak2,7,11,3,1,0,0,1.5714285714285714,0.42857142857142855,-0.2857142857142856,68.44285714285714,3,0,-0.3333333333333333,0.1111111111111111,-1,Protein,18085540.421477467,15878509.7476887,0.8779671150347373,-0.18776119141921244,0.2183556250767061,0.5080967429669508,Downregulated
Feature0922,DiisopropylSulfate,C6 H14 O4 S,182.0613,NA,NA,DiisopropylSulfate,6,14,4,0,1,0,2.3333333333333335,0.6666666666666666,-0.666666666666667,79.30000000000001,0,-4,-5,-1,-5,Other,15148226.043886,16478192.0016322,1.0877968122401362,0.12140910314229837,0.5008225013108667,0.7117393600844028,Upregulated
Feature0921,"3,4-Bis(3,4,5-trimethoxybenzyl)tetrahydro-2-furanol",C24 H32 O8,448.20981,Other,NA,"3,4-Bis(3,4,5-trimethoxybenzyl)tetrahydro-2-furanol",24,32,8,0,0,0,1.3333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,9,1,0.0625,0.25,1,Lignin,18760156.556175433,22762207.333057467,1.213327152409325,0.2789686003529847,0.45716259782236823,0.6781378640202205,Upregulated
Feature0920,NA,C17 H25 N3 O4,335.18462,NA,NA,Feature0920,17,25,4,3,0,0,1.4705882352941178,0.2352941176470588,-0.47058823529411775,73.71176470588236,7,3,0,0.16666666666666666,0,Lignin,14060325.700227268,18741484.8648241,1.3329339066819177,0.4146052463937176,0.15735622728283274,0.46825623718458564,Upregulated
Feature0919,NA,C7 H9 O7 P,236.00858,NA,NA,Feature0919,7,9,7,0,0,1,1.2857142857142858,1,0,60.3,4,-3,4,-0.2,-4,Tannin,11453805.1560725,7673429.01350186,0.6699458310091485,-0.5778836448300849,0.003780221028326304,0.20435156612062716,Downregulated
Feature0918,MFCD00020424,C18 H20 N2 O3,312.14738,NA,NA,MFCD00020424,18,20,3,2,0,0,1.1111111111111112,0.16666666666666666,-0.44444444444444464,72.96666666666667,10,7,0.38461538461538464,0.4482758620689655,5,Lignin,10939240.817713896,8970128.764948897,0.8199955476273619,-0.2863120186119628,0.33968568576083374,0.6000332386572487,Downregulated
Feature0917,NA,C16 H22 N2 O4,306.15784,NA,NA,Feature0917,16,22,4,2,0,0,1.375,0.25,-0.5,74.55,7,3,0.1,0.25,1,Lignin,247449.80605037435,258680.18611170468,1.0453844771211667,0.06403364203950195,0.7938966397085359,0.8971720531462707,Upregulated
Feature0916,Panthenol,C9 H19 N O4,205.13142,Other,NA,Panthenol,9,19,4,1,0,0,2.111111111111111,0.4444444444444444,-0.8888888888888893,85.63333333333334,1,-3,-1,-0.3333333333333333,-4,Protein,647473.755193298,613869.8569496237,0.9480999840161211,-0.07688888509078781,0.8346323861883121,0.9198876136649322,Downregulated
Feature0915,leu-gln,C11 H21 N3 O4,259.15323,NA,NA,leu-gln-peak2,11,21,4,3,0,0,1.9090909090909092,0.3636363636363637,-0.3636363636363633,70.66363636363636,3,-1,-1,-0.3333333333333333,-4,Protein,16017533.38846281,8770636.68479823,0.5475647512066738,-0.8688985169842111,0.42178860277041824,0.6594697741371865,Downregulated
Feature0914,Erythritol,C4 H10 O4,122.05787,ABC transporters,NA,Erythritol,4,10,4,0,0,0,2.5,1,-0.5,74.55,0,-4,-Inf,-1,-4,Carbohydrate,7059470.117848117,8654527.27720919,1.2259457342737903,0.29389512044242033,0.7874786789378487,0.8940944250138846,Upregulated
Feature0913,"2-amino-2,3,7-trideoxy-D-lyxo-hept-6-ulosonic acid",C7 H13 N O5,191.0794,"Metabolic pathways;Biosynthesis of secondary metabolites;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Other,"2-amino-2,3,7-trideoxy-D-lyxo-hept-6-ulosonic acid-peak2",7,13,5,1,0,0,1.8571428571428572,0.7142857142857143,0,60.3,2,-3,-4,-0.42857142857142855,-4,Carbohydrate,15347398.656890599,16965733.635424268,1.1054468587617665,0.14462967332817603,0.5279391451339102,0.7346333474948522,Upregulated
Feature0912,NA,C76 H121 N10 O14 P3,1490.82761,NA,NA,Feature0912,76,121,14,10,0,3,1.5921052631578947,0.18421052631578944,-1.026315789473684,89.55,23,9,-0.08163265306122448,0.05357142857142857,-4,Lipid,844872.3002087793,1024645.821166696,1.2127818853967545,0.2783201101029732,0.18981413235187572,0.4862119877973694,Upregulated
Feature0911,Sedanolide,C12 H18 O2,194.1307,NA,NA,Sedanolide-peak2,12,18,2,0,0,0,1.5,0.16666666666666666,-1.166666666666667,93.55,4,2,0.2,0.2727272727272727,2,Lipid,2830738.81953966,3752782.65342947,1.3257255058379969,0.406782093428687,0.5719601231086744,0.7641170729858788,Upregulated
Feature0910,mebutamate,C10 H20 N2 O4,232.1423,Other,NA,mebutamate-peak2,10,20,4,2,0,0,2,0.4,-0.5999999999999996,77.39999999999999,2,-2,-1,-0.3333333333333333,-4,Protein,9840879.776649043,10385578.816402033,1.0553506446695426,0.0777224200483744,0.8377003608485292,0.9202752342914452,Upregulated
Feature0909,Methylone,C11 H13 N O3,207.08953,Metabolic pathways;Phenylalanine metabolism;Other,NA,Methylone-peak2,11,13,3,1,0,0,1.181818181818182,0.2727272727272727,-0.3636363636363633,70.66363636363636,6,3,0.2857142857142857,0.4117647058823529,2,Lignin,2305732.57525315,1712447.9689742266,0.7426914930870568,-0.4291650413534423,0.32842095064604593,0.5910382735546541,Downregulated
Feature0908,N-Acetyl-L-histidine,C8 H11 N3 O3,197.08007,NA,NA,N-Acetyl-L-histidine,8,11,3,3,0,0,1.375,0.375,0.5,46.05,5,2,-0.5,0.14285714285714285,-1,Lignin,4080512.9916994534,3348220.8355727666,0.8205391925926202,-0.28535584998613184,0.15269754365057575,0.46778235597057083,Downregulated
Feature0907,NA,C12 H18 N4 O4,282.13282,NA,NA,Feature0907,12,18,4,4,0,0,1.5,0.3333333333333333,0.16666666666666652,55.55,6,2,-0.5,0,-2,Protein,14475032.8364242,10946398.018124433,0.7562261268644243,-0.40311040101500306,0.014053242346910369,0.2584368937065999,Downregulated
Feature0906,pro-asn,C9 H15 N3 O4,229.10627,NA,NA,pro-asn,9,15,4,3,0,0,1.6666666666666667,0.4444444444444444,0.22222222222222232,53.96666666666666,4,0,-1.5,-0.25,-3,Protein,6551607.979660797,5695595.07046378,0.8693430815985215,-0.20200245358890714,0.703278528337359,0.8470526718656479,Downregulated
Feature0905,"N-(4-Hydroxy-3,5-dimethoxybenzoyl)glycine",C11 H13 N O6,255.07429,NA,NA,"N-(4-Hydroxy-3,5-dimethoxybenzoyl)glycine-peak1",11,13,6,1,0,0,1.181818181818182,0.5454545454545454,0.18181818181818168,55.11818181818182,6,0,-0.25,0.2857142857142857,-1,Lignin,1955470.5367508265,322432.121705535,0.16488723079473352,-2.6004484170484106,0.04368825139707516,0.35607946299980225,Downregulated
Feature0904,NA,C15 H27 N O13,429.14831,NA,NA,Feature0904,15,27,13,1,0,0,1.8,0.8666666666666667,0.1333333333333333,56.5,3,-10,-11,-0.6,-11,Carbohydrate,1859491.71652842,1465359.7438229567,0.7880431683550123,-0.34365343339622023,0.016113666083917937,0.2637533176745511,Downregulated
Feature0903,NA,C6 H2 O4,137.99529,NA,NA,Feature0903,6,2,4,0,0,0,0.3333333333333333,0.6666666666666666,1,31.799999999999997,6,2,1,1,2,Condensed HC,21921649.102180965,17023421.653454967,0.7765575287746633,-0.36483528887932504,0.13374601145230824,0.45384777576550756,Downregulated
Feature0902,NA,C12 H12 N6 O3,288.09707,NA,NA,Feature0902,12,12,3,6,0,0,1,0.25,1,31.799999999999997,10,7,0.3333333333333333,0.5555555555555556,1,Lignin,2081310.69449645,887166.0484007373,0.42625353857386356,-1.2302162840660371,0.3425843459348057,0.6017631473175763,Downregulated
Feature0901,Drospirenone,C24 H30 O3,366.21955,NA,NA,Drospirenone-peak1,24,30,3,0,0,0,1.25,0.125,-1,88.8,10,7,0.3333333333333333,0.37777777777777777,7,Unsaturated HC,321360.42629787966,422561.83533848263,1.3149155924594027,0.39497019248439047,0.07387044768889856,0.39590936857023457,Upregulated
Feature0900,Methyldopa,C10 H13 N O4,211.08447,NA,NA,Methyldopa,10,13,4,1,0,0,1.3,0.4,-0.20000000000000015,66,5,1,0,0.2857142857142857,0,Lignin,598524.6332420156,816444.4332500123,1.3640949560047264,0.44794407529237634,0.3895166482632459,0.6375277315535638,Upregulated
Feature0899,"(2Z)-3-[4,5-Dihydroxy-2-(2-hydroxy-2-propanyl)-2,3-dihydro-1-benzofuran-7-yl]acrylic acid",C14 H16 O6,280.09471,NA,NA,"(2Z)-3-[4,5-Dihydroxy-2-(2-hydroxy-2-propanyl)-2,3-dihydro-1-benzofuran-7-yl]acrylic acid-peak1",14,16,6,0,0,0,1.1428571428571428,0.42857142857142855,-0.2857142857142856,68.44285714285714,7,1,0.125,0.3636363636363637,1,Lignin,496555.91608960996,385841.86845879164,0.777036091921542,-0.3639464841218984,0.5645707296428764,0.7614512866361725,Downregulated
Feature0898,N-Acetylglucosamine 1-phosphate,C8 H16 N O9 P,301.05635,Metabolic pathways;Other,Other,N-Acetylglucosamine 1-phosphate,8,16,9,1,0,1,2,1.125,0,60.3,2,-7,3,-3,-9,Carbohydrate,1509512.90001907,2432821.7348008836,1.6116601155049084,0.6885475246493431,0.10363323976123173,0.42922911529468594,Upregulated
Feature0897,NA,C14 H27 N3 O4,301.20023,NA,NA,Feature0897,14,27,4,3,0,0,1.9285714285714288,0.2857142857142857,-0.7142857142857144,80.65714285714286,3,-1,-0.5714285714285714,-0.2222222222222222,-4,Lipid,14438998.073472967,17726271.0154894,1.2276662774860911,0.29591843917005817,0.23734929653763762,0.5231694095424109,Upregulated
Feature0896,NA,C21 H33 N3 O2,359.25734,NA,NA,Feature0896,21,33,2,3,0,0,1.5714285714285714,0.09523809523809525,-0.9523809523809526,87.44285714285715,7,5,0.125,0.17647058823529413,2,Lipid,118752.33337665566,153836.65951071298,1.2954411516511237,0.37344347931619215,0.06017218815062166,0.3794192923980171,Upregulated
Feature0895,"11-(4-Hydroxyphenyl)-3-methyl-6,7,8,9-tetrahydropyridazino[1,2-a]indazol-10-ium-1-olate",C18 H18 N2 O2,294.13684,Biosynthesis of secondary metabolites;Other,NA,"11-(4-Hydroxyphenyl)-3-methyl-6,7,8,9-tetrahydropyridazino[1,2-a]indazol-10-ium-1-olate",18,18,2,2,0,0,1,0.1111111111111111,-0.44444444444444464,72.96666666666667,11,9,0.5,0.5333333333333333,7,Unsaturated HC,2711127.2741960534,1961120.4322246201,0.7233597813316096,-0.46721470823795175,0.0737981447511066,0.39590936857023457,Downregulated
Feature0894,Troxipide,C15 H22 N2 O4,294.158,NA,NA,Troxipide-peak3,15,22,4,2,0,0,1.4666666666666666,0.26666666666666666,-0.5333333333333332,75.5,6,2,0,0.18181818181818185,0,Lignin,12158707.21886303,10837321.261617197,0.8913218376378177,-0.1659816421221957,0.5969303017963463,0.7863140989447983,Downregulated
Feature0893,NA,C10 H17 N3 O3,227.12699,NA,NA,Feature0893,10,17,3,3,0,0,1.7,0.3,-0.20000000000000015,66,4,1,-0.5,-0.09090909090909093,-2,Lipid,20461839.825195365,16374556.0320658,0.8002484709074522,-0.32148007977547916,0.02083452768297313,0.2846265314109394,Downregulated
Feature0892,NA,C10 H24 N2 O6 S,300.13557,NA,NA,Feature0892,10,24,6,2,1,0,2.4,0.6,-0.4000000000000003,71.7,0,-6,-9,-1.5,-9,Other,20435800.227418866,22317488.203367267,1.0920780177437694,0.1270759256638681,0.6315356868520485,0.8123169730655809,Upregulated
Feature0891,1-alpha-linolenoyl-sn-glycerol,C21 H36 O4,352.26122,NA,NA,1-alpha-linolenoyl-sn-glycerol-peak1,21,36,4,0,0,0,1.7142857142857142,0.1904761904761905,-1.333333333333333,98.29999999999998,4,0,0,0.10526315789473684,0,Lipid,3541774.6721636066,2122818.443098317,0.5993657529324206,-0.7384914426109419,0.3228315488011163,0.5861484461709393,Downregulated
Feature0890,NA,C15 H28 N2 O9,380.17959,NA,NA,Feature0890,15,28,9,2,0,0,1.8666666666666667,0.6,-0.2666666666666666,67.89999999999999,3,-6,-2,-0.4117647058823529,-8,Amino Sugar,1031511.0679944523,588724.8083960604,0.5707401759059232,-0.8090939731904049,0.26843336885394625,0.5485236753179552,Downregulated
Feature0889,4-Methyleneglutamic acid,C6 H9 N O4,159.05318,Other,NA,4-Methyleneglutamic acid-peak2,6,9,4,1,0,0,1.5,0.6666666666666666,0.3333333333333335,50.8,3,-1,-2,0,-2,Amino Sugar,17446327.26195657,13688201.794100534,0.7845893057359415,-0.34999042384511875,0.0038612705401105734,0.20435156612062716,Downregulated
Feature0888,threonylphenylalanine,C13 H18 N2 O4,266.12654,Metabolic pathways;Biosynthesis of cofactors;Other,NA,threonylphenylalanine-peak4,13,18,4,2,0,0,1.3846153846153846,0.3076923076923077,-0.3076923076923075,69.06923076923076,6,2,0,0.2222222222222222,0,Lignin,120047.62608140433,141654.02611384934,1.1799819016645419,0.23876473197775153,0.2125499217277446,0.5042851084128842,Upregulated
Feature0887,CI-976,C23 H39 N O4,393.28787,NA,NA,CI-976,23,39,4,1,0,0,1.6956521739130437,0.17391304347826086,-1.2173913043478262,94.99565217391304,5,1,0,0.1,0,Lipid,2037168.1277058367,2189596.2346838266,1.074823528262072,0.10409980790722716,0.7441945524295708,0.8724329216717598,Upregulated
Feature0886,L-Alanyl-L-glutamine,C8 H15 N3 O4,217.10623,Metabolic pathways;Biosynthesis of amino acids;Other,NA,L-Alanyl-L-glutamine-peak2,8,15,4,3,0,0,1.875,0.5,0.25,53.175,3,-1,-4,-0.6666666666666666,-4,Protein,11052153.064671993,10733965.65499813,0.971210368892651,-0.042144270626805876,0.907749305735104,0.9502730353926686,Downregulated
Feature0885,NA,C13 H27 N O11,373.15852,NA,NA,Feature0885,13,27,11,1,0,0,2.076923076923077,0.8461538461538461,-0.1538461538461542,64.6846153846154,1,-10,-11,-0.8461538461538461,-11,Carbohydrate,16200698.003989883,11445899.332166202,0.7065065548007452,-0.5012251492826261,0.5303978626749204,0.7346581985645525,Downregulated
Feature0884,leu-phe,C15 H22 N2 O3,278.16308,NA,NA,leu-phe-peak1,15,22,3,2,0,0,1.4666666666666666,0.2,-0.666666666666667,79.30000000000001,6,3,0.1,0.21739130434782608,1,Lignin,10691638.771984933,11809031.800972823,1.104510922302741,0.14340768530621392,0.670867272487175,0.8299462183952073,Upregulated
Feature0883,"2,3,4,9-Tetrahydro-1H-β-carboline-3-carboxylic acid",C12 H12 N2 O2,216.0899,NA,NA,"2,3,4,9-Tetrahydro-1H-β-carboline-3-carboxylic acid",12,12,2,2,0,0,1,0.16666666666666666,-0.16666666666666696,65.05000000000001,8,6,0.5,0.5555555555555556,4,Lignin,11366118.142500468,4233090.592937997,0.37243063461653814,-1.4249563469326494,0.0013249605346778337,0.15098679741337404,Downregulated
Feature0882,NA,C11 H17 N5 O,235.1433,NA,NA,Feature0882,11,17,1,5,0,0,1.5454545454545454,0.09090909090909093,0,60.3,6,5,0,0.09090909090909093,0,Lipid,17666773.0122793,13741212.5680074,0.7777998029666519,-0.36252922558074663,0.12893091626773545,0.45384777576550756,Downregulated
Feature0881,Methionylleucine,C11 H22 N2 O3 S,262.13517,NA,NA,Methionylleucine-peak2,11,22,3,2,1,0,2,0.2727272727272727,-0.7272727272727275,81.02727272727273,2,-1,-0.8,-0.38461538461538464,-4,Lipid,7205376.474385907,5060959.850181144,0.7023865953669651,-0.5096627827335358,0.216309915404068,0.5069722111991797,Downregulated
Feature0880,Methylhippuric acid,C10 H11 N O3,193.0739,Phenylalanine metabolism;Other,NA,Methylhippuric acid-peak2,10,11,3,1,0,0,1.1,0.3,-0.20000000000000015,66,6,3,0.3333333333333333,0.4666666666666667,2,Lignin,17983536.606265135,13514601.498168299,0.7514985396954712,-0.41215779417373155,0.05116071520949582,0.36591042730478307,Downregulated
Feature0879,2-ethyl-1H-perimidine,C13 H12 N2,196.10009,NA,NA,2-ethyl-1H-perimidine,13,12,0,2,0,0,0.9230769230769232,0,-0.4615384615384617,73.45384615384616,9,9,0.6363636363636364,0.6363636363636364,7,Unsaturated HC,12554614.74379136,23047425.169796165,1.835773190984918,0.8763878253888828,0.007884127538230352,0.23030609530252863,Upregulated
Feature0878,NA,C12 H21 N O8,307.12682,NA,NA,Feature0878,12,21,8,1,0,0,1.75,0.6666666666666666,-0.16666666666666696,65.05000000000001,3,-5,-2,-0.2857142857142857,-6,Amino Sugar,18812824.468041867,14991593.534115333,0.7968815931697115,-0.32756272153420235,0.28636929774794806,0.5646020478032001,Downregulated
Feature0877,N-(2-Hydroxy-7-octenoyl)glycine,C10 H17 N O4,215.11577,NA,NA,N-(2-Hydroxy-7-octenoyl)glycine-peak3,10,17,4,1,0,0,1.7,0.4,-0.5999999999999996,77.39999999999999,3,-1,-0.4,0,-2,Protein,14124933.6625836,13500860.003928566,0.955817586576836,-0.06519278217453678,0.6406271538721561,0.8131443267876828,Downregulated
Feature0876,Leucyltryptophan,C17 H23 N3 O3,317.17403,NA,NA,Leucyltryptophan-peak2,17,23,3,3,0,0,1.3529411764705883,0.17647058823529413,-0.47058823529411775,73.71176470588236,8,5,0.18181818181818185,0.28,2,Lignin,11124798.750477564,16955591.40653093,1.5241256751546237,0.6079818683475975,0.021730655480489972,0.2912553665556471,Upregulated
Feature0875,uridine 5′-diphosphate,C9 H14 N2 O12 P2,404.00229,Metabolic pathways;Biosynthesis of cofactors;Other,Superpathway of scopolin and esculin biosynthesis;Superpathway of butirocin biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Superpathway of indole-3-acetate conjugate biosynthesis;Other,uridine 5′-diphosphate,9,14,12,2,0,2,1.5555555555555556,1.3333333333333333,0.6666666666666665,41.3,5,-7,1.5714285714285714,5,-11,Carbohydrate,19004905.28960772,14691106.3788253,0.7730165530926747,-0.37142878706450855,0.5253322693734515,0.7330418981207798,Downregulated
Feature0874,Azobenzene,C12 H10 N2,182.08443,Biosynthesis of secondary metabolites;Biosynthesis of alkaloids derived from shikimate pathway;Other,NA,Azobenzene-peak1,12,10,0,2,0,0,0.8333333333333334,0,-0.33333333333333304,69.79999999999998,9,9,0.7,0.7,7,Unsaturated HC,10999124.12223119,16886302.660530634,1.535240667609197,0.6184648332828687,0.011539040702251877,0.25060429422582925,Upregulated
Feature0873,DH2090000,C9 H10 O5,198.05285,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of various antibiotics;Tyrosine metabolism;Aminobenzoate degradation,Other,DH2090000-peak2,9,10,5,0,0,0,1.1111111111111112,0.5555555555555556,0,60.3,5,0,0,0.38461538461538464,0,Lignin,15202465.062538533,11448519.784429833,0.7530699618340804,-0.40914419426312143,0.04733181266724828,0.35607946299980225,Downregulated
Feature0872,"(2S,4S)-4-Amino-2-hydroxy-2-methylpentanedioic acid",C6 H11 N O5,177.06376,Other,NA,"(2S,4S)-4-Amino-2-hydroxy-2-methylpentanedioic acid",6,11,5,1,0,0,1.8333333333333333,0.8333333333333334,0.3333333333333335,50.8,2,-3,-Inf,-0.6,-4,Carbohydrate,12039455.0870774,13769655.609285066,1.1437108664548103,0.19372238056611898,0.2918945446048207,0.5677030523083425,Upregulated
Feature0871,N-Acetylvanilalanine,C12 H15 N O5,253.09502,NA,NA,N-Acetylvanilalanine-peak6,12,15,5,1,0,0,1.25,0.4166666666666667,-0.16666666666666696,65.05000000000001,6,1,0,0.29411764705882354,0,Lignin,16903753.525999032,13394008.538773734,0.7923688971312146,-0.3357558436796782,0.09423647823732781,0.41723968591020827,Downregulated
Feature0870,3-Hydroxyhexadecadienoylcarnitine,C23 H41 N O5,411.2985,NA,NA,3-Hydroxyhexadecadienoylcarnitine,23,41,5,1,0,0,1.7826086956521738,0.21739130434782608,-1.2173913043478262,94.99565217391304,4,-1,-0.1176470588235294,0.02564102564102564,-2,Lipid,198158.05495699533,273840.833533406,1.3819313759051355,0.466685976001517,0.009264456292264031,0.2324530359410441,Upregulated
Feature0869,NA,C12 H21 N O8,307.12679,NA,NA,Feature0869,12,21,8,1,0,0,1.75,0.6666666666666666,-0.16666666666666696,65.05000000000001,3,-5,-2,-0.2857142857142857,-6,Amino Sugar,942383.1128828546,593920.160968817,0.630232177178928,-0.6660446803107257,0.026030611701198744,0.3041093532540047,Downregulated
Feature0868,NA,C17 H32 N2 O8,392.21597,NA,NA,Feature0868,17,32,8,2,0,0,1.8823529411764703,0.4705882352941176,-0.5882352941176467,77.06470588235292,3,-5,-1,-0.2727272727272727,-7,Protein,1197243.2094995168,408616.74506797903,0.34129802685520594,-1.5508960210730216,0.02483424892042396,0.29968677253407894,Downregulated
Feature0867,Maleic acid,C4 H4 O4,116.01093,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine metabolism;Tyrosine metabolism;Other,Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of purine nucleotide salvage;Other,Maleic acid,4,4,4,0,0,0,1,1,1,31.799999999999997,3,-1,-Inf,0.5,-1,Tannin,754461.5776339266,686893.5543799753,0.910442061919373,-0.13536088399075993,0.4542523374123097,0.6755956624903008,Downregulated
Feature0866,NA,C12 H21 N3 O4,271.15326,NA,NA,Feature0866,12,21,4,3,0,0,1.75,0.3333333333333333,-0.33333333333333304,69.79999999999998,4,0,-0.6,-0.14285714285714285,-3,Protein,17478840.845409997,9715825.602902813,0.555862124315539,-0.8472010127178318,0.20339594252926763,0.499580028875622,Downregulated
Feature0865,"(2Z,4E)-2,4-Hexadienedial",C6 H6 O2,110.03674,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Tyrosine metabolism;Aminobenzoate degradation;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,"(2Z,4E)-2,4-Hexadienedial-peak2",6,6,2,0,0,0,1,0.3333333333333333,-0.33333333333333304,69.79999999999998,4,2,0.5,0.6,2,Lignin,5320820.003912402,5463157.361450596,1.0267510190973446,0.03808637925848859,0.9631234548597853,0.9788536492904287,Upregulated
Feature0864,(Ac)2-L-Lys-D-Ala,C13 H23 N3 O5,301.16384,NA,NA,(Ac)2-L-Lys-D-Ala,13,23,5,3,0,0,1.7692307692307692,0.38461538461538464,-0.3076923076923075,69.06923076923076,4,-1,-0.8,-0.2,-4,Protein,1738947.88693615,2088504.7405064001,1.2010162904801787,0.264255719765925,0.20005689393014317,0.49691551072971046,Upregulated
Feature0863,Pro-Hyp,C10 H16 N2 O4,228.111,NA,NA,Pro-Hyp-peak2,10,16,4,2,0,0,1.6,0.4,-0.20000000000000015,66,4,0,-0.5,0,-2,Protein,13055699.2606593,11009191.596483266,0.8432479468684784,-0.24597119429889144,0.015031891152205006,0.25983697563097224,Downregulated
Feature0862,6-Aminocaproic acid,C6 H13 N O2,131.09459,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Superpathway of indole-3-acetate conjugate biosynthesis,6-Aminocaproic acid-peak2,6,13,2,1,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,4000952.2902643,5332374.43151865,1.3327763104034407,0.4144346626834336,0.28000477097341653,0.5600095419468331,Upregulated
Feature0861,leu-gln,C11 H21 N3 O4,259.1532,NA,NA,leu-gln-peak1,11,21,4,3,0,0,1.9090909090909092,0.3636363636363637,-0.3636363636363633,70.66363636363636,3,-1,-1,-0.3333333333333333,-4,Protein,6365868.4552319,4347016.613436773,0.6828630915023232,-0.55033173600542,0.270953085636391,0.5510138380168623,Downregulated
Feature0860,1-Naphthol,C10 H8 O,144.05749,Other,NA,1-Naphthol,10,8,1,0,0,0,0.8,0.1,-0.5999999999999996,77.39999999999999,7,6,0.6666666666666666,0.6842105263157895,6,Unsaturated HC,138972.194674706,11253485.828508543,80.97652810945183,6.339431883287589,0.1073134480566729,0.43283090716191397,Upregulated
Feature0859,thr-pro,C9 H16 N2 O4,216.11107,Metabolic pathways;Other,Other,thr-pro-peak2,9,16,4,2,0,0,1.7777777777777777,0.4444444444444444,-0.22222222222222232,66.63333333333333,3,-1,-1,-0.2,-3,Protein,6675212.371229127,7335036.3679421535,1.0988468920564891,0.13599038222996473,0.33032282843186067,0.5915083206803087,Upregulated
Feature0858,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13227,NA,NA,6-(alpha-D-glucosaminyl)-1D-myo-inositol-peak2,12,23,10,1,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,15630420.921896266,11130646.692125367,0.7121143280621908,-0.48981921424728087,0.032976827805837085,0.32345137828340564,Downregulated
Feature0857,Nonivamide,C17 H27 N O3,293.199,NA,NA,Nonivamide,17,27,3,1,0,0,1.588235294117647,0.17647058823529413,-1.0588235294117645,90.47647058823529,5,2,0.07692307692307693,0.1724137931034483,1,Lipid,493526.08967214334,665404.000329862,1.3482650953101583,0.43110418649612114,0.13402454987891826,0.45384777576550756,Upregulated
Feature0856,NA,C18 H34 N2 O8,406.23163,NA,NA,Feature0856,18,34,8,2,0,0,1.8888888888888888,0.4444444444444444,-0.666666666666667,79.30000000000001,3,-5,-0.875,-0.25,-7,Protein,1733485.5938670516,431728.33577183133,0.24905216247498993,-2.0054801571617458,0.10605849024930977,0.43283090716191397,Downregulated
Feature0855,NA,C11 H24 N4 O5,292.17471,NA,NA,Feature0855,11,24,5,4,0,0,2.1818181818181817,0.4545454545454546,-0.18181818181818168,65.48181818181817,2,-3,-3.5,-1,-7,Protein,7043675.3418242065,8956208.109322831,1.271524832517807,0.3465596377263734,0.34860478186230665,0.6073771826273547,Upregulated
Feature0854,butalbital,C11 H16 N2 O3,224.11607,NA,NA,butalbital,11,16,3,2,0,0,1.4545454545454546,0.2727272727272727,-0.3636363636363633,70.66363636363636,5,2,0,0.2,0,Lignin,1494291.63786165,1660997.66836013,1.111561910857668,0.15258830464011205,0.6547623528486886,0.8228154163778454,Upregulated
Feature0853,N(6)-OH-Me-Adenosine,C11 H15 N5 O5,297.10734,NA,NA,N(6)-OH-Me-Adenosine-peak2,11,15,5,5,0,0,1.3636363636363635,0.4545454545454546,0.9090909090909092,34.39090909090909,7,2,-3,-0.14285714285714285,-3,Lignin,17567354.141758632,14776508.297051433,0.8411345372680116,-0.24959152065432233,0.09014344518357657,0.41723968591020827,Downregulated
Feature0852,Arg-pro,C11 H21 N5 O3,271.16445,NA,NA,Arg-pro,11,21,3,5,0,0,1.9090909090909092,0.2727272727272727,0,60.3,4,1,-1.3333333333333333,-0.5555555555555556,-4,Lipid,9540612.18116787,8997518.974956976,0.9430756437953844,-0.08455460123865567,0.834373714935519,0.9198876136649322,Downregulated
Feature0851,NA,C10 H18 N2 O7,278.11141,NA,NA,Feature0851,10,18,7,2,0,0,1.8,0.7,0.20000000000000015,54.599999999999994,3,-4,-6,-0.5555555555555556,-6,Amino Sugar,778705.7478877354,2256764.566984333,2.8980967112492495,1.5351057393088003,0.04978121069361178,0.360381926987087,Upregulated
Feature0850,Sedanolide,C12 H18 O2,194.1307,NA,NA,Sedanolide-peak1,12,18,2,0,0,0,1.5,0.16666666666666666,-1.166666666666667,93.55,4,2,0.2,0.2727272727272727,2,Lipid,1097438.6905123966,1358800.1995727834,1.2381559091363514,0.30819299078452694,0.3558271349233042,0.6145703098895281,Upregulated
Feature0849,Paracetamol,C8 H9 N O2,151.06336,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Aminobenzoate degradation;Other,Other,Paracetamol-peak2,8,9,2,1,0,0,1.125,0.25,-0.25,67.425,5,3,0.4,0.5,2,Lignin,2184689.6984966067,1825023.5895146234,0.8353697052586061,-0.25951326987560364,0.3856208931428264,0.6360679581148471,Downregulated
Feature0848,N-(2-Cyanoethyl)-L-glutamine,C8 H13 N3 O3,199.0957,Other,NA,N-(2-Cyanoethyl)-L-glutamine-peak1,8,13,3,3,0,0,1.625,0.375,0.25,53.175,4,1,-1,-0.14285714285714285,-2,Protein,4452119.63938096,3088015.8545181234,0.6936057663867032,-0.5278122022345934,0.013627239264431872,0.25835889181660304,Downregulated
Feature0847,1-linoleoyl-sn-glycero-3-phosphoethanolamine,C23 H44 N O7 P,477.28563,NA,NA,1-linoleoyl-sn-glycero-3-phosphoethanolamine,23,44,7,1,0,1,1.9130434782608696,0.30434782608695654,-1.391304347826087,99.95217391304348,3,-4,-0.42857142857142855,-0.14285714285714285,-6,Protein,10074703.227742177,898659.8658346473,0.08919963650741149,-3.4868183586652806,0.3771508491134192,0.62821390206306,Downregulated
Feature0846,Leucylasparagine,C10 H19 N3 O4,245.13754,NA,NA,Leucylasparagine-peak3,10,19,4,3,0,0,1.9,0.4,-0.20000000000000015,66,3,-1,-1.3333333333333333,-0.4,-4,Protein,9951169.986615254,10596979.291877573,1.0648978267008764,0.09071501544338684,0.7916335271033255,0.8964085527493538,Upregulated
Feature0845,NA,C17 H29 N O14,471.15895,NA,NA,Feature0845,17,29,14,1,0,0,1.7058823529411764,0.8235294117647058,0.11764705882352944,56.94705882352941,4,-10,-5.5,-0.4444444444444444,-11,Carbohydrate,1060910.1646441573,680882.0505587066,0.6417904863670366,-0.6398256910152664,0.01033811074971308,0.2427666729230969,Downregulated
Feature0844,lys-leu,C12 H25 N3 O3,259.1896,NA,NA,lys-leu-peak2,12,25,3,3,0,0,2.0833333333333335,0.25,-0.833333333333333,84.04999999999998,2,-1,-0.6666666666666666,-0.3333333333333333,-4,Lipid,3850032.706875943,6825619.9551109765,1.7728732389521784,0.8260893867313462,0.1396906026564759,0.45798070948295916,Upregulated
Feature0843,NA,C13 H19 N O6,285.1213,NA,NA,Feature0843,13,19,6,1,0,0,1.4615384615384617,0.4615384615384616,-0.3076923076923075,69.06923076923076,5,-1,-0.3333333333333333,0.1111111111111111,-2,Lignin,1293588.12442549,1249658.0716776769,0.966040154575999,-0.04984493729249857,0.8371631642452797,0.9202752342914452,Downregulated
Feature0842,(+)-sesamin monocatechol,C19 H18 O6,342.11045,Biosynthesis of secondary metabolites;Other,NA,(+)-sesamin monocatechol-peak2,19,18,6,0,0,0,0.9473684210526316,0.3157894736842105,-0.3157894736842106,69.3,11,5,0.38461538461538464,0.5,5,Lignin,16827363.70117654,19499512.068573333,1.1587978018927565,0.2126288530956284,0.642699662266877,0.8143105668512263,Upregulated
Feature0841,(2S)-2-Amino-4-hexynoic acid,C6 H9 N O2,127.06329,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Lysine degradation;Other,Superpathway of L-lysine degradation,(2S)-2-Amino-4-hexynoic acid,6,9,2,1,0,0,1.5,0.3333333333333333,-0.33333333333333304,69.79999999999998,3,1,0,0.25,0,Protein,1081645.6417636867,223997.7687076316,0.2070897899078945,-2.271671668380398,0.029095415001748556,0.31473439619293775,Downregulated
Feature0840,DL-Lactic Acid,C3 H6 O3,90.03171,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Other,DL-Lactic Acid,3,6,3,0,0,0,2,1,0,60.3,1,-2,-Inf,-0.3333333333333333,-2,Carbohydrate,15751915.176044099,10589363.956681967,0.672258823027852,-0.5729113100848672,0.07234984781307875,0.39590936857023457,Downregulated
Feature0839,"2-(Hydroxymethyl)-1-methyl-3,4,5-piperidinetriol",C7 H15 N O4,177.10012,NA,NA,"2-(Hydroxymethyl)-1-methyl-3,4,5-piperidinetriol",7,15,4,1,0,0,2.142857142857143,0.5714285714285714,-0.5714285714285712,76.58571428571427,1,-3,-2,-0.5,-4,Amino Sugar,3314773.07294668,4584103.798068123,1.382931409537808,0.4677296036513876,0.15486178169284723,0.46825623718458564,Upregulated
Feature0838,thr-pro,C9 H16 N2 O4,216.111,Metabolic pathways;Other,Other,thr-pro-peak1,9,16,4,2,0,0,1.7777777777777777,0.4444444444444444,-0.22222222222222232,66.63333333333333,3,-1,-1,-0.2,-3,Protein,13525506.677065667,8298247.73360921,0.6135258317294697,-0.7048040068696856,0.08083300723651728,0.39590936857023457,Downregulated
Feature0837,"(2S)-3-(1H-Imidazol-4-yl)-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",C12 H19 N3 O7,317.12237,NA,NA,"(2S)-3-(1H-Imidazol-4-yl)-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)-peak1",12,19,7,3,0,0,1.5833333333333333,0.5833333333333334,0.3333333333333335,50.8,5,-2,-2.5,-0.2727272727272727,-5,Amino Sugar,15120329.586894533,12161862.0242016,0.8043384209523337,-0.31412545977235495,0.09303200990750891,0.41723968591020827,Downregulated
Feature0836,N-(tert-Butoxycarbonyl)-L-leucine,C11 H21 N O4,231.14706,NA,NA,N-(tert-Butoxycarbonyl)-L-leucine-peak1,11,21,4,1,0,0,1.9090909090909092,0.3636363636363637,-0.9090909090909092,86.2090909090909,2,-2,-0.5,-0.125,-3,Protein,6848705.136286964,7866066.207727197,1.1485479446399114,0.19981108140066223,0.7996307463950995,0.9024480242460349,Upregulated
Feature0835,2-Aminooctanedioic acid,C8 H15 N O4,189.10017,NA,NA,2-Aminooctanedioic acid-peak3,8,15,4,1,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,2215863.331704053,2895280.59117494,1.3066151462276325,0.38583426860865466,0.3979201629681725,0.644110748404211,Upregulated
Feature0834,N-acetyldopamine,C10 H13 N O3,195.08954,Other,NA,N-acetyldopamine,10,13,3,1,0,0,1.3,0.3,-0.4000000000000003,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Lignin,14442170.8892717,9488482.246823482,0.656998336300809,-0.6060383776329256,0.027577017339976074,0.307338601144207,Downregulated
Feature0833,NA,C16 H30 N2 O9,394.19522,NA,NA,Feature0833,16,30,9,2,0,0,1.875,0.5625,-0.375,70.9875,3,-6,-1.6,-0.3684210526315789,-8,Amino Sugar,3063213.0165034803,1645075.5818862957,0.5370425017859435,-0.8968918266219007,0.0766714677874584,0.39590936857023457,Downregulated
Feature0832,"6-[(1E,3Z,5E,7E,9E,11Z)-13-Hydroxy-3,7,12-trimethyl-1,3,5,7,9,11-tridecahexaen-1-yl]-1,5,5-trimethyl-7-oxabicyclo[4.1.0]heptan-3-ol",C25 H36 O3,384.26647,NA,NA,"6-[(1E,3Z,5E,7E,9E,11Z)-13-Hydroxy-3,7,12-trimethyl-1,3,5,7,9,11-tridecahexaen-1-yl]-1,5,5-trimethyl-7-oxabicyclo[4.1.0]heptan-3-ol",25,36,3,0,0,0,1.44,0.12,-1.2000000000000002,94.5,8,5,0.2272727272727273,0.2765957446808511,5,Unsaturated HC,381325.4725329127,465269.29283450934,1.2201369337957126,0.2870430679701612,0.22174100196655358,0.5089827335113032,Upregulated
Feature0831,NA,C6 H11 N O7,209.05351,NA,NA,Feature0831,6,11,7,1,0,0,1.8333333333333333,1.1666666666666667,1,31.799999999999997,2,-5,3,-1.6666666666666667,-6,Carbohydrate,14398913.977267,14562088.4055612,1.0113324121910734,0.01625727082821783,0.7726858374819389,0.8862084012826029,Upregulated
Feature0830,NA,C29 H44 N4 O7,560.32104,NA,NA,Feature0830,29,44,7,4,0,0,1.5172413793103448,0.2413793103448276,-0.6206896551724137,77.98965517241379,10,3,-0.05555555555555555,0.11627906976744186,-1,Lipid,123866.10067820101,161798.27080303067,1.306235280816467,0.38541478041822286,0.03905406128669411,0.34278538766663114,Upregulated
Feature0829,NA,C15 H5 N10 O18 P3 S2,769.84371,NA,NA,Feature0829,15,5,18,10,2,3,0.3333333333333333,1.2,3.3333333333333335,-34.7,20,2,0.7222222222222222,0.4444444444444444,-13,Other,8530391.80244718,12632064.19457718,1.4808304808406716,0.5664064965023093,0.16884379341693034,0.4751185814755482,Upregulated
Feature0828,NA,C18 H34 N2 O8,406.23164,NA,NA,Feature0828,18,34,8,2,0,0,1.8888888888888888,0.4444444444444444,-0.666666666666667,79.30000000000001,3,-5,-0.875,-0.25,-7,Protein,5600296.832492634,2137756.9046245,0.38172207091262456,-1.38940549026828,0.001846845536602884,0.15520563728364625,Downregulated
Feature0827,N-glycoloyl-beta-D-glucosamine,C8 H15 N O7,237.08484,NA,NA,N-glycoloyl-beta-D-glucosamine,8,15,7,1,0,0,1.875,0.875,0.25,53.175,2,-5,-Inf,-0.7142857142857143,-6,Carbohydrate,18854065.762830734,12600071.5301561,0.6682946632654757,-0.5814437414412343,0.15775638506658296,0.46825623718458564,Downregulated
Feature0826,Pro-Hyp,C10 H16 N2 O4,228.11102,NA,NA,Pro-Hyp-peak1,10,16,4,2,0,0,1.6,0.4,-0.20000000000000015,66,4,0,-0.5,0,-2,Protein,3213898.98674689,2162072.781080352,0.6727258043877736,-0.5719094968217477,0.37136718785641226,0.6242377295699064,Downregulated
Feature0825,D-lysopine,C9 H18 N2 O4,218.12665,Lysine degradation,NA,D-lysopine-peak3,9,18,4,2,0,0,2,0.4444444444444444,-0.44444444444444464,72.96666666666667,2,-2,-1.3333333333333333,-0.4,-4,Protein,8223466.049948406,10319715.674308289,1.2549107166768243,0.3275847241842913,0.5000828157910381,0.7117038087448558,Upregulated
Feature0824,Glucosamine,C6 H13 N O5,179.07942,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,Other,Glucosamine-peak1,6,13,5,1,0,0,2.1666666666666665,0.8333333333333334,0,60.3,1,-4,-Inf,-1,-5,Carbohydrate,1083790.3413044005,2036182.30472967,1.8787603350284652,0.9097810404042099,0.15322629636616422,0.46778235597057083,Upregulated
Feature0823,"1,4-Bis(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",C20 H22 O7,374.13666,NA,NA,"1,4-Bis(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol-peak2",20,22,7,0,0,0,1.1,0.35,-0.4000000000000003,71.7,10,3,0.2307692307692308,0.3939393939393939,3,Lignin,15989169.1820903,20241859.888484865,1.2659732133648363,0.3402468792097355,0.43960736521205607,0.6660955963052084,Upregulated
Feature0822,Leu-arg,C12 H25 N5 O3,287.19576,NA,NA,Leu-arg-peak1,12,25,3,5,0,0,2.0833333333333335,0.25,-0.33333333333333304,69.79999999999998,3,0,-1.25,-0.6363636363636364,-5,Lipid,7009805.452950453,7130141.714343177,1.0171668475252866,0.024556346210361454,0.9346529431801682,0.9642521837680906,Upregulated
Feature0821,Gly-Tyr,C11 H14 N2 O4,238.09534,Other,NA,Gly-Tyr-peak3,11,14,4,2,0,0,1.2727272727272727,0.3636363636363637,0,60.3,6,2,0,0.2857142857142857,0,Lignin,6552623.7705766335,10179931.377872076,1.5535656760248022,0.6355832317864357,0.22963670552418397,0.5170330973050352,Upregulated
Feature0820,4-Methyleneglutamic acid,C6 H9 N O4,159.05324,Other,NA,4-Methyleneglutamic acid-peak1,6,9,4,1,0,0,1.5,0.6666666666666666,0.3333333333333335,50.8,3,-1,-2,0,-2,Amino Sugar,9684784.96899219,11136815.568771537,1.1499290489596123,0.20154484910713324,0.5305277476570183,0.7346581985645525,Upregulated
Feature0819,9-Nitrooleate,C18 H33 N O4,327.24099,NA,NA,9-Nitrooleate,18,33,4,1,0,0,1.8333333333333333,0.2222222222222222,-1.2222222222222223,95.13333333333333,3,-1,-0.15384615384615383,0,-2,Lipid,1253434.93012411,1840233.9531882666,1.4681527608346243,0.5540020879580618,0.07943700694835656,0.39590936857023457,Upregulated
Feature0818,4-Nitrosodiphenylamine,C12 H10 N2 O,198.07934,NA,NA,4-Nitrosodiphenylamine,12,10,1,2,0,0,0.8333333333333334,0.08333333333333333,-0.16666666666666696,65.05000000000001,9,8,0.6666666666666666,0.6842105263157895,6,Unsaturated HC,10849603.368818467,15471895.474821733,1.426033279639294,0.5120076506530005,0.009191958903059575,0.2324530359410441,Upregulated
Feature0817,"4-[(E)-2-{[2-(4-Hydroxyphenyl)ethyl]amino}vinyl]-2,3-dihydro-2,6-pyridinedicarboxylic acid",C17 H18 N2 O5,330.12166,NA,NA,"4-[(E)-2-{[2-(4-Hydroxyphenyl)ethyl]amino}vinyl]-2,3-dihydro-2,6-pyridinedicarboxylic acid",17,18,5,2,0,0,1.0588235294117647,0.29411764705882354,-0.117647058823529,63.65294117647058,10,5,0.3,0.44,3,Lignin,18885028.100128766,14684125.425573766,0.7775538033471946,-0.3629855879572123,0.15136798360946843,0.46695517742640485,Downregulated
Feature0816,3-(6-Amino-1H-purin-1-yl)-1-propanol,C8 H11 N5 O,193.09636,NA,NA,3-(6-Amino-1H-purin-1-yl)-1-propanol,8,11,1,5,0,0,1.375,0.125,0.75,38.925,6,5,0,0.2,0,Unsaturated HC,92546.2326745795,100405.0900577273,1.0849181771750982,0.11758624097850653,0.6247068652550408,0.8065956019375299,Upregulated
Feature0815,NA,C20 H28 N2 O8,424.18475,NA,NA,Feature0815,20,28,8,2,0,0,1.4,0.4,-0.2999999999999998,68.85,8,0,-0.2,0.14285714285714285,-2,Lignin,7617708.923863816,8636199.584836626,1.1337003909117882,0.18103942188813923,0.34301070314315885,0.6017631473175763,Upregulated
Feature0814,NA,C17 H30 N2 O12,454.18001,NA,NA,Feature0814,17,30,12,2,0,0,1.7647058823529411,0.7058823529411765,0,60.3,4,-8,-3.3333333333333335,-0.4444444444444444,-10,Carbohydrate,189520.74816189567,168478.447494995,0.888970991983814,-0.16979175165221508,0.20593314562447054,0.501943523291875,Downregulated
Feature0813,2'-Deoxyadenosine,C10 H13 N5 O3,251.10184,Metabolic pathways;ABC transporters;Other,Superpathway of butirocin biosynthesis;Other,2'-Deoxyadenosine-peak1,10,13,3,5,0,0,1.3,0.3,0.7999999999999998,37.5,7,4,-0.5,0.14285714285714285,-1,Lignin,10855435.353179717,10381439.011769716,0.9563355751300051,-0.06441115071306232,0.690473557429459,0.8394586943835308,Downregulated
Feature0812,Aspartyl-L-proline,C9 H14 N2 O5,230.09027,Biosynthesis of secondary metabolites;Other,NA,Aspartyl-L-proline,9,14,5,2,0,0,1.5555555555555556,0.5555555555555556,0.22222222222222232,53.96666666666666,4,-1,-1.5,-0.1111111111111111,-3,Amino Sugar,6023463.600281213,6602970.061881127,1.09620817855907,0.13252180345783104,0.8235343586546645,0.9136000023320247,Upregulated
Feature0811,Tyrosylalanine,C12 H16 N2 O4,252.11103,NA,NA,Tyrosylalanine,12,16,4,2,0,0,1.3333333333333333,0.3333333333333333,-0.16666666666666696,65.05000000000001,6,2,0,0.25,0,Lignin,8710399.573563557,9720598.59228231,1.1159761972096838,0.15830625607949414,0.7339121849443613,0.8668161695230521,Upregulated
Feature0810,"5-[(Z)-(4-Ethyl-3-methyl-5-oxo-1,5-dihydro-2H-pyrrol-2-ylidene)methyl]-5-methoxy-3-methyl-4-vinyl-1,5-dihydro-2H-pyrrol-2-one",C16 H20 N2 O3,288.14736,NA,Superpathway of indole-3-acetate conjugate biosynthesis,"5-[(Z)-(4-Ethyl-3-methyl-5-oxo-1,5-dihydro-2H-pyrrol-2-ylidene)methyl]-5-methoxy-3-methyl-4-vinyl-1,5-dihydro-2H-pyrrol-2-one-peak1",16,20,3,2,0,0,1.25,0.1875,-0.5,74.55,8,5,0.2727272727272727,0.36,3,Lignin,265748.10670277034,419749.315171866,1.5795006797220212,0.6594685579340284,0.18466202420468159,0.4854964193043512,Upregulated
Feature0809,MFCD02728197,C14 H20 N2 O4,280.14233,NA,NA,MFCD02728197-peak1,14,20,4,2,0,0,1.4285714285714286,0.2857142857142857,-0.4285714285714288,72.51428571428572,6,2,0,0.2,0,Lignin,10021665.986345263,8162207.350990667,0.814456135547907,-0.29609109378126364,0.41886626830790386,0.6594418759419973,Downregulated
Feature0808,NA,C11 H23 N O11,345.1272,NA,NA,Feature0808,11,23,11,1,0,0,2.090909090909091,1,0.18181818181818168,55.11818181818182,1,-10,11,-1.2222222222222223,-11,Carbohydrate,10946218.737284044,8591175.459905596,0.7848532599337791,-0.3495051491059696,0.08271111605095717,0.402486084203436,Downregulated
Feature0807,NA,C11 H19 N3 O5,273.13241,Biosynthesis of secondary metabolites;Other,NA,Feature0807,11,19,5,3,0,0,1.7272727272727273,0.4545454545454546,0,60.3,4,-1,-1.3333333333333333,-0.2727272727272727,-4,Protein,9103107.017243262,6340406.288679703,0.6965101340311166,-0.5217837510915952,0.01945589456027352,0.276960381387423,Downregulated
Feature0806,NA,C10 H15 N O5,229.09493,NA,NA,Feature0806,10,15,5,1,0,0,1.5,0.5,-0.20000000000000015,66,4,-1,-0.5,0.07692307692307693,-2,Protein,10489837.702288067,10423954.901221003,0.9937193688847357,-0.009089609579535028,0.9531080176095635,0.9749458049634153,Downregulated
Feature0805,Methohexital,C14 H18 N2 O3,262.13173,NA,NA,Methohexital,14,18,3,2,0,0,1.2857142857142858,0.21428571428571427,-0.4285714285714288,72.51428571428572,7,4,0.2222222222222222,0.3333333333333333,2,Lignin,732270.7320115484,2902414.9216405666,3.9635817666338107,1.986804738751337,0.269102517300833,0.5485675864110843,Upregulated
Feature0804,NA,C9 H17 N3 O2,199.13214,NA,NA,Feature0804,9,17,2,3,0,0,1.8888888888888888,0.2222222222222222,-0.44444444444444464,72.96666666666667,3,1,-0.5,-0.2,-2,Lipid,15383061.578160167,14257063.5725843,0.9268027369028748,-0.1096657903152115,0.30377514394075855,0.5756097246483725,Downregulated
Feature0803,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",C6 H8 O4,144.04227,Microbial metabolism in diverse environments;Other,Other,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one-peak1",6,8,4,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Tannin,981221.5049481144,743081.8410294626,0.7573028488289765,-0.40105773902349656,0.7790360954325668,0.8895054886988598,Downregulated
Feature0802,2-Aminooctanedioic acid,C8 H15 N O4,189.10014,NA,NA,2-Aminooctanedioic acid-peak2,8,15,4,1,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,13672218.156808333,12798447.537688432,0.9360915244989131,-0.09527850152588181,0.05179583680832754,0.36591042730478307,Downregulated
Feature0801,Myristicin,C11 H12 O3,192.07871,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,NA,Myristicin,11,12,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Lignin,1632671.3601070268,1756223.8514852466,1.075675052798207,0.10524232462451454,0.7124014503850982,0.8516641192324321,Upregulated
Feature0800,"6,8-Dihydroxy-3-[(2S)-2-hydroxy-4-oxopentyl]-1H-isochromen-1-one",C14 H14 O6,278.07905,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"6,8-Dihydroxy-3-[(2S)-2-hydroxy-4-oxopentyl]-1H-isochromen-1-one",14,14,6,0,0,0,1,0.42857142857142855,-0.14285714285714324,64.37142857142858,8,2,0.25,0.4545454545454546,2,Lignin,586128.973790932,909938.3955690783,1.552454214443333,0.6345507205748443,0.023439748995547047,0.2919627558710051,Upregulated
Feature0799,NA,C12 H23 N3 O2,241.17901,NA,NA,Feature0799,12,23,2,3,0,0,1.9166666666666667,0.16666666666666666,-0.833333333333333,84.04999999999998,3,1,-0.2857142857142857,-0.125,-2,Lipid,15415801.8045326,12996156.293190368,0.8430412156290955,-0.2463249297577696,0.05863048360620923,0.3790841191943452,Downregulated
Feature0798,b-Ala-Lys,C9 H19 N3 O3,217.14263,Metabolic pathways;Other,Other,b-Ala-Lys,9,19,3,3,0,0,2.111111111111111,0.3333333333333333,-0.44444444444444464,72.96666666666667,2,-1,-1.3333333333333333,-0.5555555555555556,-4,Protein,8173598.200548157,11837349.347583996,1.4482421397702339,0.534302834907681,0.14381221875702652,0.4622730523233452,Upregulated
Feature0797,6-Methoxyquinoline,C10 H9 N O,159.06843,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,NA,6-Methoxyquinoline,10,9,1,1,0,0,0.9,0.1,-0.4000000000000003,71.7,7,6,0.625,0.6470588235294118,5,Unsaturated HC,738244.5542698443,645020.725166118,0.873722293561747,-0.1947532926966649,0.5516847775869862,0.7556057723065784,Downregulated
Feature0796,D-PANTOTHENIC ACID,C9 H17 N O5,219.11064,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,Other,D-PANTOTHENIC ACID-peak2,9,17,5,1,0,0,1.8888888888888888,0.5555555555555556,-0.44444444444444464,72.96666666666667,2,-3,-1.3333333333333333,-0.2727272727272727,-4,Amino Sugar,6894043.488767597,8144833.013364563,1.1814304662619066,0.24053472120245817,0.41097244956057705,0.6580220506196762,Upregulated
Feature0795,1-Deoxy-1-(4-morpholinyl)-alpha-D-fructofuranose,C10 H19 N O6,249.12123,NA,NA,1-Deoxy-1-(4-morpholinyl)-alpha-D-fructofuranose-peak2,10,19,6,1,0,0,1.9,0.6,-0.4000000000000003,71.7,2,-4,-1.6666666666666667,-0.3333333333333333,-5,Amino Sugar,12150276.110553574,10623398.892356703,0.8743339489321856,-0.193743677348798,0.7039166359501261,0.8470526718656479,Downregulated
Feature0794,N-Phenyl-beta-D-glucopyranosylamine,C12 H17 N O5,255.11067,NA,NA,N-Phenyl-beta-D-glucopyranosylamine-peak2,12,17,5,1,0,0,1.4166666666666667,0.4166666666666667,-0.33333333333333304,69.79999999999998,5,0,-0.16666666666666666,0.17647058823529413,-1,Lignin,10998690.431061333,11442346.138346134,1.0403371392317649,0.05705113440275632,0.3652583874472874,0.6199876837031111,Upregulated
Feature0793,Aspartame,C14 H18 N2 O5,294.1216,Other,NA,Aspartame-peak2,14,18,5,2,0,0,1.2857142857142858,0.35714285714285715,-0.14285714285714324,64.37142857142858,7,2,0,0.2631578947368421,0,Lignin,10065076.537869094,10900728.655481016,1.0830249143628312,0.11506643169440894,0.7740231011002188,0.8871414974721046,Upregulated
Feature0792,mebutamate,C10 H20 N2 O4,232.14227,Other,NA,mebutamate-peak1,10,20,4,2,0,0,2,0.4,-0.5999999999999996,77.39999999999999,2,-2,-1,-0.3333333333333333,-4,Protein,7999501.084547644,6177652.373900693,0.7722547079634564,-0.3728513337805453,0.336073048353167,0.5980123360401941,Downregulated
Feature0791,Methyl alpha-aspartylphenylalaninate,C14 H18 N2 O5,294.12162,Other,NA,Methyl alpha-aspartylphenylalaninate,14,18,5,2,0,0,1.2857142857142858,0.35714285714285715,-0.14285714285714324,64.37142857142858,7,2,0,0.2631578947368421,0,Lignin,11375141.914341424,9631220.60533524,0.8466901492624455,-0.24009399062764367,0.4267586357933594,0.6594697741371865,Downregulated
Feature0790,delta-guanidinovaleric acid,C6 H13 N3 O2,159.1008,NA,NA,delta-guanidinovaleric acid-peak2,6,13,2,3,0,0,2.1666666666666665,0.3333333333333333,0,60.3,2,0,-3,-1,-3,Protein,15830318.280318266,11752507.95014909,0.7424050320429064,-0.42972160575977686,0.09165328755362497,0.41723968591020827,Downregulated
Feature0789,Cynometrine,C16 H19 N3 O2,285.14778,NA,NA,Cynometrine,16,19,2,3,0,0,1.1875,0.125,-0.375,70.9875,9,7,0.3636363636363637,0.4166666666666667,4,Unsaturated HC,201272.54058377634,255257.969456437,1.268220536771086,0.3428056442474929,0.09549881394535828,0.41723968591020827,Upregulated
Feature0788,2-Amino-3-methoxybenzoic acid,C8 H9 N O3,167.05827,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Other,2-Amino-3-methoxybenzoic acid,8,9,3,1,0,0,1.125,0.375,0,60.3,5,2,0.25,0.4545454545454546,1,Lignin,4228689.623935146,4583925.3908328,1.0840061102822387,0.11637288884034482,0.7278317597497123,0.8612423231516927,Upregulated
Feature0787,Fluoranthene,C16 H10,202.0783,Microbial metabolism in diverse environments;Other,NA,Fluoranthene-peak1,16,10,0,0,0,0,0.625,0,-0.625,78.1125,12,12,0.75,0.75,12,Condensed HC,11808470.92850386,12658138.480817366,1.0719540707224453,0.10024309295941733,0.8083406886399453,0.9080431873713976,Upregulated
Feature0786,NA,C7 H11 O3 P S,206.01667,NA,NA,Feature0786,7,11,3,0,1,1,1.5714285714285714,0.42857142857142855,-1.1428571428571432,92.87142857142858,3,0,-1,-0.14285714285714285,-2,Protein,14331404.441056034,10655710.356290657,0.7435217113658871,-0.427553224267279,0.19204897621072634,0.4862119877973694,Downregulated
Feature0785,NA,C15 H27 N3 O6,345.19012,NA,NA,Feature0785,15,27,6,3,0,0,1.8,0.4,-0.4000000000000003,71.7,4,-2,-0.8333333333333334,-0.2222222222222222,-5,Protein,12455925.882918067,16244309.598684933,1.3041430842938957,0.383102163799612,0.14968040614370248,0.46695517742640485,Upregulated
Feature0784,Pro-Pro,C10 H16 N2 O3,212.11603,NA,NA,Pro-Pro,10,16,3,2,0,0,1.6,0.3,-0.4000000000000003,71.7,4,1,-0.2,0.07692307692307693,-1,Lipid,10163552.885105073,7952313.160313477,0.7824343760701811,-0.3539583387376744,0.06903846665792279,0.3925920914282487,Downregulated
Feature0783,NA,C79 H121 N6 O18 P3,1534.79514,NA,NA,Feature0783,79,121,18,6,0,3,1.5316455696202531,0.2278481012658228,-1.037974683544304,89.88227848101266,24,6,-0.05769230769230769,0.09836065573770492,-3,Lipid,404799.56360270333,494388.83278579265,1.2213176031756252,0.2884384214091197,0.24948366816131237,0.5310276106497658,Upregulated
Feature0782,NA,C13 H24 N2 O8,336.15338,NA,NA,Feature0782,13,24,8,2,0,0,1.8461538461538465,0.6153846153846154,-0.1538461538461542,64.6846153846154,3,-5,-2.3333333333333335,-0.42857142857142855,-7,Amino Sugar,12907694.116858633,9133480.773616197,0.7075997223769839,-0.4989946128926642,0.005434475322122267,0.23030609530252863,Downregulated
Feature0781,Pyroquilon,C11 H11 N O,173.08408,NA,NA,Pyroquilon,11,11,1,1,0,0,1,0.09090909090909093,-0.5454545454545459,75.84545454545456,7,6,0.5555555555555556,0.5789473684210527,5,Unsaturated HC,7138573.06046562,11762035.660139453,1.6476732199155026,0.7204301437622728,0.03599891735220901,0.33805559870221996,Upregulated
Feature0780,NA,C11 H19 N O5,245.12631,NA,NA,Feature0780,11,19,5,1,0,0,1.7272727272727273,0.4545454545454546,-0.5454545454545459,75.84545454545456,3,-2,-0.6,-0.06666666666666667,-3,Protein,14423220.4185757,12932405.072908767,0.8966378310528411,-0.15740272384929163,0.4149394461317525,0.6580333694263849,Downregulated
Feature0779,7-Methylguanine,C6 H7 N5 O,165.06508,NA,NA,7-Methylguanine-peak2,6,7,1,5,0,0,1.1666666666666667,0.16666666666666666,1.6666666666666663,12.800000000000004,6,5,NA,1,0,Lignin,1229400.82777751,729683.6528275124,0.5935278684874664,-0.7526123231756295,0.0072972994644470495,0.23030609530252863,Downregulated
Feature0778,N~6~-(5-Oxo-D-isoleucyl)-L-lysine,C12 H23 N3 O4,273.16888,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,N~6~-(5-Oxo-D-isoleucyl)-L-lysine-peak5,12,23,4,3,0,0,1.9166666666666667,0.3333333333333333,-0.5,74.55,3,-1,-0.8,-0.2857142857142857,-4,Protein,6451085.019463167,6265081.762541373,0.9711671360150091,-0.042208492806099,0.8738025626065002,0.935214143108896,Downregulated
Feature0777,Alanyltyrosine,C12 H16 N2 O4,252.11102,NA,NA,Alanyltyrosine,12,16,4,2,0,0,1.3333333333333333,0.3333333333333333,-0.16666666666666696,65.05000000000001,6,2,0,0.25,0,Lignin,9191958.52460197,7165674.584433227,0.779559064072639,-0.3592697605896465,0.1725521003038289,0.4760639379718015,Downregulated
Feature0776,asn-leu,C10 H19 N3 O4,245.13754,NA,NA,asn-leu-peak2,10,19,4,3,0,0,1.9,0.4,-0.20000000000000015,66,3,-1,-1.3333333333333333,-0.4,-4,Protein,6911666.526263706,9243719.629138406,1.3374082204361437,0.4194398900447467,0.3905774195144117,0.63864686163843,Upregulated
Feature0775,6-Aminocaproic acid,C6 H13 N O2,131.0946,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Superpathway of indole-3-acetate conjugate biosynthesis,6-Aminocaproic acid-peak1,6,13,2,1,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,186161.450040879,236265.68338867667,1.2691439787173733,0.3438557457738161,0.4768504964897096,0.6963661560806622,Upregulated
Feature0774,NA,C16 H31 N3 O4,329.23158,NA,NA,Feature0774,16,31,4,3,0,0,1.9375,0.25,-0.875,85.2375,3,-1,-0.4444444444444444,-0.18181818181818185,-4,Lipid,9574123.840330873,11284025.91423898,1.1785961934924183,0.2370695118430709,0.507427147813903,0.7157429756539546,Upregulated
Feature0773,N~2~-Acetyl-L-ornithine,C7 H14 N2 O3,174.10045,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Other,N~2~-Acetyl-L-ornithine-peak2,7,14,3,2,0,0,2,0.42857142857142855,-0.2857142857142856,68.44285714285714,2,-1,-1.5,-0.42857142857142855,-3,Protein,6690681.889382773,11041802.72037893,1.6503254680066033,0.7227505728195304,0.11539527357126629,0.44732172409548077,Upregulated
Feature0772,Betaine,C5 H11 N O2,117.07893,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Biosynthesis of alkaloids derived from shikimate pathway;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Superpathway of indole-3-acetate conjugate biosynthesis;Other,Betaine-peak1,5,11,2,1,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,1484101.0368568,1836510.4018224466,1.2374564508842467,0.30737775412246426,0.008311770359513334,0.23030609530252863,Upregulated
Feature0771,"3-(2,6-Dioxocyclohexyl)propanenitrile",C9 H11 N O2,165.07901,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;ABC transporters;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various plant secondary metabolites;Phenylalanine metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of scopolin and esculin biosynthesis;Superpathway of aromatic amino acid biosynthesis;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of indole-3-acetate conjugate biosynthesis;Other,"3-(2,6-Dioxocyclohexyl)propanenitrile",9,11,2,1,0,0,1.2222222222222223,0.2222222222222222,-0.44444444444444464,72.96666666666667,5,3,0.3333333333333333,0.42857142857142855,2,Lignin,5864504.22480596,3576029.56649503,0.6097752562559285,-0.7136504857025964,0.0180165257788337,0.2637533176745511,Downregulated
Feature0770,NA,C22 H40 N2 O7,444.2837,NA,NA,Feature0770,22,40,7,2,0,0,1.818181818181818,0.3181818181818182,-0.9090909090909092,86.2090909090909,4,-3,-0.38461538461538464,-0.09090909090909093,-5,Protein,572324.8198314363,500798.4078511347,0.8750247944840697,-0.19260419751678837,0.7066728722574307,0.8478072560935465,Downregulated
Feature0769,NA,C20 H30 N2 O8,426.2003,NA,NA,Feature0769,20,30,8,2,0,0,1.5,0.4,-0.4000000000000003,71.7,7,-1,-0.3,0.07142857142857142,-3,Protein,507735.89899747266,167031.0128018604,0.32897223365860884,-1.6039622740074233,0.1991172667075017,0.4953078558039763,Downregulated
Feature0768,N1-(2-{2-[2-(acetylamino)phenoxy]ethoxy}phenyl)acetamide,C18 H20 N2 O4,328.14237,NA,NA,N1-(2-{2-[2-(acetylamino)phenoxy]ethoxy}phenyl)acetamide,18,20,4,2,0,0,1.1111111111111112,0.2222222222222222,-0.33333333333333304,69.79999999999998,10,6,0.3333333333333333,0.42857142857142855,4,Lignin,8089168.761716537,9035478.237377856,1.1169847611709995,0.15960950351774,0.5660770638711623,0.7622691146246018,Upregulated
Feature0767,N-Methylhexanamide,C7 H15 N O,129.11533,NA,NA,N-Methylhexanamide,7,15,1,1,0,0,2.142857142857143,0.14285714285714285,-1.4285714285714288,101.01428571428572,1,0,-0.2,-0.09090909090909093,-1,Lipid,345836.75435349066,446602.79068050766,1.291368789055951,0.36890106428839625,0.48656840288331865,0.7043756731345155,Upregulated
Feature0766,Alanylclavam,C8 H12 N2 O4,200.0797,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,Alanylclavam-peak1,8,12,4,2,0,0,1.5,0.5,0.25,53.175,4,0,-1,0,-2,Protein,518622.4826229457,401946.59599490196,0.7750273261622739,-0.3676809165988215,0.720604470196438,0.8568018164604311,Downregulated
Feature0765,NA,C11 H19 N3 O5,273.13243,Biosynthesis of secondary metabolites;Other,NA,Feature0765,11,19,5,3,0,0,1.7272727272727273,0.4545454545454546,0,60.3,4,-1,-1.3333333333333333,-0.2727272727272727,-4,Protein,12067945.570722567,9977935.475365866,0.8268130989563651,-0.2743668497504026,0.2962785434413039,0.57033619612451,Downregulated
Feature0764,"β,β-dimethylacrylshikonin",C21 H22 O6,370.14171,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites,NA,"β,β-dimethylacrylshikonin",21,22,6,0,0,0,1.0476190476190477,0.2857142857142857,-0.4761904761904763,73.87142857142857,11,5,0.3333333333333333,0.4444444444444444,5,Lignin,14538763.704013033,17552953.9181791,1.2073209438938801,0.271809240811621,0.4936339940351401,0.7080575663806328,Upregulated
Feature0763,Prolylleucine,C11 H20 N2 O3,228.14738,NA,NA,Prolylleucine-peak2,11,20,3,2,0,0,1.818181818181818,0.2727272727272727,-0.7272727272727275,81.02727272727273,3,0,-0.3333333333333333,-0.06666666666666667,-2,Lipid,1286448.2785795038,4665877.60528299,3.626945352544645,1.8587550082784778,0.18123065812969105,0.48423459758942683,Upregulated
Feature0762,Troxipide,C15 H22 N2 O4,294.15799,NA,NA,Troxipide-peak2,15,22,4,2,0,0,1.4666666666666666,0.26666666666666666,-0.5333333333333332,75.5,6,2,0,0.18181818181818185,0,Lignin,5156162.384383413,4276179.759757676,0.8293338031224617,-0.2699751980151963,0.38948328645257113,0.6375277315535638,Downregulated
Feature0761,Troxipide,C15 H22 N2 O4,294.158,NA,NA,Troxipide-peak1,15,22,4,2,0,0,1.4666666666666666,0.26666666666666666,-0.5333333333333332,75.5,6,2,0,0.18181818181818185,0,Lignin,5574485.825969657,8170310.952024314,1.4656618039930391,0.5515522453612902,0.16411036718834024,0.4734778652324074,Upregulated
Feature0760,NA,C13 H24 N2 O9,352.14823,NA,NA,Feature0760,13,24,9,2,0,0,1.8461538461538465,0.6923076923076923,0,60.3,3,-6,-4,-0.5384615384615384,-8,Amino Sugar,1198541.601344202,320991.7337843643,0.2678186000589066,-1.9006719352673258,0.03721728556060867,0.3383465574204546,Downregulated
Feature0759,MFCD15144952,C5 H8 O4,132.04225,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Phenylalanine metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,MFCD15144952,5,8,4,0,0,0,1.6,0.8,0,60.3,2,-2,-2,0,-2,Carbohydrate,10554928.569577318,9623367.246518048,0.9117415795930321,-0.13330312430236246,0.40970026920854585,0.6572227123309219,Downregulated
Feature0758,threonylphenylalanine,C13 H18 N2 O4,266.12671,Metabolic pathways;Biosynthesis of cofactors;Other,NA,threonylphenylalanine-peak3,13,18,4,2,0,0,1.3846153846153846,0.3076923076923077,-0.3076923076923075,69.06923076923076,6,2,0,0.2222222222222222,0,Lignin,8037433.170052103,10210447.327744206,1.2703617077388423,0.34523933137824264,0.3586736987302077,0.6165116688402364,Upregulated
Feature0757,NA,C6 H14 O4,150.08923,NA,NA,Feature0757,6,14,4,0,0,0,2.3333333333333335,0.6666666666666666,-1,88.8,0,-4,-2,-0.5,-4,Other,8086024.47724762,9841947.34506787,1.2171552748524381,0.28351322718887506,0.09631330087885633,0.41723968591020827,Upregulated
Feature0756,NA,C17 H26 N2 O8,386.16898,NA,NA,Feature0756,17,26,8,2,0,0,1.5294117647058822,0.4705882352941176,-0.23529411764705888,67.00588235294117,6,-2,-0.5714285714285714,0,-4,Protein,12744632.0422751,11056827.366119167,0.8675674063749089,-0.20495224144445204,0.2777048005446292,0.5571101578849338,Downregulated
Feature0755,Proacacipetalin,C11 H17 N O6,259.10561,NA,NA,Proacacipetalin-peak1,11,17,6,1,0,0,1.5454545454545454,0.5454545454545454,-0.18181818181818168,65.48181818181817,4,-2,-0.75,0,-3,Protein,13275628.914907267,8606156.26649143,0.6482673116019035,-0.6253392669615315,0.08254597883076749,0.402486084203436,Downregulated
Feature0754,NA,C17 H34 N6 O4,386.26429,NA,NA,Feature0754,17,34,4,6,0,0,2,0.2352941176470588,-0.47058823529411775,73.71176470588236,4,0,-0.8571428571428571,-0.4444444444444444,-6,Lipid,14232467.794672532,13532193.250301499,0.9507973912554253,-0.07279014998735135,0.7559235600192765,0.87699965252227,Downregulated
Feature0753,Ectoine,C6 H10 N2 O2,142.07423,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,Ectoine-peak1,6,10,2,2,0,0,1.6666666666666667,0.3333333333333333,0,60.3,3,1,-0.5,0,-1,Protein,14854646.2412261,12746462.6492978,0.8580791788849567,-0.2208173169595104,0.11898969110862108,0.4526122839818135,Downregulated
Feature0752,N-Acetylvanilalanine,C12 H15 N O5,253.09502,NA,NA,N-Acetylvanilalanine-peak5,12,15,5,1,0,0,1.25,0.4166666666666667,-0.16666666666666696,65.05000000000001,6,1,0,0.29411764705882354,0,Lignin,13256207.052097833,10337974.543082584,0.7798591635189169,-0.35871448685922186,0.028885851387678088,0.31473439619293775,Downregulated
Feature0751,Malonyl-L-carnitine,C10 H17 N O6,247.10558,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,Malonyl-L-carnitine,10,17,6,1,0,0,1.7,0.6,-0.20000000000000015,66,3,-3,-1.3333333333333333,-0.16666666666666666,-4,Amino Sugar,2178109.2374019,796599.7614675603,0.3657299403485214,-1.4511493576687782,0.07090267103291911,0.39590936857023457,Downregulated
Feature0750,NA,C12 H19 N O9,321.10608,NA,NA,Feature0750,12,19,9,1,0,0,1.5833333333333333,0.75,0.16666666666666652,55.55,4,-5,-3,-0.2307692307692308,-6,Carbohydrate,987372.674869233,766888.0908371323,0.7766956797125244,-0.36457865374426424,0.054748910105067355,0.3736903134868504,Downregulated
Feature0749,NA,C6 H15 N O4,165.10013,NA,NA,Feature0749,6,15,4,1,0,0,2.5,0.6666666666666666,-0.666666666666667,79.30000000000001,0,-4,-5,-1,-5,Other,2920716.2664025133,2492673.7571810368,0.8534460487842243,-0.22862813977330707,0.3023613563366478,0.5748598626647378,Downregulated
Feature0748,NA,C18 H29 N O12,451.16875,NA,NA,Feature0748,18,29,12,1,0,0,1.6111111111111112,0.6666666666666666,-0.11111111111111072,63.466666666666654,5,-7,-1.6,-0.18181818181818185,-8,Amino Sugar,1585869.3150769128,608301.3583686664,0.3835759684518295,-1.3824157584766128,0.3617613159842089,0.6171436750022657,Downregulated
Feature0747,Isovalerylglutamic acid,C10 H17 N O5,231.11065,NA,NA,Isovalerylglutamic acid-peak5,10,17,5,1,0,0,1.7,0.5,-0.4000000000000003,71.7,3,-2,-0.75,-0.07692307692307693,-3,Protein,7320592.794898449,9294993.398627564,1.2697050169359274,0.3444933631116083,0.3430575380222928,0.6017631473175763,Upregulated
Feature0746,NA,C11 H19 N3 O5,273.13243,Biosynthesis of secondary metabolites;Other,NA,Feature0746,11,19,5,3,0,0,1.7272727272727273,0.4545454545454546,0,60.3,4,-1,-1.3333333333333333,-0.2727272727272727,-4,Protein,7527505.516370207,7725884.7952373335,1.0263539200915506,0.0375283047415854,0.8565430955158082,0.9259629890260237,Upregulated
Feature0745,NA,C11 H20 N4 O5,288.1433,NA,NA,Feature0745,11,20,5,4,0,0,1.818181818181818,0.4545454545454546,0.18181818181818168,55.11818181818182,4,-1,-2.5,-0.5555555555555556,-5,Protein,4154337.435198603,3800701.0215728297,0.9148753756424537,-0.12835286207853677,0.6321986789822673,0.8125527786008807,Downregulated
Feature0744,Imazapyr,C13 H15 N3 O3,261.1114,NA,NA,Imazapyr,13,15,3,3,0,0,1.1538461538461535,0.2307692307692308,0,60.3,8,5,0.2857142857142857,0.4117647058823529,2,Lignin,7118717.244753897,9420158.261556437,1.3232943433030122,0.4041339991769941,0.2848017524836672,0.5636146830693134,Upregulated
Feature0743,NA,C17 H26 N2 O8,386.16902,NA,NA,Feature0743,17,26,8,2,0,0,1.5294117647058822,0.4705882352941176,-0.23529411764705888,67.00588235294117,6,-2,-0.5714285714285714,0,-4,Protein,5996484.514312644,4754192.20863315,0.792829898465619,-0.3349167257601019,0.0408252849639208,0.35607946299980225,Downregulated
Feature0742,Gly-Phe,C11 H14 N2 O3,222.1005,NA,NA,Gly-Phe-peak1,11,14,3,2,0,0,1.2727272727272727,0.2727272727272727,-0.18181818181818168,65.48181818181817,6,3,0.16666666666666666,0.3333333333333333,1,Lignin,6468287.2711272435,6750700.88593555,1.0436612665718987,0.06165354300605218,0.9120055120781342,0.9534409248736919,Upregulated
Feature0741,NA,C14 H24 N2 O11,396.13811,NA,NA,Feature0741,14,24,11,2,0,0,1.7142857142857142,0.7857142857142857,0.2857142857142856,52.15714285714286,4,-7,-9,-0.5384615384615384,-9,Carbohydrate,1842037.9419142033,1682587.7113496833,0.9134381399338479,-0.1306210652492024,0.6832250883086812,0.8366735803800379,Downregulated
Feature0740,NA,C22 H32 N4 O5,432.23734,NA,NA,Feature0740,22,32,5,4,0,0,1.4545454545454546,0.2272727272727273,-0.45454545454545414,73.25454545454544,9,4,0,0.16129032258064516,0,Lignin,8584160.65483523,3866129.3494989434,0.45037942612610066,-1.1507871700087111,0.5333478921148905,0.736341751623981,Downregulated
Feature0739,NP-007065,C8 H10 O3,154.06301,Microbial metabolism in diverse environments;Aminobenzoate degradation,NA,NP-007065-peak2,8,10,3,0,0,0,1.25,0.375,-0.5,74.55,4,1,0.2,0.38461538461538464,1,Lignin,6027994.473763326,13829714.025557764,2.294247960204874,1.1980213249307201,0.04897825195078353,0.35641545489778387,Upregulated
Feature0738,Adipic acid,C6 H10 O4,146.05793,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Aminobenzoate degradation;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,Adipic acid,6,10,4,0,0,0,1.6666666666666667,0.6666666666666666,-0.33333333333333304,69.79999999999998,2,-2,-1,0,-2,Amino Sugar,1351758.7034874966,1755500.9308708601,1.298679214227895,0.37704511577782734,0.12346871186752009,0.45317690246982556,Upregulated
Feature0737,(-)-Caryophyllene oxide,C15 H24 O,220.1827,Biosynthesis of secondary metabolites;Other,Other,(-)-Caryophyllene oxide-peak1,15,24,1,0,0,0,1.6,0.06666666666666667,-1.4666666666666668,102.1,4,3,0.21428571428571427,0.2413793103448276,3,Lipid,484819.7320106007,677629.3400543313,1.3976934008938293,0.48304792471815383,0.09353284139431303,0.41723968591020827,Upregulated
Feature0736,"N-(3-methoxyphenyl)-N'-[2-(2-methyl-4,5-dihydro-1H-imidazol-1-yl)ethyl]urea",C14 H20 N4 O2,276.15866,Metabolic pathways;Other,NA,"N-(3-methoxyphenyl)-N'-[2-(2-methyl-4,5-dihydro-1H-imidazol-1-yl)ethyl]urea-peak2",14,20,2,4,0,0,1.4285714285714286,0.14285714285714285,-0.2857142857142856,68.44285714285714,7,5,0.125,0.2222222222222222,1,Lignin,1565294.2005882266,236959.8227553582,0.15138356908644418,-2.7237194687175936,0.09581219450470345,0.41723968591020827,Downregulated
Feature0735,"(2R)-2-{[(2R)-2-{[(2S,3R,4R,5S,6R)-3-Acetamido-2,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-4-yl]oxy}propanoyl]amino}propanoic acid",C14 H24 N2 O9,364.14823,NA,NA,"(2R)-2-{[(2R)-2-{[(2S,3R,4R,5S,6R)-3-Acetamido-2,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-4-yl]oxy}propanoyl]amino}propanoic acid",14,24,9,2,0,0,1.7142857142857142,0.6428571428571429,0,60.3,4,-5,-2.3333333333333335,-0.3333333333333333,-7,Amino Sugar,4953463.46457179,3772294.97573479,0.7615469464375856,-0.392995118837932,0.33933258093391594,0.6000332386572487,Downregulated
Feature0734,"7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione",C11 H14 N4 O2,234.11166,NA,NA,"7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione-peak1",11,14,2,4,0,0,1.2727272727272727,0.18181818181818185,0.18181818181818168,55.11818181818182,7,5,0.2,0.3333333333333333,1,Lignin,12102785.071568167,10990092.848966233,0.9080631262951313,-0.1391355013058496,0.16328247852279865,0.4734778652324074,Downregulated
Feature0733,Stearidonic acid,C18 H28 O2,276.20889,Biosynthesis of secondary metabolites;Other,NA,Stearidonic acid,18,28,2,0,0,0,1.5555555555555556,0.1111111111111111,-1.333333333333333,98.29999999999998,5,3,0.1875,0.2352941176470588,3,Lipid,1122440.4700073702,1249559.397191701,1.1132522664507063,0.15478054894126195,0.831268707345777,0.9179720927273443,Upregulated
Feature0732,1-Linoleoyl-2-Hydroxy-sn-glycero-3-PC,C26 H50 N O7 P,519.33266,NA,NA,1-Linoleoyl-2-Hydroxy-sn-glycero-3-PC,26,50,7,1,0,1,1.9230769230769231,0.2692307692307692,-1.4615384615384617,101.95384615384616,3,-4,-0.35294117647058826,-0.12195121951219512,-6,Lipid,7890621.691764896,2409375.2022044226,0.30534668829947637,-1.711479896668148,0.4700740386011629,0.6900415978321557,Downregulated
Feature0731,NA,C12 H22 N2 O9,338.1325,NA,NA,Feature0731,12,22,9,2,0,0,1.8333333333333333,0.75,0.16666666666666652,55.55,3,-6,-8,-0.6363636363636364,-8,Carbohydrate,1971245.9702154594,1661325.4413430067,0.8427793722573454,-0.24677309148941015,0.7031730011006121,0.8470526718656479,Downregulated
Feature0730,NA,C16 H29 N3 O6,359.20577,NA,NA,Feature0730,16,29,6,3,0,0,1.8125,0.375,-0.5,74.55,4,-2,-0.7142857142857143,-0.2,-5,Protein,8253688.803033973,11352597.450933091,1.375457413267143,0.4599114718101148,0.21667525437320312,0.5069722111991797,Upregulated
Feature0729,Pyridoxal,C8 H9 N O3,167.05826,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Other,Pyridoxal-peak3,8,9,3,1,0,0,1.125,0.375,0,60.3,5,2,0.25,0.4545454545454546,1,Lignin,3503849.10535273,3129863.1415536865,0.893264249528407,-0.16284107173593085,0.5343991663131362,0.7371923352886423,Downregulated
Feature0728,NA,C12 H17 N3 O7,315.10673,NA,NA,Feature0728,12,17,7,3,0,0,1.4166666666666667,0.5833333333333334,0.5,46.05,6,-1,-2,-0.09090909090909093,-4,Lignin,239687.42636962832,164255.17628209532,0.6852890815757396,-0.5452153935616053,0.41420393213686524,0.6580333694263849,Downregulated
Feature0727,NS1800000,C8 H9 N O4,183.05316,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,NA,NS1800000,8,9,4,1,0,0,1.125,0.5,0.25,53.175,5,1,0,0.4,0,Lignin,2405833.9703598334,2230322.71048878,0.9270476425084301,-0.10928461165203582,0.7707797643595613,0.8847614925965286,Downregulated
Feature0726,NA,C16 H23 N5 O10,445.14456,NA,NA,Feature0726,16,23,10,5,0,0,1.4375,0.625,0.75,38.925,8,-2,-7,-0.3333333333333333,-7,Lignin,4414401.356558528,3898295.8106047735,0.8830859488598675,-0.17937423576846162,0.8532961254803306,0.92558845302131,Downregulated
Feature0725,4-Hydroxyprolyllysine,C11 H21 N3 O4,259.15322,NA,NA,4-Hydroxyprolyllysine-peak3,11,21,4,3,0,0,1.9090909090909092,0.3636363636363637,-0.3636363636363633,70.66363636363636,3,-1,-1,-0.3333333333333333,-4,Protein,7756115.0459542265,6344541.048004113,0.8180050206080396,-0.2898183969720584,0.5801591585115111,0.7726333447472483,Downregulated
Feature0724,methoxyresorcinol,C7 H8 O3,140.04734,Microbial metabolism in diverse environments;Other,NA,methoxyresorcinol-peak2,7,8,3,0,0,0,1.1428571428571428,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,1,0.25,0.4545454545454546,1,Lignin,4563787.642343214,5206865.48607666,1.1409088007879498,0.19018347356394244,0.2831779354536618,0.5619987758948393,Upregulated
Feature0723,fructosylglycine,C8 H15 N O7,237.08491,NA,NA,fructosylglycine-peak1,8,15,7,1,0,0,1.875,0.875,0.25,53.175,2,-5,-Inf,-0.7142857142857143,-6,Carbohydrate,6139419.323903743,4866259.036965253,0.7926252924309212,-0.335289090888966,0.1544895537275416,0.46816691236933006,Downregulated
Feature0722,pseudouridine,C9 H12 N2 O6,244.06949,Metabolic pathways;ABC transporters;Other,Other,pseudouridine-peak1,9,12,6,2,0,0,1.3333333333333333,0.6666666666666666,0.6666666666666665,41.3,5,-1,-3,0,-3,Tannin,1479394.8460276932,1369400.2183106057,0.9256489043392081,-0.11146300725284156,0.8172293362919811,0.9127191231804745,Downregulated
Feature0721,NA,C22 H28 N2 O9,464.17958,NA,NA,Feature0721,22,28,9,2,0,0,1.2727272727272727,0.4090909090909091,-0.18181818181818168,65.48181818181817,10,1,-0.09090909090909093,0.2258064516129032,-1,Lignin,3978181.1278988165,2168273.3883339064,0.545041394200957,-0.8755622926296505,0.043105619201421766,0.35607946299980225,Downregulated
Feature0720,Xamoterol [USAN:BAN:INN],C16 H25 N3 O5,339.17949,NA,NA,Xamoterol [USAN:BAN:INN],16,25,5,3,0,0,1.5625,0.3125,-0.375,70.9875,6,1,-0.25,0.04761904761904761,-2,Protein,211482.221736543,250663.56556708802,1.1852701541945958,0.24521592469003253,0.5672430558589285,0.7624035936741783,Upregulated
Feature0719,N2-Dimethylguanosine,C12 H17 N5 O5,311.12308,NA,NA,N2-Dimethylguanosine,12,17,5,5,0,0,1.4166666666666667,0.4166666666666667,0.6666666666666665,41.3,7,2,-1.5,-0.1111111111111111,-3,Lignin,1160102.250145274,1743245.46473222,1.502665359466307,0.5875237597586119,0.39494034698619446,0.642062329937249,Upregulated
Feature0718,UNII:74D1OHC38H,C19 H32 O4,324.23009,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,UNII:74D1OHC38H-peak1,19,32,4,0,0,0,1.6842105263157894,0.21052631578947367,-1.2631578947368425,96.3,4,0,0,0.1176470588235294,0,Lipid,1244995.4711858516,1839503.0737138633,1.4775178836287222,0.5631755926473605,0.5312610940032921,0.7346581985645525,Upregulated
Feature0717,NA,C33 H47 N O8,585.33043,NA,NA,Feature0717,33,47,8,1,0,0,1.4242424242424243,0.24242424242424243,-0.8484848484848486,84.48181818181818,11,3,0.08333333333333333,0.21428571428571427,2,Lignin,187209.694407681,223239.69206474,1.192457969503425,0.25393841653887905,0.37113475450074374,0.6242377295699064,Upregulated
Feature0716,perlolyrine,C16 H12 N2 O2,264.0899,Other,NA,perlolyrine,16,12,2,2,0,0,0.75,0.125,-0.125,63.8625,12,10,0.6666666666666666,0.6923076923076923,8,Condensed HC,881535.0232005017,1179164.024216219,1.337625838092224,0.41967462044971365,0.32256938179456585,0.5861484461709393,Upregulated
Feature0715,"4-(4-methylphenyl)-2-phenyl-1,3-thiazole",C16 H13 N S,251.07697,NA,NA,"4-(4-methylphenyl)-2-phenyl-1,3-thiazole",16,13,0,1,1,0,0.8125,0,-0.5,74.55,11,11,0.6428571428571429,0.6428571428571429,9,Unsaturated HC,10611759.843550596,10137167.87430029,0.9552767895007778,-0.06600928322267774,0.46832410143349473,0.6898617633289913,Downregulated
Feature0714,N-acetyl-L-2-aminoadipic acid 6-phosphate,C8 H14 N O8 P,283.04574,NA,NA,N-acetyl-L-2-aminoadipic acid 6-phosphate,8,14,8,1,0,1,1.75,1,0,60.3,3,-5,3.5,-1.5,-7,Carbohydrate,869958.2887759546,1604578.1258544168,1.8444311026820426,0.883175899265646,0.0565187732326481,0.3769401647878184,Upregulated
Feature0713,3-Butynoic acid,C4 H4 O2,84.02115,Metabolic pathways;Other,NA,3-Butynoic acid-peak1,4,4,2,0,0,0,1,0.5,0,60.3,3,1,0.5,0.6666666666666666,1,Lignin,1468318.9153845867,1777724.73451959,1.2107211286956436,0.2758666003095598,0.48791288657968807,0.7046244073878871,Upregulated
Feature0712,threonylphenylalanine,C13 H18 N2 O4,266.12668,Metabolic pathways;Biosynthesis of cofactors;Other,NA,threonylphenylalanine-peak2,13,18,4,2,0,0,1.3846153846153846,0.3076923076923077,-0.3076923076923075,69.06923076923076,6,2,0,0.2222222222222222,0,Lignin,9483846.279210247,7951152.331959386,0.8383889930174518,-0.25430831864102726,0.4461904688904653,0.6687322960777052,Downregulated
Feature0711,NA,C29 H28 O9,520.17351,NA,NA,Feature0711,29,28,9,0,0,0,0.9655172413793104,0.3103448275862069,-0.3448275862068968,70.12758620689655,16,7,0.35,0.4693877551020408,7,Lignin,12156445.963472817,10124055.565475658,0.8328137677653484,-0.26393417595871366,0.6626551254403191,0.8270457467005496,Downregulated
Feature0710,asn-phe,C13 H17 N3 O4,279.12195,NA,NA,asn-phe-peak2,13,17,4,3,0,0,1.3076923076923077,0.3076923076923077,0,60.3,7,3,0,0.25,0,Lignin,9229147.694249153,9707593.292072786,1.051840713105259,0.07291624473243966,0.7056094359994588,0.8478072560935465,Upregulated
Feature0709,N-Acetylvanilalanine,C12 H15 N O5,253.09509,NA,NA,N-Acetylvanilalanine-peak4,12,15,5,1,0,0,1.25,0.4166666666666667,-0.16666666666666696,65.05000000000001,6,1,0,0.29411764705882354,0,Lignin,11614699.578502636,8079671.53354031,0.6956418871560636,-0.523583289653838,0.2753485254171982,0.5546259239675787,Downregulated
Feature0708,gepefrine,C9 H13 N O,151.09965,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of alkaloids derived from shikimate pathway;Tyrosine metabolism;Other,NA,gepefrine,9,13,1,1,0,0,1.4444444444444444,0.1111111111111111,-0.8888888888888893,85.63333333333334,4,3,0.2857142857142857,0.3333333333333333,2,Unsaturated HC,233879.76657237532,277428.9678734493,1.1862033725247347,0.24635137866941365,0.28120666442583636,0.5605282439044939,Upregulated
Feature0707,D-lysopine,C9 H18 N2 O4,218.12663,Lysine degradation,NA,D-lysopine-peak2,9,18,4,2,0,0,2,0.4444444444444444,-0.44444444444444464,72.96666666666667,2,-2,-1.3333333333333333,-0.4,-4,Protein,7323614.396236323,7011166.642401127,0.9573369463586496,-0.06290130676506268,0.8556594033616177,0.9259629890260237,Downregulated
Feature0706,NA,C22 H28 N2 O9,464.17958,NA,NA,Feature0706,22,28,9,2,0,0,1.2727272727272727,0.4090909090909091,-0.18181818181818168,65.48181818181817,10,1,-0.09090909090909093,0.2258064516129032,-1,Lignin,6356224.679367786,8294195.892263453,1.3048934407851085,0.38393199934097944,0.11041946499011586,0.44011899692530887,Upregulated
Feature0705,"1,4-Bis(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",C20 H22 O7,374.13662,NA,NA,"1,4-Bis(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol-peak1",20,22,7,0,0,0,1.1,0.35,-0.4000000000000003,71.7,10,3,0.2307692307692308,0.3939393939393939,3,Lignin,14984395.629283834,11742195.263368301,0.7836282192403318,-0.3517587434469469,0.267144397036742,0.5485236753179552,Downregulated
Feature0704,6-[2-Formyl-5-(hydroxymethyl)-1H-pyrrol-1-yl]norleucine,C12 H18 N2 O4,254.12667,NA,NA,6-[2-Formyl-5-(hydroxymethyl)-1H-pyrrol-1-yl]norleucine-peak1,12,18,4,2,0,0,1.5,0.3333333333333333,-0.33333333333333304,69.79999999999998,5,1,-0.16666666666666666,0.125,-1,Protein,4438559.776210937,2975327.2977562733,0.6703362008782542,-0.577043247545338,0.042601992787651914,0.35607946299980225,Downregulated
Feature0703,NA,C12 H17 N3 O5,283.11687,NA,NA,Feature0703,12,17,5,3,0,0,1.4166666666666667,0.4166666666666667,0.16666666666666652,55.55,6,1,-0.5,0.07692307692307693,-2,Lignin,317676.632979644,354753.3845686457,1.1167122404982726,0.15925747347540223,0.505179589507625,0.7147986458639677,Upregulated
Feature0702,Isovalerylglutamic acid,C10 H17 N O5,231.11063,NA,NA,Isovalerylglutamic acid-peak4,10,17,5,1,0,0,1.7,0.5,-0.4000000000000003,71.7,3,-2,-0.75,-0.07692307692307693,-3,Protein,6850685.199560944,4391272.567902267,0.6409975703136528,-0.641609206534902,0.3366090340802376,0.5981373757723136,Downregulated
Feature0701,NA,C20 H42 N9 O17 P,711.2437,NA,NA,Feature0701,20,42,17,9,0,1,2.1,0.85,0.7000000000000002,40.349999999999994,5,-12,3.142857142857143,-9,-22,Carbohydrate,421678.48136409,718800.08604741,1.704616473959401,0.7694471800954295,0.257451459036656,0.5404247479654217,Upregulated
Feature0700,NA,C77 H114 N8 O16 P2,1468.7833,NA,NA,Feature0700,77,114,16,8,0,2,1.4805194805194806,0.2077922077922078,-0.883116883116883,85.46883116883116,26,10,0,0.13559322033898305,0,Lignin,283270.50607151835,470363.69052836,1.6604753422850367,0.7315962992771008,0.13495157928707857,0.45384777576550756,Upregulated
Feature0699,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",C10 H18 N2 O5,246.12154,Metabolic pathways;Other,NA,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose-peak2",10,18,5,2,0,0,1.8,0.5,-0.20000000000000015,66,3,-2,-1.3333333333333333,-0.2727272727272727,-4,Protein,8033385.360660917,6327544.52293025,0.7876560427333558,-0.34436233040127295,0.49317973090423517,0.7080575663806328,Downregulated
Feature0698,"(2Z,4E)-2,4-Hexadienedial",C6 H6 O2,110.03674,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Tyrosine metabolism;Aminobenzoate degradation;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,"(2Z,4E)-2,4-Hexadienedial-peak1",6,6,2,0,0,0,1,0.3333333333333333,-0.33333333333333304,69.79999999999998,4,2,0.5,0.6,2,Lignin,8999295.818582848,6140967.32676332,0.6823830942508522,-0.5513461899406836,0.15002606112241756,0.46695517742640485,Downregulated
Feature0697,MFCD00056023,C12 H14 N2 O3,234.10044,NA,NA,MFCD00056023,12,14,3,2,0,0,1.1666666666666667,0.25,-0.16666666666666696,65.05000000000001,7,4,0.2857142857142857,0.4117647058823529,2,Lignin,11048430.029311366,8694775.65164347,0.7869693366909437,-0.3456206709280922,0.04222248657121768,0.35607946299980225,Downregulated
Feature0696,"8-Methyl-1,2-naphthalenediol",C11 H10 O2,174.0681,Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,NA,"8-Methyl-1,2-naphthalenediol-peak3",11,10,2,0,0,0,0.9090909090909092,0.18181818181818185,-0.5454545454545459,75.84545454545456,7,5,0.5555555555555556,0.6,5,Lignin,479535.92790135765,900505.6527157903,1.8778689985894608,0.9090964231208709,0.1384749919124664,0.45798070948295916,Upregulated
Feature0695,Linamarin,C10 H17 N O6,247.10559,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,Linamarin-peak1,10,17,6,1,0,0,1.7,0.6,-0.20000000000000015,66,3,-3,-1.3333333333333333,-0.16666666666666666,-4,Amino Sugar,6859490.77966455,1608750.2279744332,0.234529104222093,-2.09216112774815,4.8760982302397715e-5,0.08260110402026173,Downregulated
Feature0694,Otonecine,C9 H15 N O3,185.10524,Other,NA,Otonecine,9,15,3,1,0,0,1.6666666666666667,0.3333333333333333,-0.666666666666667,79.30000000000001,3,0,-0.2,0.07692307692307693,-1,Protein,14107536.256571572,10440949.251046024,0.740097282839335,-0.43421317516566865,0.3449019791416556,0.6035784634978973,Downregulated
Feature0693,N-(Carboxyacetyl)phenylalanine,C12 H13 N O5,251.07938,NA,NA,N-(Carboxyacetyl)phenylalanine,12,13,5,1,0,0,1.0833333333333333,0.4166666666666667,0,60.3,7,2,0.16666666666666666,0.4117647058823529,1,Lignin,836735.0242577937,756234.6295183339,0.9037922491521545,-0.1459369102591692,0.7040437792130061,0.8470526718656479,Downregulated
Feature0692,NA,C10 H23 N O6,253.1525,NA,NA,Feature0692,10,23,6,1,0,0,2.3,0.6,-0.7999999999999998,83.1,0,-6,-2.3333333333333335,-0.6666666666666666,-7,Other,1559938.5594132734,1512083.7750506196,0.9693226479505366,-0.044951135006020354,0.9335131605851681,0.9640795504757004,Downregulated
Feature0691,Meconin,C10 H10 O4,194.05794,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Superpathway of scopolin and esculin biosynthesis;Other,Meconin-peak1,10,10,4,0,0,0,1,0.4,-0.20000000000000015,66,6,2,0.3333333333333333,0.5,2,Lignin,190644.334384255,174135.48120365967,0.9134049630485176,-0.13067346616733855,0.8512995321903434,0.92558845302131,Downregulated
Feature0690,1581740,C12 H13 N O4,235.08444,NA,NA,1581740-peak2,12,13,4,1,0,0,1.0833333333333333,0.3333333333333333,-0.16666666666666696,65.05000000000001,7,3,0.2857142857142857,0.4444444444444444,2,Lignin,455868.21919722634,315055.04019857233,0.6911099017899891,-0.5330129455475291,0.16199688281344327,0.4734778652324074,Downregulated
Feature0689,1-Deoxynojirimycin,C6 H13 N O4,163.08449,Biosynthesis of secondary metabolites;Other,Superpathway of butirocin biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis,1-Deoxynojirimycin-peak2,6,13,4,1,0,0,2.1666666666666665,0.6666666666666666,-0.33333333333333304,69.79999999999998,1,-3,-4,-0.6666666666666666,-4,Amino Sugar,7051912.28490322,10965963.027077144,1.5550339516492782,0.6369460796107458,0.337503962785409,0.5981373757723136,Upregulated
Feature0688,NA,C9 H23 N10 O5 P,382.15886,NA,NA,Feature0688,9,23,5,10,0,1,2.5555555555555554,0.5555555555555556,1.3333333333333337,22.29999999999999,4,-1,1.7142857142857142,2.111111111111111,-12,Other,1422583.58338703,588578.5976168177,0.4137392027366649,-1.273206432179649,0.03866758893159737,0.34143592688945573,Downregulated
Feature0687,NA,C15 H29 N3 O4,315.21588,NA,NA,Feature0687,15,29,4,3,0,0,1.9333333333333331,0.26666666666666666,-0.7999999999999998,83.1,3,-1,-0.5,-0.2,-4,Lipid,7574582.196985897,5761934.816191876,0.7606934173193981,-0.39461297418381114,0.7177523149460863,0.8556456168322802,Downregulated
Feature0686,"2,3,4,5,6-Pentahydroxy-N-(2-hydroxyethyl)hexanamide",C8 H17 N O7,239.10053,Metabolic pathways;Biosynthesis of cofactors;Other,NA,"2,3,4,5,6-Pentahydroxy-N-(2-hydroxyethyl)hexanamide",8,17,7,1,0,0,2.125,0.875,0,60.3,1,-6,-Inf,-1,-7,Carbohydrate,529373.1364791883,403726.968262334,0.7626510308919048,-0.3909050262525089,0.1535744656835724,0.46778235597057083,Downregulated
Feature0685,ser-asn,C7 H13 N3 O5,219.08553,Biosynthesis of secondary metabolites;Other,NA,ser-asn,7,13,5,3,0,0,1.8571428571428572,0.7142857142857143,0.8571428571428572,35.87142857142857,3,-2,5,-1.6666666666666667,-5,Carbohydrate,7518902.290325204,10452028.705895241,1.3901003500662827,0.4751890335367559,0.09858157088642021,0.4217100532363531,Upregulated
Feature0684,dihydroxyphenylalanine,C9 H11 N O4,197.06882,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Biosynthesis of alkaloids derived from shikimate pathway;Tyrosine metabolism;Other,Other,dihydroxyphenylalanine,9,11,4,1,0,0,1.2222222222222223,0.4444444444444444,0,60.3,5,1,0,0.3333333333333333,0,Lignin,12579233.755462434,9613174.453865487,0.7642098589424051,-0.38795922510666114,0.06556527840515791,0.38614481760703634,Downregulated
Feature0683,D-Glucono-delta-lactone,C6 H10 O6,178.04778,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Other,D-Glucono-delta-lactone,6,10,6,0,0,0,1.6666666666666667,1,0.3333333333333335,50.8,2,-4,-Inf,-0.3333333333333333,-4,Carbohydrate,150930.49915758966,181007.51851746466,1.1992772801239526,0.2621652570936305,0.30486457681895834,0.5763754381762052,Upregulated
Feature0682,NA,C18 H29 N O12,451.16881,NA,NA,Feature0682,18,29,12,1,0,0,1.6111111111111112,0.6666666666666666,-0.11111111111111072,63.466666666666654,5,-7,-1.6,-0.18181818181818185,-8,Amino Sugar,2979984.2152752266,669053.474701173,0.2245157780607171,-2.1551112595864663,0.09583026917370989,0.41723968591020827,Downregulated
Feature0681,leu-lys,C12 H25 N3 O3,259.18959,NA,NA,leu-lys,12,25,3,3,0,0,2.0833333333333335,0.25,-0.833333333333333,84.04999999999998,2,-1,-0.6666666666666666,-0.3333333333333333,-4,Lipid,3917737.0310654268,4968263.5391465705,1.2681462537559478,0.3427211393265225,0.6465558401327169,0.8173623829737481,Upregulated
Feature0680,lys-leu,C12 H25 N3 O3,259.18958,NA,NA,lys-leu-peak1,12,25,3,3,0,0,2.0833333333333335,0.25,-0.833333333333333,84.04999999999998,2,-1,-0.6666666666666666,-0.3333333333333333,-4,Lipid,3730688.64228949,4184163.9238056033,1.1215527011221766,0.16549741343465663,0.8668101380972075,0.9323024596423299,Upregulated
Feature0679,NA,C14 H27 N3 O4,301.2002,NA,NA,Feature0679,14,27,4,3,0,0,1.9285714285714288,0.2857142857142857,-0.7142857142857144,80.65714285714286,3,-1,-0.5714285714285714,-0.2222222222222222,-4,Lipid,10684736.566890093,11043037.888754299,1.03353394064712,0.047585766798453284,0.8097577537705238,0.9084302217796473,Upregulated
Feature0678,Zalcitabine,C9 H13 N3 O3,211.09565,Other,NA,Zalcitabine-peak1,9,13,3,3,0,0,1.4444444444444444,0.3333333333333333,0.22222222222222232,53.96666666666666,5,2,-0.3333333333333333,0.1111111111111111,-1,Lignin,3081094.438809513,2474272.22718616,0.803049785173797,-0.316438664309273,0.09179244363922402,0.41723968591020827,Downregulated
Feature0677,N-(2-Hydroxy-7-octenoyl)glycine,C10 H17 N O4,215.11578,NA,NA,N-(2-Hydroxy-7-octenoyl)glycine-peak2,10,17,4,1,0,0,1.7,0.4,-0.5999999999999996,77.39999999999999,3,-1,-0.4,0,-2,Protein,11092081.494960366,9935943.594948735,0.8957690762967333,-0.15880123249305106,0.6663101182647837,0.8275141791352959,Downregulated
Feature0676,2'-O-Methylguanosine,C11 H15 N5 O5,297.10741,NA,NA,2'-O-Methylguanosine,11,15,5,5,0,0,1.3636363636363635,0.4545454545454546,0.9090909090909092,34.39090909090909,7,2,-3,-0.14285714285714285,-3,Lignin,792070.1725139329,1348229.879879263,1.7021596402249914,0.7673663492215581,0.3231774785853939,0.5861484461709393,Upregulated
Feature0675,NA,C16 H23 N5 O10,445.14457,NA,NA,Feature0675,16,23,10,5,0,0,1.4375,0.625,0.75,38.925,8,-2,-7,-0.3333333333333333,-7,Lignin,10672734.412444122,8445594.05762404,0.7913242971526308,-0.3376590398704687,0.14904340751253406,0.46695517742640485,Downregulated
Feature0674,Cyclo(phenylalanyl-prolyl),C14 H16 N2 O2,244.12117,NA,NA,Cyclo(phenylalanyl-prolyl)-peak1,14,16,2,2,0,0,1.1428571428571428,0.14285714285714285,-0.4285714285714288,72.51428571428572,8,6,0.4,0.4545454545454546,4,Lignin,11098287.401499901,9700460.33660123,0.8740502012310692,-0.19421195133174393,0.006740541279493237,0.23030609530252863,Downregulated
Feature0673,NA,C14 H20 N2 O10,376.1119,NA,NA,Feature0673,14,20,10,2,0,0,1.4285714285714286,0.7142857142857143,0.4285714285714284,48.08571428571429,6,-4,-3,-0.14285714285714285,-6,Tannin,184096.14734618968,321785.14032310835,1.747918926939828,0.8056382704138206,0.27507108090478616,0.5546259239675787,Upregulated
Feature0672,N(6)-[(indol-3-yl)acetyl]-L-lysine,C16 H21 N3 O3,303.15835,NA,NA,N(6)-[(indol-3-yl)acetyl]-L-lysine,16,21,3,3,0,0,1.3125,0.1875,-0.375,70.9875,8,5,0.2,0.30434782608695654,2,Lignin,5567611.170803066,7113694.750425966,1.2776924487346868,0.3535406093033134,0.29617247729747165,0.57033619612451,Upregulated
Feature0671,Cyclopentanone,C5 H8 O,84.05754,Other,NA,Cyclopentanone-peak5,5,8,1,0,0,0,1.6,0.2,-1.2000000000000002,94.5,2,1,0.25,0.3333333333333333,1,Lipid,301261.718095299,529505.3737049096,1.7576258180185031,0.8136279669844846,0.14756683833789075,0.4658688473133245,Upregulated
Feature0670,Leu-Gly-Pro,C13 H23 N3 O4,285.16888,NA,NA,Leu-Gly-Pro-peak3,13,23,4,3,0,0,1.7692307692307692,0.3076923076923077,-0.4615384615384617,73.45384615384616,4,0,-0.5,-0.125,-3,Protein,6387775.1472099135,6473120.414120477,1.0133607187078024,0.019147811312921415,0.9139385441644579,0.9541658691110259,Upregulated
Feature0669,NA,C21 H32 N2 O8,440.21604,NA,NA,Feature0669,21,32,8,2,0,0,1.5238095238095235,0.380952380952381,-0.4761904761904763,73.87142857142857,7,-1,-0.2727272727272727,0.06666666666666667,-3,Protein,608287.2392897853,215263.521595897,0.35388465792448826,-1.4986488773910758,0.15551004748946903,0.46825623718458564,Downregulated
Feature0668,N(6)-OH-Me-Adenosine,C11 H15 N5 O5,297.10731,NA,NA,N(6)-OH-Me-Adenosine-peak1,11,15,5,5,0,0,1.3636363636363635,0.4545454545454546,0.9090909090909092,34.39090909090909,7,2,-3,-0.14285714285714285,-3,Lignin,10278192.03119829,11092440.875430433,1.0792210188095905,0.10999035146874832,0.14270318086691414,0.46161586781018427,Upregulated
Feature0667,2762577,C15 H23 N3 O4,309.16893,NA,NA,2762577-peak1,15,23,4,3,0,0,1.5333333333333334,0.26666666666666666,-0.4000000000000003,71.7,6,2,-0.125,0.1,-1,Lipid,3298909.31748071,7499097.692616167,2.273205162954594,1.184727897186963,0.07529071463800893,0.39590936857023457,Upregulated
Feature0666,NA,C19 H35 P S,326.21985,NA,NA,Feature0666,19,35,0,0,1,1,1.8421052631578947,0,-2,117.3,3,3,0.0588235294117647,0.0588235294117647,1,Lipid,4331118.196132024,1727755.93543068,0.3989168286780261,-1.325840108744269,0.3166500959661651,0.5836836371781107,Downregulated
Feature0665,xylometazoline,C16 H24 N2,244.19396,NA,NA,xylometazoline,16,24,0,2,0,0,1.5,0,-1.125,92.3625,6,6,0.2857142857142857,0.2857142857142857,4,Lipid,134701.74819982168,191602.75680178867,1.4224221983931336,0.5083497442281498,0.2564993593919083,0.5397638693290592,Upregulated
Feature0664,Threonylglutamine,C9 H17 N3 O5,247.11681,NA,NA,Threonylglutamine,9,17,5,3,0,0,1.8888888888888888,0.5555555555555556,0.22222222222222232,53.96666666666666,3,-2,-5,-0.7142857142857143,-5,Amino Sugar,4913731.979690867,9859332.02866089,2.0064855123174956,1.0046707392810474,0.11858942112168598,0.4526122839818135,Upregulated
Feature0663,(S)-(+)-2-Aminobutyric Acid,C4 H9 N O2,103.06328,Metabolic pathways;Microbial metabolism in diverse environments;Other,Other,(S)-(+)-2-Aminobutyric Acid,4,9,2,1,0,0,2.25,0.5,-0.5,74.55,1,-1,-2,-0.5,-2,Protein,9057297.35066039,10021951.03055751,1.1065056873535002,0.14601086649871095,0.1908746278020045,0.4862119877973694,Upregulated
Feature0662,"(2E)-N-(4-Aminobutyl)-3-(2,4-dihydroxy-5-methoxyphenyl)acrylamide",C14 H20 N2 O4,280.14231,NA,NA,"(2E)-N-(4-Aminobutyl)-3-(2,4-dihydroxy-5-methoxyphenyl)acrylamide-peak2",14,20,4,2,0,0,1.4285714285714286,0.2857142857142857,-0.4285714285714288,72.51428571428572,6,2,0,0.2,0,Lignin,324791.607967211,321190.9733309893,0.9889140157938281,-0.016083008059291002,0.9543520748255052,0.9749458049634153,Downregulated
Feature0661,Phenyl D-glucopyranosiduronic acid,C12 H14 O7,270.07397,NA,NA,Phenyl D-glucopyranosiduronic acid-peak2,12,14,7,0,0,0,1.1666666666666667,0.5833333333333334,0,60.3,6,-1,-0.2,0.29411764705882354,-1,Lignin,1128120.9909354497,1311969.07222824,1.1629684074403595,0.21781190588404958,0.4432569569176732,0.6668537167127339,Upregulated
Feature0660,Prolylleucine,C11 H20 N2 O3,228.14739,NA,NA,Prolylleucine-peak1,11,20,3,2,0,0,1.818181818181818,0.2727272727272727,-0.7272727272727275,81.02727272727273,3,0,-0.3333333333333333,-0.06666666666666667,-2,Lipid,1156632.035154739,2131760.809664657,1.8430760560591435,0.8821156062021388,0.3204001846934128,0.5861484461709393,Upregulated
Feature0659,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",C10 H13 N O3,195.08957,Other,NA,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime-peak1",10,13,3,1,0,0,1.3,0.3,-0.4000000000000003,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Lignin,7743411.306417016,5691884.173818373,0.7350615831424931,-0.44406297150646057,7.034723818319192e-4,0.13209075561330955,Downregulated
Feature0658,2'-deamino-2'-hydroxy-6'-dehydroparomamine,C12 H22 N2 O8,322.13771,Biosynthesis of secondary metabolites;Other,Kanamycin biosynthesis,2'-deamino-2'-hydroxy-6'-dehydroparomamine,12,22,8,2,0,0,1.8333333333333333,0.6666666666666666,0,60.3,3,-5,-3.5,-0.5,-7,Amino Sugar,1763945.1561525501,1174400.7933089337,0.6657807864449096,-0.5868808580838847,0.04187368446027113,0.35607946299980225,Downregulated
Feature0657,asn-val,C9 H17 N3 O4,231.12192,NA,NA,asn-val-peak3,9,17,4,3,0,0,1.8888888888888888,0.4444444444444444,0,60.3,3,-1,-2,-0.5,-4,Protein,9245813.179638833,8145024.865501223,0.8809419687862858,-0.18288110877426544,0.5055069526239866,0.7147986458639677,Downregulated
Feature0656,NA,C16 H29 N3 O9,407.19049,NA,NA,Feature0656,16,29,9,3,0,0,1.8125,0.5625,-0.125,63.8625,4,-5,-2,-0.4117647058823529,-8,Amino Sugar,858845.636181821,367155.598972284,0.4274989398613603,-1.2260072525698902,0.18202999574830742,0.48456142817500325,Downregulated
Feature0655,butoctamide,C16 H29 N O5,315.20464,NA,NA,butoctamide,16,29,5,1,0,0,1.8125,0.3125,-1,88.8,3,-2,-0.3,-0.04,-3,Protein,3864783.40748682,5162560.672400236,1.3357956004466833,0.41769926770560684,0.0767982446790382,0.39590936857023457,Upregulated
Feature0654,NA,C23 H33 N3 O5,431.24202,NA,NA,Feature0654,23,33,5,3,0,0,1.434782608695652,0.21739130434782608,-0.6086956521739131,77.64782608695651,9,4,0.06666666666666667,0.2,1,Lignin,191773.31153277634,301288.050166184,1.5710635007452032,0.6517414940367798,0.0021614878477625586,0.15919827887433802,Upregulated
Feature0653,NA,C18 H31 N O14,485.17464,NA,NA,Feature0653,18,31,14,1,0,0,1.7222222222222223,0.7777777777777778,0,60.3,4,-10,-3.6666666666666665,-0.4,-11,Carbohydrate,10265761.96177864,8627519.918866329,0.84041690728737,-0.25082290882323194,0.16581873949048526,0.4734778652324074,Downregulated
Feature0652,NA,C29 H28 O9,520.17353,NA,NA,Feature0652,29,28,9,0,0,0,0.9655172413793104,0.3103448275862069,-0.3448275862068968,70.12758620689655,16,7,0.35,0.4693877551020408,7,Lignin,12246380.960039634,14910144.285483234,1.2175143280398961,0.2839387504353155,0.22810083657145314,0.5170330973050352,Upregulated
Feature0651,N6-acetyl-N6-hydroxy-L-lysine,C8 H16 N2 O4,204.11098,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,NA,N6-acetyl-N6-hydroxy-L-lysine-peak1,8,16,4,2,0,0,2,0.5,-0.25,67.425,2,-2,-2,-0.5,-4,Protein,4381460.804445824,4026430.7313703033,0.9189699305959157,-0.12191043869391947,0.8207675571463472,0.9136000023320247,Downregulated
Feature0650,1-(5-Amino-5-carboxypentyl)-5-oxoproline,C11 H18 N2 O5,258.12159,NA,NA,1-(5-Amino-5-carboxypentyl)-5-oxoproline,11,18,5,2,0,0,1.6363636363636365,0.4545454545454546,-0.18181818181818168,65.48181818181817,4,-1,-0.75,-0.07692307692307693,-3,Protein,161303.218576234,328649.94854111737,2.037466774947166,1.0267765334493435,0.38881458156197535,0.6375277315535638,Upregulated
Feature0649,L-Isoleucyl-L-alanyl-D-arginine,C15 H30 N6 O4,358.23298,NA,NA,L-Isoleucyl-L-alanyl-D-arginine-peak2,15,30,4,6,0,0,2,0.26666666666666666,-0.2666666666666666,67.89999999999999,4,0,-1.2,-0.5714285714285714,-6,Lipid,12490196.708036933,10445691.56796799,0.8363112136774126,-0.2578881874151862,0.32687743550294796,0.5903308909829359,Downregulated
Feature0648,NA,C14 H29 N O2,243.2198,NA,NA,Feature0648,14,29,2,1,0,0,2.0714285714285716,0.14285714285714285,-1.5714285714285712,105.08571428571427,1,-1,-0.18181818181818185,-0.08333333333333333,-2,Lipid,161146.99885037466,194782.381384979,1.2087248461005151,0.2734858671303361,0.06176986958946328,0.3794192923980171,Upregulated
Feature0647,Leucyltryptophan,C17 H23 N3 O3,317.17403,NA,NA,Leucyltryptophan-peak1,17,23,3,3,0,0,1.3529411764705883,0.17647058823529413,-0.47058823529411775,73.71176470588236,8,5,0.18181818181818185,0.28,2,Lignin,6945029.35224614,5754495.3600253165,0.8285775434720395,-0.2712913746915948,0.5027304584732002,0.7129214458200539,Downregulated
Feature0646,"8-Methyl-1,2-naphthalenediol",C11 H10 O2,174.0681,Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,NA,"8-Methyl-1,2-naphthalenediol-peak2",11,10,2,0,0,0,0.9090909090909092,0.18181818181818185,-0.5454545454545459,75.84545454545456,7,5,0.5555555555555556,0.6,5,Lignin,334079.940807001,374407.3739116133,1.1207119260354204,0.16441548751893417,0.8540110697002995,0.92558845302131,Upregulated
Feature0645,NA,C32 H37 N4 O2 P3,602.213,NA,NA,Feature0645,32,37,2,4,0,3,1.15625,0.0625,-1.125,92.3625,18,16,0.391304347826087,0.4166666666666667,9,Unsaturated HC,4398702.81090197,8434301.923032267,1.917452095678813,0.9391905348651466,0.41240041423361534,0.6580333694263849,Upregulated
Feature0644,N-Acetylserotonin,C12 H14 N2 O2,218.10552,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Other,N-Acetylserotonin,12,14,2,2,0,0,1.1666666666666667,0.16666666666666666,-0.33333333333333304,69.79999999999998,7,5,0.375,0.4444444444444444,3,Lignin,9463267.532980183,8269585.651739247,0.8738615518285976,-0.19452336700589667,0.18121520874594524,0.48423459758942683,Downregulated
Feature0643,Homo-L-arginine,C7 H16 N4 O2,188.12733,NA,NA,Homo-L-arginine,7,16,2,4,0,0,2.2857142857142856,0.2857142857142857,0,60.3,2,0,-4,-1.5,-4,Lipid,4334463.558203206,4145889.1472447133,0.956494175478392,-0.06417191150575431,0.8978241892820031,0.9454870002106172,Downregulated
Feature0642,NA,C9 H19 N O3,189.13649,NA,NA,Feature0642,9,19,3,1,0,0,2.111111111111111,0.3333333333333333,-1.1111111111111107,91.96666666666664,1,-2,-0.6,-0.2307692307692308,-3,Protein,297429.6677098577,253082.27128125666,0.8508978718563412,-0.23294211057681774,0.5690327214652721,0.7634736581619005,Downregulated
Feature0641,N-Aceyl-L-tyrosine,C11 H13 N O4,223.08448,NA,NA,N-Aceyl-L-tyrosine,11,13,4,1,0,0,1.181818181818182,0.3636363636363637,-0.18181818181818168,65.48181818181817,6,2,0.16666666666666666,0.375,1,Lignin,9755745.968078103,8300887.5940190395,0.8508716423306302,-0.23298658335219158,0.044694209793587535,0.35607946299980225,Downregulated
Feature0640,NA,C15 H29 N3 O4,315.21588,NA,NA,Feature0640,15,29,4,3,0,0,1.9333333333333331,0.26666666666666666,-0.7999999999999998,83.1,3,-1,-0.5,-0.2,-4,Lipid,6344510.463368027,6413799.601067823,1.010921116467513,0.01567042620117955,0.958528337948171,0.976983757210711,Upregulated
Feature0639,Cyclopentanone,C5 H8 O,84.05753,Other,NA,Cyclopentanone-peak4,5,8,1,0,0,0,1.6,0.2,-1.2000000000000002,94.5,2,1,0.25,0.3333333333333333,1,Lipid,807123.5150187816,1153742.7642499395,1.429450069018361,0.5154602272179201,0.6523955595795663,0.8222902365534117,Upregulated
Feature0638,apronalide,C9 H16 N2 O2,184.12119,NA,NA,apronalide-peak2,9,16,2,2,0,0,1.7777777777777777,0.2222222222222222,-0.666666666666667,79.30000000000001,3,1,-0.2,0,-1,Lipid,10251437.6484621,9586713.233352054,0.9351579321940502,-0.09671806277237836,0.2402808519114382,0.5245306226004849,Downregulated
Feature0637,Leucylasparagine,C10 H19 N3 O4,245.13752,NA,NA,Leucylasparagine-peak2,10,19,4,3,0,0,1.9,0.4,-0.20000000000000015,66,3,-1,-1.3333333333333333,-0.4,-4,Protein,5415024.674189833,3419664.2209203998,0.6315140607243921,-0.6631132387660271,0.1276288416953982,0.45384777576550756,Downregulated
Feature0636,Acetophenone,C8 H8 O,120.05748,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylpropanoid biosynthesis;Phenylalanine metabolism;Other,Anaerobic aromatic compound degradation (Thauera aromatica);Other,Acetophenone-peak2,8,8,1,0,0,0,1,0.125,-0.75,81.675,5,4,0.5714285714285714,0.6,4,Unsaturated HC,2484867.111322697,2116779.2333727255,0.8518681839070107,-0.2312978864270584,0.7839943804401451,0.892491879248216,Downregulated
Feature0635,NA,C16 H23 N5 O10,445.14463,NA,NA,Feature0635,16,23,10,5,0,0,1.4375,0.625,0.75,38.925,8,-2,-7,-0.3333333333333333,-7,Lignin,9729960.028954873,7789930.63908951,0.8006128099095852,-0.3208233956680508,0.08958286606511152,0.41723968591020827,Downregulated
Feature0634,NA,C9 H12 N2 O4,212.0797,NA,NA,Feature0634,9,12,4,2,0,0,1.3333333333333333,0.4444444444444444,0.22222222222222232,53.96666666666666,5,1,-0.3333333333333333,0.2,-1,Lignin,11028582.519428333,9278038.046489473,0.841272033839794,-0.24935570889978223,0.048165394762961194,0.35641545489778387,Downregulated
Feature0633,HC Blue 1,C11 H17 N3 O4,255.12193,NA,NA,HC Blue 1,11,17,4,3,0,0,1.5454545454545454,0.3636363636363637,0,60.3,5,1,-0.5,0,-2,Protein,654654.3484021307,454610.007268892,0.6944275377968488,-0.5261039353319099,0.38892099579743716,0.6375277315535638,Downregulated
Feature0632,beta-Pyracin,C8 H7 N O3,165.04262,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Other,beta-Pyracin,8,7,3,1,0,0,0.875,0.375,0.25,53.175,6,3,0.5,0.6363636363636364,2,Lignin,8625451.87799242,7259216.84922024,0.8416042373086461,-0.24878612655850021,0.04468293172700795,0.35607946299980225,Downregulated
Feature0631,ET8750000,C4 H7 N,69.05786,NA,Superpathway of linamarin and lotaustralin biosynthesis;Other,ET8750000,4,7,0,1,0,0,1.75,0,-1,88.8,2,2,0.3333333333333333,0.3333333333333333,1,Lipid,6501273.0972407535,4172590.178112,0.6418112446134459,-0.6397790288482844,0.27283804666169453,0.552825229959312,Downregulated
Feature0630,Isovalerylglutamic acid,C10 H17 N O5,231.11073,NA,NA,Isovalerylglutamic acid-peak3,10,17,5,1,0,0,1.7,0.5,-0.4000000000000003,71.7,3,-2,-0.75,-0.07692307692307693,-3,Protein,5233194.570248026,4162504.9620833,0.7954042041066359,-0.3302399073635917,0.06221027125195405,0.3794192923980171,Downregulated
Feature0629,NP-021733,C7 H13 N O2,143.09464,ABC transporters,NA,NP-021733-peak1,7,13,2,1,0,0,1.8571428571428572,0.2857142857142857,-0.8571428571428568,84.72857142857141,2,0,-0.25,0,-1,Lipid,7557733.823109673,10917251.414346289,1.4445138807302322,0.5305840672216379,0.007751073385514146,0.23030609530252863,Upregulated
Feature0628,propionylcarnitine,C10 H19 N O4,217.13149,NA,NA,propionylcarnitine,10,19,4,1,0,0,1.9,0.4,-0.7999999999999998,83.1,2,-2,-0.6,-0.14285714285714285,-3,Protein,5989350.61726484,5842782.741254287,0.9755285864233665,-0.03574394538780061,0.5855236254486195,0.7767243707987167,Downregulated
Feature0627,Tetrahydrothiophene,C4 H8 S,88.03465,NA,NA,Tetrahydrothiophene,4,8,0,0,1,0,2,0,-1.5,103.05,1,1,0,0,0,Lipid,177072.736123757,187965.29676901133,1.0615146119255845,0.0861242303177035,0.49221962388853324,0.7078268615171267,Upregulated
Feature0626,4-[(Z)-2-Aminovinyl]phenol,C8 H9 N O,135.06839,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;2-Oxocarboxylic acid metabolism;Phenylalanine metabolism;Other,NA,4-[(Z)-2-Aminovinyl]phenol,8,9,1,1,0,0,1.125,0.125,-0.5,74.55,5,4,0.5,0.5384615384615384,3,Unsaturated HC,2771036.064190617,4706755.638760324,1.6985544502955088,0.7643074672086808,0.19093879925518492,0.4862119877973694,Upregulated
Feature0625,glu-asp,C9 H14 N2 O7,262.08011,NA,NA,glu-asp,9,14,7,2,0,0,1.5555555555555556,0.7777777777777778,0.6666666666666665,41.3,4,-3,-Inf,-0.42857142857142855,-5,Carbohydrate,974861.2236387277,360593.89869307633,0.36989254465075355,-1.4348218722945516,0.07716595028512623,0.39590936857023457,Downregulated
Feature0624,NA,C13 H15 N O4,249.1001,NA,NA,Feature0624,13,15,4,1,0,0,1.1538461538461535,0.3076923076923077,-0.3076923076923075,69.06923076923076,7,3,0.25,0.4,2,Lignin,1703120.9849571434,745220.8345476569,0.4375618885151658,-1.1924410095096636,0.007568787818816484,0.23030609530252863,Downregulated
Feature0623,NA,C10 H20 N2 O4 S,264.11437,NA,NA,Feature0623,10,20,4,2,1,0,2,0.4,-0.4000000000000003,71.7,2,-2,-1.6666666666666667,-0.6,-5,Protein,1217510.4455952463,384969.1477864203,0.316193712488608,-1.66111941489409,0.04845489729572614,0.35641545489778387,Downregulated
Feature0622,Succinic anhydride,C4 H4 O3,100.01602,NA,NA,Succinic anhydride,4,4,3,0,0,0,1,0.75,0.5,46.05,3,0,0,0.6,0,Tannin,5291958.69228103,3352054.188999303,0.6334241032320764,-0.6587563286393996,0.046410315022095305,0.35607946299980225,Downregulated
Feature0621,dapdiamide A,C12 H20 N4 O5,300.14339,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics,NA,dapdiamide A,12,20,5,4,0,0,1.6666666666666667,0.4166666666666667,0.16666666666666652,55.55,5,0,-1.3333333333333333,-0.2727272727272727,-4,Protein,1767083.1918766533,1588985.367131361,0.8992136728117756,-0.15326412255386215,0.7844695810128983,0.892491879248216,Downregulated
Feature0620,Pyridostigmine,C9 H12 N2 O2,180.08989,Metabolic pathways;Other,NA,Pyridostigmine,9,12,2,2,0,0,1.3333333333333333,0.2222222222222222,-0.22222222222222232,66.63333333333333,5,3,0.2,0.3333333333333333,1,Lignin,7156884.7409821935,7555489.549998114,1.0556952952914562,0.07819349056188571,0.8779322394577966,0.9371248983248314,Upregulated
Feature0619,"1-Methyl-3,4-dihydro-6,7-isoquinolinediol",C10 H11 N O2,177.07899,NA,NA,"1-Methyl-3,4-dihydro-6,7-isoquinolinediol",10,11,2,1,0,0,1.1,0.2,-0.4000000000000003,71.7,6,4,0.42857142857142855,0.5,3,Lignin,5705032.877601869,6227964.341491343,1.0916614286207742,0.1265254835585841,0.6023035177958631,0.7867481750107239,Upregulated
Feature0618,Marimastat,C15 H29 N3 O5,331.21084,NA,NA,Marimastat-peak6,15,29,5,3,0,0,1.9333333333333331,0.3333333333333333,-0.666666666666667,79.30000000000001,3,-2,-0.7142857142857143,-0.2631578947368421,-5,Protein,3859697.65427344,4331268.880626623,1.1221782814597048,0.1663018963972061,0.24984002697040342,0.5310276106497658,Upregulated
Feature0617,NA,C61 H95 N10 O14 P3,1284.62434,NA,NA,Feature0617,61,95,14,10,0,3,1.5573770491803278,0.22950819672131148,-0.8524590163934427,84.5950819672131,21,7,-0.17647058823529413,0.02439024390243902,-6,Lipid,107038.03355784886,131413.98527536934,1.2277316847786302,0.29599530066302715,0.1277467394811657,0.45384777576550756,Upregulated
Feature0616,5-Hydroxyindole-3-acetic acid,C10 H9 N O3,191.05831,Metabolic pathways;Other,NA,5-Hydroxyindole-3-acetic acid,10,9,3,1,0,0,0.9,0.3,0,60.3,7,4,0.5,0.6,3,Lignin,9454005.141975757,8309741.634550737,0.8789652120724483,-0.18612202777093917,0.19580726316757174,0.4903287788808408,Downregulated
Feature0615,NA,C14 H27 N3 O4,301.2002,NA,NA,Feature0615,14,27,4,3,0,0,1.9285714285714288,0.2857142857142857,-0.7142857142857144,80.65714285714286,3,-1,-0.5714285714285714,-0.2222222222222222,-4,Lipid,4766093.877286224,6185827.075151667,1.2978819205873109,0.3761591350072379,0.03691870469888471,0.33805559870221996,Upregulated
Feature0614,NA,C14 H27 N3 O4,301.2002,NA,NA,Feature0614,14,27,4,3,0,0,1.9285714285714288,0.2857142857142857,-0.7142857142857144,80.65714285714286,3,-1,-0.5714285714285714,-0.2222222222222222,-4,Lipid,5292191.75061009,6681626.193266793,1.2625442365153394,0.3363339373165093,0.017567474845859965,0.2637533176745511,Upregulated
Feature0613,NA,C16 H23 N5 O10,445.14459,NA,NA,Feature0613,16,23,10,5,0,0,1.4375,0.625,0.75,38.925,8,-2,-7,-0.3333333333333333,-7,Lignin,5384664.88272897,4347383.409678496,0.807363782957506,-0.30870922359967146,0.12009736719019652,0.4526122839818135,Downregulated
Feature0612,MFCD00142316,C12 H14 N2 O3,234.1004,NA,NA,MFCD00142316,12,14,3,2,0,0,1.1666666666666667,0.25,-0.16666666666666696,65.05000000000001,7,4,0.2857142857142857,0.4117647058823529,2,Lignin,119888.55978198966,147703.457591814,1.2320062719946263,0.3010096006371254,0.1353322716097211,0.45384777576550756,Upregulated
Feature0611,NP-015145,C14 H13 N O2,227.09462,Other,NA,NP-015145,14,13,2,1,0,0,0.9285714285714286,0.14285714285714285,-0.4285714285714288,72.51428571428572,9,7,0.5454545454545454,0.5833333333333334,6,Lignin,9063454.480124693,7164395.267140133,0.7904707065998932,-0.33921609495535593,0.057156534292611645,0.3782155042643911,Downregulated
Feature0610,NA,C13 H25 N3 O5,303.17945,NA,NA,Feature0610,13,25,5,3,0,0,1.9230769230769231,0.38461538461538464,-0.4615384615384617,73.45384615384616,3,-2,-1,-0.3333333333333333,-5,Protein,9423792.64534359,8983555.0232966,0.9532844536573587,-0.06902132603289256,0.9244878860989044,0.9584348097010674,Downregulated
Feature0609,2-Hexenoylcarnitine,C13 H23 N O4,257.16273,NA,NA,2-Hexenoylcarnitine,13,23,4,1,0,0,1.7692307692307692,0.3076923076923077,-0.9230769230769234,86.6076923076923,3,-1,-0.25,0,-2,Protein,274526.016966242,5581687.937452277,20.33209092214618,4.34568668232266,0.012812981880468784,0.25835889181660304,Upregulated
Feature0608,ile-his,C12 H20 N4 O3,268.15361,NA,NA,ile-his-peak3,12,20,3,4,0,0,1.6666666666666667,0.25,-0.16666666666666696,65.05000000000001,5,2,-0.4,-0.07692307692307693,-2,Lipid,3804367.30005626,4683962.1650551,1.2312066095683853,0.3000728817153565,0.5844777981013822,0.7765268362387253,Upregulated
Feature0607,Leonurine,C14 H21 N3 O5,311.14823,NA,NA,Leonurine-peak2,14,21,5,3,0,0,1.5,0.35714285714285715,-0.14285714285714324,64.37142857142858,6,1,-0.3333333333333333,0.0588235294117647,-2,Protein,146687.311791419,176448.564274298,1.2028890714501457,0.2665036055666253,0.06162805121811054,0.3794192923980171,Upregulated
Feature0606,N~6~-(5-Oxo-D-isoleucyl)-L-lysine,C12 H23 N3 O4,273.1689,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,N~6~-(5-Oxo-D-isoleucyl)-L-lysine-peak4,12,23,4,3,0,0,1.9166666666666667,0.3333333333333333,-0.5,74.55,3,-1,-0.8,-0.2857142857142857,-4,Protein,4992222.340367917,5880141.241184686,1.1778604477683041,0.23616861961069033,0.30697387753757155,0.5765119163510489,Upregulated
Feature0605,ile-his,C12 H20 N4 O3,268.15359,NA,NA,ile-his-peak2,12,20,3,4,0,0,1.6666666666666667,0.25,-0.16666666666666696,65.05000000000001,5,2,-0.4,-0.07692307692307693,-2,Lipid,3522896.6204343596,7108536.15796184,2.0178100364141214,1.0127903605575777,0.19172964782572546,0.4862119877973694,Upregulated
Feature0604,Apaxifylline,C16 H22 N4 O3,318.1693,NA,NA,Apaxifylline,16,22,3,4,0,0,1.375,0.1875,-0.25,67.425,8,5,0.1111111111111111,0.23809523809523808,1,Lignin,59419.9150557312,596396.1609695209,10.036974310887995,3.3272525230846943,0.41446606561871985,0.6580333694263849,Upregulated
Feature0603,Levetiracetam,C8 H14 N2 O2,170.10558,NA,NA,Levetiracetam-peak2,8,14,2,2,0,0,1.75,0.25,-0.5,74.55,3,1,-0.25,0,-1,Lipid,633741.5511727179,1027411.511146941,1.621183760549943,0.6970476290469806,0.2617667345996932,0.5437149951031542,Upregulated
Feature0602,Butenylcarnitine,C11 H19 N O4,229.13142,NA,NA,Butenylcarnitine,11,19,4,1,0,0,1.7272727272727273,0.3636363636363637,-0.7272727272727275,81.02727272727273,3,-1,-0.3333333333333333,0,-2,Protein,5948417.080195163,4982397.693087087,0.8376005962452818,-0.2556656256370208,0.07801032555362747,0.39590936857023457,Downregulated
Feature0601,NA,C12 H24 N O13 P,421.09864,NA,NA,Feature0601,12,24,13,1,0,1,2,1.0833333333333333,0,60.3,2,-11,4.333333333333333,-1.8571428571428572,-13,Carbohydrate,8439415.87044127,8208666.37290127,0.9726581198174876,-0.039995294522686485,0.6987336451285767,0.8458497039175863,Downregulated
Feature0600,NA,C10 H20 N2 O6,264.13219,NA,NA,Feature0600,10,20,6,2,0,0,2,0.6,-0.20000000000000015,66,2,-4,-3,-0.6,-6,Amino Sugar,11605908.795491245,12469791.90637115,1.0744347664713265,0.10357789324011922,0.6736506141874125,0.831278088956534,Upregulated
Feature0599,NA,C16 H14 O3 S,286.0665,NA,NA,Feature0599,16,14,3,0,1,0,0.875,0.1875,-0.375,70.9875,10,7,0.5,0.5555555555555556,6,Lignin,4414882.7625864,5500270.835846807,1.24584754151536,0.31712753179911035,0.1119543035301209,0.44353045445343764,Upregulated
Feature0598,NA,C10 H22 N2 O4,234.15795,NA,NA,Feature0598,10,22,4,2,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-3,-1.25,-0.5,-5,Protein,7735052.486197086,8101188.576821246,1.0473346614360428,0.06672250936287344,0.8276623675924183,0.915780568714276,Upregulated
Feature0597,NP-021030,C9 H8 O4,180.04228,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various antibiotics;Phenylalanine metabolism;Tyrosine metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of scopolin and esculin biosynthesis;Superpathway of aromatic amino acid biosynthesis;Superpathway of 4-hydroxybenzoate biosynthesis (yeast);Other,NP-021030,9,8,4,0,0,0,0.8888888888888888,0.4444444444444444,0,60.3,6,2,0.4,0.5714285714285714,2,Lignin,8911831.997770587,7015916.039222657,0.7872585615368177,-0.3450905529496102,0.06953733862528243,0.39349391135295464,Downregulated
Feature0596,NA,C7 H15 N O6,209.08992,NA,NA,Feature0596,7,15,6,1,0,0,2.142857142857143,0.8571428571428571,0,60.3,1,-5,-Inf,-1,-6,Carbohydrate,5289385.657405237,5246045.10047368,0.991806126507172,-0.011869957805573882,0.9569647252121782,0.9759772694216918,Downregulated
Feature0595,NA,C13 H25 N3 O4,287.18456,NA,NA,Feature0595,13,25,4,3,0,0,1.9230769230769231,0.3076923076923077,-0.615384615384615,77.83846153846153,3,-1,-0.6666666666666666,-0.25,-4,Protein,111072.08180595834,100548.27871063753,0.9052524907770634,-0.14360785364514864,0.260727460238745,0.5437149951031542,Downregulated
Feature0594,"2-Methyl-1,2,3,4-tetrahydro-4,6,7-isoquinolinetriol",C10 H13 N O3,195.08955,Other,NA,"2-Methyl-1,2,3,4-tetrahydro-4,6,7-isoquinolinetriol",10,13,3,1,0,0,1.3,0.3,-0.4000000000000003,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Lignin,634130.6057931383,549922.9520622876,0.8672077124782078,-0.2055505075860465,0.47475465408698775,0.6942757851074962,Downregulated
Feature0593,3-Methylcrotonylglycine,C7 H11 N O3,157.07391,NA,NA,3-Methylcrotonylglycine-peak1,7,11,3,1,0,0,1.5714285714285714,0.42857142857142855,-0.2857142857142856,68.44285714285714,3,0,-0.3333333333333333,0.1111111111111111,-1,Protein,7555601.20929383,8303471.053193937,1.0989821753668236,0.1361679870892998,0.30616069728292866,0.5763754381762052,Upregulated
Feature0592,7098783,C14 H18 N2 O4,278.1267,Metabolic pathways;Biosynthesis of cofactors;Other,NA,7098783,14,18,4,2,0,0,1.2857142857142858,0.2857142857142857,-0.2857142857142856,68.44285714285714,7,3,0.125,0.3,1,Lignin,2654280.1879062066,2529699.7409723834,0.9530643194710741,-0.06935451427711231,0.6848522651715154,0.8370416574318522,Downregulated
Feature0591,NA,C18 H27 N O12,449.1534,NA,NA,Feature0591,18,27,12,1,0,0,1.5,0.6666666666666666,0,60.3,6,-6,-1.4,-0.09090909090909093,-7,Amino Sugar,72374.5352282428,89071.92831862933,1.230708121823913,0.2994886488030205,0.17183147802886395,0.4760067902771642,Upregulated
Feature0590,5-Pentylresorcinol,C11 H16 O2,180.11499,NA,NA,5-Pentylresorcinol,11,16,2,0,0,0,1.4545454545454546,0.18181818181818185,-1.0909090909090908,91.39090909090908,4,2,0.2222222222222222,0.3,2,Lignin,1394816.7757677068,2079730.26021488,1.4910419033856237,0.5763208028642448,0.03869875912796665,0.34143592688945573,Upregulated
Feature0589,NA,C16 H28 N2 O5,328.19992,NA,NA,Feature0589,16,28,5,2,0,0,1.75,0.3125,-0.75,81.675,4,-1,-0.3333333333333333,-0.04347826086956521,-3,Protein,92172.44618681884,116296.78147577567,1.2617304442594552,0.335403726272922,0.08339587695124323,0.402486084203436,Upregulated
Feature0588,NA,C16 H25 N O9,375.15307,NA,NA,Feature0588,16,25,9,1,0,0,1.5625,0.5625,-0.25,67.425,5,-4,-0.8333333333333334,-0.04761904761904761,-5,Amino Sugar,372208.7649692223,377625.9446986447,1.0145541433713157,0.020845858972303406,0.9484092539989518,0.9724293424211538,Upregulated
Feature0587,asn-phe,C13 H17 N3 O4,279.12194,NA,NA,asn-phe-peak1,13,17,4,3,0,0,1.3076923076923077,0.3076923076923077,0,60.3,7,3,0,0.25,0,Lignin,7669333.83082133,6000931.1934363935,0.7824579456066966,-0.35391488059940057,0.4452352528966399,0.6686423035522234,Downregulated
Feature0586,4'-Methoxyacetophenone,C9 H10 O2,150.06812,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine metabolism;Other,Other,4'-Methoxyacetophenone,9,10,2,0,0,0,1.1111111111111112,0.2222222222222222,-0.666666666666667,79.30000000000001,5,3,0.42857142857142855,0.5,3,Lignin,876672.0780858814,1280440.0662605632,1.4605690066646875,0.5465305219610481,0.3981015074257432,0.644110748404211,Upregulated
Feature0585,N6-Dimethyladenosine,C12 H17 N5 O4,295.1281,NA,NA,N6-Dimethyladenosine,12,17,4,5,0,0,1.4166666666666667,0.3333333333333333,0.5,46.05,7,3,-0.6666666666666666,0,-2,Lignin,298152.99845109263,463996.023282669,1.5562346368915703,0.6380595950025683,0.014592563801631339,0.25983697563097224,Upregulated
Feature0584,NA,C20 H38 N4 O6,430.27924,NA,NA,Feature0584,20,38,6,4,0,0,1.9,0.3,-0.7000000000000002,80.25,4,-2,-0.6,-0.2307692307692308,-6,Lipid,320831.3446765647,210770.228134045,0.6569502376599952,-0.6061440007478354,0.36161860677755586,0.6171436750022657,Downregulated
Feature0583,NA,C13 H25 N3 O4,287.18453,NA,NA,Feature0583,13,25,4,3,0,0,1.9230769230769231,0.3076923076923077,-0.615384615384615,77.83846153846153,3,-1,-0.6666666666666666,-0.25,-4,Protein,2555440.0221142867,2903684.37461155,1.1362756900900133,0.18431291272211522,0.2907083142663472,0.5677030523083425,Upregulated
Feature0582,"(1R,5R)-3,3,5-Trimethylcyclohexyl 5-oxo-L-prolinate",C14 H23 N O3,253.16772,NA,NA,"(1R,5R)-3,3,5-Trimethylcyclohexyl 5-oxo-L-prolinate",14,23,3,1,0,0,1.6428571428571428,0.21428571428571427,-1,88.8,4,1,0,0.13043478260869565,0,Lipid,1423803.66809343,1886348.6889399933,1.324865731990944,0.40584615770896565,0.15640528221357522,0.46825623718458564,Upregulated
Feature0581,NA,C22 H37 N2 O8 P3 S,582.1482,NA,NA,Feature0581,22,37,8,2,1,3,1.681818181818182,0.3636363636363637,-1.2727272727272725,96.57272727272726,7,-1,-0.875,-0.25,-7,Protein,12285840.276339244,11036583.86861872,0.8983173816668923,-0.15470284584474234,0.6406069336456753,0.8131443267876828,Downregulated
Feature0580,NA,C16 H29 N3 O6,359.20575,NA,NA,Feature0580,16,29,6,3,0,0,1.8125,0.375,-0.5,74.55,4,-2,-0.7142857142857143,-0.2,-5,Protein,2668495.4035429866,3890747.22582983,1.4580303270015185,0.5440207280048129,0.17040167600461043,0.4760067902771642,Upregulated
Feature0579,VLK,C17 H34 N4 O4,358.25811,NA,NA,VLK,17,34,4,4,0,0,2,0.2352941176470588,-0.8235294117647056,83.7705882352941,3,-1,-0.5555555555555556,-0.2727272727272727,-5,Lipid,10868426.205805963,12861250.077784933,1.183359010241464,0.242887828301341,0.43383688380097263,0.6634526387347742,Upregulated
Feature0578,N~6~-(5-Oxo-D-isoleucyl)-L-lysine,C12 H23 N3 O4,273.16891,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,N~6~-(5-Oxo-D-isoleucyl)-L-lysine-peak3,12,23,4,3,0,0,1.9166666666666667,0.3333333333333333,-0.5,74.55,3,-1,-0.8,-0.2857142857142857,-4,Protein,4746898.444032307,4456455.53976787,0.9388141735727303,-0.09108847204126322,0.8204163091026699,0.9136000023320247,Downregulated
Feature0577,NA,C8 H9 N5 O3,223.07054,NA,NA,Feature0577,8,9,3,5,0,0,1.125,0.375,1.5,17.549999999999997,7,4,-Inf,0.3333333333333333,-1,Lignin,5393116.248364363,3863837.1371226767,0.7164386894672464,-0.4810848463471665,0.03200304345829313,0.32345137828340564,Downregulated
Feature0576,NA,C15 H21 N5 O2,303.16956,NA,NA,Feature0576,15,21,2,5,0,0,1.4,0.13333333333333333,-0.13333333333333375,64.10000000000001,8,6,0.125,0.2222222222222222,1,Lignin,11118970.990816267,9820922.169204174,0.8832581879488471,-0.17909287668884902,0.07840127233550767,0.39590936857023457,Downregulated
Feature0575,Methionylleucine,C11 H22 N2 O3 S,262.13515,NA,NA,Methionylleucine-peak1,11,22,3,2,1,0,2,0.2727272727272727,-0.7272727272727275,81.02727272727273,2,-1,-0.8,-0.38461538461538464,-4,Lipid,8026068.015361897,5602430.536891037,0.6980292873382064,-0.5186405257716658,0.29141599499876736,0.5677030523083425,Downregulated
Feature0574,NA,C11 H19 N3 O4,257.13761,NA,NA,Feature0574,11,19,4,3,0,0,1.7272727272727273,0.3636363636363637,-0.18181818181818168,65.48181818181817,4,0,-0.75,-0.16666666666666666,-3,Protein,157902.71767476966,134320.48287360766,0.8506533950243083,-0.2333566799435814,0.09290727392439391,0.41723968591020827,Downregulated
Feature0573,NA,C19 H23 N3 O5,373.16384,NA,NA,Feature0573,19,23,5,3,0,0,1.2105263157894737,0.2631578947368421,-0.21052631578947345,66.29999999999998,10,5,0.18181818181818185,0.3333333333333333,2,Lignin,158644.09252623434,180241.94611233767,1.1361402951864203,0.18414099564577716,0.19302601196369099,0.48658640515847107,Upregulated
Feature0572,3-Methoxy-4-hydroxyhippuric acid,C10 H11 N O5,225.06369,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,Superpathway of chorismate metabolism;Other,3-Methoxy-4-hydroxyhippuric acid-peak1,10,11,5,1,0,0,1.1,0.5,0.20000000000000015,54.599999999999994,6,1,0,0.38461538461538464,0,Lignin,10449422.37347053,9222034.532157853,0.8825401254303946,-0.18026622166678147,0.16265863410442916,0.4734778652324074,Downregulated
Feature0571,NA,C11 H22 N4 O3,258.16921,NA,NA,Feature0571,11,22,3,4,0,0,2,0.2727272727272727,-0.3636363636363633,70.66363636363636,3,0,-1,-0.4545454545454546,-4,Lipid,116985.32169470939,81329.40769207897,0.6952103607008079,-0.5244785121304818,0.5764983566454737,0.7684542405421365,Downregulated
Feature0570,glu-leu,C11 H20 N2 O5,260.13722,NA,NA,glu-leu,11,20,5,2,0,0,1.818181818181818,0.4545454545454546,-0.3636363636363633,70.66363636363636,3,-2,-1,-0.2307692307692308,-4,Protein,271039.8199034743,289245.80069520336,1.0671708710484413,0.09379119310487861,0.8263727817713032,0.9149513021703188,Upregulated
Feature0569,NA,C13 H24 N2 O10,368.14308,NA,NA,Feature0569,13,24,10,2,0,0,1.8461538461538465,0.7692307692307693,0.15384615384615374,55.91538461538462,3,-7,-9,-0.6666666666666666,-9,Carbohydrate,239086.72041197366,239485.980974104,1.0016699403523641,0.0024072052792679477,0.9873623169226555,0.9938156653992741,Upregulated
Feature0568,6-methyltetrahydropterin,C7 H11 N5 O,181.09637,NA,NA,6-methyltetrahydropterin,7,11,1,5,0,0,1.5714285714285714,0.14285714285714285,0.8571428571428572,35.87142857142857,5,4,-1,-0.3333333333333333,-1,Lipid,244021.34732043368,205979.69724229132,0.8441052371201425,-0.24450521964363267,0.07953287156689585,0.39590936857023457,Downregulated
Feature0567,Cyclopentanone,C5 H8 O,84.05754,Other,NA,Cyclopentanone-peak3,5,8,1,0,0,0,1.6,0.2,-1.2000000000000002,94.5,2,1,0.25,0.3333333333333333,1,Lipid,244359.08586414933,485320.424542695,1.986095269698739,0.9899348282164167,0.1238612195062156,0.45317690246982556,Upregulated
Feature0566,NA,C39 H72 N2 O5,648.54423,NA,NA,Feature0566,39,72,5,2,0,0,1.8461538461538465,0.1282051282051282,-1.435897435897436,101.22307692307692,5,0,-0.0625,0.0144927536231884,-2,Lipid,8834117.757482715,277035.086494256,0.0313596777968689,-4.994945453129237,0.18626485105814228,0.4854964193043512,Downregulated
Feature0565,NA,C13 H24 N2 O3,256.17864,NA,NA,Feature0565,13,24,3,2,0,0,1.8461538461538465,0.2307692307692308,-0.9230769230769234,86.6076923076923,3,0,-0.25,-0.05263157894736842,-2,Lipid,335541.1280556947,469426.4682997473,1.399013203000944,0.48440957780938915,0.0016495034793870074,0.15098679741337404,Upregulated
Feature0564,NP-004713,C15 H24 O2,236.17762,Other,Other,NP-004713,15,24,2,0,0,0,1.6,0.13333333333333333,-1.333333333333333,98.29999999999998,4,2,0.15384615384615383,0.21428571428571427,2,Lipid,319051.6186240627,405649.456562645,1.2714226566598936,0.3464437024943508,0.15748745306165277,0.46825623718458564,Upregulated
Feature0563,NA,C16 H31 N3 O4,329.23156,NA,NA,Feature0563,16,31,4,3,0,0,1.9375,0.25,-0.875,85.2375,3,-1,-0.4444444444444444,-0.18181818181818185,-4,Lipid,2331497.6478939,3063010.67621429,1.3137524196008448,0.3936934212705556,0.17091473331836995,0.4760067902771642,Upregulated
Feature0562,1774244,C7 H15 N3 O2,173.11643,NA,NA,1774244,7,15,2,3,0,0,2.142857142857143,0.2857142857142857,-0.2857142857142856,68.44285714285714,2,0,-1.5,-0.6666666666666666,-3,Lipid,2132184.606002313,1832454.3129609933,0.8594257306813167,-0.2185551237207857,0.2471083348687185,0.5305469192238392,Downregulated
Feature0561,1-Methyl-4-(1-methyl-2-propenyl)-benzene,C13 H18,174.14087,NA,NA,1-Methyl-4-(1-methyl-2-propenyl)-benzene,13,18,0,0,0,0,1.3846153846153846,0,-1.384615384615385,99.76153846153846,5,5,0.38461538461538464,0.38461538461538464,5,Unsaturated HC,1148900.2381915408,6283464.113825361,5.469112029880007,2.451306614721523,0.4427704959553919,0.6668537167127339,Upregulated
Feature0560,anthramycin,C16 H17 N3 O4,315.12196,NA,NA,anthramycin,16,17,4,3,0,0,1.0625,0.25,0,60.3,10,6,0.3333333333333333,0.4545454545454546,3,Lignin,277485.710846953,205529.31518533468,0.7406843204935126,-0.4330692976958798,0.5577696583416357,0.7571008022682139,Downregulated
Feature0559,"(8Z,11Z,14Z)-Heptadecatrienal",C17 H28 O,248.21402,Other,NA,"(8Z,11Z,14Z)-Heptadecatrienal",17,28,1,0,0,0,1.6470588235294117,0.0588235294117647,-1.5294117647058822,103.88823529411764,4,3,0.1875,0.21212121212121213,3,Lipid,755979.743952634,1422948.67583951,1.8822576758467553,0.9124641425295199,0.03341538230630682,0.3253198714188722,Upregulated
Feature0558,NA,C30 H51 N4 O17 P3,832.24652,NA,NA,Feature0558,30,51,17,4,0,3,1.7,0.5666666666666667,-0.666666666666667,79.30000000000001,9,-8,-2.5,-0.4482758620689655,-15,Amino Sugar,9491402.858041067,9334066.457931807,0.9834232723589469,-0.024115598464272508,0.8786333664366667,0.9372826969418849,Downregulated
Feature0557,NA,C16 H29 N3 O6,359.20577,NA,NA,Feature0557,16,29,6,3,0,0,1.8125,0.375,-0.5,74.55,4,-2,-0.7142857142857143,-0.2,-5,Protein,7186647.08250427,9890731.428436924,1.3762650809047916,0.4607583727105153,0.13370576429105607,0.45384777576550756,Upregulated
Feature0556,NA,C12 H23 N3 O5,289.16381,NA,NA,Feature0556,12,23,5,3,0,0,1.9166666666666667,0.4166666666666667,-0.33333333333333304,69.79999999999998,3,-2,-1.25,-0.38461538461538464,-5,Protein,3689488.967332823,4217129.304198557,1.1430117670868578,0.19284025589751033,0.30553195845195846,0.5763754381762052,Upregulated
Feature0555,NA,C17 H31 N3 O9,421.20619,NA,NA,Feature0555,17,31,9,3,0,0,1.8235294117647056,0.5294117647058824,-0.23529411764705888,67.00588235294117,4,-5,-1.6,-0.3684210526315789,-8,Protein,3394963.2478592,859797.6154683557,0.2532568256844983,-1.9813269423526618,0.011423371214688947,0.25060429422582925,Downregulated
Feature0554,"3,6-Dideoxy-3-[(Z)-(1-hydroxyethylidene)amino]-alpha-D-glucopyranose",C8 H15 N O5,205.09504,NA,NA,"3,6-Dideoxy-3-[(Z)-(1-hydroxyethylidene)amino]-alpha-D-glucopyranose-peak1",8,15,5,1,0,0,1.875,0.625,-0.25,67.425,2,-3,-2,-0.3333333333333333,-4,Amino Sugar,2364000.230853803,2313704.8713629167,0.9787244692980757,-0.031025325686708082,0.84863328943488,0.9253621977140241,Downregulated
Feature0553,Hopantenic acid,C10 H19 N O5,233.12632,NA,NA,Hopantenic acid,10,19,5,1,0,0,1.9,0.5,-0.5999999999999996,77.39999999999999,2,-3,-1,-0.2307692307692308,-4,Protein,1836670.6378370733,3819882.989524387,2.0797866045394033,1.0564355089594657,0.14862323002278024,0.46695517742640485,Upregulated
Feature0552,4-Acetamidobenzoic acid,C9 H9 N O3,179.05826,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of alkaloids derived from shikimate pathway;Other,Other,4-Acetamidobenzoic acid,9,9,3,1,0,0,1,0.3333333333333333,0,60.3,6,3,0.4,0.5384615384615384,2,Lignin,9967498.94332356,8873073.903166626,0.8902006364505307,-0.16779756263942214,0.09117320561050954,0.41723968591020827,Downregulated
Feature0551,NP-019811,C6 H7 N O2,125.04764,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,Other,NP-019811-peak2,6,7,2,1,0,0,1.1666666666666667,0.3333333333333333,0,60.3,4,2,0.3333333333333333,0.5,1,Lignin,757321.3782209597,862444.3118768833,1.1388088817760171,0.18752565007571564,0.8538604090213006,0.92558845302131,Upregulated
Feature0550,NA,C32 H66 N3 O18 P3 S,905.32735,NA,NA,Feature0550,32,66,18,3,1,3,2.0625,0.5625,-1.0625,90.58125,3,-15,-3.142857142857143,-0.8125,-22,Amino Sugar,65503.5532731101,82682.18015032126,1.2622548857095846,0.33600326152476595,0.055668457989981414,0.3757066447610698,Upregulated
Feature0549,N~6~-(5-Oxo-D-isoleucyl)-L-lysine,C12 H23 N3 O4,273.1689,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,N~6~-(5-Oxo-D-isoleucyl)-L-lysine-peak2,12,23,4,3,0,0,1.9166666666666667,0.3333333333333333,-0.5,74.55,3,-1,-0.8,-0.2857142857142857,-4,Protein,3841906.6681607533,3896262.9676228403,1.0141482613080002,0.02026857957795422,0.8727501983108003,0.935214143108896,Upregulated
Feature0548,1726033,C6 H13 N O6,195.07434,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,1726033-peak1,6,13,6,1,0,0,2.1666666666666665,1,0.3333333333333335,50.8,1,-5,6,-1.5,-6,Carbohydrate,4699018.800440896,3367580.7815874335,0.716656162616643,-0.48064698637423714,0.12038757418590934,0.4526122839818135,Downregulated
Feature0547,4-Hydroxyprolylproline,C10 H16 N2 O4,228.111,NA,NA,4-Hydroxyprolylproline,10,16,4,2,0,0,1.6,0.4,-0.20000000000000015,66,4,0,-0.5,0,-2,Protein,9233234.23415691,7645266.04453131,0.8280160397370664,-0.2722693800311299,0.1653003728498183,0.4734778652324074,Downregulated
Feature0546,NA,C13 H24 N2 O8,336.15337,NA,NA,Feature0546,13,24,8,2,0,0,1.8461538461538465,0.6153846153846154,-0.1538461538461542,64.6846153846154,3,-5,-2.3333333333333335,-0.42857142857142855,-7,Amino Sugar,7022309.048474753,4271849.0112807965,0.6083254071833598,-0.7170848341396068,0.27759329670335864,0.5571101578849338,Downregulated
Feature0545,valienone,C7 H10 O5,174.05284,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various plant secondary metabolites;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of branched chain amino acid biosynthesis;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic amino acid biosynthesis;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,valienone,7,10,5,0,0,0,1.4285714285714286,0.7142857142857143,0,60.3,3,-2,-1,0.1111111111111111,-2,Tannin,312814.4542612057,223469.13134660633,0.7143823704514805,-0.485231616858309,0.350569536355138,0.6093000912850749,Downregulated
Feature0544,Oxepanone,C6 H10 O2,114.06804,Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,NA,Oxepanone-peak1,6,10,2,0,0,0,1.6666666666666667,0.3333333333333333,-1,88.8,2,0,0,0.2,0,Protein,1113595.5128481432,929748.0541843283,0.8349064300792621,-0.2603135744561521,0.11290799066589972,0.4445323712633174,Downregulated
Feature0543,NA,C17 H31 N3 O6,373.22139,NA,NA,Feature0543,17,31,6,3,0,0,1.8235294117647056,0.35294117647058826,-0.5882352941176467,77.06470588235292,4,-2,-0.625,-0.18181818181818185,-5,Protein,6731685.9852719,8952543.085089799,1.3299109769345838,0.411329676227589,0.06473852030149994,0.38614481760703634,Upregulated
Feature0542,NA,C16 H29 N3 O6,359.20576,NA,NA,Feature0542,16,29,6,3,0,0,1.8125,0.375,-0.5,74.55,4,-2,-0.7142857142857143,-0.2,-5,Protein,4388901.323569223,5836687.4276824165,1.3298743802551016,0.4112899753939389,0.11206082320311175,0.44353045445343764,Upregulated
Feature0541,NA,C37 H51 N3 O12,729.34763,NA,NA,Feature0541,37,51,12,3,0,0,1.3783783783783785,0.32432432432432434,-0.4864864864864869,74.16486486486487,14,2,-0.04545454545454545,0.17857142857142858,-1,Lignin,78597.9941599692,94654.79310818373,1.2042901872983476,0.26818306762317184,0.12669681445613726,0.45384777576550756,Upregulated
Feature0540,NA,C9 H16 N2 O3,200.1161,NA,NA,Feature0540,9,16,3,2,0,0,1.7777777777777777,0.3333333333333333,-0.44444444444444464,72.96666666666667,3,0,-0.5,-0.09090909090909093,-2,Protein,8722583.49112536,7432906.48102899,0.8521450655750639,-0.23082904522168596,0.21623895042333588,0.5069722111991797,Downregulated
Feature0539,(3S)-3-{(Z)-[(3S)-3-{(Z)-[(3R)-3-Amino-1-hydroxy-4-methylpentylidene]amino}-1-hydroxybutylidene]amino}-5-methylhexanoic acid,C17 H33 N3 O4,343.24723,NA,NA,(3S)-3-{(Z)-[(3S)-3-{(Z)-[(3R)-3-Amino-1-hydroxy-4-methylpentylidene]amino}-1-hydroxybutylidene]amino}-5-methylhexanoic acid-peak4,17,33,4,3,0,0,1.9411764705882353,0.2352941176470588,-0.9411764705882356,87.12352941176471,3,-1,-0.4,-0.16666666666666666,-4,Lipid,2659707.049934403,2305554.7491591866,0.8668453727699256,-0.20615342535403314,0.6545091322883126,0.8228154163778454,Downregulated
Feature0538,NA,C15 H27 N3 O6,345.19008,NA,NA,Feature0538,15,27,6,3,0,0,1.8,0.4,-0.4000000000000003,71.7,4,-2,-0.8333333333333334,-0.2222222222222222,-5,Protein,5871158.790822342,6952510.4298164,1.1841802747158536,0.2438887276228533,0.7523982247998808,0.8765905039965599,Upregulated
Feature0537,Anhydroecgonine methyl ester,C10 H15 N O2,181.11031,NA,NA,Anhydroecgonine methyl ester,10,15,2,1,0,0,1.5,0.2,-0.7999999999999998,83.1,4,2,0.14285714285714285,0.25,1,Lipid,1320714.4130628733,1365309.6622090032,1.0337660047509507,0.047909665354070666,0.6748148582361662,0.8313719053469567,Upregulated
Feature0536,"1-(beta-D-Ribofuranosyl)-1,3,4,7-tetrahydro-2H-1,3-diazepin-2-one",C10 H16 N2 O5,244.10587,NA,NA,"1-(beta-D-Ribofuranosyl)-1,3,4,7-tetrahydro-2H-1,3-diazepin-2-one-peak2",10,16,5,2,0,0,1.6,0.5,0,60.3,4,-1,-1,-0.09090909090909093,-3,Protein,3632827.2832704536,5314159.9046166,1.4628165586315809,0.5487488627465653,0.14333526946172193,0.46161586781018427,Upregulated
Feature0535,NA,C14 H25 N3 O7,347.16934,NA,NA,Feature0535,14,25,7,3,0,0,1.7857142857142858,0.5,-0.14285714285714324,64.37142857142858,4,-3,-1.5,-0.3333333333333333,-6,Protein,1854926.70170873,1666325.9377795933,0.8983244115493078,-0.15469155591868464,0.5765674968884625,0.7684542405421365,Downregulated
Feature0534,NA,C10 H21 N O10,315.11663,NA,NA,Feature0534,10,21,10,1,0,0,2.1,1,0.20000000000000015,54.599999999999994,1,-9,10,-1.25,-10,Carbohydrate,976127.2188941477,580884.69542424,0.5950911768266466,-0.7488173671757525,0.1143813430739775,0.44645621006294445,Downregulated
Feature0533,NA,C16 H14 O3 S,286.06646,NA,NA,Feature0533,16,14,3,0,1,0,0.875,0.1875,-0.375,70.9875,10,7,0.5,0.5555555555555556,6,Lignin,6353770.823987104,6092917.703219056,0.9589451480082881,-0.06047979993556036,0.7543724803090257,0.8766653050016304,Downregulated
Feature0532,NA,C19 H34 N4 O5,398.25301,NA,NA,Feature0532,19,34,5,4,0,0,1.7894736842105263,0.2631578947368421,-0.6315789473684212,78.30000000000001,5,0,-0.4,-0.12,-4,Lipid,6095945.538144093,3817898.222371167,0.6263012355477053,-0.675071369837719,0.6553724690221773,0.8228154163778454,Downregulated
Feature0531,1-Aminocyclohexanecarboxylic acid,C7 H13 N O2,143.09463,ABC transporters,NA,1-Aminocyclohexanecarboxylic acid,7,13,2,1,0,0,1.8571428571428572,0.2857142857142857,-0.8571428571428568,84.72857142857141,2,0,-0.25,0,-1,Lipid,260056.59655496868,527515.840232492,2.028465523353836,1.0203887821058621,0.06546786106892379,0.38614481760703634,Upregulated
Feature0530,ascopyrone P,C6 H8 O4,144.04226,Microbial metabolism in diverse environments;Other,Other,ascopyrone P,6,8,4,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Tannin,1429814.4471108534,1507977.0881369966,1.0546662828761326,0.07678657409637449,0.8295328942475149,0.917251124579171,Upregulated
Feature0529,gln-phe,C14 H19 N3 O4,293.13766,NA,NA,gln-phe-peak2,14,19,4,3,0,0,1.3571428571428572,0.2857142857142857,-0.14285714285714324,64.37142857142858,7,3,0,0.2222222222222222,0,Lignin,7068831.66535503,6731596.320379553,0.952292633218542,-0.07052312259373399,0.8232842503421592,0.9136000023320247,Downregulated
Feature0528,lys-gln,C11 H22 N4 O4,274.16413,NA,NA,lys-gln,11,22,4,4,0,0,2,0.3636363636363637,-0.18181818181818168,65.48181818181817,3,-1,-1.6666666666666667,-0.6,-5,Protein,4136748.7936593564,5176165.9997656,1.2512642797405105,0.32338653355139113,0.22010933928762766,0.5089827335113032,Upregulated
Feature0527,2-O-ETHYL ASCORBIC ACID,C8 H12 O6,204.06331,NA,NA,2-O-ETHYL ASCORBIC ACID,8,12,6,0,0,0,1.5,0.75,0,60.3,3,-3,-1.5,0,-3,Carbohydrate,502287.23060299334,325823.72356871,0.648680085252337,-0.6244209467273552,0.06991833962056632,0.39349391135295464,Downregulated
Feature0526,NA,C9 H16 N2 O3,200.11609,NA,NA,Feature0526,9,16,3,2,0,0,1.7777777777777777,0.3333333333333333,-0.44444444444444464,72.96666666666667,3,0,-0.5,-0.09090909090909093,-2,Protein,8669505.705333194,7287143.512355837,0.8405489032521227,-0.2505963367859381,0.06271393262777142,0.3794192923980171,Downregulated
Feature0525,"1-(beta-D-Ribofuranosyl)-1,3,4,7-tetrahydro-2H-1,3-diazepin-2-one",C10 H16 N2 O5,244.10586,NA,NA,"1-(beta-D-Ribofuranosyl)-1,3,4,7-tetrahydro-2H-1,3-diazepin-2-one-peak1",10,16,5,2,0,0,1.6,0.5,0,60.3,4,-1,-1,-0.09090909090909093,-3,Protein,1759998.85291964,3062705.0580816222,1.740174462614529,0.799231951896629,0.35859577749413646,0.6165116688402364,Upregulated
Feature0524,"3-Hydroxy-2,4,5-pyridinetrimethanol",C8 H11 N O4,185.06883,NA,NA,"3-Hydroxy-2,4,5-pyridinetrimethanol-peak1",8,11,4,1,0,0,1.375,0.5,0,60.3,4,0,-0.3333333333333333,0.2,-1,Lignin,372267.642106912,128745.7872095346,0.345842003567315,-1.5318149955480311,0.4203295824207582,0.6594697741371865,Downregulated
Feature0523,4-Ethoxy-m-anisaldehyde,C10 H12 O3,180.07871,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of various plant secondary metabolites;Other,NA,4-Ethoxy-m-anisaldehyde,10,12,3,0,0,0,1.2,0.3,-0.5999999999999996,77.39999999999999,5,2,0.2857142857142857,0.4117647058823529,2,Lignin,1251031.0461234907,2732672.607023887,2.184336364386389,1.1271950329367824,0.024036631893541115,0.29653705466967917,Upregulated
Feature0522,3-Hydroxypyridine,C5 H5 N O,95.0371,NA,NA,3-Hydroxypyridine-peak2,5,5,1,1,0,0,1,0.2,0,60.3,4,3,0.6666666666666666,0.7142857142857143,2,Lignin,5211616.178284937,6088388.771209003,1.1682342987147223,0.22432964724454463,0.173613647939292,0.477437531833053,Upregulated
Feature0521,Gabexate,C16 H23 N3 O4,321.16895,NA,NA,Gabexate,16,23,4,3,0,0,1.4375,0.25,-0.375,70.9875,7,3,0,0.18181818181818185,0,Lignin,10125863.752180643,11932697.72867327,1.1784375161184169,0.23687526509981427,0.4910357053946309,0.7067242862689079,Upregulated
Feature0520,"N1-[4-(1,3-Oxazol-5-yl)phenyl]cyclopropane-1-carboxamide",C13 H12 N2 O2,228.08992,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"N1-[4-(1,3-Oxazol-5-yl)phenyl]cyclopropane-1-carboxamide",13,12,2,2,0,0,0.9230769230769232,0.15384615384615383,-0.1538461538461542,64.6846153846154,9,7,0.5555555555555556,0.6,5,Lignin,8037696.775882663,5972218.3811766235,0.7430260866640844,-0.42851523211778303,2.7803100681717793e-4,0.13209075561330955,Downregulated
Feature0519,Methyl vinyl ketone,C4 H6 O,70.04188,Other,NA,Methyl vinyl ketone-peak2,4,6,1,0,0,0,1.5,0.25,-1,88.8,2,1,0.3333333333333333,0.42857142857142855,1,Lipid,1411304.66404635,1246837.0983039434,0.883464166219885,-0.1787564754079093,0.2572888193857781,0.5404247479654217,Downregulated
Feature0518,NA,C13 H17 N O5,267.11069,NA,NA,Feature0518,13,17,5,1,0,0,1.3076923076923077,0.38461538461538464,-0.3076923076923075,69.06923076923076,6,1,0,0.2631578947368421,0,Lignin,1547732.8911482901,3094769.2169295433,1.9995499447152536,0.9996753172036129,0.05185097681816932,0.36591042730478307,Upregulated
Feature0517,NA,C20 H20 N6 O5,424.14931,NA,NA,Feature0517,20,20,5,6,0,0,1,0.25,0.3999999999999999,48.9,14,9,0.3333333333333333,0.4782608695652174,3,Lignin,2004898.0180784634,4878312.649649316,2.4331974023919654,1.2828533691457382,0.14617506832795127,0.4658688473133245,Upregulated
Feature0516,gamma-Glu-His,C11 H16 N4 O5,284.11217,NA,NA,gamma-Glu-His,11,16,5,4,0,0,1.4545454545454546,0.4545454545454546,0.5454545454545454,44.75454545454545,6,1,-1.5,-0.1111111111111111,-3,Lignin,3268291.91411532,4331183.73941251,1.3252132469277609,0.40622452988794033,0.435619087238149,0.6640970014604831,Upregulated
Feature0515,6-methoxymellein,C11 H12 O4,208.07356,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Other,Anaerobic aromatic compound degradation (Thauera aromatica);Other,6-methoxymellein-peak2,11,12,4,0,0,0,1.0909090909090908,0.3636363636363637,-0.3636363636363633,70.66363636363636,6,2,0.2857142857142857,0.4444444444444444,2,Lignin,346297.86517330015,136707.517611821,0.3947685832351509,-1.3409209141465903,0.2523690574034001,0.5343914790516997,Downregulated
Feature0514,NA,C8 H18 N2 O3,190.13174,NA,NA,Feature0514,8,18,3,2,0,0,2.25,0.375,-0.75,81.675,1,-2,-1.3333333333333333,-0.5555555555555556,-4,Protein,3226015.1877957666,2794501.0692074997,0.8662392786553783,-0.20716250359876642,0.5877909356549514,0.7779045664058498,Downregulated
Feature0513,NP-019722,C8 H13 N O4,187.08446,Metabolic pathways;Lysine degradation;Other,Superpathway of L-lysine degradation,NP-019722-peak1,8,13,4,1,0,0,1.625,0.5,-0.25,67.425,3,-1,-0.6666666666666666,0,-2,Protein,9129816.004394883,5724072.251538304,0.626964688968854,-0.67354390303081,0.06893629243616588,0.3925920914282487,Downregulated
Feature0512,glutaral,C5 H8 O2,100.05243,NA,NA,glutaral,5,8,2,0,0,0,1.6,0.4,-0.7999999999999998,83.1,2,0,0,0.25,0,Protein,1115459.4612199797,1133890.5903605404,1.016523351839611,0.023643357530148214,0.9479808104204777,0.9724293424211538,Upregulated
Feature0511,Pyridoxal,C8 H9 N O3,167.0583,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Other,Pyridoxal-peak2,8,9,3,1,0,0,1.125,0.375,0,60.3,5,2,0.25,0.4545454545454546,1,Lignin,8074156.9923498435,7289750.277979983,0.9028497073919821,-0.1474422449954475,0.32758698776745104,0.5903535715724065,Downregulated
Feature0510,D-lysopine,C9 H18 N2 O4,218.12663,Lysine degradation,NA,D-lysopine-peak1,9,18,4,2,0,0,2,0.4444444444444444,-0.44444444444444464,72.96666666666667,2,-2,-1.3333333333333333,-0.4,-4,Protein,3568308.58556466,2705396.849582147,0.7581734552125449,-0.3994001484073147,0.2812567929863163,0.5605282439044939,Downregulated
Feature0509,NA,C14 H25 N3 O6,331.17445,NA,NA,Feature0509,14,25,6,3,0,0,1.7857142857142858,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,-2,-1,-0.25,-5,Protein,5407561.988759734,6219472.862969257,1.1501436092451973,0.2018140102223518,0.3512531021989855,0.6093000912850749,Upregulated
Feature0508,N-valeryl-Glycine,C7 H13 N O3,159.08952,Metabolic pathways;Lysine degradation;Other,Superpathway of L-lysine degradation,N-valeryl-Glycine,7,13,3,1,0,0,1.8571428571428572,0.42857142857142855,-0.5714285714285712,76.58571428571427,2,-1,-0.6666666666666666,-0.1111111111111111,-2,Protein,660595.7469136347,861467.6272485286,1.3040768598244632,0.3830289017928002,0.68986346028162715,0.8394586943835308,Upregulated
Feature0507,(4S)-4-Hydroxy-4-methyltetrahydro-2H-pyran-2-one,C6 H10 O3,130.06296,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I,(4S)-4-Hydroxy-4-methyltetrahydro-2H-pyran-2-one-peak2,6,10,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,1813048.3145871365,1461401.59553193,0.8060466915161703,-0.3110646833453118,0.2428151136511379,0.5266694014404963,Downregulated
Feature0506,gamma-Glutamyl-N~5~-acetylornithine,C12 H21 N3 O6,303.14309,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites;Other,NA,gamma-Glutamyl-N~5~-acetylornithine,12,21,6,3,0,0,1.75,0.5,0,60.3,4,-2,-1.6666666666666667,-0.3333333333333333,-5,Protein,5455718.412307177,7327730.17735346,1.3431283698262986,0.4255971972905392,0.18151716376668714,0.48423633924530396,Upregulated
Feature0505,(3S)-3-{(Z)-[(3S)-3-{(Z)-[(3R)-3-Amino-1-hydroxy-4-methylpentylidene]amino}-1-hydroxybutylidene]amino}-5-methylhexanoic acid,C17 H33 N3 O4,343.24723,NA,NA,(3S)-3-{(Z)-[(3S)-3-{(Z)-[(3R)-3-Amino-1-hydroxy-4-methylpentylidene]amino}-1-hydroxybutylidene]amino}-5-methylhexanoic acid-peak3,17,33,4,3,0,0,1.9411764705882353,0.2352941176470588,-0.9411764705882356,87.12352941176471,3,-1,-0.4,-0.16666666666666666,-4,Lipid,6145245.204363316,7631022.0032413,1.241776649989985,0.3124057090427737,0.3148630082559289,0.5829267059951295,Upregulated
Feature0504,NA,C9 H7 N O3 S,209.01467,NA,NA,Feature0504,9,7,3,1,1,0,0.7777777777777778,0.3333333333333333,0.44444444444444464,47.633333333333326,7,4,0.5,0.6363636363636364,2,Condensed HC,285058.66716851766,140607.727335595,0.4932589095860473,-1.0195829847403148,0.1959578413827209,0.4903287788808408,Downregulated
Feature0503,Acetylcarnitine,C9 H17 N O4,203.1157,NA,NA,Acetylcarnitine-peak2,9,17,4,1,0,0,1.8888888888888888,0.4444444444444444,-0.666666666666667,79.30000000000001,2,-2,-0.75,-0.16666666666666666,-3,Protein,266213.44451427297,549092.4938912487,2.062602416242014,1.0444657565638273,0.025932963266600214,0.3041093532540047,Upregulated
Feature0502,NA,C20 H31 N O14,509.17464,NA,NA,Feature0502,20,31,14,1,0,0,1.55,0.7,0,60.3,6,-8,-1.8,-0.16666666666666666,-9,Amino Sugar,6396263.455118497,6547324.939485554,1.0236171454517202,0.03367621764338689,0.8514308551414613,0.92558845302131,Upregulated
Feature0501,NA,C16 H28 N2 O5,328.19969,NA,NA,Feature0501,16,28,5,2,0,0,1.75,0.3125,-0.75,81.675,4,-1,-0.3333333333333333,-0.04347826086956521,-3,Protein,137772.804603856,174174.32455934933,1.2642141172937589,0.3382408304430383,0.10335877329137667,0.42914157342056886,Upregulated
Feature0500,NA,C16 H29 N3 O4,327.21588,NA,NA,Feature0500,16,29,4,3,0,0,1.8125,0.25,-0.75,81.675,4,0,-0.3333333333333333,-0.09090909090909093,-3,Lipid,2807669.5853841603,4478711.3871336235,1.5951703898665206,0.6737105352667471,0.31411980861220856,0.582824705135905,Upregulated
Feature0499,NA,C9 H22 N2 O2,190.16816,NA,NA,Feature0499,9,22,2,2,0,0,2.4444444444444446,0.2222222222222222,-1.333333333333333,98.29999999999998,0,-2,-0.8,-0.5,-4,Lipid,5842068.869430203,4091579.745577287,0.7003648599535173,-0.5138213949574016,0.39849221275365815,0.6441276797754741,Downregulated
Feature0498,NA,C13 H25 N3 O4,287.18455,NA,NA,Feature0498,13,25,4,3,0,0,1.9230769230769231,0.3076923076923077,-0.615384615384615,77.83846153846153,3,-1,-0.6666666666666666,-0.25,-4,Protein,8966683.58029197,8288849.27502294,0.9244052386593797,-0.11340265922018626,0.7747758028080953,0.887403793074316,Downregulated
Feature0497,NA,C14 H27 N3 O5,317.19512,NA,NA,Feature0497,14,27,5,3,0,0,1.9285714285714288,0.35714285714285715,-0.5714285714285712,76.58571428571427,3,-2,-0.8333333333333334,-0.29411764705882354,-5,Protein,5630487.518742677,7106791.24681031,1.2621982063104369,0.33593847831422174,0.09655133227674241,0.41723968591020827,Upregulated
Feature0496,"8-Methyl-1,2-naphthalenediol",C11 H10 O2,174.0681,Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,NA,"8-Methyl-1,2-naphthalenediol-peak1",11,10,2,0,0,0,0.9090909090909092,0.18181818181818185,-0.5454545454545459,75.84545454545456,7,5,0.5555555555555556,0.6,5,Lignin,459486.048229631,755304.0159913003,1.643801849700195,0.7170364014014948,0.4153573197017667,0.6580333694263849,Upregulated
Feature0495,7-Methylguanosine,C11 H15 N5 O5,297.10741,NA,NA,7-Methylguanosine,11,15,5,5,0,0,1.3636363636363635,0.4545454545454546,0.9090909090909092,34.39090909090909,7,2,-3,-0.14285714285714285,-3,Lignin,2059442.78901896,3003474.211124583,1.458391671348794,0.5443782275030544,0.18560901664552498,0.4854964193043512,Upregulated
Feature0494,1-(6-Amino-9H-purin-9-yl)-1-deoxy-Î²-D-ribofuranuronamide,C10 H12 N6 O4,280.09207,NA,NA,1-(6-Amino-9H-purin-9-yl)-1-deoxy-Î²-D-ribofuranuronamide,10,12,4,6,0,0,1.2,0.4,1.4,20.4,8,4,-Inf,0,-2,Lignin,926549.918183992,460733.195235459,0.49725674374725676,-1.0079371580068228,0.030054733385047355,0.31622806431223743,Downregulated
Feature0493,NA,C7 H10 N2 O2,154.07425,NA,NA,Feature0493,7,10,2,2,0,0,1.4285714285714286,0.2857142857142857,0,60.3,4,2,0,0.25,0,Lignin,6865295.89551438,5946038.610571267,0.8661008499948657,-0.20739307072488747,0.10793364914294602,0.43326919821836624,Downregulated
Feature0492,tyr-his,C15 H18 N4 O4,318.13296,NA,NA,tyr-his,15,18,4,4,0,0,1.2,0.26666666666666666,0.1333333333333333,56.5,9,5,0.14285714285714285,0.3333333333333333,1,Lignin,3407343.70853952,7109528.7510530725,2.0865311395604436,1.061106451660112,0.16491542736825926,0.4734778652324074,Upregulated
Feature0491,NA,C16 H33 N O2,271.25118,NA,NA,Feature0491,16,33,2,1,0,0,2.0625,0.125,-1.625,106.6125,1,-1,-0.15384615384615383,-0.07142857142857142,-2,Lipid,161423.27603036835,238237.89607497366,1.475858388787465,0.5615542989082659,0.11770743022330048,0.45214600181013836,Upregulated
Feature0490,(3S)-3-{(Z)-[(3S)-3-{(Z)-[(3R)-3-Amino-1-hydroxy-4-methylpentylidene]amino}-1-hydroxybutylidene]amino}-5-methylhexanoic acid,C17 H33 N3 O4,343.24723,NA,NA,(3S)-3-{(Z)-[(3S)-3-{(Z)-[(3R)-3-Amino-1-hydroxy-4-methylpentylidene]amino}-1-hydroxybutylidene]amino}-5-methylhexanoic acid-peak2,17,33,4,3,0,0,1.9411764705882353,0.2352941176470588,-0.9411764705882356,87.12352941176471,3,-1,-0.4,-0.16666666666666666,-4,Lipid,3547285.9784353036,3138768.493133417,0.884836608103956,-0.17651701985104185,0.7550896579846873,0.8767113643770119,Downregulated
Feature0489,NA,C89 H119 N4 O11 P3,1512.80906,NA,NA,Feature0489,89,119,11,4,0,3,1.3370786516853932,0.12359550561797752,-1.1235955056179776,92.32247191011236,34,23,0.22535211267605632,0.28104575163398693,16,Unsaturated HC,849523.999047175,1030287.3172075697,1.2127818853418368,0.27832011003764456,0.18981413248850845,0.4862119877973694,Upregulated
Feature0488,met-val,C10 H20 N2 O3 S,248.11947,NA,NA,met-val,10,20,3,2,1,0,2,0.3,-0.5999999999999996,77.39999999999999,2,-1,-1,-0.4545454545454546,-4,Lipid,6106986.161231247,4000426.89686689,0.655057468815412,-0.6103066136754288,0.12561664603265715,0.453719825968702,Downregulated
Feature0487,"N,N-dimethyl-9H-purin-6-amine",C7 H9 N5,163.08581,NA,NA,"N,N-dimethyl-9H-purin-6-amine",7,9,0,5,0,0,1.2857142857142858,0,0.8571428571428572,35.87142857142857,6,6,0.5,0.5,1,Unsaturated HC,138101.04534292768,197736.67352584348,1.4318260447256623,0.5178562274792097,0.44317612150383284,0.6668537167127339,Upregulated
Feature0486,dihomomethionine,C7 H15 N O2 S,177.08241,2-Oxocarboxylic acid metabolism;Other,NA,dihomomethionine,7,15,2,1,1,0,2.142857142857143,0.2857142857142857,-0.8571428571428568,84.72857142857141,1,-1,-1,-0.5,-3,Lipid,245442.30455530967,301069.44409502635,1.2266403896447333,0.29471236055954525,0.496079614555805,0.7099241665400493,Upregulated
Feature0485,Υ-L-Glutamyl-L-glutamic acid,C10 H16 N2 O7,276.09576,Other,NA,Υ-L-Glutamyl-L-glutamic acid,10,16,7,2,0,0,1.6,0.7,0.3999999999999999,48.9,4,-3,-5,-0.3333333333333333,-5,Amino Sugar,267437.33678496,425285.344984412,1.5902242749537019,0.6692302482429624,0.43672022410093164,0.6640970014604831,Upregulated
Feature0484,NA,C13 H17 N5 O7,355.11293,NA,NA,Feature0484,13,17,7,5,0,0,1.3076923076923077,0.5384615384615384,0.9230769230769228,33.99230769230769,8,1,-4,-0.1111111111111111,-4,Lignin,7110367.6686969595,5882474.586002014,0.8273094810412288,-0.2735009792249952,0.0475052884521578,0.35607946299980225,Downregulated
Feature0483,NA,C25 H34 O2,366.25594,NA,NA,Feature0483,25,34,2,0,0,0,1.36,0.08,-1.2000000000000002,94.5,9,7,0.30434782608695654,0.3333333333333333,7,Unsaturated HC,708844.7418897504,859264.8697903213,1.2122046183196016,0.27763324412336304,0.2879654801978138,0.5646020478032001,Upregulated
Feature0482,NA,C15 H29 N3 O4,315.21585,NA,NA,Feature0482,15,29,4,3,0,0,1.9333333333333331,0.26666666666666666,-0.7999999999999998,83.1,3,-1,-0.5,-0.2,-4,Lipid,3359964.5527848303,3012966.50676009,0.8967256824965195,-0.15726137733334708,0.7219315661523057,0.8568018164604311,Downregulated
Feature0481,NA,C16 H29 N3 O4,327.2159,NA,NA,Feature0481,16,29,4,3,0,0,1.8125,0.25,-0.75,81.675,4,0,-0.3333333333333333,-0.09090909090909093,-3,Lipid,2640032.349949787,2929498.8408693667,1.109645054510444,0.15009827118005217,0.6044939521535638,0.7867481750107239,Upregulated
Feature0480,Gly-Tyr,C11 H14 N2 O4,238.09535,Other,NA,Gly-Tyr-peak2,11,14,4,2,0,0,1.2727272727272727,0.3636363636363637,0,60.3,6,2,0,0.2857142857142857,0,Lignin,2952885.9752211035,4279939.069904056,1.4494088514825185,0.5354646099437372,0.35882409342734856,0.6165116688402364,Upregulated
Feature0479,Gly-Tyr,C11 H14 N2 O4,238.09534,Other,NA,Gly-Tyr-peak1,11,14,4,2,0,0,1.2727272727272727,0.3636363636363637,0,60.3,6,2,0,0.2857142857142857,0,Lignin,168524.63684623767,275131.46464020235,1.6325889780212552,0.7071616224925893,0.07448321599931015,0.39590936857023457,Upregulated
Feature0478,Phenacetin,C10 H13 N O2,179.09463,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",NA,Phenacetin-peak2,10,13,2,1,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Lignin,5927459.17047362,4642745.249159154,0.783260603849623,-0.35243569882890574,0.01566427753324013,0.26272560535949285,Downregulated
Feature0477,metharbital,C9 H14 N2 O3,198.10047,NA,NA,metharbital-peak1,9,14,3,2,0,0,1.5555555555555556,0.3333333333333333,-0.22222222222222232,66.63333333333333,4,1,-0.25,0.09090909090909093,-1,Protein,10455620.196503224,8534884.993488943,0.8162963873097981,-0.29283502251279553,0.15507830222079041,0.46825623718458564,Downregulated
Feature0476,NA,C17 H31 N3 O4,341.23157,NA,NA,Feature0476,17,31,4,3,0,0,1.8235294117647056,0.2352941176470588,-0.8235294117647056,83.7705882352941,4,0,-0.3,-0.08333333333333333,-3,Lipid,363215.66272231936,687946.2049769456,1.8940433345323129,0.92146933914825635,0.24783681433531743,0.5310276106497658,Upregulated
Feature0475,Lys-phe,C15 H23 N3 O3,293.17398,NA,NA,Lys-phe-peak1,15,23,3,3,0,0,1.5333333333333334,0.2,-0.5333333333333332,75.5,6,3,0,0.14285714285714285,0,Lipid,2843731.1304792766,3920672.4135869965,1.3787071399138267,0.46331603722562503,0.41364435019092494,0.6580333694263849,Upregulated
Feature0474,NA,C25 H41 N5 O6,507.30589,NA,NA,Feature0474,25,41,6,5,0,0,1.64,0.24,-0.5599999999999996,76.25999999999999,8,2,-0.21428571428571427,0,-3,Lipid,2662490.1457128664,10815706.678987967,4.062252285291416,2.0222798406770055,0.0549285053472407,0.3736903134868504,Upregulated
Feature0473,NA,C14 H23 N3 O,249.18412,NA,NA,Feature0473,14,23,1,3,0,0,1.6428571428571428,0.07142857142857142,-0.8571428571428568,84.72857142857141,5,4,0.1,0.14285714285714285,1,Lipid,87708.70073721703,94709.0960681284,1.0798141492471216,0.11078302624775492,0.6040710028444489,0.7867481750107239,Upregulated
Feature0472,NA,C17 H31 N3 O6,373.22136,NA,NA,Feature0472,17,31,6,3,0,0,1.8235294117647056,0.35294117647058826,-0.5882352941176467,77.06470588235292,4,-2,-0.625,-0.18181818181818185,-5,Protein,3589026.2562638302,5507404.641075781,1.534512218032358,0.6177801328193981,0.07703634964564796,0.39590936857023457,Upregulated
Feature0471,NA,C14 H27 N3 O4,301.20021,NA,NA,Feature0471,14,27,4,3,0,0,1.9285714285714288,0.2857142857142857,-0.7142857142857144,80.65714285714286,3,-1,-0.5714285714285714,-0.2222222222222222,-4,Lipid,4902880.306846676,5152286.9410191765,1.050869411154952,0.07158340042792563,0.6408191713468456,0.8131443267876828,Upregulated
Feature0470,NA,C17 H25 N3 O4,335.18463,NA,NA,Feature0470,17,25,4,3,0,0,1.4705882352941178,0.2352941176470588,-0.47058823529411775,73.71176470588236,7,3,0,0.16666666666666666,0,Lignin,5662357.09108922,4473166.638203717,0.7899831406329146,-0.3401062304391758,0.7886610039145465,0.8948370667322451,Downregulated
Feature0469,NA,C17 H25 N3 O4,335.18461,NA,NA,Feature0469,17,25,4,3,0,0,1.4705882352941178,0.2352941176470588,-0.47058823529411775,73.71176470588236,7,3,0,0.16666666666666666,0,Lignin,3658201.600248813,3851817.9943724265,1.052926660496361,0.0744049518213817,0.8331659733566119,0.9194678559388277,Upregulated
Feature0468,linatine,C10 H17 N3 O5,259.11681,Other,NA,linatine,10,17,5,3,0,0,1.7,0.5,0.20000000000000015,54.599999999999994,4,-1,-2,-0.3333333333333333,-4,Protein,720326.1744542887,401025.1916939457,0.5567272242991281,-0.8449574612955987,0.07715013400943929,0.39590936857023457,Downregulated
Feature0467,NA,C6 H9 O P S,160.01125,NA,NA,Feature0467,6,9,1,0,1,1,1.5,0.16666666666666666,-1.666666666666667,107.8,3,2,0,0.14285714285714285,0,Lipid,172387.28280561432,177140.75848879467,1.027574398794489,0.03924285219028577,0.7386649875451661,0.8689572839593829,Upregulated
Feature0466,mycosporine,C11 H19 N O6,261.12129,Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,mycosporine-peak1,11,19,6,1,0,0,1.7272727272727273,0.5454545454545454,-0.3636363636363633,70.66363636363636,3,-3,-1,-0.14285714285714285,-4,Protein,2482888.66099358,3149535.2930121436,1.2684963858797402,0.3431194089715772,0.0762066297239529,0.39590936857023457,Upregulated
Feature0465,NA,C17 H32 N2 O8,392.21598,NA,NA,Feature0465,17,32,8,2,0,0,1.8823529411764703,0.4705882352941176,-0.5882352941176467,77.06470588235292,3,-5,-1,-0.2727272727272727,-7,Protein,355734.15690606565,113210.80909535004,0.3182455406587347,-1.6517877960462046,0.04350064177011393,0.35607946299980225,Downregulated
Feature0464,NA,C14 H25 N3 O6,331.17446,NA,NA,Feature0464,14,25,6,3,0,0,1.7857142857142858,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,-2,-1,-0.25,-5,Protein,4951723.941386607,6264844.34115225,1.2651844923725568,0.3393477776654454,0.21159864044245422,0.5042851084128842,Upregulated
Feature0463,NA,C12 H20 N2 O5,272.13725,NA,NA,Feature0463,12,20,5,2,0,0,1.6666666666666667,0.4166666666666667,-0.33333333333333304,69.79999999999998,4,-1,-0.6,-0.06666666666666667,-3,Protein,139850.13528698866,105603.45728550873,0.7551187352718552,-0.4052245824766366,0.13159880808656202,0.45384777576550756,Downregulated
Feature0462,2-(acetylamino)-3-(1H-indol-3-yl)propanoic acid,C13 H14 N2 O3,246.10046,NA,Superpathway of indole-3-acetate conjugate biosynthesis,2-(acetylamino)-3-(1H-indol-3-yl)propanoic acid,13,14,3,2,0,0,1.0769230769230769,0.2307692307692308,-0.1538461538461542,64.6846153846154,8,5,0.375,0.47368421052631576,3,Lignin,168975.86857133234,222590.705059388,1.3172928592784385,0.397576119823408,0.5989296839437936,0.7865713119297694,Upregulated
Feature0461,D-PANTOTHENIC ACID,C9 H17 N O5,219.11065,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,Other,D-PANTOTHENIC ACID-peak1,9,17,5,1,0,0,1.8888888888888888,0.5555555555555556,-0.44444444444444464,72.96666666666667,2,-3,-1.3333333333333333,-0.2727272727272727,-4,Amino Sugar,2263016.3667370398,4198873.24412775,1.8554321152267899,0.8917552180565904,0.16789618933701445,0.47405832082810595,Upregulated
Feature0460,(−)-trans-Methyl dihydrojasmonate,C13 H22 O3,226.15687,NA,NA,(−)-trans-Methyl dihydrojasmonate,13,22,3,0,0,0,1.6923076923076923,0.2307692307692308,-1.2307692307692308,95.37692307692308,3,0,0,0.13043478260869565,0,Lipid,1110417.59998764,1612369.98686053,1.4520392930357706,0.5380804940367196,0.2544289066486174,0.5374096856144113,Upregulated
Feature0459,NA,C13 H25 N3 O4,287.18453,NA,NA,Feature0459,13,25,4,3,0,0,1.9230769230769231,0.3076923076923077,-0.615384615384615,77.83846153846153,3,-1,-0.6666666666666666,-0.25,-4,Protein,1624139.4310517102,1695756.3148668099,1.0440952805195576,0.062253373268691126,0.8425216819314728,0.9218399058025261,Upregulated
Feature0458,7-hydroxyflavanone 7-O-beta-D-glucoside,C21 H22 O8,402.13151,NA,NA,7-hydroxyflavanone 7-O-beta-D-glucoside,21,22,8,0,0,0,1.0476190476190477,0.380952380952381,-0.2857142857142856,68.44285714285714,11,3,0.2307692307692308,0.4117647058823529,3,Lignin,434387.9537836273,3150996.71575998,7.253876835934362,2.858752249899426,0.04475668529473597,0.35607946299980225,Upregulated
Feature0457,Alpha-Methyltryptamine,C11 H14 N2,174.11571,Metabolic pathways;Other,NA,Alpha-Methyltryptamine,11,14,0,2,0,0,1.2727272727272727,0,-0.7272727272727275,81.02727272727273,6,6,0.4444444444444444,0.4444444444444444,4,Unsaturated HC,1964374.2526121233,1101235.6885281221,0.5606038091080434,-0.8349465478722626,0.13793434231182303,0.45798070948295916,Downregulated
Feature0456,"(2S,3S)-2,3-dihydro-3-hydroxyanthranilic acid zwitterion",C7 H9 N O3,155.05826,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"(2S,3S)-2,3-dihydro-3-hydroxyanthranilic acid zwitterion",7,9,3,1,0,0,1.2857142857142858,0.42857142857142855,0,60.3,4,1,0,0.3333333333333333,0,Lignin,2322020.991032567,2513906.6095314436,1.0826373315486473,0.11455004109750726,0.7227684744521582,0.8568018164604311,Upregulated
Feature0455,acetoacetic acid,C4 H6 O3,102.03167,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Tyrosine metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,acetoacetic acid-peak2,4,6,3,0,0,0,1.5,0.75,0,60.3,2,-1,-1,0.2,-1,Carbohydrate,1194581.8997071967,1955262.0498255831,1.6367752184298425,0.710856207259037,0.43053623801048024,0.6620361130263338,Upregulated
Feature0454,4-Hydroxyprolyllysine,C11 H21 N3 O4,259.15322,NA,NA,4-Hydroxyprolyllysine-peak2,11,21,4,3,0,0,1.9090909090909092,0.3636363636363637,-0.3636363636363633,70.66363636363636,3,-1,-1,-0.3333333333333333,-4,Protein,7608302.380596464,7991458.546832577,1.0503602705398882,0.07088425300844843,0.7423197272739266,0.8708376855969748,Upregulated
Feature0453,apronalide,C9 H16 N2 O2,184.12119,NA,NA,apronalide-peak1,9,16,2,2,0,0,1.7777777777777777,0.2222222222222222,-0.666666666666667,79.30000000000001,3,1,-0.2,0,-1,Lipid,8180115.4874789035,6885892.737686063,0.8417842936601722,-0.24847750332430443,0.17168618239626662,0.4760067902771642,Downregulated
Feature0452,NA,C28 H40,376.313,NA,NA,Feature0452,28,40,0,0,0,0,1.4285714285714286,0,-1.4285714285714288,101.01428571428572,9,9,0.32142857142857145,0.32142857142857145,9,Unsaturated HC,1232722.558267036,1473542.3023980067,1.195355996786102,0.2574403406426564,0.2409240249488217,0.5247143918712548,Upregulated
Feature0451,afegostat,C6 H13 N O3,147.08956,Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,afegostat-peak2,6,13,3,1,0,0,2.1666666666666665,0.5,-0.666666666666667,79.30000000000001,1,-2,-1.5,-0.42857142857142855,-3,Protein,1103414.58567391,1130446.3152035805,1.0244982528603797,0.034917524035040254,0.9394437381611984,0.9668394243287182,Upregulated
Feature0450,3-oxovaleric acid,C5 H8 O3,116.0473,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Other,3-oxovaleric acid-peak2,5,8,3,0,0,0,1.6,0.6,-0.4000000000000003,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,3545893.79760152,3015735.5265606167,0.8504867034090225,-0.2336394140555121,0.3397550637013463,0.6000332386572487,Downregulated
Feature0449,NA,C16 H29 N3 O6,359.20566,NA,NA,Feature0449,16,29,6,3,0,0,1.8125,0.375,-0.5,74.55,4,-2,-0.7142857142857143,-0.2,-5,Protein,5969963.79968547,7479429.06708273,1.252843286499792,0.325205964596433,0.0758423779954877,0.39590936857023457,Upregulated
Feature0448,2-Aminoadipic acid,C6 H11 N O4,161.06884,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of butirocin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Other,2-Aminoadipic acid,6,11,4,1,0,0,1.8333333333333333,0.6666666666666666,0,60.3,2,-2,-3,-0.3333333333333333,-3,Amino Sugar,3752194.02331583,2899877.3790823333,0.7728484617433773,-0.3717425331609349,0.10010423552704481,0.42394143745703483,Downregulated
Feature0447,Marimastat,C15 H29 N3 O5,331.21084,NA,NA,Marimastat-peak5,15,29,5,3,0,0,1.9333333333333331,0.3333333333333333,-0.666666666666667,79.30000000000001,3,-2,-0.7142857142857143,-0.2631578947368421,-5,Protein,4957394.0279062735,6016217.130852804,1.2135846166324846,0.2792747032481047,0.3105645051406729,0.5800646762398355,Upregulated
Feature0446,(+/-)-Metanephrine,C10 H15 N O3,197.10522,Metabolic pathways;Tyrosine metabolism,NA,(+/-)-Metanephrine-peak2,10,15,3,1,0,0,1.5,0.3,-0.5999999999999996,77.39999999999999,4,1,0,0.2,0,Lipid,8166199.399331523,6119662.335366414,0.7493892857756281,-0.4162127436799926,0.04491243701628679,0.35607946299980225,Downregulated
Feature0445,NA,C15 H29 N3 O4,315.21587,NA,NA,Feature0445,15,29,4,3,0,0,1.9333333333333331,0.26666666666666666,-0.7999999999999998,83.1,3,-1,-0.5,-0.2,-4,Lipid,5996202.6269560065,5974930.50026251,0.9964524002911664,-0.005127204528553325,0.9911089910926929,0.9952747121088282,Downregulated
Feature0444,Hypoxanthine,C5 H4 N4 O,136.0385,Metabolic pathways;Other,Superpathway of purine nucleotide salvage;Other,Hypoxanthine-peak2,5,4,1,4,0,0,0.8,0.2,2,3.299999999999997,6,5,Inf,3,1,Condensed HC,74380.15662668853,60410.984345838,0.8121922174624969,-0.30010689166114257,0.4689011522214775,0.6900415978321557,Downregulated
Feature0443,orciprenaline,C11 H17 N O3,211.12082,Biosynthesis of alkaloids derived from shikimate pathway;Other,NA,orciprenaline,11,17,3,1,0,0,1.5454545454545454,0.2727272727272727,-0.7272727272727275,81.02727272727273,4,1,0,0.17647058823529413,0,Lipid,105921.30312547566,122542.9287562247,1.156924293227953,0.21029446050578185,0.4629429127420581,0.6840367259145498,Upregulated
Feature0442,Marimastat,C15 H29 N3 O5,331.21084,NA,NA,Marimastat-peak4,15,29,5,3,0,0,1.9333333333333331,0.3333333333333333,-0.666666666666667,79.30000000000001,3,-2,-0.7142857142857143,-0.2631578947368421,-5,Protein,5681577.46830175,6354214.891476333,1.1183892021058084,0.1614223368706901,0.5178747488350205,0.72558973657982,Upregulated
Feature0441,GLY-MET,C7 H14 N2 O3 S,206.07248,NA,NA,GLY-MET,7,14,3,2,1,0,2,0.42857142857142855,0,60.3,2,-1,-4,-1,-4,Protein,3839408.0806685733,5443787.782920243,1.4178716272254894,0.5037269182269627,0.2713216781756129,0.5511018259346382,Upregulated
Feature0440,NA,C11 H21 N O12,359.10644,NA,NA,Feature0440,11,21,12,1,0,0,1.9090909090909092,1.0909090909090908,0.5454545454545454,44.75454545454545,2,-10,5.5,-1.25,-11,Carbohydrate,1076544.9671260165,1233347.33396425,1.1456533369496296,0.1961705652789517,0.4169775562334941,0.6580333694263849,Upregulated
Feature0439,3-Hydroxypyridine,C5 H5 N O,95.0371,NA,NA,3-Hydroxypyridine-peak1,5,5,1,1,0,0,1,0.2,0,60.3,4,3,0.6666666666666666,0.7142857142857143,2,Lignin,5108129.87811514,5087328.044108857,0.9959277006453175,-0.0058870812149011895,0.9669809216506524,0.9803701129972048,Downregulated
Feature0438,NA,C17 H33 N O15,491.18523,NA,NA,Feature0438,17,33,15,1,0,0,1.9411764705882353,0.8823529411764706,0,60.3,2,-13,-14,-0.7647058823529411,-14,Carbohydrate,4694414.891992133,3777130.0160530265,0.8046008081850973,-0.3136549078012163,0.011297336140191258,0.25060429422582925,Downregulated
Feature0437,ARG-PHE,C15 H23 N5 O3,321.18018,NA,NA,ARG-PHE-peak1,15,23,3,5,0,0,1.5333333333333334,0.2,-0.13333333333333375,64.10000000000001,7,4,-0.14285714285714285,0.0588235294117647,-1,Lipid,3416883.51482469,3497891.1478302665,1.0237080464271353,0.0338043285922969,0.9544382454218148,0.9749458049634153,Upregulated
Feature0436,NA,C8 H19 N O4,193.13145,NA,NA,Feature0436,8,19,4,1,0,0,2.375,0.5,-1,88.8,0,-4,-1.6666666666666667,-0.6,-5,Other,1968063.44353052,1379456.1452706,0.7009205672739828,-0.5126771366615946,0.15381037324416055,0.46778235597057083,Downregulated
Feature0435,NA,C16 H28 N4 O5,356.20606,NA,NA,Feature0435,16,28,5,4,0,0,1.75,0.3125,-0.375,70.9875,5,0,-0.5714285714285714,-0.15789473684210523,-4,Protein,2930475.0229211934,2488864.1599951233,0.8493040003849417,-0.2356470495358454,0.6907911520761718,0.8394586943835308,Downregulated
Feature0434,N-Acetylvanilalanine,C12 H15 N O5,253.09502,NA,NA,N-Acetylvanilalanine-peak3,12,15,5,1,0,0,1.25,0.4166666666666667,-0.16666666666666696,65.05000000000001,6,1,0,0.29411764705882354,0,Lignin,5086022.308119687,5285885.021016033,1.039296468003546,0.05560725376893331,0.42513868465595434,0.6594697741371865,Upregulated
Feature0433,Chelidonic acid,C7 H4 O6,184.00082,Metabolic pathways;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,Other,Chelidonic acid,7,4,6,0,0,0,0.5714285714285714,0.8571428571428571,1.1428571428571428,27.728571428571428,6,0,0,0.75,0,Condensed HC,5388232.4640636565,5046765.290741224,0.9366272380414509,-0.09445310124934522,0.607789877559014,0.7895675249884737,Downregulated
Feature0432,NA,C11 H19 N3 O7,305.12233,NA,NA,Feature0432,11,19,7,3,0,0,1.7272727272727273,0.6363636363636364,0.36363636363636376,49.93636363636363,4,-3,-6,-0.5555555555555556,-6,Amino Sugar,3760570.8925041733,2981328.3464189097,0.7927861039294584,-0.33499641991058676,0.3849250281991122,0.6355389841806004,Downregulated
Feature0431,Fenspiride,C15 H20 N2 O2,260.15248,NA,NA,Fenspiride,15,20,2,2,0,0,1.3333333333333333,0.13333333333333333,-0.666666666666667,79.30000000000001,7,5,0.2727272727272727,0.3333333333333333,3,Lignin,8266833.963663316,6302320.076946343,0.762362000331451,-0.39145188447953705,0.08086460538683657,0.39590936857023457,Downregulated
Feature0430,NA,C13 H18 N2 O6,298.11654,NA,NA,Feature0430,13,18,6,2,0,0,1.3846153846153846,0.4615384615384616,0,60.3,6,0,-0.4,0.125,-2,Lignin,5699982.394773804,5748964.597401966,1.0085933954240058,0.012344683233343855,0.9494676106048336,0.9724293424211538,Upregulated
Feature0429,Gly-Lys,C8 H17 N3 O3,203.12694,NA,NA,Gly-Lys,8,17,3,3,0,0,2.125,0.375,-0.25,67.425,2,-1,-2,-0.7142857142857143,-4,Protein,2533033.8719590767,4071876.26522082,1.6075095995741997,0.684827352929111,0.23318730194357876,0.5201446342203138,Upregulated
Feature0428,1-Deoxy-1-(4-morpholinyl)-alpha-D-fructofuranose,C10 H19 N O6,249.1212,NA,NA,1-Deoxy-1-(4-morpholinyl)-alpha-D-fructofuranose-peak1,10,19,6,1,0,0,1.9,0.6,-0.4000000000000003,71.7,2,-4,-1.6666666666666667,-0.3333333333333333,-5,Amino Sugar,567889.504778357,703306.9916461019,1.2384574564740325,0.30854430993418225,0.521805238831389,0.7287205891017089,Upregulated
Feature0427,"1-Methyl-1,2,3,4-tetrahydro-Î²-carboline-3-carboxylic acid",C13 H14 N2 O2,230.10552,NA,NA,"1-Methyl-1,2,3,4-tetrahydro-Î²-carboline-3-carboxylic acid-peak2",13,14,2,2,0,0,1.0769230769230769,0.15384615384615383,-0.3076923076923075,69.06923076923076,8,6,0.4444444444444444,0.5,4,Lignin,5899734.391726716,3786186.87684997,0.6417554800703223,-0.6399043845907249,0.002015657627060341,0.15520563728364625,Downregulated
Feature0426,eutypine,C12 H10 O2,186.06813,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,NA,eutypine,12,10,2,0,0,0,0.8333333333333334,0.16666666666666666,-0.5,74.55,8,6,0.6,0.6363636363636364,6,Lignin,197327.57053877,261754.89807297135,1.3264993703530292,0.4076239907654193,0.41425791065958006,0.6580333694263849,Upregulated
Feature0425,threonylphenylalanine,C13 H18 N2 O4,266.12661,Metabolic pathways;Biosynthesis of cofactors;Other,NA,threonylphenylalanine-peak1,13,18,4,2,0,0,1.3846153846153846,0.3076923076923077,-0.3076923076923075,69.06923076923076,6,2,0,0.2222222222222222,0,Lignin,203028.23356841633,187672.53782530967,0.9243666978074155,-0.11346281017219033,0.6747071433586933,0.8313719053469567,Downregulated
Feature0424,NA,C19 H34 N4 O7,430.24288,NA,NA,Feature0424,19,34,7,4,0,0,1.7894736842105263,0.3684210526315789,-0.4210526315789478,72.30000000000001,5,-2,-0.75,-0.21739130434782608,-6,Protein,654829.2063439527,262625.77935536526,0.401059966188221,-1.3181101313882861,0.23778892584229322,0.5231694095424109,Downregulated
Feature0423,Methylhippuric acid,C10 H11 N O3,193.0739,Phenylalanine metabolism;Other,NA,Methylhippuric acid-peak1,10,11,3,1,0,0,1.1,0.3,-0.20000000000000015,66,6,3,0.3333333333333333,0.4666666666666667,2,Lignin,1049463.3883866786,524640.148666566,0.49991276920397,-1.0002517168317888,0.2166569388581424,0.5069722111991797,Downregulated
Feature0422,NA,C13 H25 N3 O5,303.17947,NA,NA,Feature0422,13,25,5,3,0,0,1.9230769230769231,0.38461538461538464,-0.4615384615384617,73.45384615384616,3,-2,-1,-0.3333333333333333,-5,Protein,5392224.350911637,5685746.577705753,1.0544343498512803,0.07646927427584485,0.6704032060535434,0.8299462183952073,Upregulated
Feature0421,1-Methylguanine,C6 H7 N5 O,165.06508,NA,NA,1-Methylguanine,6,7,1,5,0,0,1.1666666666666667,0.16666666666666666,1.6666666666666663,12.800000000000004,6,5,NA,1,0,Lignin,4456745.592667666,2320407.3981451825,0.5206506294554409,-0.94161248481124,0.11525244422514742,0.44732172409548077,Downregulated
Feature0420,NA,C10 H23 N O7,269.14745,NA,NA,Feature0420,10,23,7,1,0,0,2.3,0.7,-0.5999999999999996,77.39999999999999,0,-7,-4,-0.8181818181818182,-8,Carbohydrate,4948622.21978684,3508528.2354332767,0.7089909230501749,-0.49616093759792457,0.30159229490569095,0.5743234421814979,Downregulated
Feature0419,N-(3-Carboxypropanoyl)-5-hydroxynorvaline,C9 H15 N O6,233.08989,NA,NA,N-(3-Carboxypropanoyl)-5-hydroxynorvaline-peak1,9,15,6,1,0,0,1.6666666666666667,0.6666666666666666,0,60.3,3,-3,-2,-0.2,-4,Amino Sugar,799728.8827728927,892119.38075397,1.1155272742691655,0.15772578742502688,0.5407019239738591,0.7446740318794449,Upregulated
Feature0418,2'-Deoxycytidine-5'-monophosphorate,C9 H14 N3 O7 P,307.05702,Metabolic pathways;Other,Other,2'-Deoxycytidine-5'-monophosphorate,9,14,7,3,0,1,1.5555555555555556,0.7777777777777778,0.44444444444444464,47.633333333333326,5,-2,3,-1.6666666666666667,-6,Carbohydrate,6112527.4140027,5765491.854738194,0.9432255210063336,-0.08432534080721614,0.7028005905738235,0.8470526718656479,Downregulated
Feature0417,NA,C12 H18 N4 O6,314.12269,NA,NA,Feature0417,12,18,6,4,0,0,1.5,0.5,0.5,46.05,6,0,-2,-0.2,-4,Protein,128593.799964595,122574.27413146333,0.9531896107371507,-0.0691648678867429,0.6102240000996901,0.7912648547240121,Downregulated
Feature0416,NA,C8 H18 N O9 P,303.07198,NA,NA,Feature0416,8,18,9,1,0,1,2.25,1.125,-0.25,67.425,1,-8,3.3333333333333335,-3.6666666666666665,-10,Carbohydrate,201858.76227650835,260032.61183487068,1.288190856330899,0.36534635671617743,0.1249205450170633,0.453719825968702,Upregulated
Feature0415,TC2700000,C2 H7 O4 P,126.00817,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,NA,TC2700000,2,7,4,0,0,1,3.5,2,-2,117.3,0,-4,1.6666666666666667,3,-5,Other,715851.4456521337,575251.047248534,0.8035899777005912,-0.315468523862227,0.10674736369016695,0.43283090716191397,Downregulated
Feature0414,Levetiracetam,C8 H14 N2 O2,170.10556,NA,NA,Levetiracetam-peak1,8,14,2,2,0,0,1.75,0.25,-0.5,74.55,3,1,-0.25,0,-1,Lipid,7148173.61949277,5839853.72541693,0.8169714442150501,-0.2916424424763994,0.028351940035049854,0.31390971515931015,Downregulated
Feature0413,NP-003800,C10 H15 N O3,197.10521,Metabolic pathways;Tyrosine metabolism,NA,NP-003800-peak2,10,15,3,1,0,0,1.5,0.3,-0.5999999999999996,77.39999999999999,4,1,0,0.2,0,Lipid,79403.9959390439,76827.40966389317,0.9675509242994684,-0.047590499469204496,0.7222835875693182,0.8568018164604311,Downregulated
Feature0412,dictyoquinazol B,C18 H20 N2 O4,328.14238,NA,NA,dictyoquinazol B,18,20,4,2,0,0,1.1111111111111112,0.2222222222222222,-0.33333333333333304,69.79999999999998,10,6,0.3333333333333333,0.42857142857142855,4,Lignin,5027215.5968851205,4728656.497395697,0.9406114391285681,-0.08832921742918166,0.7755161205209442,0.8874730707625317,Downregulated
Feature0411,"2-(2,4-Dihydroxyphenyl)-5,7-dihydroxy-6-(3-hydroxy-3-methylbutyl)-4H-chromen-4-one",C20 H20 O7,372.12097,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Other,"2-(2,4-Dihydroxyphenyl)-5,7-dihydroxy-6-(3-hydroxy-3-methylbutyl)-4H-chromen-4-one",20,20,7,0,0,0,1,0.35,-0.2999999999999998,68.85,11,4,0.3076923076923077,0.4545454545454546,4,Lignin,1975005.3674805993,8100042.324309637,4.101276106728963,2.0360728722678725,0.041470889104478034,0.35607946299980225,Upregulated
Feature0410,NA,C7 H16 O6,196.09463,NA,NA,Feature0410,7,16,6,0,0,0,2.2857142857142856,0.8571428571428571,-0.5714285714285712,76.58571428571427,0,-6,-6,-0.75,-6,Carbohydrate,1536275.8074558168,1611088.1211743867,1.0486971892387373,0.06859816061337261,0.6778482422035896,0.8338960946208286,Upregulated
Feature0409,NA,C20 H29 N3 O4,375.21585,NA,NA,Feature0409,20,29,4,3,0,0,1.45,0.2,-0.5999999999999996,77.39999999999999,8,4,0.07692307692307693,0.2,1,Lignin,675964.9540550606,898577.3166170263,1.3293253018910693,0.4106941926481563,0.5694467227083436,0.7634736581619005,Upregulated
Feature0408,"4,5,7-Trihydroxycoumarin",C9 H6 O5,194.02152,Biosynthesis of various plant secondary metabolites,NA,"4,5,7-Trihydroxycoumarin",9,6,5,0,0,0,0.6666666666666666,0.5555555555555556,0.44444444444444464,47.633333333333326,7,2,0.5,0.6923076923076923,2,Condensed HC,82251.8961107751,96984.0266397138,1.1791099199597512,0.2376982166967379,0.13944803350151772,0.45798070948295916,Upregulated
Feature0407,NA,C11 H21 N3 O2,227.16337,NA,NA,Feature0407,11,21,2,3,0,0,1.9090909090909092,0.18181818181818185,-0.7272727272727275,81.02727272727273,3,1,-0.3333333333333333,-0.14285714285714285,-2,Lipid,8565695.302128997,5571136.117770083,0.6504009214973339,-0.6205987934419924,0.010912184305805527,0.24646986952046082,Downregulated
Feature0406,Clavamycin D,C13 H21 N3 O6,315.14297,NA,NA,Clavamycin D,13,21,6,3,0,0,1.6153846153846154,0.4615384615384616,0,60.3,5,-1,-1,-0.14285714285714285,-4,Protein,8030351.235704973,7129695.1886361735,0.8878435051428069,-0.17162269111735812,0.08756755405887319,0.41320177319145174,Downregulated
Feature0405,NA,C21 H38 N4 O7,458.27426,NA,NA,Feature0405,21,38,7,4,0,0,1.8095238095238095,0.3333333333333333,-0.5714285714285712,76.58571428571427,5,-2,-0.6,-0.18518518518518515,-6,Protein,154024.061507721,130301.35759342067,0.8459805326383297,-0.24130362987462442,0.1452992329938188,0.4658688473133245,Downregulated
Feature0404,pro-gln,C10 H17 N3 O4,243.1219,NA,NA,pro-gln,10,17,4,3,0,0,1.7,0.4,0,60.3,4,0,-1,-0.2,-3,Protein,3744016.185578503,706706.7592513784,0.18875633122888924,-2.405403059035958,0.35158040264326584,0.6093000912850749,Downregulated
Feature0403,NA,C13 H25 N3 O4,287.18453,NA,NA,Feature0403,13,25,4,3,0,0,1.9230769230769231,0.3076923076923077,-0.615384615384615,77.83846153846153,3,-1,-0.6666666666666666,-0.25,-4,Protein,2632319.94935558,3015600.418286807,1.1456055784651322,0.19611042285830152,0.34315419144556003,0.6017631473175763,Upregulated
Feature0402,NA,C11 H15 N5 O,233.12763,NA,NA,Feature0402,11,15,1,5,0,0,1.3636363636363635,0.09090909090909093,0.18181818181818168,55.11818181818182,7,6,0.2,0.2727272727272727,1,Unsaturated HC,6645928.047821507,5212182.11405453,0.7842670092949697,-0.3505831811029664,0.14669756201351222,0.4658688473133245,Downregulated
Feature0401,NA,C19 H36 N4 O6,416.26354,NA,NA,Feature0401,19,36,6,4,0,0,1.894736842105263,0.3157894736842105,-0.6315789473684212,78.30000000000001,4,-2,-0.6666666666666666,-0.25,-6,Protein,4188732.5187117234,4185665.6112668333,0.9992678196969633,-0.0010566997868369623,0.9978896029513689,0.9986422592908042,Downregulated
Feature0400,Monoethyl malonic acid,C5 H8 O4,132.04224,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Phenylalanine metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,Monoethyl malonic acid,5,8,4,0,0,0,1.6,0.8,0,60.3,2,-2,-2,0,-2,Carbohydrate,2093024.6388362467,1746603.24969439,0.8344876678879078,-0.26103736538147776,0.1426907522020436,0.46161586781018427,Downregulated
Feature0399,4-Hydroxyprolylthreonine,C9 H16 N2 O5,232.10595,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,Other,4-Hydroxyprolylthreonine-peak1,9,16,5,2,0,0,1.7777777777777777,0.5555555555555556,0,60.3,3,-2,-2,-0.3333333333333333,-4,Amino Sugar,3204006.88778779,4078495.9600628368,1.272936077512255,0.34815997385707526,0.5286853686175028,0.7346333474948522,Upregulated
Feature0398,NA,C7 H7 O2 P S,185.99051,NA,NA,Feature0398,7,7,2,0,1,1,1,0.2857142857142857,-0.8571428571428568,84.72857142857141,5,3,0.3333333333333333,0.5,1,Lignin,7438541.686903063,6851121.671513333,0.9210302180030808,-0.11867960453380887,0.4734467006340466,0.6937878121748052,Downregulated
Feature0397,gln-phe,C14 H19 N3 O4,293.13756,NA,NA,gln-phe-peak1,14,19,4,3,0,0,1.3571428571428572,0.2857142857142857,-0.14285714285714324,64.37142857142858,7,3,0,0.2222222222222222,0,Lignin,4697976.182347253,3573419.878624127,0.7606296285731139,-0.394733957965962,0.30686458633955965,0.5765119163510489,Downregulated
Feature0396,Phenacetin,C10 H13 N O2,179.09463,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",NA,Phenacetin-peak1,10,13,2,1,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Lignin,1865896.5525034633,1087682.5605219847,0.5829275792715555,-0.7786114353306822,0.0011121718074685323,0.1464780426635451,Downregulated
Feature0395,asn-tyr,C13 H17 N3 O5,295.11689,NA,NA,asn-tyr-peak2,13,17,5,3,0,0,1.3076923076923077,0.38461538461538464,0.15384615384615374,55.91538461538462,7,2,-0.2,0.2,-1,Lignin,3436599.6639957903,4943809.60573155,1.4385759439850792,0.5246413845242675,0.23429452405013515,0.5205827096922604,Upregulated
Feature0394,6-Hydroxymelatonin,C13 H16 N2 O3,248.11602,Other,Other,6-Hydroxymelatonin-peak2,13,16,3,2,0,0,1.2307692307692308,0.2307692307692308,-0.3076923076923075,69.06923076923076,7,4,0.25,0.3684210526315789,2,Lignin,113054.29240092673,143476.45399159234,1.2690933793365304,0.34379822595551224,0.11340929186923306,0.44471143617240927,Upregulated
Feature0393,beta-Aspartylaspartic acid,C8 H12 N2 O7,248.0644,NA,NA,beta-Aspartylaspartic acid,8,12,7,2,0,0,1.5,0.875,1,31.799999999999997,4,-3,5,-0.6,-5,Carbohydrate,1200651.484772116,614833.9904360943,0.5120836464486529,-0.9655486079820691,0.24643859426932366,0.5299934619693243,Downregulated
Feature0392,N-Acetyltyramine,C10 H13 N O2,179.09462,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",NA,N-Acetyltyramine-peak1,10,13,2,1,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Lignin,3331825.43054362,2590450.7874226067,0.7774869486484318,-0.3631096373653077,0.2123289086197095,0.5042851084128842,Downregulated
Feature0391,Asp-Trp,C15 H17 N3 O5,319.11688,NA,NA,Asp-Trp,15,17,5,3,0,0,1.1333333333333333,0.3333333333333333,0.1333333333333333,56.5,9,4,0.14285714285714285,0.3684210526315789,1,Lignin,3951624.76200419,4313648.708303253,1.0916139482118872,0.12646273402989122,0.8262856012908611,0.9149513021703188,Upregulated
Feature0390,Cyclopentanone,C5 H8 O,84.05753,Other,NA,Cyclopentanone-peak2,5,8,1,0,0,0,1.6,0.2,-1.2000000000000002,94.5,2,1,0.25,0.3333333333333333,1,Lipid,1432720.9952988166,1891919.69052638,1.3205081078132663,0.40109315956337926,0.16801060436065648,0.47405832082810595,Upregulated
Feature0389,asn-val,C9 H17 N3 O4,231.12194,NA,NA,asn-val-peak2,9,17,4,3,0,0,1.8888888888888888,0.4444444444444444,0,60.3,3,-1,-2,-0.5,-4,Protein,3619863.8155818433,4312331.860773044,1.1912967118294464,0.25253278463128953,0.5310326234624667,0.7346581985645525,Upregulated
Feature0388,NA,C16 H29 N3 O6,359.20577,NA,NA,Feature0388,16,29,6,3,0,0,1.8125,0.375,-0.5,74.55,4,-2,-0.7142857142857143,-0.2,-5,Protein,3126111.87419595,3354985.0452728868,1.073213365448031,0.1019369266748487,0.790638435351663,0.8958806083516503,Upregulated
Feature0387,NA,C26 H43 N5 O5,505.32642,NA,NA,Feature0387,26,43,5,5,0,0,1.6538461538461535,0.19230769230769232,-0.6923076923076925,80.03076923076924,8,3,-0.125,0.02702702702702703,-2,Lipid,3820283.7909793234,3625458.37856218,0.9490023717931174,-0.07551640198250287,0.8741618392655717,0.935214143108896,Downregulated
Feature0386,cis-acetylacrylic acid,C5 H6 O3,114.03164,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylalanine metabolism;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,cis-acetylacrylic acid-peak1,5,6,3,0,0,0,1.2,0.6,0,60.3,3,0,0,0.42857142857142855,0,Lignin,1062800.6244784207,1249184.8360135655,1.1753708148474364,0.23311598091282093,0.482123936824306,0.6986673019504323,Upregulated
Feature0385,N-(2-Phenylethyl)-beta-D-glucopyranuronosylamine,C14 H19 N O6,297.12132,NA,NA,N-(2-Phenylethyl)-beta-D-glucopyranuronosylamine,14,19,6,1,0,0,1.3571428571428572,0.42857142857142855,-0.2857142857142856,68.44285714285714,6,0,-0.14285714285714285,0.2,-1,Lignin,326663.06478973565,258573.69610357133,0.7915608588011269,-0.33722781930035073,0.22951143777804633,0.5170330973050352,Downregulated
Feature0384,NA,C8 H19 N O7,241.11608,NA,NA,Feature0384,8,19,7,1,0,0,2.375,0.875,-0.25,67.425,0,-7,-Inf,-1.2857142857142858,-8,Carbohydrate,5306156.370431143,2858823.6393874967,0.5387748569413546,-0.8922455689060085,0.13064363977765903,0.45384777576550756,Downregulated
Feature0383,Kyotorphin,C15 H23 N5 O4,337.17513,NA,NA,Kyotorphin,15,23,4,5,0,0,1.5333333333333334,0.26666666666666666,0,60.3,7,3,-0.3333333333333333,0,-2,Lipid,2531620.06549395,4304920.75655712,1.7004608295033312,0.7659257736246076,0.20675197516816907,0.5026064024853513,Upregulated
Feature0382,NA,C17 H25 N3 O4,335.18464,NA,NA,Feature0382,17,25,4,3,0,0,1.4705882352941178,0.2352941176470588,-0.47058823529411775,73.71176470588236,7,3,0,0.16666666666666666,0,Lignin,7855958.623668403,8858225.898453424,1.1275805185334598,0.17323045746407212,0.5923576963776156,0.7816283742544378,Upregulated
Feature0381,NL8513000,C11 H13 N O2,191.09464,NA,Other,NL8513000-peak2,11,13,2,1,0,0,1.181818181818182,0.18181818181818185,-0.5454545454545459,75.84545454545456,6,4,0.375,0.4444444444444444,3,Lignin,204398.04224302934,426792.39169983234,2.0880453991451446,1.062153079920021,0.11252649470051818,0.4443353893302513,Upregulated
Feature0380,S-Allyl-L-cysteine,C6 H11 N O2 S,161.05105,NA,Other,S-Allyl-L-cysteine,6,11,2,1,1,0,1.8333333333333333,0.3333333333333333,-0.33333333333333304,69.79999999999998,2,0,-1,-0.3333333333333333,-2,Protein,305544.242049528,510577.1443199393,1.6710416170669515,0.7407476639726783,0.5018855199628389,0.7126521968290437,Upregulated
Feature0379,"4-cyclopropyl-6-methoxy-1,3,5-triazin-2-amine",C7 H10 N4 O,166.08548,Metabolic pathways;ABC transporters;Other,NA,"4-cyclopropyl-6-methoxy-1,3,5-triazin-2-amine",7,10,1,4,0,0,1.4285714285714286,0.14285714285714285,0.5714285714285716,44.014285714285705,5,4,0,0.2,0,Lignin,136126.599708697,146140.18891964233,1.0735608560881842,0.10240397441806602,0.44317172375033415,0.6668537167127339,Upregulated
Feature0378,?-Ribazole,C14 H18 N2 O4,278.12667,Metabolic pathways;Biosynthesis of cofactors;Other,NA,?-Ribazole-peak2,14,18,4,2,0,0,1.2857142857142858,0.2857142857142857,-0.2857142857142856,68.44285714285714,7,3,0.125,0.3,1,Lignin,1988838.1275583967,778296.2554121693,0.39133212734997547,-1.353534538275467,0.0013973546298730014,0.15098679741337404,Downregulated
Feature0377,Pheneturide,C11 H14 N2 O2,206.10554,Other,NA,Pheneturide,11,14,2,2,0,0,1.2727272727272727,0.18181818181818185,-0.3636363636363633,70.66363636363636,6,4,0.2857142857142857,0.375,2,Lignin,941709.7476648793,512848.6119312633,0.5445930799834597,-0.8767494443767038,0.05676126342638928,0.37707286370315074,Downregulated
Feature0376,pyricarbate,C11 H15 N3 O4,253.10625,NA,NA,pyricarbate,11,15,4,3,0,0,1.3636363636363635,0.3636363636363637,0.18181818181818168,55.11818181818182,6,2,-0.25,0.16666666666666666,-1,Lignin,8543219.159334358,7608186.165142073,0.8905526152667331,-0.16722724432187144,0.24363726712802114,0.5271028486779921,Downregulated
Feature0375,NA,C31 H37 N O11,599.23689,NA,NA,Feature0375,31,37,11,1,0,0,1.1935483870967742,0.3548387096774194,-0.387096774193548,71.33225806451611,14,3,0.10526315789473684,0.30612244897959184,2,Lignin,2132726.8255071705,7460431.64796566,3.4980718387088987,1.8065599177000575,0.022248170498155258,0.2912553665556471,Upregulated
Feature0374,NA,C7 H14 N2 O2,158.10555,NA,NA,Feature0374,7,14,2,2,0,0,2,0.2857142857142857,-0.5714285714285712,76.58571428571427,2,0,-0.6666666666666666,-0.25,-2,Lipid,2520025.1994681936,2403723.5468788533,0.9538490120599256,-0.06816717959153655,0.8413297144916407,0.9218399058025261,Downregulated
Feature0373,NA,C15 H27 N3 O6,345.19011,NA,NA,Feature0373,15,27,6,3,0,0,1.8,0.4,-0.4000000000000003,71.7,4,-2,-0.8333333333333334,-0.2222222222222222,-5,Protein,5541482.9200187735,5751865.977043146,1.0379651187346184,0.05375796212147773,0.9339164948823049,0.9640795504757004,Upregulated
Feature0372,arg-gln,C11 H22 N6 O4,302.17037,NA,NA,arg-gln,11,22,4,6,0,0,2,0.3636363636363637,0.36363636363636376,49.93636363636363,4,0,-6,-1.3333333333333333,-6,Protein,8209207.504567291,8957721.46591741,1.0911798076651948,0.12588885258063903,0.6767057426189549,0.8330955872067657,Upregulated
Feature0371,NA,C18 H31 N6 O4 P3,488.16202,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,Feature0371,18,31,4,6,0,3,1.7222222222222223,0.2222222222222222,-1.1111111111111107,91.96666666666664,8,4,-1,-0.42857142857142855,-5,Lipid,7181416.33983011,5242499.795634077,0.730009171945335,-0.45401350454275774,0.2818487706809568,0.5610479641992254,Downregulated
Feature0370,L-Hydroxyproline,C5 H9 N O3,131.05821,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Other,L-Hydroxyproline,5,9,3,1,0,0,1.8,0.6,0,60.3,2,-1,-2,-0.2,-2,Amino Sugar,5669940.19596533,5827097.36839439,1.0277176067114238,0.03944389939074072,0.7454368188619788,0.8732849039780028,Upregulated
Feature0369,Penicillic acid,C8 H10 O4,170.05799,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Tyrosine metabolism;Other,NA,Penicillic acid-peak1,8,10,4,0,0,0,1.25,0.5,-0.25,67.425,4,0,0,0.3333333333333333,0,Lignin,6818252.49225052,9377565.40778833,1.3753620034527427,0.45981139452746506,0.10332967538113817,0.42914157342056886,Upregulated
Feature0368,NA,C11 H21 N5 O2,255.16954,NA,NA,Feature0368,11,21,2,5,0,0,1.9090909090909092,0.18181818181818185,-0.18181818181818168,65.48181818181817,4,2,-0.75,-0.4,-3,Lipid,8219167.370159296,6514321.944601533,0.7925768695564692,-0.33537723036105904,0.01368961227341589,0.25835889181660304,Downregulated
Feature0367,Marimastat,C15 H29 N3 O5,331.21084,NA,NA,Marimastat-peak3,15,29,5,3,0,0,1.9333333333333331,0.3333333333333333,-0.666666666666667,79.30000000000001,3,-2,-0.7142857142857143,-0.2631578947368421,-5,Protein,3219385.684477933,3618157.1096315766,1.1238656887481033,0.16846963186208133,0.3409303580439559,0.6009740130348192,Upregulated
Feature0366,Desthiobiotin,C10 H18 N2 O3,214.13169,Metabolic pathways;Biosynthesis of cofactors;Other,Other,Desthiobiotin-peak2,10,18,3,2,0,0,1.8,0.3,-0.5999999999999996,77.39999999999999,3,0,-0.4,-0.07692307692307693,-2,Lipid,1126515.0061524634,2293706.419924375,2.036108180891772,1.0258142155834789,0.26838692415632714,0.5485236753179552,Upregulated
Feature0365,NA,C20 H36 N4 O6,428.2636,NA,NA,Feature0365,20,36,6,4,0,0,1.8,0.3,-0.5999999999999996,77.39999999999999,5,-1,-0.5,-0.15384615384615383,-5,Lipid,117025.00376850346,134575.27230862266,1.149970245459994,0.20159653309777859,0.4314568292686378,0.6620361130263338,Upregulated
Feature0364,NA,C13 H17 N5 O7,355.11296,NA,NA,Feature0364,13,17,7,5,0,0,1.3076923076923077,0.5384615384615384,0.9230769230769228,33.99230769230769,8,1,-4,-0.1111111111111111,-4,Lignin,5738994.08157511,4677892.168532583,0.8151066375117607,-0.29493928051858426,0.022517900874286623,0.2912553665556471,Downregulated
Feature0363,Acetylcarnitine,C9 H17 N O4,203.11573,NA,NA,Acetylcarnitine-peak1,9,17,4,1,0,0,1.8888888888888888,0.4444444444444444,-0.666666666666667,79.30000000000001,2,-2,-0.75,-0.16666666666666666,-3,Protein,620137.5564802503,870157.422118284,1.4031683987292844,0.48868816179641744,0.024332143210794216,0.29653705466967917,Upregulated
Feature0362,NA,C8 H12 N6,192.11229,NA,NA,Feature0362,8,12,0,6,0,0,1.5,0,0.75,38.925,6,6,0,0,0,Lipid,6276569.577904543,9126202.566600867,1.4540112163701504,0.5400383983766123,0.22515592609092017,0.5155824363504518,Upregulated
Feature0361,Aniflorine,C20 H21 N3 O3,351.15844,NA,NA,Aniflorine,20,21,3,3,0,0,1.05,0.15,-0.2999999999999998,68.85,12,9,0.42857142857142855,0.4838709677419355,6,Lignin,2585398.2211613436,4531524.969631527,1.7527377146550351,0.8096101226933439,0.0173396416378916,0.2637533176745511,Upregulated
Feature0360,N6-Methyladenine,C6 H7 N5,149.07016,NA,NA,N6-Methyladenine,6,7,0,5,0,0,1.1666666666666667,0,1.3333333333333337,22.29999999999999,6,6,1,1,1,Unsaturated HC,115234.42803497847,108420.9261814856,0.9408726890940554,-0.0879285719744478,0.7774877513107634,0.8887073216737067,Downregulated
Feature0359,afegostat,C6 H13 N O3,147.08956,Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,afegostat-peak1,6,13,3,1,0,0,2.1666666666666665,0.5,-0.666666666666667,79.30000000000001,1,-2,-1.5,-0.42857142857142855,-3,Protein,177956.67989938732,229375.76477012734,1.2889415834225004,0.3661868802888453,0.4249811446770984,0.6594697741371865,Upregulated
Feature0358,NA,C43 H57 N6 O4 P3,814.36502,NA,NA,Feature0358,43,57,4,6,0,3,1.3255813953488371,0.09302325581395347,-1.0697674418604652,90.78837209302326,20,16,0.23333333333333336,0.28125,7,Unsaturated HC,2653648.0575954234,6329659.089830277,2.385266980567813,1.2541507546938722,0.07649595650312999,0.39590936857023457,Upregulated
Feature0357,"Methyl 2,3-dihydro-3-hydroxy-2-oxo-1H-indole-3-acetate",C11 H11 N O4,221.06882,NA,NA,"Methyl 2,3-dihydro-3-hydroxy-2-oxo-1H-indole-3-acetate",11,11,4,1,0,0,1,0.3636363636363637,0,60.3,7,3,0.3333333333333333,0.5,2,Lignin,7095796.1825915165,7219433.963651977,1.017424088555952,0.024921156998269932,0.8863120012385302,0.941126558385276,Upregulated
Feature0356,MFCD00037215,C8 H14 N2 O5,218.09028,NA,NA,MFCD00037215,8,14,5,2,0,0,1.75,0.625,0.25,53.175,3,-2,-4,-0.42857142857142855,-4,Amino Sugar,286630.307521765,256466.09832195233,0.8947626667235035,-0.16042303256329715,0.6571920184870241,0.8228257792439163,Downregulated
Feature0355,(3S)-3-{(Z)-[(3S)-3-{(Z)-[(3R)-3-Amino-1-hydroxy-4-methylpentylidene]amino}-1-hydroxybutylidene]amino}-5-methylhexanoic acid,C17 H33 N3 O4,343.24723,NA,NA,(3S)-3-{(Z)-[(3S)-3-{(Z)-[(3R)-3-Amino-1-hydroxy-4-methylpentylidene]amino}-1-hydroxybutylidene]amino}-5-methylhexanoic acid-peak1,17,33,4,3,0,0,1.9411764705882353,0.2352941176470588,-0.9411764705882356,87.12352941176471,3,-1,-0.4,-0.16666666666666666,-4,Lipid,3518523.86414993,3511060.24607625,0.9978787644018202,-0.003063546479934217,0.9960084251831387,0.997775441904339,Downregulated
Feature0354,NA,C13 H25 N3 O5,303.17954,NA,NA,Feature0354,13,25,5,3,0,0,1.9230769230769231,0.38461538461538464,-0.4615384615384617,73.45384615384616,3,-2,-1,-0.3333333333333333,-5,Protein,2193625.3547061235,2901260.59612488,1.3225870998895148,0.40336273514906124,0.3159167895715043,0.5833555243474817,Upregulated
Feature0353,Phosphonoacetic acid,C2 H5 O5 P,139.98747,Metabolic pathways;Microbial metabolism in diverse environments;Other,Superpathway of L-lysine degradation;Other,Phosphonoacetic acid,2,5,5,0,0,1,2.5,2.5,0,60.3,1,-4,1.25,1.6666666666666667,-5,Other,1078873.8615327014,836628.5947251014,0.7754646994010453,-0.3668669862993727,0.24627561598012085,0.5299934619693243,Downregulated
Feature0352,"Hydroxy-1,4-benzoquinone",C6 H4 O3,124.01601,Metabolic pathways;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,NA,"Hydroxy-1,4-benzoquinone",6,4,3,0,0,0,0.6666666666666666,0.5,0.3333333333333335,50.8,5,2,0.6666666666666666,0.7777777777777778,2,Condensed HC,6589935.436042117,5005905.218587513,0.7596288715074324,-0.3966333552911722,0.04147245185203629,0.35607946299980225,Downregulated
Feature0351,Leu-Gly-Pro,C13 H23 N3 O4,285.16889,NA,NA,Leu-Gly-Pro-peak2,13,23,4,3,0,0,1.7692307692307692,0.3076923076923077,-0.4615384615384617,73.45384615384616,4,0,-0.5,-0.125,-3,Protein,1206668.33226695,1560944.05128734,1.293598256908605,0.37138963992992846,0.03581405642984776,0.33805559870221996,Upregulated
Feature0350,APM,C7 H13 N O4,175.08448,NA,NA,APM-peak3,7,13,4,1,0,0,1.8571428571428572,0.5714285714285714,-0.2857142857142856,68.44285714285714,2,-2,-1.5,-0.25,-3,Amino Sugar,310736.3752328003,327336.953139179,1.0534233492745795,0.07508534249449725,0.8610992626674108,0.9285182374020331,Upregulated
Feature0349,NA,C22 H41 N5 O5,455.31091,NA,NA,Feature0349,22,41,5,5,0,0,1.8636363636363635,0.2272727272727273,-0.7272727272727275,81.02727272727273,5,0,-0.4166666666666667,-0.1724137931034483,-5,Lipid,306237.9649078823,258149.5341421897,0.8429703816110525,-0.246446152988718,0.7093951077853815,0.849869386554764,Downregulated
Feature0348,Bicine,C6 H13 N O4,163.08447,Biosynthesis of secondary metabolites;Other,Superpathway of butirocin biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis,Bicine,6,13,4,1,0,0,2.1666666666666665,0.6666666666666666,-0.33333333333333304,69.79999999999998,1,-3,-4,-0.6666666666666666,-4,Amino Sugar,671511.5753283619,817670.6933771704,1.2176568854786132,0.28410766415191346,0.28796704209088836,0.5646020478032001,Upregulated
Feature0347,Ethyl L-tyrosinate,C11 H15 N O3,209.1052,Biosynthesis of alkaloids derived from shikimate pathway;Other,NA,Ethyl L-tyrosinate,11,15,3,1,0,0,1.3636363636363635,0.2727272727272727,-0.5454545454545459,75.84545454545456,5,2,0.14285714285714285,0.29411764705882354,1,Lignin,297600.546802647,258319.39058440735,0.868007110066606,-0.20422123468785974,0.5675271142993736,0.7624035936741783,Downregulated
Feature0346,Uracil,C4 H4 N2 O2,112.02723,Metabolic pathways;Other,Other,Uracil-peak1,4,4,2,2,0,0,1,0.5,1.5,17.549999999999997,4,2,NA,1,0,Lignin,1517830.5742499067,1693011.7153931335,1.1154154779296095,0.15758119561544945,0.5542465774644829,0.7562901141909594,Upregulated
Feature0345,Gly-Ser,C5 H10 N2 O4,162.06409,NA,NA,Gly-Ser,5,10,4,2,0,0,2,0.8,0.7999999999999998,37.5,2,-2,4,-2,-4,Carbohydrate,3178640.966226843,5112414.55588651,1.608364898774687,0.6855947559759322,0.1631914775819823,0.4734778652324074,Upregulated
Feature0344,L-Isoleucyl-L-alanyl-D-arginine,C15 H30 N6 O4,358.23296,NA,NA,L-Isoleucyl-L-alanyl-D-arginine-peak1,15,30,4,6,0,0,2,0.26666666666666666,-0.2666666666666666,67.89999999999999,4,0,-1.2,-0.5714285714285714,-6,Lipid,3804624.3060542066,3486689.2354472834,0.9164345688216834,-0.12589621532925224,0.5552137595458336,0.7562901141909594,Downregulated
Feature0343,Oglufanide,C16 H19 N3 O5,333.13251,NA,NA,Oglufanide,16,19,5,3,0,0,1.1875,0.3125,0,60.3,9,4,0.125,0.3333333333333333,1,Lignin,2884229.892075383,4201878.23532667,1.4568458106864557,0.5428481938545177,0.15160882383974184,0.46695517742640485,Upregulated
Feature0342,NA,C13 H21 N3 O5,299.1482,NA,NA,Feature0342,13,21,5,3,0,0,1.6153846153846154,0.38461538461538464,-0.1538461538461542,64.6846153846154,5,0,-0.6,-0.06666666666666667,-3,Protein,190321.932533521,506196.53835468367,2.659685784062372,1.4112558154439585,0.36860729255285585,0.6231744047749879,Upregulated
Feature0341,NA,C19 H41 N O2,315.3138,NA,NA,Feature0341,19,41,2,1,0,0,2.1578947368421053,0.10526315789473684,-1.7894736842105263,111.3,0,-2,-0.1875,-0.1176470588235294,-3,Lipid,139855.8915724957,161010.202969501,1.151257920986759,0.20321108250901362,0.29795517095232965,0.572300932924636,Upregulated
Feature0340,"(5-Benzyl-3,6-dioxo-2-piperazinyl)acetic acid",C13 H14 N2 O4,262.09538,NA,NA,"(5-Benzyl-3,6-dioxo-2-piperazinyl)acetic acid",13,14,4,2,0,0,1.0769230769230769,0.3076923076923077,0,60.3,8,4,0.2857142857142857,0.4444444444444444,2,Lignin,1516900.4291463345,350207.618057932,0.23087053792648618,-2.1148440166186355,0.4891750568166238,0.7053893716081695,Downregulated
Feature0339,ophthalmic acid,C11 H19 N3 O6,289.12729,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,ophthalmic acid,11,19,6,3,0,0,1.7272727272727273,0.5454545454545454,0.18181818181818168,55.11818181818182,4,-2,-2.5,-0.4,-5,Protein,6367465.652231987,6283009.564930843,0.9867363105018809,-0.019263495877215084,0.9596975460803201,0.9775872778473014,Downregulated
Feature0338,1581740,C12 H13 N O4,235.08445,NA,NA,1581740-peak1,12,13,4,1,0,0,1.0833333333333333,0.3333333333333333,-0.16666666666666696,65.05000000000001,7,3,0.2857142857142857,0.4444444444444444,2,Lignin,391438.391846876,107420.65158432887,0.2744254365993563,-1.8655138832200973,0.022523289857609072,0.2912553665556471,Downregulated
Feature0337,Leu-Glu,C11 H20 N2 O5,260.13726,NA,NA,Leu-Glu-peak1,11,20,5,2,0,0,1.818181818181818,0.4545454545454546,-0.3636363636363633,70.66363636363636,3,-2,-1,-0.2307692307692308,-4,Protein,3598853.01129511,2829532.3479519836,0.7862317074555171,-0.3469735483901396,0.5559152679473608,0.7562901141909594,Downregulated
Feature0336,"3-[(1S,4R)-4-Hydroxy-2-cyclohexen-1-yl]-L-alanine",C9 H15 N O3,185.10525,Other,NA,"3-[(1S,4R)-4-Hydroxy-2-cyclohexen-1-yl]-L-alanine",9,15,3,1,0,0,1.6666666666666667,0.3333333333333333,-0.666666666666667,79.30000000000001,3,0,-0.2,0.07692307692307693,-1,Protein,1520225.1675800167,770455.7053310437,0.5068036773509678,-0.9805011022224576,0.018027759533001737,0.2637533176745511,Downregulated
Feature0335,N-Acetyl-L-leucine,C8 H15 N O3,173.10526,Other,NA,N-Acetyl-L-leucine-peak2,8,15,3,1,0,0,1.875,0.375,-0.75,81.675,2,-1,-0.5,-0.09090909090909093,-2,Protein,5703574.34680809,5064710.143098227,0.8879888005549725,-0.17138661367875027,0.19012729905053993,0.4862119877973694,Downregulated
Feature0334,Alanyltryptophan,C14 H17 N3 O3,275.12704,NA,NA,Alanyltryptophan-peak2,14,17,3,3,0,0,1.2142857142857142,0.21428571428571427,-0.14285714285714324,64.37142857142858,8,5,0.25,0.3684210526315789,2,Lignin,5511616.114961067,4161050.92753339,0.754960222327237,-0.405527461791399,0.08705256688248492,0.4119191293266186,Downregulated
Feature0333,Leucyl-leucyl-norleucine,C18 H35 N3 O4,357.26288,NA,NA,Leucyl-leucyl-norleucine-peak3,18,35,4,3,0,0,1.9444444444444444,0.2222222222222222,-1,88.8,3,-1,-0.3636363636363637,-0.15384615384615383,-4,Lipid,3388000.8475838066,3624244.9499975066,1.069729646786299,0.09724622978186194,0.6803918732982742,0.8353437703403417,Upregulated
Feature0332,N-Acetylvanilalanine,C12 H15 N O5,253.09505,NA,NA,N-Acetylvanilalanine-peak2,12,15,5,1,0,0,1.25,0.4166666666666667,-0.16666666666666696,65.05000000000001,6,1,0,0.29411764705882354,0,Lignin,4817644.00442189,4012858.5712909466,0.8329504146856288,-0.2636974799884673,0.04902290495347322,0.35641545489778387,Downregulated
Feature0331,tyr-thr,C13 H18 N2 O5,282.12167,NA,NA,tyr-thr-peak2,13,18,5,2,0,0,1.3846153846153846,0.38461538461538464,-0.1538461538461542,64.6846153846154,6,1,-0.16666666666666666,0.17647058823529413,-1,Lignin,2865110.57963207,4276816.4952021735,1.492723012370221,0.5779464857986464,0.2915899109091218,0.5677030523083425,Upregulated
Feature0330,Alanyltryptophan,C14 H17 N3 O3,275.12702,NA,NA,Alanyltryptophan-peak1,14,17,3,3,0,0,1.2142857142857142,0.21428571428571427,-0.14285714285714324,64.37142857142858,8,5,0.25,0.3684210526315789,2,Lignin,3417624.30897571,4468454.299889663,1.307473816871608,0.3867820557282684,0.17628803975814736,0.4787739794294037,Upregulated
Feature0329,NA,C17 H31 N3 O6,373.22136,NA,NA,Feature0329,17,31,6,3,0,0,1.8235294117647056,0.35294117647058826,-0.5882352941176467,77.06470588235292,4,-2,-0.625,-0.18181818181818185,-5,Protein,3822147.1073958133,4792364.95172326,1.253841052441463,0.32635447143447116,0.03759202960987247,0.3387281816974679,Upregulated
Feature0328,pre-putrebactin,C16 H30 N4 O7,390.2116,NA,NA,pre-putrebactin,16,30,7,4,0,0,1.875,0.4375,-0.25,67.425,4,-3,-1.4,-0.4117647058823529,-7,Protein,5697857.619987413,4777141.253537743,0.8384100783389348,-0.25427203559524053,0.7689779965478714,0.8843507984739266,Downregulated
Feature0327,"6,7-dihydro-5H-dibenzo[d,f][1,3]diazepin-6-one",C13 H10 N2 O,210.07933,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"6,7-dihydro-5H-dibenzo[d,f][1,3]diazepin-6-one",13,10,1,2,0,0,0.7692307692307693,0.07692307692307693,-0.1538461538461542,64.6846153846154,10,9,0.7,0.7142857142857143,7,Condensed HC,229411.598157075,293030.8485195557,1.277314882392831,0.35311422063011416,0.35176829355183187,0.6093000912850749,Upregulated
Feature0326,Brivaracetam,C11 H20 N2 O2,212.15246,NA,NA,Brivaracetam,11,20,2,2,0,0,1.818181818181818,0.18181818181818185,-0.9090909090909092,86.2090909090909,3,1,-0.14285714285714285,0,-1,Lipid,6695331.555823283,5268817.894701123,0.7869390560828244,-0.3456761832862126,0.1000741944795592,0.42394143745703483,Downregulated
Feature0325,ile-his,C12 H20 N4 O3,268.15361,NA,NA,ile-his-peak1,12,20,3,4,0,0,1.6666666666666667,0.25,-0.16666666666666696,65.05000000000001,5,2,-0.4,-0.07692307692307693,-2,Lipid,3606750.15763223,6428317.679576163,1.7823019057677798,0.8337417370069317,0.029653625034787898,0.31473439619293775,Upregulated
Feature0324,"2,3-dihydro-2-spiro[1-(benzyl)piperidin-4-yl]-1,3-benzothiazole",C18 H20 N2 S,296.13484,NA,NA,"2,3-dihydro-2-spiro[1-(benzyl)piperidin-4-yl]-1,3-benzothiazole",18,20,0,2,1,0,1.1111111111111112,0,-0.666666666666667,79.30000000000001,10,10,0.4666666666666667,0.4666666666666667,7,Unsaturated HC,76291.05093672826,91335.42373174221,1.1971970841965587,0.2596606702330755,0.03649500845388369,0.33805559870221996,Upregulated
Feature0323,3-Buten-1-amine,C4 H9 N,71.07351,NA,NA,3-Buten-1-amine-peak1,4,9,0,1,0,0,2.25,0,-1.5,103.05,1,1,0,0,0,Lipid,517938.57369204966,572935.1364239383,1.1061835621545886,0.14559080893265047,0.6650854089182394,0.8275141791352959,Upregulated
Feature0322,"1-(beta-D-Ribofuranosyl)-1,2-dihydropyrimidine",C9 H14 N2 O4,214.09536,NA,NA,"1-(beta-D-Ribofuranosyl)-1,2-dihydropyrimidine",9,14,4,2,0,0,1.5555555555555556,0.4444444444444444,0,60.3,4,0,-0.6666666666666666,0,-2,Protein,5914343.029238846,5551326.014171087,0.9386209062827258,-0.09138550043370386,0.43638293176277904,0.6640970014604831,Downregulated
Feature0321,NA,C14 H26 N4 O5,330.1904,NA,NA,Feature0321,14,26,5,4,0,0,1.8571428571428572,0.35714285714285715,-0.2857142857142856,68.44285714285714,4,-1,-1,-0.3333333333333333,-5,Protein,2825717.7503005867,2603210.1453614365,0.9212562525342523,-0.11832558912519342,0.6331402267561901,0.8130361577998497,Downregulated
Feature0320,Bis(methylbenzylidene)sorbitol,C22 H26 O6,386.17299,NA,NA,Bis(methylbenzylidene)sorbitol,22,26,6,0,0,0,1.181818181818182,0.2727272727272727,-0.6363636363636367,78.43636363636364,10,4,0.25,0.3684210526315789,4,Lignin,2039145.9412002766,7161121.551713207,3.5118239489509255,1.8122205230219997,0.006449766718281208,0.23030609530252863,Upregulated
Feature0319,6-Quinolinecarboxylic acid,C10 H7 N O2,173.04768,Other,NA,6-Quinolinecarboxylic acid,10,7,2,1,0,0,0.7,0.2,0,60.3,8,6,0.7142857142857143,0.75,5,Condensed HC,6337746.07206872,9055592.581040693,1.4288348693788602,0.51483919362477,0.013716096224284347,0.25835889181660304,Upregulated
Feature0318,(4S)-4-Hydroxy-4-methyltetrahydro-2H-pyran-2-one,C6 H10 O3,130.06297,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I,(4S)-4-Hydroxy-4-methyltetrahydro-2H-pyran-2-one-peak1,6,10,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,924209.9494432494,207483.97346801165,0.22449874467700923,-2.1552207169735764,0.17763126524462497,0.48056479319715995,Downregulated
Feature0317,CMPF,C12 H16 O5,240.09978,NA,NA,CMPF,12,16,5,0,0,0,1.3333333333333333,0.4166666666666667,-0.5,74.55,5,0,0,0.2631578947368421,0,Lignin,130595.28703505466,172214.76523239232,1.3186905066962031,0.3991060074649644,0.023033453735632405,0.2919627558710051,Upregulated
Feature0316,Asp-tyr,C13 H16 N2 O6,296.10088,NA,NA,Asp-tyr,13,16,6,2,0,0,1.2307692307692308,0.4615384615384616,0.15384615384615374,55.91538461538462,7,1,-0.2,0.25,-1,Lignin,3659944.9546047403,5128936.954833827,1.4013699709830014,0.4868378871311684,0.23032921720997554,0.5170330973050352,Upregulated
Feature0315,Aspartame,C14 H18 N2 O5,294.12149,Other,NA,Aspartame-peak1,14,18,5,2,0,0,1.2857142857142858,0.35714285714285715,-0.14285714285714324,64.37142857142858,7,2,0,0.2631578947368421,0,Lignin,580388.3249091897,553877.6134017387,0.9543224589991555,-0.06745126954285711,0.9222718249356227,0.9573091124025398,Downregulated
Feature0314,4-Amino-3-hydroxybenzoic acid,C7 H7 N O3,153.04263,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Aminobenzoate degradation;Other,Other,4-Amino-3-hydroxybenzoic acid,7,7,3,1,0,0,1,0.42857142857142855,0.2857142857142856,52.15714285714286,5,2,0.3333333333333333,0.5555555555555556,1,Lignin,193187.76505830267,186263.55351916334,0.9641581259711263,-0.05265832099808016,0.9043088562312134,0.9485443978053717,Downregulated
Feature0313,L-gamma-Glutamyl-L-leucine,C11 H20 N2 O5,260.13725,NA,NA,L-gamma-Glutamyl-L-leucine-peak1,11,20,5,2,0,0,1.818181818181818,0.4545454545454546,-0.3636363636363633,70.66363636363636,3,-2,-1,-0.2307692307692308,-4,Protein,254869.5409158313,285416.30819340935,1.1198525613057304,0.16330880096593495,0.7579761713377954,0.877656619443763,Upregulated
Feature0312,Phenyl D-glucopyranosiduronic acid,C12 H14 O7,270.07399,NA,NA,Phenyl D-glucopyranosiduronic acid-peak1,12,14,7,0,0,0,1.1666666666666667,0.5833333333333334,0,60.3,6,-1,-0.2,0.29411764705882354,-1,Lignin,279764.97931893566,202180.42312775168,0.7226795277233875,-0.4685720690972007,0.15941572367542278,0.4704707942616136,Downregulated
Feature0311,NA,C13 H23 N3 O6,317.15873,NA,NA,Feature0311,13,23,6,3,0,0,1.7692307692307692,0.4615384615384616,-0.1538461538461542,64.6846153846154,4,-2,-1.25,-0.2857142857142857,-5,Protein,2293334.8466688036,3240684.9250059566,1.4130884243586286,0.498851745496524,0.010820644708695653,0.24646986952046082,Upregulated
Feature0310,NA,C15 H29 N3 O4,315.21588,NA,NA,Feature0310,15,29,4,3,0,0,1.9333333333333331,0.26666666666666666,-0.7999999999999998,83.1,3,-1,-0.5,-0.2,-4,Lipid,3673474.047499603,3894951.1838794765,1.060290921758553,0.08446016459323981,0.7646423032928918,0.8813077766218278,Upregulated
Feature0309,Leu-Gly-Pro,C13 H23 N3 O4,285.16893,NA,NA,Leu-Gly-Pro-peak1,13,23,4,3,0,0,1.7692307692307692,0.3076923076923077,-0.4615384615384617,73.45384615384616,4,0,-0.5,-0.125,-3,Protein,6522678.777943723,6612301.924946907,1.0137402361904195,0.019688019234166434,0.9415120770868555,0.9683797562751263,Upregulated
Feature0308,2-Methoxy-5-methylaniline,C8 H11 N O,137.08405,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Biosynthesis of alkaloids derived from shikimate pathway;Tyrosine metabolism;Other,NA,2-Methoxy-5-methylaniline,8,11,1,1,0,0,1.375,0.125,-0.75,81.675,4,3,0.3333333333333333,0.38461538461538464,2,Unsaturated HC,7169331.55276031,4606616.023659663,0.6425447044482189,-0.638131262927752,0.24592957091797302,0.5299934619693243,Downregulated
Feature0307,NA,C11 H14 N2 O5 S,286.06233,NA,NA,Feature0307,11,14,5,2,1,0,1.2727272727272727,0.4545454545454546,0.36363636363636376,49.93636363636363,6,1,-0.6666666666666666,0.09090909090909093,-2,Lignin,4082616.7209526035,3255980.0448524533,0.7975228309192665,-0.3264022749659224,4.773446912375239e-4,0.13209075561330955,Downregulated
Feature0306,Salsolinol,C10 H13 N O2,179.09459,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",NA,Salsolinol,10,13,2,1,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Lignin,673812.8302624377,454357.9599467717,0.6743088578022588,-0.5685185456813178,0.27822620635811923,0.5571101578849338,Downregulated
Feature0305,tyr-thr,C13 H18 N2 O5,282.12161,NA,NA,tyr-thr-peak1,13,18,5,2,0,0,1.3846153846153846,0.38461538461538464,-0.1538461538461542,64.6846153846154,6,1,-0.16666666666666666,0.17647058823529413,-1,Lignin,3002719.4768286063,2503261.3526808536,0.8336647402456432,-0.26246077695829284,0.38468896160103805,0.6355389841806004,Downregulated
Feature0304,3-oxovaleric acid,C5 H8 O3,116.0473,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Other,3-oxovaleric acid-peak1,5,8,3,0,0,0,1.6,0.6,-0.4000000000000003,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,3020230.408537403,3351168.4926150134,1.1095737871991933,0.15000561065048051,0.26891570488396455,0.5485675864110843,Upregulated
Feature0303,L-Phenylalanine,C9 H11 N O2,165.079,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;ABC transporters;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various plant secondary metabolites;Phenylalanine metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of scopolin and esculin biosynthesis;Superpathway of aromatic amino acid biosynthesis;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of indole-3-acetate conjugate biosynthesis;Other,L-Phenylalanine-peak1,9,11,2,1,0,0,1.2222222222222223,0.2222222222222222,-0.44444444444444464,72.96666666666667,5,3,0.3333333333333333,0.42857142857142855,2,Lignin,448751.719965352,804598.230916857,1.7929696870665586,0.8423510974151946,0.2279949503474263,0.5170330973050352,Upregulated
Feature0302,(E)-5-(methylsulfanyl)pentanal oxime,C6 H13 N O S,147.0718,2-Oxocarboxylic acid metabolism;Other,NA,(E)-5-(methylsulfanyl)pentanal oxime,6,13,1,1,1,0,2.1666666666666665,0.16666666666666666,-1,88.8,1,0,-0.6666666666666666,-0.42857142857142855,-2,Lipid,98099.18370332956,117332.12940631,1.196056123781259,0.2582850881991958,0.15704860910820978,0.46825623718458564,Upregulated
Feature0301,NA,C16 H31 N3 O5,345.2265,NA,NA,Feature0301,16,31,5,3,0,0,1.9375,0.3125,-0.75,81.675,3,-2,-0.625,-0.23809523809523808,-5,Protein,1547411.21568326,1746579.5493500233,1.128710669567443,0.17467571722233127,0.4218990904710985,0.6594697741371865,Upregulated
Feature0300,NA,C9 H15 N O5,217.09502,NA,NA,Feature0300,9,15,5,1,0,0,1.6666666666666667,0.5555555555555556,-0.22222222222222232,66.63333333333333,3,-2,-1,-0.09090909090909093,-3,Amino Sugar,930845.7240831973,897517.6063599983,0.964195873858663,-0.05260183895156271,0.8797399878641194,0.9372827292086907,Downregulated
Feature0299,ser-trp,C14 H17 N3 O4,291.12193,NA,NA,ser-trp,14,17,4,3,0,0,1.2142857142857142,0.2857142857142857,0,60.3,8,4,0.14285714285714285,0.3333333333333333,1,Lignin,5600051.296691174,5207999.59054379,0.9299914080467387,-0.10471070729639345,0.7851576965781543,0.8926557973177136,Downregulated
Feature0298,Caffeic acid,C9 H8 O4,180.04231,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various antibiotics;Phenylalanine metabolism;Tyrosine metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of scopolin and esculin biosynthesis;Superpathway of aromatic amino acid biosynthesis;Superpathway of 4-hydroxybenzoate biosynthesis (yeast);Other,Caffeic acid-peak1,9,8,4,0,0,0,0.8888888888888888,0.4444444444444444,0,60.3,6,2,0.4,0.5714285714285714,2,Lignin,250522.361340184,273307.8331721553,1.0909518484101743,0.12558742650763052,0.582154376821994,0.7746814723774217,Upregulated
Feature0297,4-Phenyl-3-buten-2-one,C10 H10 O,146.07318,NA,NA,4-Phenyl-3-buten-2-one-peak2,10,10,1,0,0,0,1,0.1,-0.7999999999999998,83.1,6,5,0.5555555555555556,0.5789473684210527,5,Unsaturated HC,5615567.50860687,3973515.410502027,0.7075892871756769,-0.4990158889385844,0.061590437184435805,0.3794192923980171,Downregulated
Feature0296,Adenylsuccinic acid,C14 H18 N5 O11 P,463.07418,Metabolic pathways;Biosynthesis of cofactors;Other,Superpathway of purine nucleotide salvage;Other,Adenylsuccinic acid,14,18,11,5,0,1,1.2857142857142858,0.7857142857142857,1,31.799999999999997,9,-2,2.6666666666666665,-1,-8,Tannin,313211.4611317257,235828.02191782667,0.7529354802845025,-0.4094018505235261,0.5561002543184264,0.7562901141909594,Downregulated
Feature0295,acetoacetic acid,C4 H6 O3,102.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Tyrosine metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,acetoacetic acid-peak1,4,6,3,0,0,0,1.5,0.75,0,60.3,2,-1,-1,0.2,-1,Carbohydrate,5078498.294621937,5154369.418634913,1.0149396769697299,0.021393983250036233,0.8822182698648618,0.9393323376185267,Upregulated
Feature0294,NA,C16 H21 N5 O9,427.13397,NA,NA,Feature0294,16,21,9,5,0,0,1.3125,0.5625,0.75,38.925,9,0,-2.5,-0.07692307692307693,-5,Lignin,2763474.6081429166,2489573.4243906965,0.9008852178539521,-0.15058479149198992,0.4697341053401893,0.6900415978321557,Downregulated
Feature0293,"2-amino-2,3,7-trideoxy-D-lyxo-hept-6-ulosonic acid",C7 H13 N O5,191.07946,"Metabolic pathways;Biosynthesis of secondary metabolites;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Other,"2-amino-2,3,7-trideoxy-D-lyxo-hept-6-ulosonic acid-peak1",7,13,5,1,0,0,1.8571428571428572,0.7142857142857143,0,60.3,2,-3,-4,-0.42857142857142855,-4,Carbohydrate,5638846.98326244,5113083.1117151,0.9067603939053598,-0.14120671744364088,0.4395904306024338,0.6660955963052084,Downregulated
Feature0292,Succinyladenosine,C14 H17 N5 O8,383.10785,NA,NA,Succinyladenosine,14,17,8,5,0,0,1.2142857142857142,0.5714285714285714,1,31.799999999999997,9,1,-4,0,-4,Lignin,1911867.2556078134,1762666.1435361966,0.921960527524081,-0.11722310992070026,0.26611251653043166,0.5470808288865914,Downregulated
Feature0291,NA,C14 H28 N6 O4,344.21736,NA,NA,Feature0291,14,28,4,6,0,0,2,0.2857142857142857,-0.14285714285714324,64.37142857142858,4,0,-1.5,-0.6666666666666666,-6,Lipid,5564658.988278513,5918615.258431736,1.063607899585366,0.08896639747398537,0.8951381260127055,0.9441867904517578,Upregulated
Feature0290,cys-val,C8 H16 N2 O3 S,220.08817,NA,NA,cys-val-peak1,8,16,3,2,1,0,2,0.375,-0.25,67.425,2,-1,-2,-0.7142857142857143,-4,Protein,5144187.88550186,3960039.1787924166,0.7698084259234013,-0.3774286326612155,0.2320988485600177,0.5200733458474471,Downregulated
Feature0289,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13214,NA,NA,6-(alpha-D-glucosaminyl)-1D-myo-inositol-peak1,12,23,10,1,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,6115237.832293694,4764333.237590473,0.7790920595811847,-0.36013428386086566,0.19187107825332317,0.4862119877973694,Downregulated
Feature0288,NA,C24 H36 N4 O6,476.26356,NA,NA,Feature0288,24,36,6,4,0,0,1.5,0.25,-0.5,74.55,9,3,-0.07142857142857142,0.1176470588235294,-1,Lipid,108991.50159880897,102985.74426330827,0.944897012634916,-0.08177100095858117,0.8589559738122222,0.9273877754225012,Downregulated
Feature0287,R-Palmitoyl-(2-methyl) ethanolamide,C19 H39 N O2,313.29814,NA,NA,R-Palmitoyl-(2-methyl) ethanolamide-peak1,19,39,2,1,0,0,2.0526315789473686,0.10526315789473684,-1.6842105263157894,108.3,1,-1,-0.125,-0.0588235294117647,-2,Lipid,125690.71165867934,185097.28991998933,1.4726409571347812,0.5584057314591824,0.16515008416769153,0.4734778652324074,Upregulated
Feature0286,Deoxyadenosine monophosphate,C10 H14 N5 O6 P,331.06822,Metabolic pathways;Other,NA,Deoxyadenosine monophosphate,10,14,6,5,0,1,1.4,0.6,0.7999999999999998,37.5,7,1,2.5,-2,-5,Lignin,6484397.798463474,4933834.8536819965,0.7608778805722106,-0.39426317234181874,0.5473451531235245,0.75077140841396806,Downregulated
Feature0285,PYRIDOXAMINE,C8 H12 N2 O2,168.08993,Metabolic pathways;Microbial metabolism in diverse environments;Other,Other,PYRIDOXAMINE-peak1,8,12,2,2,0,0,1.5,0.25,-0.25,67.425,4,2,0,0.2,0,Lipid,3532097.6746634133,3390443.615439073,0.959895203283743,-0.05905118692401163,0.7209205687362376,0.8568018164604311,Downregulated
Feature0284,3-[(1S)-2-Cyclohexen-1-yl]-L-alanine,C9 H15 N O2,169.11033,NA,NA,3-[(1S)-2-Cyclohexen-1-yl]-L-alanine,9,15,2,1,0,0,1.6666666666666667,0.2222222222222222,-0.8888888888888893,85.63333333333334,3,1,0,0.14285714285714285,0,Lipid,540061.3464546353,743385.090782062,1.3764826823141394,0.46098645933654403,0.0124015797226157,0.25835889181660304,Upregulated
Feature0283,APM,C7 H13 N O4,175.08448,NA,NA,APM-peak2,7,13,4,1,0,0,1.8571428571428572,0.5714285714285714,-0.2857142857142856,68.44285714285714,2,-2,-1.5,-0.25,-3,Amino Sugar,5879930.2114207065,4772896.20724958,0.811726676275696,-0.3009340684154944,0.053133337033737474,0.36911520896690736,Downregulated
Feature0282,NA,C13 H22 N2 O10,366.12745,NA,NA,Feature0282,13,22,10,2,0,0,1.6923076923076923,0.7692307692307693,0.3076923076923075,51.53076923076924,4,-6,-8,-0.5,-8,Carbohydrate,781967.1646975171,513779.846959884,0.6570350650958929,-0.6059577275513022,0.06260479119441674,0.3794192923980171,Downregulated
Feature0281,NA,C16 H30 N4 O5,358.22175,NA,NA,Feature0281,16,30,5,4,0,0,1.875,0.3125,-0.5,74.55,4,-1,-0.7142857142857143,-0.2631578947368421,-5,Protein,1811192.1996635234,1949442.5622352867,1.0763311384608696,0.10612199826587468,0.8429338926139982,0.9218399058025261,Upregulated
Feature0280,methoxyresorcinol,C7 H8 O3,140.04735,Microbial metabolism in diverse environments;Other,NA,methoxyresorcinol-peak1,7,8,3,0,0,0,1.1428571428571428,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,1,0.25,0.4545454545454546,1,Lignin,4288527.47366093,3638846.7193608503,0.8485072654214628,-0.23700108185762211,0.14617489238959294,0.4658688473133245,Downregulated
Feature0279,Acetophenone,C8 H8 O,120.05746,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylpropanoid biosynthesis;Phenylalanine metabolism;Other,Anaerobic aromatic compound degradation (Thauera aromatica);Other,Acetophenone-peak1,8,8,1,0,0,0,1,0.125,-0.75,81.675,5,4,0.5714285714285714,0.6,4,Unsaturated HC,2759498.23331895,2100012.341092374,0.7610123883161948,-0.39400815572244824,0.5545100259605735,0.7562901141909594,Downregulated
Feature0278,NA,C19 H41 N O,299.31886,NA,NA,Feature0278,19,41,1,1,0,0,2.1578947368421053,0.05263157894736842,-1.8947368421052628,114.29999999999998,0,-1,-0.1176470588235294,-0.08571428571428572,-2,Lipid,159249.70783813435,223073.74544955132,1.4007796213748125,0.4862300006235754,0.032360515139873196,0.32345137828340564,Upregulated
Feature0277,NA,C16 H35 N O,257.27187,NA,NA,Feature0277,16,35,1,1,0,0,2.1875,0.0625,-1.875,113.7375,0,-1,-0.14285714285714285,-0.10344827586206896,-2,Lipid,7381096.785725816,5968265.61372134,0.8085879086781889,-0.3065234646396645,0.6918924404278891,0.8401905333941536,Downregulated
Feature0276,NA,C19 H29 N3 O4,363.21589,NA,NA,Feature0276,19,29,4,3,0,0,1.5263157894736843,0.21052631578947367,-0.6315789473684212,78.30000000000001,7,3,0,0.14285714285714285,0,Lipid,4204964.665573443,4073083.6522359266,0.9686368319769146,-0.04597223307918268,0.9670593027262864,0.9803701129972048,Downregulated
Feature0275,Trigonelline,C7 H7 N O2,137.04766,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various antibiotics;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminobenzoate degradation;Other",Superpathway of chorismate metabolism;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic amino acid biosynthesis;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of aromatic compound degradation via 3-oxoadipate;Other,Trigonelline-peak2,7,7,2,1,0,0,1,0.2857142857142857,0,60.3,5,3,0.5,0.6,2,Lignin,1134659.7810089644,1282827.2416276836,1.130583160784077,0.1770671143700545,0.6588628933431209,0.824146285809492,Upregulated
Feature0274,N-(5-acetamidopentyl)acetamide,C9 H18 N2 O2,186.13687,NA,NA,N-(5-acetamidopentyl)acetamide,9,18,2,2,0,0,2,0.2222222222222222,-0.8888888888888893,85.63333333333334,2,0,-0.4,-0.16666666666666666,-2,Lipid,2826564.1487130965,3447606.7683422267,1.2197164426329699,0.28654579175914496,0.4507707223076217,0.6727802674793931,Upregulated
Feature0273,"N-(3-methoxyphenyl)-N'-[2-(2-methyl-4,5-dihydro-1H-imidazol-1-yl)ethyl]urea",C14 H20 N4 O2,276.15865,Metabolic pathways;Other,NA,"N-(3-methoxyphenyl)-N'-[2-(2-methyl-4,5-dihydro-1H-imidazol-1-yl)ethyl]urea-peak1",14,20,2,4,0,0,1.4285714285714286,0.14285714285714285,-0.2857142857142856,68.44285714285714,7,5,0.125,0.2222222222222222,1,Lignin,855613.188686365,260785.521717886,0.3047937142229816,-1.71409494452608,0.13275964325451367,0.45384777576550756,Downregulated
Feature0272,N-benzoyl-4-methoxyanthranilic acid,C15 H13 N O4,271.08448,NA,NA,N-benzoyl-4-methoxyanthranilic acid,15,13,4,1,0,0,0.8666666666666667,0.26666666666666666,-0.13333333333333375,64.10000000000001,10,6,0.5,0.5833333333333334,5,Lignin,5285380.457989624,3937033.586767947,0.7448912368865606,-0.4248983048284782,0.003280197638334238,0.2036229837521672,Downregulated
Feature0271,Prolylaspartic acid,C9 H14 N2 O5,230.09029,Biosynthesis of secondary metabolites;Other,NA,Prolylaspartic acid,9,14,5,2,0,0,1.5555555555555556,0.5555555555555556,0.22222222222222232,53.96666666666666,4,-1,-1.5,-0.1111111111111111,-3,Amino Sugar,97189.5217244642,82964.84099969966,0.8536397702923982,-0.22830070332315014,0.3866227637654914,0.6364810124574756,Downregulated
Feature0270,NA,C12 H22 N4 O3,270.16921,NA,NA,Feature0270,12,22,3,4,0,0,1.8333333333333333,0.25,-0.33333333333333304,69.79999999999998,4,1,-0.6,-0.2307692307692308,-3,Lipid,74442.67220307597,97844.85321772004,1.3143651392685645,0.39436612149974204,0.14715994026326634,0.4658688473133245,Upregulated
Feature0269,NA,C19 H29 N3 O5,379.21071,NA,NA,Feature0269,19,29,5,3,0,0,1.5263157894736843,0.2631578947368421,-0.5263157894736841,75.3,7,2,-0.09090909090909093,0.1111111111111111,-1,Lipid,5280878.764038427,4495723.6191689,0.8513211190879342,-0.23222467445617623,0.7669599781769795,0.8826292140161708,Downregulated
Feature0268,Enicoflavine,C10 H13 N O4,211.0845,NA,NA,Enicoflavine,10,13,4,1,0,0,1.3,0.4,-0.20000000000000015,66,5,1,0,0.2857142857142857,0,Lignin,420644.2675541013,379983.979731886,0.9033380674396431,-0.14666208841824607,0.6737572704470609,0.831278088956534,Downregulated
Feature0267,Methylone,C11 H13 N O3,207.08954,Metabolic pathways;Phenylalanine metabolism;Other,NA,Methylone-peak1,11,13,3,1,0,0,1.181818181818182,0.2727272727272727,-0.3636363636363633,70.66363636363636,6,3,0.2857142857142857,0.4117647058823529,2,Lignin,5650193.00727261,4493222.6852231,0.7952334866153556,-0.33054958602950707,0.10571508108448611,0.43283090716191397,Downregulated
Feature0266,D-ribosylnicotinate,C11 H13 N O6,255.07429,NA,NA,D-ribosylnicotinate-peak1,11,13,6,1,0,0,1.181818181818182,0.5454545454545454,0.18181818181818168,55.11818181818182,6,0,-0.25,0.2857142857142857,-1,Lignin,2985356.9624340767,3196742.3581996234,1.070807410445549,0.09869902819298224,0.8533514045165627,0.92558845302131,Upregulated
Feature0265,Leucyl-leucyl-norleucine,C18 H35 N3 O4,357.26288,NA,NA,Leucyl-leucyl-norleucine-peak2,18,35,4,3,0,0,1.9444444444444444,0.2222222222222222,-1,88.8,3,-1,-0.3636363636363637,-0.15384615384615383,-4,Lipid,2358531.5292377565,1890193.66809045,0.8014281957474334,-0.31935482750768796,0.6395449104124075,0.8131443267876828,Downregulated
Feature0264,Phenethylamine,C8 H11 N,121.0891,Metabolic pathways;Phenylalanine metabolism;Other,Other,Phenethylamine,8,11,0,1,0,0,1.375,0,-1,88.8,4,4,0.42857142857142855,0.42857142857142855,3,Unsaturated HC,706072.8773934384,1128850.6873683943,1.5987736160262893,0.6769656698011276,0.2488900067631623,0.5310276106497658,Upregulated
Feature0263,asn-ile,C10 H19 N3 O4,245.13753,NA,NA,asn-ile,10,19,4,3,0,0,1.9,0.4,-0.20000000000000015,66,3,-1,-1.3333333333333333,-0.4,-4,Protein,3983222.9234229,5035349.163388584,1.2641394318602588,0.3381555984511718,0.2074163009866999,0.5026064024853513,Upregulated
Feature0262,NA,C14 H27 N3 O4,301.2002,NA,NA,Feature0262,14,27,4,3,0,0,1.9285714285714288,0.2857142857142857,-0.7142857142857144,80.65714285714286,3,-1,-0.5714285714285714,-0.2222222222222222,-4,Lipid,1791126.5686751034,1474087.8731051318,0.82299481169302,-0.2810447592202237,0.6842420842067387,0.8368997044377007,Downregulated
Feature0261,beta-Aspartylleucine,C10 H18 N2 O5,246.12156,Metabolic pathways;Other,NA,beta-Aspartylleucine,10,18,5,2,0,0,1.8,0.5,-0.20000000000000015,66,3,-2,-1.3333333333333333,-0.2727272727272727,-4,Protein,2674491.4364411933,3323403.3757814164,1.242630030703593,0.31339682549846615,0.6116050866004246,0.7920940494656874,Upregulated
Feature0260,.alpha.-Aminoadipic acid,C6 H11 N O4,161.06884,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of butirocin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Other,.alpha.-Aminoadipic acid,6,11,4,1,0,0,1.8333333333333333,0.6666666666666666,0,60.3,2,-2,-3,-0.3333333333333333,-3,Amino Sugar,945120.3224325913,806975.0959868457,0.8538331859268653,-0.22797385799672412,0.762096071105691,0.8800209573640358,Downregulated
Feature0259,Norsolorinic acid,C20 H18 O7,370.10536,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Other,Norsolorinic acid,20,18,7,0,0,0,0.9,0.35,-0.20000000000000015,66,12,5,0.38461538461538464,0.5151515151515151,5,Lignin,3006030.3099281867,6225542.4926262265,2.0710178709990963,1.0503400027571368,0.028948371394988244,0.31473439619293775,Upregulated
Feature0258,NA,C7 H16 N2 O3,176.11612,NA,NA,Feature0258,7,16,3,2,0,0,2.2857142857142856,0.42857142857142855,-0.5714285714285712,76.58571428571427,1,-2,-2,-0.7142857142857143,-4,Protein,6268205.32830545,5270562.474699956,0.8408407508445169,-0.2500955045398908,0.455051561951116,0.6761906543378864,Downregulated
Feature0257,1-Deoxynojirimycin,C6 H13 N O4,163.08449,Biosynthesis of secondary metabolites;Other,Superpathway of butirocin biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis,1-Deoxynojirimycin-peak1,6,13,4,1,0,0,2.1666666666666665,0.6666666666666666,-0.33333333333333304,69.79999999999998,1,-3,-4,-0.6666666666666666,-4,Amino Sugar,147878.322420009,238213.76750926132,1.6108768588318072,0.687846213508911,0.2631238130875171,0.5442389980100781,Upregulated
Feature0256,NA,C19 H41 N O2,315.31381,NA,NA,Feature0256,19,41,2,1,0,0,2.1578947368421053,0.10526315789473684,-1.7894736842105263,111.3,0,-2,-0.1875,-0.1176470588235294,-3,Lipid,4367010.342115324,2885981.794208799,0.6608598487565904,-0.5975837489373583,0.6857124889201845,0.8374887932449839,Downregulated
Feature0255,NP-003800,C10 H15 N O3,197.1052,Metabolic pathways;Tyrosine metabolism,NA,NP-003800-peak1,10,15,3,1,0,0,1.5,0.3,-0.5999999999999996,77.39999999999999,4,1,0,0.2,0,Lipid,140952.80525759156,217397.07674913833,1.5423394827215016,0.6251203502940876,0.1457718107190222,0.4658688473133245,Upregulated
Feature0254,Desthiobiotin,C10 H18 N2 O3,214.13173,Metabolic pathways;Biosynthesis of cofactors;Other,Other,Desthiobiotin-peak1,10,18,3,2,0,0,1.8,0.3,-0.5999999999999996,77.39999999999999,3,0,-0.4,-0.07692307692307693,-2,Lipid,5706269.58474271,4470711.834707153,0.7834736456652587,-0.3520433484696677,0.07880168513900793,0.39590936857023457,Downregulated
Feature0253,asn-leu,C10 H19 N3 O4,245.13756,NA,NA,asn-leu-peak1,10,19,4,3,0,0,1.9,0.4,-0.20000000000000015,66,3,-1,-1.3333333333333333,-0.4,-4,Protein,3947412.833891377,5174964.737794293,1.3109763167823494,0.3906416230354265,0.023345728754448278,0.2919627558710051,Upregulated
Feature0252,Isovalerylglutamic acid,C10 H17 N O5,231.11066,NA,NA,Isovalerylglutamic acid-peak2,10,17,5,1,0,0,1.7,0.5,-0.4000000000000003,71.7,3,-2,-0.75,-0.07692307692307693,-3,Protein,274784.95593496534,143367.65513388935,0.521744921027703,-0.9385834434769722,0.062427886474898164,0.3794192923980171,Downregulated
Feature0251,NA,C13 H24 N4 O6,332.1696,NA,NA,Feature0251,13,24,6,4,0,0,1.8461538461538465,0.4615384615384616,0,60.3,4,-2,-2,-0.5,-6,Protein,4294401.406621924,5619846.82330925,1.3086449754425618,0.3880737591327509,0.08063939898530885,0.39590936857023457,Upregulated
Feature0250,NA,C8 H10 N2 O2,166.07426,NA,NA,Feature0250,8,10,2,2,0,0,1.25,0.25,0,60.3,5,3,0.25,0.4,1,Lignin,1636315.53491345,1256708.53248139,0.7680111235684512,-0.3808008883669397,0.23005848127615608,0.5170330973050352,Downregulated
Feature0249,Isovalerylglutamic acid,C10 H17 N O5,231.11064,NA,NA,Isovalerylglutamic acid-peak1,10,17,5,1,0,0,1.7,0.5,-0.4000000000000003,71.7,3,-2,-0.75,-0.07692307692307693,-3,Protein,1332412.97955247,1030288.222967906,0.7732499148379346,-0.3709933254643792,0.4170512941927812,0.6580333694263849,Downregulated
Feature0248,Cyclopentanone,C5 H8 O,84.05754,Other,NA,Cyclopentanone-peak1,5,8,1,0,0,0,1.6,0.2,-1.2000000000000002,94.5,2,1,0.25,0.3333333333333333,1,Lipid,257076.291052736,512702.8049496273,1.994360517845081,0.9959262273358919,0.20424084549403057,0.5000410123515109,Upregulated
Feature0247,L-dihydroanticapsin,C9 H15 N O4,201.10006,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics,NA,L-dihydroanticapsin,9,15,4,1,0,0,1.6666666666666667,0.4444444444444444,-0.44444444444444464,72.96666666666667,3,-1,-0.5,0,-2,Protein,5132254.21675888,4760891.893351973,0.9276414792170156,-0.10836076377498233,0.38445355634485623,0.6355389841806004,Downregulated
Feature0246,NA,C14 H25 N3 O4,299.18456,NA,NA,Feature0246,14,25,4,3,0,0,1.7857142857142858,0.2857142857142857,-0.5714285714285712,76.58571428571427,4,0,-0.42857142857142855,-0.1111111111111111,-3,Lipid,715970.7176812111,1106748.3433593344,1.545801128492686,0.6283547245716092,0.18787310081303238,0.4862119877973694,Upregulated
Feature0245,Methyl vinyl ketone,C4 H6 O,70.04188,Other,NA,Methyl vinyl ketone-peak1,4,6,1,0,0,0,1.5,0.25,-1,88.8,2,1,0.3333333333333333,0.42857142857142855,1,Lipid,1212329.5112844766,1170103.5671202382,0.9651695815607924,-0.051145646825332056,0.7840734183885814,0.892491879248216,Downregulated
Feature0244,SLH,C15 H25 N5 O5,355.18569,NA,NA,SLH,15,25,5,5,0,0,1.6666666666666667,0.3333333333333333,0,60.3,6,1,-0.8,-0.2,-4,Protein,4257921.07233108,2965871.00986232,0.6965537781184369,-0.5216933530735107,0.06970638724302394,0.39349391135295464,Downregulated
Feature0243,N~6~-(5-Oxo-D-isoleucyl)-L-lysine,C12 H23 N3 O4,273.16894,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,N~6~-(5-Oxo-D-isoleucyl)-L-lysine-peak1,12,23,4,3,0,0,1.9166666666666667,0.3333333333333333,-0.5,74.55,3,-1,-0.8,-0.2857142857142857,-4,Protein,1788319.95980171,1974405.0717044065,1.104055826745528,0.14281312404778942,0.802052484416174,0.9039766524291409,Upregulated
Feature0242,asn-lys,C10 H20 N4 O4,260.14846,NA,NA,asn-lys,10,20,4,4,0,0,2,0.4,0,60.3,3,-1,-2.5,-0.75,-5,Protein,3399525.10670267,5753708.10173846,1.6925034883237569,0.7591588072609509,0.13895897559647954,0.45798070948295916,Upregulated
Feature0241,Tyrosyltyrosine,C18 H20 N2 O5,344.13731,NA,NA,Tyrosyltyrosine,18,20,5,2,0,0,1.1111111111111112,0.2777777777777778,-0.22222222222222232,66.63333333333333,10,5,0.2727272727272727,0.4074074074074074,3,Lignin,2699693.5370554235,3175497.7719593667,1.1762437952208853,0.2341871126433604,0.48709533342470634,0.7043756731345155,Upregulated
Feature0240,ELK,C17 H32 N4 O6,388.23223,NA,NA,ELK,17,32,6,4,0,0,1.8823529411764703,0.35294117647058826,-0.47058823529411775,73.71176470588236,4,-2,-0.8571428571428571,-0.3,-6,Protein,3317800.692311473,3608723.1866399334,1.0876853437889236,0.12126126007084392,0.45795683009507465,0.6784208663929336,Upregulated
Feature0239,7-Methylguanine,C6 H7 N5 O,165.06507,NA,NA,7-Methylguanine-peak1,6,7,1,5,0,0,1.1666666666666667,0.16666666666666666,1.6666666666666663,12.800000000000004,6,5,NA,1,0,Lignin,234711.46160423697,165899.91673447832,0.7068249483879637,-0.5005751321336906,0.4798432648008637,0.6986673019504323,Downregulated
Feature0238,Leonurine,C14 H21 N3 O5,311.14813,NA,NA,Leonurine-peak1,14,21,5,3,0,0,1.5,0.35714285714285715,-0.14285714285714324,64.37142857142858,6,1,-0.3333333333333333,0.0588235294117647,-2,Protein,4571743.492324093,3619080.087681453,0.791619235365643,-0.3371214263757807,0.1565122859424154,0.46825623718458564,Downregulated
Feature0237,Neostigmine,C12 H18 N2 O2,222.13678,Other,NA,Neostigmine,12,18,2,2,0,0,1.5,0.16666666666666666,-0.666666666666667,79.30000000000001,5,3,0.125,0.2222222222222222,1,Lipid,5485160.70769013,4588585.837486456,0.8365453779783176,-0.2574842942428001,0.07404651281256054,0.39590936857023457,Downregulated
Feature0236,N'3-(2-furylmethylidene)pyridine-3-carbohydrazide,C11 H9 N3 O2,215.06947,NA,NA,N'3-(2-furylmethylidene)pyridine-3-carbohydrazide,11,9,2,3,0,0,0.8181818181818182,0.18181818181818185,0.36363636363636376,49.93636363636363,9,7,0.6666666666666666,0.7142857142857143,4,Lignin,728802.5042954626,636431.685967582,0.8732567221113271,-0.19552225171972787,0.6404447313737608,0.8131443267876828,Downregulated
Feature0235,NA,C14 H21 N O10,363.11672,NA,NA,Feature0235,14,21,10,1,0,0,1.5,0.7142857142857143,0.1428571428571428,56.22857142857143,5,-5,-2,-0.125,-6,Carbohydrate,76035.86822628746,108601.6413316124,1.4282948806266953,0.5142938637501584,0.2409845318039175,0.5247143918712548,Upregulated
Feature0234,NA,C20 H36 N4 O7,444.25844,NA,NA,Feature0234,20,36,7,4,0,0,1.8,0.35,-0.5,74.55,5,-2,-0.6666666666666666,-0.2,-6,Protein,179886.16755141565,124951.495825319,0.6946142525917395,-0.5257160816155774,0.5983380679440814,0.7865713119297694,Downregulated
Feature0233,Anhalamine,C11 H15 N O3,209.10519,Biosynthesis of alkaloids derived from shikimate pathway;Other,NA,Anhalamine-peak2,11,15,3,1,0,0,1.3636363636363635,0.2727272727272727,-0.5454545454545459,75.84545454545456,5,2,0.14285714285714285,0.29411764705882354,1,Lignin,843592.338307471,821077.488273286,0.9733107461841612,-0.03902761114963433,0.7568910814566463,0.87699965252227,Downregulated
Feature0232,NA,C19 H37 N O2,311.28246,NA,NA,Feature0232,19,37,2,1,0,0,1.9473684210526316,0.10526315789473684,-1.5789473684210522,105.29999999999998,2,0,-0.0625,0,-1,Lipid,139263.21170692035,186598.83443955466,1.3399004098243275,0.422125774121864,0.04887009695489157,0.35641545489778387,Upregulated
Feature0231,NA,C13 H25 N O9,339.15309,NA,NA,Feature0231,13,25,9,1,0,0,1.9230769230769231,0.6923076923076923,-0.3076923076923075,69.06923076923076,2,-7,-2.6666666666666665,-0.4666666666666667,-8,Amino Sugar,87263.25570680336,425587.44056997943,4.8770520549899565,2.286009370994875,0.4004920655615673,0.6461271991059953,Upregulated
Feature0230,NA,C15 H27 N3 O6,345.19008,NA,NA,Feature0230,15,27,6,3,0,0,1.8,0.4,-0.4000000000000003,71.7,4,-2,-0.8333333333333334,-0.2222222222222222,-5,Protein,2347175.1271776035,2672531.6191436867,1.1386161979133245,0.1872815287157566,0.6592197268428935,0.824146285809492,Upregulated
Feature0229,NA,C16 H31 N3 O4,329.23158,NA,NA,Feature0229,16,31,4,3,0,0,1.9375,0.25,-0.875,85.2375,3,-1,-0.4444444444444444,-0.18181818181818185,-4,Lipid,2024307.7308261634,2401396.235693733,1.1862802276181952,0.2464448490413349,0.15333268751089374,0.46778235597057083,Upregulated
Feature0228,NA,C47 H83 N10 O10 P3,1040.55075,NA,NA,Feature0228,47,83,10,10,0,3,1.7659574468085106,0.2127659574468085,-1.0212765957446803,89.4063829787234,13,3,-0.4166666666666667,-0.1724137931034483,-10,Lipid,78143.10631500097,92645.18311876403,1.185583572085093,0.24559736234176788,0.12236711880518589,0.45317690246982556,Upregulated
Feature0227,NA,C13 H25 N3 O4,287.18455,NA,NA,Feature0227,13,25,4,3,0,0,1.9230769230769231,0.3076923076923077,-0.615384615384615,77.83846153846153,3,-1,-0.6666666666666666,-0.25,-4,Protein,1425038.8478079366,1832773.3825406467,1.286121697917153,0.3630271626305543,0.05828143700925951,0.3790841191943452,Upregulated
Feature0226,NA,C16 H32 N2 O10,412.20583,NA,NA,Feature0226,16,32,10,2,0,0,2,0.625,-0.375,70.9875,2,-8,-2.5,-0.5555555555555556,-10,Amino Sugar,3378726.06294731,2941219.365314807,0.8705113437782346,-0.200064996889249,0.6243571424688277,0.8065956019375299,Downregulated
Feature0225,NA,C20 H29 N3 O4,375.2159,NA,NA,Feature0225,20,29,4,3,0,0,1.45,0.2,-0.5999999999999996,77.39999999999999,8,4,0.07692307692307693,0.2,1,Lignin,421066.082362197,568693.3145030866,1.3506034760926247,0.43360417574235716,0.497030732890495,0.7099241665400493,Upregulated
Feature0224,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",C10 H18 N2 O5,246.12156,Metabolic pathways;Other,NA,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose-peak1",10,18,5,2,0,0,1.8,0.5,-0.20000000000000015,66,3,-2,-1.3333333333333333,-0.2727272727272727,-4,Protein,558968.8711811337,310734.70602617733,0.5559069959827582,-0.8470845566468245,0.07640580289682508,0.39590936857023457,Downregulated
Feature0223,NA,C15 H27 N3 O6,345.19008,NA,NA,Feature0223,15,27,6,3,0,0,1.8,0.4,-0.4000000000000003,71.7,4,-2,-0.8333333333333334,-0.2222222222222222,-5,Protein,2701551.4874207634,2974589.8586495067,1.1010672469135208,0.1389025831856378,0.6896464734574612,0.8394586943835308,Upregulated
Feature0222,NA,C9 H21 N O7,255.13179,NA,NA,Feature0222,9,21,7,1,0,0,2.3333333333333335,0.7777777777777778,-0.44444444444444464,72.96666666666667,0,-7,-8,-1,-8,Carbohydrate,173798.40497937566,183342.41444223767,1.0549142523143098,0.07712573562581622,0.4981406300579753,0.7103116391567426,Upregulated
Feature0221,NA,C18 H32 N4 O7,416.22724,NA,NA,Feature0221,18,32,7,4,0,0,1.7777777777777777,0.3888888888888889,-0.33333333333333304,69.79999999999998,5,-2,-0.8571428571428571,-0.23809523809523808,-6,Protein,1212245.374229296,1135000.2716277253,0.9362793175014749,-0.09498910582676001,0.8164111803452139,0.9127191231804745,Downregulated
Feature0220,Succinyl proline,C9 H13 N O5,215.07938,Other,NA,Succinyl proline-peak1,9,13,5,1,0,0,1.4444444444444444,0.5555555555555556,0,60.3,4,-1,-0.6666666666666666,0.09090909090909093,-2,Lignin,484722.22999760567,321277.6206126637,0.6628076880531159,-0.5933377580917609,0.17026129487612987,0.4760067902771642,Downregulated
Feature0219,NA,C17 H31 N O9,393.19997,NA,NA,Feature0219,17,31,9,1,0,0,1.8235294117647056,0.5294117647058824,-0.5882352941176467,77.06470588235292,3,-6,-1,-0.21739130434782608,-7,Protein,3070411.37584513,318548.720674519,0.1037478961876366,-3.2688460132753865,0.2552046760468701,0.5383769878249041,Downregulated
Feature0218,Leucyl-leucyl-norleucine,C18 H35 N3 O4,357.2629,NA,NA,Leucyl-leucyl-norleucine-peak1,18,35,4,3,0,0,1.9444444444444444,0.2222222222222222,-1,88.8,3,-1,-0.3636363636363637,-0.15384615384615383,-4,Lipid,2591676.6915163733,2459302.16767025,0.9489232108775606,-0.0756367492304825,0.902344677339749,0.9478425405251708,Downregulated
Feature0217,NA,C10 H23 N O6,253.15257,NA,NA,Feature0217,10,23,6,1,0,0,2.3,0.6,-0.7999999999999998,83.1,0,-6,-2.3333333333333335,-0.6666666666666666,-7,Other,159375.10738866,246513.53268244566,1.546750535397511,0.6292405333310234,0.35589933530202306,0.6145703098895281,Upregulated
Feature0216,NP-008521,C14 H18 N2 O2,246.13679,NA,NA,NP-008521,14,18,2,2,0,0,1.2857142857142858,0.14285714285714285,-0.5714285714285712,76.58571428571427,7,5,0.3,0.3636363636363637,3,Lignin,5727667.7433193205,4598112.9962404,0.8027897570705949,-0.3169058856578467,0.03267103637541273,0.32345137828340564,Downregulated
Feature0215,Tryptophyl-tyrosine,C20 H21 N3 O4,367.15331,NA,NA,Tryptophyl-tyrosine,20,21,4,3,0,0,1.05,0.2,-0.20000000000000015,66,12,8,0.38461538461538464,0.4666666666666667,5,Lignin,2460318.929410007,2522535.362001687,1.0252879542761555,0.03602915057318673,0.9123540373201031,0.9534409248736919,Upregulated
Feature0214,Arachidonoyl Serinol,C23 H39 N O3,377.29295,NA,NA,Arachidonoyl Serinol,23,39,3,1,0,0,1.6956521739130437,0.13043478260869565,-1.304347826086956,97.47391304347823,5,2,0.05263157894736842,0.12195121951219512,1,Lipid,230825.98216783535,291621.461622825,1.263382305943292,0.3372912720858864,0.09611828353026132,0.41723968591020827,Upregulated
Feature0213,NA,C8 H9 N5 O3,223.07054,NA,NA,Feature0213,8,9,3,5,0,0,1.125,0.375,1.5,17.549999999999997,7,4,-Inf,0.3333333333333333,-1,Lignin,3980670.2287193267,3348212.5055480734,0.84111777996372,-0.2496202626920694,0.16045016547650867,0.47167290218904195,Downregulated
Feature0212,Amino-levulinic acid,C5 H9 N O3,131.05828,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Other,Amino-levulinic acid,5,9,3,1,0,0,1.8,0.6,0,60.3,2,-1,-2,-0.2,-2,Amino Sugar,2034718.66921135,1753798.2215632366,0.8619364672380004,-0.21434656174309047,0.1925718554600737,0.4862119877973694,Downregulated
Feature0211,N-Acetyl-L-tyrosine,C11 H13 N O4,223.08448,NA,NA,N-Acetyl-L-tyrosine,11,13,4,1,0,0,1.181818181818182,0.3636363636363637,-0.18181818181818168,65.48181818181817,6,2,0.16666666666666666,0.375,1,Lignin,845487.1082964446,424466.0694199653,0.5020373051875547,-0.9941335235212408,0.016099748708058262,0.2637533176745511,Downregulated
Feature0210,NA,C16 H21 N5 O9,427.13399,NA,NA,Feature0210,16,21,9,5,0,0,1.3125,0.5625,0.75,38.925,9,0,-2.5,-0.07692307692307693,-5,Lignin,1106877.7476036197,921123.4541444543,0.8321817437731297,-0.26502945569583397,0.4963774425493294,0.7099241665400493,Downregulated
Feature0209,NA,C20 H33 N O11,463.2054,NA,NA,Feature0209,20,33,11,1,0,0,1.65,0.55,-0.4000000000000003,71.7,5,-6,-0.875,-0.1111111111111111,-7,Protein,82181.82498536333,643960.574033326,7.835802796397087,2.9700810897647645,0.4032840130240406,0.6500124815059227,Upregulated
Feature0208,2-Keto-glutaramic acid,C5 H7 N O4,145.03751,Metabolic pathways;Other,Superpathway of butirocin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Other,2-Keto-glutaramic acid,5,7,4,1,0,0,1.4,0.8,0.7999999999999998,37.5,3,-1,-Inf,0,-2,Tannin,3679937.3270049365,1695449.6363424233,0.4607278563959491,-1.1180132664930091,0.21749044781203952,0.5080832331812387,Downregulated
Feature0207,NA,C14 H28 N6 O4,344.21733,NA,NA,Feature0207,14,28,4,6,0,0,2,0.2857142857142857,-0.14285714285714324,64.37142857142858,4,0,-1.5,-0.6666666666666666,-6,Lipid,339326.08006208995,226837.34899864334,0.6684937065760952,-0.5810141165196635,0.41704737444522993,0.6580333694263849,Downregulated
Feature0206,Diacetin,C7 H12 O5,176.0685,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis,Diacetin,7,12,5,0,0,0,1.7142857142857142,0.7142857142857143,-0.2857142857142856,68.44285714285714,2,-3,-1.5,-0.1111111111111111,-3,Carbohydrate,3918577.6200391967,4044553.2852858566,1.032148314378777,0.04565029347885352,0.722315492328991,0.8568018164604311,Upregulated
Feature0205,Marimastat,C15 H29 N3 O5,331.21071,NA,NA,Marimastat-peak2,15,29,5,3,0,0,1.9333333333333331,0.3333333333333333,-0.666666666666667,79.30000000000001,3,-2,-0.7142857142857143,-0.2631578947368421,-5,Protein,2937911.750734263,3237150.6435409766,1.1018542822914696,0.1399334434046951,0.637288891901131,0.8131443267876828,Upregulated
Feature0204,melanostatin,C13 H24 N4 O3,284.18484,NA,NA,melanostatin,13,24,3,4,0,0,1.8461538461538465,0.2307692307692308,-0.4615384615384617,73.45384615384616,4,1,-0.5,-0.2,-3,Lipid,62927.951730707166,69524.71590789183,1.104830429018487,0.1438249596737762,0.15765443727616416,0.46825623718458564,Upregulated
Feature0203,NA,C17 H31 N5 O6,401.22757,NA,NA,Feature0203,17,31,6,5,0,0,1.8235294117647056,0.35294117647058826,-0.23529411764705888,67.00588235294117,5,-1,-1,-0.3333333333333333,-6,Protein,433221.03502278135,278553.87451483664,0.6429832625744699,-0.6371469114789153,0.20913970466183435,0.5028674357354733,Downregulated
Feature0202,NL8513000,C11 H13 N O2,191.09465,NA,Other,NL8513000-peak1,11,13,2,1,0,0,1.181818181818182,0.18181818181818185,-0.5454545454545459,75.84545454545456,6,4,0.375,0.4444444444444444,3,Lignin,3795614.21090601,2294388.9706836333,0.6044842397552213,-0.7262233691820088,0.00842914870646799,0.23030609530252863,Downregulated
Feature0201,NA,C17 H32 N4 O5,372.2374,NA,NA,Feature0201,17,32,5,4,0,0,1.8823529411764703,0.29411764705882354,-0.5882352941176467,77.06470588235292,4,-1,-0.625,-0.23809523809523808,-5,Lipid,3944242.1675977698,4016238.7800033665,1.0182535983710772,0.02609691264030701,0.9333247760324737,0.9640795504757004,Upregulated
Feature0200,(+/-)-Metanephrine,C10 H15 N O3,197.10522,Metabolic pathways;Tyrosine metabolism,NA,(+/-)-Metanephrine-peak1,10,15,3,1,0,0,1.5,0.3,-0.5999999999999996,77.39999999999999,4,1,0,0.2,0,Lipid,4382751.70614744,3094542.0956240934,0.7060728745558533,-0.5021110015685819,0.008222652637049457,0.23030609530252863,Downregulated
Feature0199,N-Acetyl-L-leucine,C8 H15 N O3,173.10521,Other,NA,N-Acetyl-L-leucine-peak1,8,15,3,1,0,0,1.875,0.375,-0.75,81.675,2,-1,-0.5,-0.09090909090909093,-2,Protein,758764.5859590584,549250.264545648,0.7238744067785006,-0.4661886854732359,0.18842492419214937,0.4862119877973694,Downregulated
Feature0198,NA,C15 H20 N2 O3,276.14743,NA,NA,Feature0198,15,20,3,2,0,0,1.3333333333333333,0.2,-0.5333333333333332,75.5,7,4,0.2,0.30434782608695654,2,Lignin,5444020.687441364,4434271.149626563,0.8145213628331429,-0.29597555740205106,0.009489309563466842,0.2324530359410441,Downregulated
Feature0197,NA,C14 H25 N3 O6,331.17449,NA,NA,Feature0197,14,25,6,3,0,0,1.7857142857142858,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,-2,-1,-0.25,-5,Protein,1972894.6109824302,2051650.0621350934,1.0399187319557053,0.056470788380189096,0.8948909824769924,0.9441867904517578,Upregulated
Feature0196,Crotetamide,C12 H22 N2 O2,226.16812,Microbial metabolism in diverse environments;Other,NA,Crotetamide,12,22,2,2,0,0,1.8333333333333333,0.16666666666666666,-1,88.8,3,1,-0.125,0,-1,Lipid,5679599.63164303,4251856.86209798,0.7486191171661826,-0.41769620469291263,0.02688022336047126,0.30466056797140506,Downregulated
Feature0195,NA,C14 H25 N3 O7,347.1693,NA,NA,Feature0195,14,25,7,3,0,0,1.7857142857142858,0.5,-0.14285714285714324,64.37142857142858,4,-3,-1.5,-0.3333333333333333,-6,Protein,901690.1189482274,1524639.3697833032,1.6908684455383767,0.7577644182621359,0.12958164669280506,0.45384777576550756,Upregulated
Feature0194,Methionylphenylalanine,C14 H20 N2 O3 S,296.11939,NA,NA,Methionylphenylalanine-peak2,14,20,3,2,1,0,1.4285714285714286,0.21428571428571427,-0.4285714285714288,72.51428571428572,6,3,0,0.15789473684210523,0,Lignin,3647992.85093898,3250985.1973032933,0.8911709343033667,-0.16622591519439348,0.6373045818643346,0.8131443267876828,Downregulated
Feature0193,NA,C18 H26 N4 O5,378.19035,NA,NA,Feature0193,18,26,5,4,0,0,1.4444444444444444,0.2777777777777778,-0.22222222222222232,66.63333333333333,8,3,-0.1111111111111111,0.13043478260869565,-1,Lignin,4914258.199445473,5626269.579142626,1.1448868477805048,0.1952050199706099,0.7402672208733514,0.8696343080162671,Upregulated
Feature0192,glu-tyr,C14 H18 N2 O6,310.11656,NA,NA,glu-tyr,14,18,6,2,0,0,1.2857142857142858,0.42857142857142855,0,60.3,7,1,-0.16666666666666666,0.2222222222222222,-1,Lignin,3432860.7219561534,2467955.44883217,0.7189209375863785,-0.4760949740472487,0.19342683907995883,0.48687231114628565,Downregulated
Feature0191,"(2Z)-8-Hydroxy-2-octene-4,6-diynoic acid",C8 H6 O3,150.03171,Metabolic pathways;Microbial metabolism in diverse environments;Phenylalanine metabolism;Aminobenzoate degradation;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of aromatic compound degradation via 3-oxoadipate;Other,"(2Z)-8-Hydroxy-2-octene-4,6-diynoic acid-peak2",8,6,3,0,0,0,0.75,0.375,0,60.3,6,3,0.6,0.6923076923076923,3,Condensed HC,3928961.125404523,2676488.0408415636,0.6812202909149411,-0.553806686931414,0.09062886125149608,0.41723968591020827,Downregulated
Feature0190,DLK,C16 H30 N4 O6,374.21636,NA,NA,DLK,16,30,6,4,0,0,1.875,0.375,-0.375,70.9875,4,-2,-1,-0.3333333333333333,-6,Protein,2793217.9901956734,4118333.9906731965,1.4744047922964634,0.5601326653183135,0.10292328694703017,0.42914157342056886,Upregulated
Feature0189,NP-007065,C8 H10 O3,154.06303,Microbial metabolism in diverse environments;Aminobenzoate degradation,NA,NP-007065-peak1,8,10,3,0,0,0,1.25,0.375,-0.5,74.55,4,1,0.2,0.38461538461538464,1,Lignin,568144.9435737713,490459.10670391866,0.8632640530404273,-0.2121261800436137,0.6903642676593917,0.8394586943835308,Downregulated
Feature0188,NA,C16 H29 N3 O6,359.20576,NA,NA,Feature0188,16,29,6,3,0,0,1.8125,0.375,-0.5,74.55,4,-2,-0.7142857142857143,-0.2,-5,Protein,1449786.0728515103,1805894.8333310033,1.245628487642374,0.3168738444801393,0.5319404029429374,0.7349975877531288,Upregulated
Feature0187,NA,C12 H22 N2 O3,242.16305,NA,NA,Feature0187,12,22,3,2,0,0,1.8333333333333333,0.25,-0.833333333333333,84.04999999999998,3,0,-0.2857142857142857,-0.0588235294117647,-2,Lipid,65880.21201140377,75205.87510706493,1.1415548434186416,0.19100017224543767,0.2019725151367014,0.4974607521671786,Upregulated
Feature0186,NA,C9 H9 O P S,196.01126,NA,NA,Feature0186,9,9,1,0,1,1,1,0.1111111111111111,-1.1111111111111107,91.96666666666664,6,5,0.5,0.5384615384615384,3,Unsaturated HC,130858.55000575967,165165.47102360666,1.2621679746286123,0.3359039230284019,0.07367490946657501,0.39590936857023457,Upregulated
Feature0185,DH2090000,C9 H10 O5,198.05286,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of various antibiotics;Tyrosine metabolism;Aminobenzoate degradation,Other,DH2090000-peak1,9,10,5,0,0,0,1.1111111111111112,0.5555555555555556,0,60.3,5,0,0,0.38461538461538464,0,Lignin,76698.54401728109,86218.53514874577,1.1241221884123342,0.16879886032362357,0.33430118801136893,0.5961118026223778,Upregulated
Feature0184,NA,C8 H11 N O7,233.05354,NA,NA,Feature0184,8,11,7,1,0,0,1.375,0.875,0.75,38.925,4,-3,-Inf,-0.14285714285714285,-4,Tannin,636232.117325752,690156.9602194827,1.0847565557054721,0.1173713050808548,0.47500922959834,0.6942757851074962,Upregulated
Feature0183,NA,C23 H32,308.25044,NA,NA,Feature0183,23,32,0,0,0,0,1.391304347826087,0,-1.391304347826087,99.95217391304348,8,8,0.34782608695652173,0.34782608695652173,8,Unsaturated HC,297797.22608992935,383559.49616303534,1.2879888143995248,0.3651200643528345,0.071325283679806,0.39590936857023457,Upregulated
Feature0182,NA,C15 H27 N3 O5,329.19521,NA,NA,Feature0182,15,27,5,3,0,0,1.8,0.3333333333333333,-0.5333333333333332,75.5,4,-1,-0.5714285714285714,-0.15789473684210523,-4,Protein,2262202.6111616464,3503654.3552360833,1.5487800862527288,0.6311323081066468,0.020337783094352753,0.28009922407994764,Upregulated
Feature0181,NA,C13 H26 N2 O6,306.17912,NA,NA,Feature0181,13,26,6,2,0,0,2,0.4615384615384616,-0.615384615384615,77.83846153846153,2,-4,-1.2,-0.375,-6,Protein,4979095.854791037,2472887.6396211735,0.49665395319547545,-1.0096871000268641,0.149805922431963,0.46695517742640485,Downregulated
Feature0180,(+)-castanospermine,C8 H15 N O4,189.10012,NA,NA,(+)-castanospermine-peak1,8,15,4,1,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,202209.3384545904,321529.0714050845,1.590080230034922,0.6690995608262039,0.6566218635082246,0.8228257792439163,Upregulated
Feature0179,NA,C20 H29 N3 O6,407.20564,NA,NA,Feature0179,20,29,6,3,0,0,1.45,0.3,-0.4000000000000003,71.7,8,2,-0.09090909090909093,0.14285714285714285,-1,Lignin,235252.31167174628,358110.29256636434,1.5222392078597087,0.6061950847786073,0.43461777589973527,0.6634526387347742,Upregulated
Feature0178,"(2Z)-N-(4-Aminobutyl)-3-(3,4-dihydroxyphenyl)acrylamide",C13 H18 N2 O3,250.13174,NA,NA,"(2Z)-N-(4-Aminobutyl)-3-(3,4-dihydroxyphenyl)acrylamide",13,18,3,2,0,0,1.3846153846153846,0.2307692307692308,-0.4615384615384617,73.45384615384616,6,3,0.125,0.2631578947368421,1,Lignin,442271.69600060635,569764.3340113936,1.2882676851439583,0.3654323977262279,0.3862152045897616,0.6364285569796266,Upregulated
Feature0177,NA,C13 H23 N3 O6,317.15872,NA,NA,Feature0177,13,23,6,3,0,0,1.7692307692307692,0.4615384615384616,-0.1538461538461542,64.6846153846154,4,-2,-1.25,-0.2857142857142857,-5,Protein,593362.1152333013,1287795.59723695,2.1703367373405826,1.1179189005507046,0.06651320960404253,0.3871937356331548,Upregulated
Feature0176,NA,C16 H32 N6 O4,372.24864,NA,NA,Feature0176,16,32,4,6,0,0,2,0.25,-0.375,70.9875,4,0,-1,-0.5,-6,Lipid,2600138.9732532767,3180389.791685017,1.2231614634450612,0.2906148594139573,0.20348891376870082,0.499580028875622,Upregulated
Feature0175,Etilevodopa,C11 H15 N O4,225.10013,NA,NA,Etilevodopa-peak1,11,15,4,1,0,0,1.3636363636363635,0.3636363636363637,-0.3636363636363633,70.66363636363636,5,1,0,0.25,0,Lignin,4706287.318227286,3692624.67162968,0.7846152225615877,-0.34994276903000143,0.0130438539051224,0.25835889181660304,Downregulated
Feature0174,"1-Methyl-1,2,3,4-tetrahydro-Î²-carboline-3-carboxylic acid",C13 H14 N2 O2,230.10555,NA,NA,"1-Methyl-1,2,3,4-tetrahydro-Î²-carboline-3-carboxylic acid-peak1",13,14,2,2,0,0,1.0769230769230769,0.15384615384615383,-0.3076923076923075,69.06923076923076,8,6,0.4444444444444444,0.5,4,Lignin,1817473.5058458168,370948.25100974663,0.20410105006571447,-2.292644490073311,7.461746813512869e-4,0.13209075561330955,Downregulated
Feature0173,"4-hydroxy-5,8-dimethylquinoline-3-carboxylic acid",C12 H11 N O3,217.07394,Metabolic pathways;Other,NA,"4-hydroxy-5,8-dimethylquinoline-3-carboxylic acid",12,11,3,1,0,0,0.9166666666666666,0.25,-0.16666666666666696,65.05000000000001,8,5,0.5,0.5789473684210527,4,Lignin,358267.57498608466,182006.39359739967,0.5080180465800427,-0.9770483473995919,0.006560791596776977,0.23030609530252863,Downregulated
Feature0172,N-(2-Acetylphenyl)formamide,C9 H9 N O2,163.06336,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,N-(2-Acetylphenyl)formamide,9,9,2,1,0,0,1,0.2222222222222222,-0.22222222222222232,66.63333333333333,6,4,0.5,0.5714285714285714,3,Lignin,2782480.335975817,2435879.3109754,0.8754345105267872,-0.19192883727036208,0.25322817508313444,0.5355412341957924,Downregulated
Feature0171,"(2S,3S,4R,5R)-2,3,4,5,6-Pentahydroxyhexanamide",C6 H13 N O6,195.07434,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,"(2S,3S,4R,5R)-2,3,4,5,6-Pentahydroxyhexanamide",6,13,6,1,0,0,2.1666666666666665,1,0.3333333333333335,50.8,1,-5,6,-1.5,-6,Carbohydrate,2824152.192014763,1986020.2271072434,0.7032270543785416,-0.5079375203290445,0.005867673036057936,0.23030609530252863,Downregulated
Feature0170,NA,C17 H32 N4 O5,372.23738,NA,NA,Feature0170,17,32,5,4,0,0,1.8823529411764703,0.29411764705882354,-0.5882352941176467,77.06470588235292,4,-1,-0.625,-0.23809523809523808,-5,Lipid,1716469.3738627967,1945069.2146689834,1.1331802619301843,0.1803773777574876,0.7197188485205944,0.8568018164604311,Upregulated
Feature0169,Ser-met,C8 H16 N2 O4 S,236.08315,Microbial metabolism in diverse environments;Other,NA,Ser-met,8,16,4,2,1,0,2,0.5,0,60.3,2,-2,-5,-1,-5,Protein,3923018.8958760034,3500002.1179526797,0.8921705989313455,-0.16460848933903252,0.5599740523176124,0.7588768357008283,Downregulated
Feature0168,DL-TYROSINE,C9 H11 N O3,181.07393,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various plant secondary metabolites;Biosynthesis of various antibiotics;Phenylalanine metabolism;Tyrosine metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of aromatic amino acid biosynthesis;Superpathway of 4-hydroxybenzoate biosynthesis (yeast);Other,DL-TYROSINE,9,11,3,1,0,0,1.2222222222222223,0.3333333333333333,-0.22222222222222232,66.63333333333333,5,2,0.2,0.38461538461538464,1,Lignin,1672265.38022983,1188127.220772905,0.7104896356878555,-0.4931144906702471,0.05632059462041018,0.3769401647878184,Downregulated
Feature0167,NA,C9 H19 N O8,269.11107,NA,NA,Feature0167,9,19,8,1,0,0,2.111111111111111,0.8888888888888888,0,60.3,1,-7,-Inf,-1,-8,Carbohydrate,5187273.7340908265,2392655.678554207,0.4612549483998974,-1.1163637062212166,0.12606465349873958,0.45384777576550756,Downregulated
Feature0166,LLK,C18 H36 N4 O4,372.27367,NA,NA,LLK,18,36,4,4,0,0,2,0.2222222222222222,-0.8888888888888893,85.63333333333334,3,-1,-0.5,-0.25,-5,Lipid,5529951.12930378,5261708.776411504,0.95149281673199,-0.07173532993221,0.8095912702725423,0.9084302217796473,Downregulated
Feature0165,NA,C14 H25 N3 O6,331.17443,NA,NA,Feature0165,14,25,6,3,0,0,1.7857142857142858,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,-2,-1,-0.25,-5,Protein,2512361.2838169867,3197068.663451313,1.2725353968972417,0.3477057869240488,0.10654645348860813,0.43283090716191397,Upregulated
Feature0164,Paracetamol,C8 H9 N O2,151.06335,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Aminobenzoate degradation;Other,Other,Paracetamol-peak1,8,9,2,1,0,0,1.125,0.25,-0.25,67.425,5,3,0.4,0.5,2,Lignin,3288520.759172627,3004104.087203847,0.9135122771612555,-0.130503976783764,0.43635343215318867,0.6640970014604831,Downregulated
Feature0163,Leucylasparagine,C10 H19 N3 O4,245.13751,NA,NA,Leucylasparagine-peak1,10,19,4,3,0,0,1.9,0.4,-0.20000000000000015,66,3,-1,-1.3333333333333333,-0.4,-4,Protein,1977315.1527995968,3132199.3516592467,1.5840668328589391,0.663633204988312,0.44687423799289394,0.6687322960777052,Upregulated
Feature0162,2-Pentadecylfuran,C19 H34 O,278.26093,NA,NA,2-Pentadecylfuran,19,34,1,0,0,0,1.7894736842105263,0.05263157894736842,-1.6842105263157894,108.3,3,2,0.1111111111111111,0.13513513513513514,2,Lipid,348399.22009931935,948280.515558976,2.72182157953352,1.4445724985984356,0.1703022771716816,0.4760067902771642,Upregulated
Feature0161,Maclurin,C13 H10 O6,262.04778,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,Maclurin,13,10,6,0,0,0,0.7692307692307693,0.4615384615384616,0.15384615384615374,55.91538461538462,9,3,0.42857142857142855,0.6,3,Condensed HC,123471.105549567,155346.172236399,1.258158105452744,0.33131322875149116,0.09558447151405512,0.41723968591020827,Upregulated
Feature0160,NA,C17 H32 N4 O6,388.23229,NA,NA,Feature0160,17,32,6,4,0,0,1.8823529411764703,0.35294117647058826,-0.47058823529411775,73.71176470588236,4,-2,-0.8571428571428571,-0.3,-6,Protein,3178376.597519599,1685792.2941255507,0.5303941312181637,-0.914863282689678,0.5994915186104725,0.7865713119297694,Downregulated
Feature0159,2-Aminooctanedioic acid,C8 H15 N O4,189.10016,NA,NA,2-Aminooctanedioic acid-peak1,8,15,4,1,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,403795.41852699436,460603.231806765,1.1406846404721478,0.18989999187858703,0.7342864245959739,0.8668161695230521,Upregulated
Feature0158,DL-Metanephrine,C10 H15 N O3,197.1052,Metabolic pathways;Tyrosine metabolism,NA,DL-Metanephrine,10,15,3,1,0,0,1.5,0.3,-0.5999999999999996,77.39999999999999,4,1,0,0.2,0,Lipid,161344.01597013065,108059.065436164,0.6697432488365035,-0.5783199614388741,0.29797486590290967,0.572300932924636,Downregulated
Feature0157,NP-019811,C6 H7 N O2,125.04763,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,Other,NP-019811-peak1,6,7,2,1,0,0,1.1666666666666667,0.3333333333333333,0,60.3,4,2,0.3333333333333333,0.5,1,Lignin,1219634.1952687635,496865.97969176597,0.4073893480678234,-1.2955198359645892,0.005928286421194158,0.23030609530252863,Downregulated
Feature0156,nitrilotriacetic acid,C6 H9 N O6,191.04305,NA,NA,nitrilotriacetic acid,6,9,6,1,0,0,1.5,1,1,31.799999999999997,3,-3,4,-0.5,-4,Carbohydrate,5387449.37714934,4692748.327851944,0.871051957862668,-0.1991693173776704,0.1355649200338529,0.45384777576550756,Downregulated
Feature0155,NA,C9 H20 N2 O3,204.14739,NA,NA,Feature0155,9,20,3,2,0,0,2.2222222222222223,0.3333333333333333,-0.8888888888888893,85.63333333333334,1,-2,-1,-0.4545454545454546,-4,Protein,1408287.9239055493,740559.383200392,0.5258579375917872,-0.927254991973759,0.1354469578040007,0.45384777576550756,Downregulated
Feature0154,4-Ethyl-2-hydroxy-6-methoxyphenyl hydrogen sulfate,C9 H12 O6 S,248.0355,NA,NA,4-Ethyl-2-hydroxy-6-methoxyphenyl hydrogen sulfate,9,12,6,0,1,0,1.3333333333333333,0.6666666666666666,0.22222222222222232,53.96666666666666,4,-2,-1.5,0,-3,Tannin,90310.8469999522,122355.131085047,1.3548220966758484,0.4381034219895109,0.1055006032080593,0.43283090716191397,Upregulated
Feature0153,2H-Pyran,C5 H6 O,82.04189,NA,NA,2H-Pyran,5,6,1,0,0,0,1.2,0.2,-0.7999999999999998,83.1,3,2,0.5,0.5555555555555556,2,Lignin,312528.028343209,325431.7081703807,1.0412880722909155,0.05836924536383881,0.8978575657957,0.9454870002106172,Upregulated
Feature0152,Pivagabine,C9 H17 N O3,187.12087,Metabolic pathways;Biosynthesis of cofactors;Other,Other,Pivagabine-peak1,9,17,3,1,0,0,1.8888888888888888,0.3333333333333333,-0.8888888888888893,85.63333333333334,2,-1,-0.4,-0.07692307692307693,-2,Protein,3937168.0372481034,3486164.8274582867,0.8854498447810607,-0.17551750528446322,0.2833216969387206,0.5619987758948393,Downregulated
Feature0151,NA,C16 H32 N4 O4,344.24234,NA,NA,Feature0151,16,32,4,4,0,0,2,0.25,-0.75,81.675,3,-1,-0.625,-0.3,-5,Lipid,3970924.43286137,5762448.662618287,1.451160494249441,0.5372070862228637,0.01560776308574582,0.26272560535949285,Upregulated
Feature0150,VLH,C17 H29 N5 O4,367.22207,NA,NA,VLH,17,29,4,5,0,0,1.7058823529411764,0.2352941176470588,-0.35294117647058787,70.35882352941175,6,2,-0.375,-0.1,-3,Lipid,3348748.8920810833,3262215.4290862833,0.9741594649872288,-0.037770141352367,0.9285061327706956,0.9614238318542533,Downregulated
Feature0149,2-[(2Z)-2-({4-[(3-Aminopropyl)amino]butyl}imino)-2-hydroxyethyl]-2-hydroxysuccinic acid,C13 H25 N3 O6,319.17443,Other,NA,2-[(2Z)-2-({4-[(3-Aminopropyl)amino]butyl}imino)-2-hydroxyethyl]-2-hydroxysuccinic acid-peak2,13,25,6,3,0,0,1.9230769230769231,0.4615384615384616,-0.3076923076923075,69.06923076923076,3,-3,-1.5,-0.42857142857142855,-6,Protein,4640720.27989159,3728742.44011235,0.803483557556599,-0.31565959391701215,0.649773075107312,0.8208169942071487,Downregulated
Feature0148,NA,C13 H21 N O8,319.12681,NA,NA,Feature0148,13,21,8,1,0,0,1.6153846153846154,0.6153846153846154,-0.1538461538461542,64.6846153846154,4,-4,-1.25,-0.125,-5,Amino Sugar,152474.36597917392,72055.57032394613,0.4725749791528106,-1.0813848481565291,0.11531610389165349,0.44732172409548077,Downregulated
Feature0147,NA,C13 H23 N3 O6,317.15872,NA,NA,Feature0147,13,23,6,3,0,0,1.7692307692307692,0.4615384615384616,-0.1538461538461542,64.6846153846154,4,-2,-1.25,-0.2857142857142857,-5,Protein,902148.1249822876,1360826.45132073,1.508429063517089,0.5930468528529101,0.017431809741471675,0.2637533176745511,Upregulated
Feature0146,NA,C9 H13 N O4 S,231.05654,NA,NA,Feature0146,9,13,4,1,1,0,1.4444444444444444,0.4444444444444444,0,60.3,4,0,-0.6666666666666666,0,-2,Lignin,3891465.8726280434,2916395.340810133,0.7494336160888876,-0.4161274032130975,0.03175937859066945,0.32345137828340564,Downregulated
Feature0145,NA,C17 H25 N3 O5,351.17943,NA,NA,Feature0145,17,25,5,3,0,0,1.4705882352941178,0.29411764705882354,-0.35294117647058787,70.35882352941175,7,2,-0.1111111111111111,0.13043478260869565,-1,Lignin,4805096.48975017,5402182.067842363,1.1242608924432311,0.16897686167889434,0.7596432668088561,0.8780106829437524,Upregulated
Feature0144,Kynurenine,C10 H12 N2 O3,208.08476,Metabolic pathways;Biosynthesis of cofactors;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,Kynurenine,10,12,3,2,0,0,1.2,0.3,0,60.3,6,3,0.2,0.38461538461538464,1,Lignin,4451459.19155845,2996490.0352597632,0.6731478165501716,-0.5710047538141306,0.0033656691529283835,0.2036229837521672,Downregulated
Feature0143,6-methoxymellein,C11 H12 O4,208.07361,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Other,Anaerobic aromatic compound degradation (Thauera aromatica);Other,6-methoxymellein-peak1,11,12,4,0,0,0,1.0909090909090908,0.3636363636363637,-0.3636363636363633,70.66363636363636,6,2,0.2857142857142857,0.4444444444444444,2,Lignin,96194.23198842129,97274.6892076955,1.0112320374822916,0.01611407628652359,0.9014232094506158,0.9478425405251708,Upregulated
Feature0142,NA,C14 H26 N4 O5,330.19042,NA,NA,Feature0142,14,26,5,4,0,0,1.8571428571428572,0.35714285714285715,-0.2857142857142856,68.44285714285714,4,-1,-1,-0.3333333333333333,-5,Protein,2860697.4529659,2417891.112694633,0.8452103560227329,-0.24261765074381644,0.5567259577308892,0.7562901141909594,Downregulated
Feature0141,Isobutyric acid,C4 H8 O2,88.05244,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Superpathway of L-lysine degradation;Other,Isobutyric acid,4,8,2,0,0,0,2,0.5,-1,88.8,1,-1,-0.5,0,-1,Protein,313375.1734955067,465784.9386357893,1.486349200672937,0.5717731003278147,0.1606583616074836,0.47167290218904195,Upregulated
Feature0140,6-Hydroxymelatonin,C13 H16 N2 O3,248.11607,Other,Other,6-Hydroxymelatonin-peak1,13,16,3,2,0,0,1.2307692307692308,0.2307692307692308,-0.3076923076923075,69.06923076923076,7,4,0.25,0.3684210526315789,2,Lignin,4169260.7890980234,3365092.70803026,0.8071197457423294,-0.30914536466466275,0.0016934764763011255,0.15098679741337404,Downregulated
Feature0139,NA,C15 H27 N3 O5,329.19515,NA,NA,Feature0139,15,27,5,3,0,0,1.8,0.3333333333333333,-0.5333333333333332,75.5,4,-1,-0.5714285714285714,-0.15789473684210523,-4,Protein,2139197.2090868866,2884467.901118113,1.3483880255945848,0.4312357205895982,0.007855485429385177,0.23030609530252863,Upregulated
Feature0138,Metalaxyl,C15 H21 N O4,279.14696,NA,NA,Metalaxyl,15,21,4,1,0,0,1.4,0.26666666666666666,-0.666666666666667,79.30000000000001,6,2,0.1,0.25,1,Lignin,183607.46091432066,211606.574442579,1.152494421462121,0.20475976744557958,0.640718391644117,0.8131443267876828,Upregulated
Feature0137,NA,C14 H27 N3 O4,301.20021,NA,NA,Feature0137,14,27,4,3,0,0,1.9285714285714288,0.2857142857142857,-0.7142857142857144,80.65714285714286,3,-1,-0.5714285714285714,-0.2222222222222222,-4,Lipid,2137654.9139020666,2225527.8869731133,1.0411071836242471,0.05811860401007036,0.892876543623341,0.9441529932099071,Upregulated
Feature0136,NA,C9 H17 N3 O2,199.13218,NA,NA,Feature0136,9,17,2,3,0,0,1.8888888888888888,0.2222222222222222,-0.44444444444444464,72.96666666666667,3,1,-0.5,-0.2,-2,Lipid,4193490.5312592764,3474922.90712761,0.8286468948062974,-0.27117062722521634,0.02675375318420572,0.30466056797140506,Downregulated
Feature0135,Icacine,C22 H31 N O6,405.21514,NA,NA,Icacine-peak1,22,31,6,1,0,0,1.4090909090909092,0.2727272727272727,-0.7272727272727275,81.02727272727273,8,2,0.06666666666666667,0.2222222222222222,1,Lignin,164192.82929265167,2939884.4406573796,17.905072062662555,4.162296419981806,0.42437902464349236,0.6594697741371865,Upregulated
Feature0134,"(1S,4E,8E,12E)-2,2,5,9,13-Pentamethyl-4,8,12-cyclopentadecatrien-1-ol",C20 H34 O,290.261,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"(1S,4E,8E,12E)-2,2,5,9,13-Pentamethyl-4,8,12-cyclopentadecatrien-1-ol",20,34,1,0,0,0,1.7,0.05,-1.5999999999999996,105.89999999999998,4,3,0.15789473684210523,0.1794871794871795,3,Lipid,175636.41628214435,228113.310889072,1.298781401475581,0.37715863051962056,0.04999994875185552,0.36042516249209894,Upregulated
Feature0133,lamifiban,C24 H28 N4 O6,468.20092,NA,NA,lamifiban-peak1,24,28,6,4,0,0,1.1666666666666667,0.25,-0.16666666666666696,65.05000000000001,13,7,0.21428571428571427,0.35294117647058826,3,Lignin,1363849.3721534,784997.1344471701,0.5755746569049099,-0.7969250246342608,0.021950600358485315,0.2912553665556471,Downregulated
Feature0132,N-Acetyl-L-aspartic acid,C6 H9 N O5,175.04806,Metabolic pathways;Other,NA,N-Acetyl-L-aspartic acid,6,9,5,1,0,0,1.5,0.8333333333333334,0.6666666666666665,41.3,3,-2,-Inf,-0.2,-3,Carbohydrate,447063.783190885,283946.26200971,0.6351359083105869,-0.6548627577018951,0.07172413474648073,0.39590936857023457,Downregulated
Feature0131,NA,C20 H26 O7 S,410.14012,NA,NA,Feature0131,20,26,7,0,1,0,1.3,0.35,-0.5,74.55,8,1,0,0.2258064516129032,0,Lignin,3236429.978297067,5551376.393183326,1.715277769149923,0.7784422228856028,0.3092099383481406,0.5794265880107856,Upregulated
Feature0130,Nipecotic acid,C6 H11 N O2,129.07895,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Lysine degradation;Other,Superpathway of L-lysine degradation,Nipecotic acid,6,11,2,1,0,0,1.8333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,2,0,-0.3333333333333333,0,-1,Protein,3573629.16195439,3473024.177866983,0.9718479507727135,-0.0411974784073129,0.6835299934608247,0.8366735803800379,Downregulated
Feature0129,Cyclo(leucylleucine),C12 H22 N2 O2,226.16814,Microbial metabolism in diverse environments;Other,NA,Cyclo(leucylleucine),12,22,2,2,0,0,1.8333333333333333,0.16666666666666666,-1,88.8,3,1,-0.125,0,-1,Lipid,5630131.40496994,6791872.6843499,1.2063435461478653,0.27064082078966323,0.13299209304077805,0.45384777576550756,Upregulated
Feature0128,N-Acetylvanilalanine,C12 H15 N O5,253.09502,NA,NA,N-Acetylvanilalanine-peak1,12,15,5,1,0,0,1.25,0.4166666666666667,-0.16666666666666696,65.05000000000001,6,1,0,0.29411764705882354,0,Lignin,356808.70917271497,336719.44474089466,0.9436973820555036,-0.0836037939875642,0.6698324330595418,0.8299462183952073,Downregulated
Feature0127,"(1R)-6-Hydroxy-7-methoxy-1-methyl-1,2,3,4-tetrahydro-1-isoquinoliniumcarboxylate",C12 H15 N O4,237.10002,NA,NA,"(1R)-6-Hydroxy-7-methoxy-1-methyl-1,2,3,4-tetrahydro-1-isoquinoliniumcarboxylate-peak2",12,15,4,1,0,0,1.25,0.3333333333333333,-0.33333333333333304,69.79999999999998,6,2,0.14285714285714285,0.3333333333333333,1,Lignin,261916.58532751,258828.84383526767,0.9882109737786124,-0.017109018328734644,0.981641296333547,0.990833218993064,Downregulated
Feature0126,Trigonelline,C7 H7 N O2,137.04768,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various antibiotics;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminobenzoate degradation;Other",Superpathway of chorismate metabolism;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic amino acid biosynthesis;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of aromatic compound degradation via 3-oxoadipate;Other,Trigonelline-peak1,7,7,2,1,0,0,1,0.2857142857142857,0,60.3,5,3,0.5,0.6,2,Lignin,2770399.6780681834,1386869.8359440328,0.5006027999942252,-0.998261734491389,0.23401731043881197,0.5205827096922604,Downregulated
Feature0125,Methyl picolinate,C7 H7 N O2,137.04767,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various antibiotics;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminobenzoate degradation;Other",Superpathway of chorismate metabolism;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic amino acid biosynthesis;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of aromatic compound degradation via 3-oxoadipate;Other,Methyl picolinate,7,7,2,1,0,0,1,0.2857142857142857,0,60.3,5,3,0.5,0.6,2,Lignin,381338.71652141865,366175.218960002,0.9602361446544467,-0.058538852775157066,0.8744467092391295,0.935214143108896,Downregulated
Feature0124,Pyrazinoic acid,C5 H4 N2 O2,124.02723,NA,NA,Pyrazinoic acid,5,4,2,2,0,0,0.8,0.4,1.2000000000000002,26.09999999999999,5,3,1,1,1,Condensed HC,57135.45048496907,61538.8795965512,1.0770699989972174,0.10711201397171402,0.23668449093279528,0.5231694095424109,Upregulated
Feature0123,NA,C13 H23 N3 O6,317.15875,NA,NA,Feature0123,13,23,6,3,0,0,1.7692307692307692,0.4615384615384616,-0.1538461538461542,64.6846153846154,4,-2,-1.25,-0.2857142857142857,-5,Protein,2613288.6938536,3700001.8580636433,1.4158412221221368,0.5016594851237337,0.080598407947972725,0.39590936857023457,Upregulated
Feature0122,NA,C13 H24 N4 O5,316.17479,NA,NA,Feature0122,13,24,5,4,0,0,1.8461538461538465,0.38461538461538464,-0.1538461538461542,64.6846153846154,4,-1,-1.25,-0.38461538461538464,-5,Protein,2496132.676174897,2117833.05515806,0.8484457077832307,-0.23710575052062882,0.38109931728281965,0.6329237681148006,Downregulated
Feature0121,delta-guanidinovaleric acid,C6 H13 N3 O2,159.10079,NA,NA,delta-guanidinovaleric acid-peak1,6,13,2,3,0,0,2.1666666666666665,0.3333333333333333,0,60.3,2,0,-3,-1,-3,Protein,4715108.965204056,3460405.2321875165,0.7338971925620726,-0.44635011651780054,0.04672562398921991,0.35607946299980225,Downregulated
Feature0120,NA,C14 H28 N6 O4,344.2173,NA,NA,Feature0120,14,28,4,6,0,0,2,0.2857142857142857,-0.14285714285714324,64.37142857142858,4,0,-1.5,-0.6666666666666666,-6,Lipid,4325091.93031362,4455589.220426111,1.030172142515137,0.04288543294450936,0.9074173569191208,0.9502730353926686,Upregulated
Feature0119,NA,C27 H39 N5 O6,529.28996,NA,NA,Feature0119,27,39,6,5,0,0,1.4444444444444444,0.2222222222222222,-0.44444444444444464,72.96666666666667,11,5,0,0.15789473684210523,0,Lignin,94616.49110980106,118201.44826578833,1.2492689897854832,0.32108414824079706,0.09214878237294485,0.41723968591020827,Upregulated
Feature0118,L-Glutaminyl-L-Leucine,C11 H21 N3 O4,259.15319,NA,NA,L-Glutaminyl-L-Leucine,11,21,4,3,0,0,1.9090909090909092,0.3636363636363637,-0.3636363636363633,70.66363636363636,3,-1,-1,-0.3333333333333333,-4,Protein,2363852.1547026564,2443952.4488096,1.0338854923509457,0.04807640928397768,0.6662447981195823,0.8275141791352959,Upregulated
Feature0117,NA,C9 H19 N O8,269.11113,NA,NA,Feature0117,9,19,8,1,0,0,2.111111111111111,0.8888888888888888,0,60.3,1,-7,-Inf,-1,-8,Carbohydrate,692366.736587189,375515.8163478163,0.5423654784439922,-0.8826627410123626,0.39452177885182316,0.6419979763448496,Downregulated
Feature0116,Val-pro,C10 H18 N2 O3,214.13173,Metabolic pathways;Biosynthesis of cofactors;Other,Other,Val-pro,10,18,3,2,0,0,1.8,0.3,-0.5999999999999996,77.39999999999999,3,0,-0.4,-0.07692307692307693,-2,Lipid,775688.0862259603,556735.4445621726,0.7177310757355037,-0.4784847081904964,0.3256610860342689,0.5887618780598203,Downregulated
Feature0115,NA,C17 H31 N3 O6,373.22139,NA,NA,Feature0115,17,31,6,3,0,0,1.8235294117647056,0.35294117647058826,-0.5882352941176467,77.06470588235292,4,-2,-0.625,-0.18181818181818185,-5,Protein,719400.028483517,959162.49960951,1.333281153229043,0.41498103819076243,0.059874611858062525,0.3794192923980171,Upregulated
Feature0114,Pyridoxal,C8 H9 N O3,167.05829,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Other,Pyridoxal-peak1,8,9,3,1,0,0,1.125,0.375,0,60.3,5,2,0.25,0.4545454545454546,1,Lignin,332897.5509768223,287503.29025370104,0.8636389466070845,-0.21149979037600125,0.6990493420806498,0.8458497039175863,Downregulated
Feature0113,Fasoracetam,C10 H16 N2 O2,196.12116,NA,NA,Fasoracetam,10,16,2,2,0,0,1.6,0.2,-0.5999999999999996,77.39999999999999,4,2,0,0.14285714285714285,0,Lipid,2336548.2206038367,2144524.3820989467,0.9178173012602047,-0.12372109244417273,0.3969136483988781,0.644110748404211,Downregulated
Feature0112,NA,C22 H42 N4 O5,442.31572,NA,NA,Feature0112,22,42,5,4,0,0,1.9090909090909092,0.2272727272727273,-0.9090909090909092,86.2090909090909,4,-1,-0.38461538461538464,-0.16129032258064516,-5,Lipid,2267751.69871611,1742728.7164156632,0.7684830386864271,-0.3799146765757625,0.6013045153182122,0.7865713119297694,Downregulated
Feature0111,DL-Ornithine,C5 H12 N2 O2,132.08986,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Biosynthesis of various antibiotics;Other,Other,DL-Ornithine,5,12,2,2,0,0,2.4,0.4,-0.4000000000000003,71.7,1,-1,-3,-1,-3,Other,112664.29165886364,116240.558902879,1.0317426860929808,0.04508321127948981,0.736321626563121,0.8685503152360042,Upregulated
Feature0110,N-[(5S)-5-Amino-5-carboxypentanoyl]cysteinyl-D-valine,C14 H25 N3 O6 S,363.1465,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Other,N-[(5S)-5-Amino-5-carboxypentanoyl]cysteinyl-D-valine,14,25,6,3,1,0,1.7857142857142858,0.42857142857142855,-0.14285714285714324,64.37142857142858,4,-2,-1.5,-0.42857142857142855,-6,Protein,3911478.2239245865,5862912.85252006,1.4988995251614872,0.5839036792100727,0.009289792158984447,0.2324530359410441,Upregulated
Feature0109,L-Alanyl-L-glutamine,C8 H15 N3 O4,217.10628,Metabolic pathways;Biosynthesis of amino acids;Other,NA,L-Alanyl-L-glutamine-peak1,8,15,4,3,0,0,1.875,0.5,0.25,53.175,3,-1,-4,-0.6666666666666666,-4,Protein,1439078.64889404,982401.1049923374,0.6826597738402497,-0.550761352224102,0.0042921017993853465,0.20458153706421098,Downregulated
Feature0108,"3-(1-hydroxyethyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione",C9 H14 N2 O3,198.10045,NA,NA,"3-(1-hydroxyethyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione-peak1",9,14,3,2,0,0,1.5555555555555556,0.3333333333333333,-0.22222222222222232,66.63333333333333,4,1,-0.25,0.09090909090909093,-1,Protein,3500882.32913924,3363322.5074925367,0.9607070993212945,-0.05783144616323469,0.37675715542471994,0.62821390206306,Downregulated
Feature0107,NA,C14 H27 N3 O5,317.19514,NA,NA,Feature0107,14,27,5,3,0,0,1.9285714285714288,0.35714285714285715,-0.5714285714285712,76.58571428571427,3,-2,-0.8333333333333334,-0.29411764705882354,-5,Protein,1933204.14684277,2011923.0478041633,1.0407193938053327,0.05758113132988531,0.8132782320347669,0.9117758604016513,Upregulated
Feature0106,"(2E)-N-(4-Aminobutyl)-3-(2,4-dihydroxy-5-methoxyphenyl)acrylamide",C14 H20 N2 O4,280.14221,NA,NA,"(2E)-N-(4-Aminobutyl)-3-(2,4-dihydroxy-5-methoxyphenyl)acrylamide-peak1",14,20,4,2,0,0,1.4285714285714286,0.2857142857142857,-0.4285714285714288,72.51428571428572,6,2,0,0.2,0,Lignin,217508.653840649,119974.70489606533,0.5515858922282747,-0.858342537006804,0.07791738925633103,0.39590936857023457,Downregulated
Feature0105,NA,C14 H27 N3 O4,301.20018,NA,NA,Feature0105,14,27,4,3,0,0,1.9285714285714288,0.2857142857142857,-0.7142857142857144,80.65714285714286,3,-1,-0.5714285714285714,-0.2222222222222222,-4,Lipid,2966119.015842857,2994861.87770808,1.0096903939834174,0.013912980561679627,0.9715808860275127,0.9830086982891479,Upregulated
Feature0104,NA,C14 H27 N O10,369.16362,NA,NA,Feature0104,14,27,10,1,0,0,1.9285714285714288,0.7142857142857143,-0.2857142857142856,68.44285714285714,2,-8,-3,-0.5,-9,Carbohydrate,2017767.20773517,1766509.3483399267,0.8754772808121577,-0.19185835458937395,0.16326095074422353,0.4734778652324074,Downregulated
Feature0103,NA,C15 H28 N4 O5,344.20609,NA,NA,Feature0103,15,28,5,4,0,0,1.8666666666666667,0.3333333333333333,-0.4000000000000003,71.7,4,-1,-0.8333333333333334,-0.29411764705882354,-5,Protein,4861199.6454031635,5640585.25673185,1.160327834316718,0.21453247614756404,0.2913135336598799,0.5677030523083425,Upregulated
Feature0102,NP-006105,C15 H16 O5,276.09975,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics,NA,NP-006105,15,16,5,0,0,0,1.0666666666666669,0.3333333333333333,-0.4000000000000003,71.7,8,3,0.3,0.44,3,Lignin,214121.41019920734,264099.6806151827,1.2334108969741895,0.30265349744865705,0.7382447968655413,0.8689572839593829,Upregulated
Feature0101,"N,N-diacetyllegionaminic acid",C13 H22 N2 O8,334.13758,Metabolic pathways;Other,NA,"N,N-diacetyllegionaminic acid",13,22,8,2,0,0,1.6923076923076923,0.6153846153846154,0,60.3,4,-4,-2,-0.2857142857142857,-6,Amino Sugar,724828.5513283627,592568.730621046,0.8175295103029128,-0.2906572864793868,0.39234474230025984,0.6409180264769915,Downregulated
Feature0100,NA,C16 H31 N3 O9,409.20616,NA,NA,Feature0100,16,31,9,3,0,0,1.9375,0.5625,-0.25,67.425,3,-6,-2.25,-0.5294117647058824,-9,Amino Sugar,243268.02530384334,211495.864650206,0.8693944236446458,-0.20191725278645037,0.635898952979567,0.8131443267876828,Downregulated
Feature0099,NA,C14 H27 N3 O4,301.20024,NA,NA,Feature0099,14,27,4,3,0,0,1.9285714285714288,0.2857142857142857,-0.7142857142857144,80.65714285714286,3,-1,-0.5714285714285714,-0.2222222222222222,-4,Lipid,3454858.1136467867,4551724.997761363,1.317485363518091,0.39778693446426694,0.013315555701805383,0.25835889181660304,Upregulated
Feature0098,NA,C20 H30 N6 O8,482.21265,NA,NA,Feature0098,20,30,8,6,0,0,1.5,0.4,0.20000000000000015,54.599999999999994,9,1,-0.8333333333333334,-0.1,-5,Protein,80395.1872175175,329506.79292025813,4.098588538997284,2.0351271637848893,0.20996841776364847,0.5030926445426033,Upregulated
Feature0097,imazamox,C15 H19 N3 O4,305.13767,NA,NA,imazamox,15,19,4,3,0,0,1.2666666666666666,0.26666666666666666,-0.13333333333333375,64.10000000000001,8,4,0.125,0.3,1,Lignin,1125641.156718014,1864485.4681851799,1.656376418948099,0.7280305689959901,0.11765978419043718,0.45214600181013836,Upregulated
Feature0096,4-Phenyl-3-buten-2-one,C10 H10 O,146.07318,NA,NA,4-Phenyl-3-buten-2-one-peak1,10,10,1,0,0,0,1,0.1,-0.7999999999999998,83.1,6,5,0.5555555555555556,0.5789473684210527,5,Unsaturated HC,199884.38270026434,137317.78346327832,0.686986054679382,-0.5416472812138513,0.14782494804710258,0.4658688473133245,Downregulated
Feature0095,Proglumide,C18 H26 N2 O4,334.18921,NA,NA,Proglumide,18,26,4,2,0,0,1.4444444444444444,0.2222222222222222,-0.666666666666667,79.30000000000001,7,3,0.08333333333333333,0.21428571428571427,1,Lignin,180906.28595580466,182034.55496652,1.0062367595728043,0.00896979984903975,0.985995831799966,0.993030284821131,Upregulated
Feature0094,3477,C12 H20 N2 O3,240.14735,NA,NA,3477,12,20,3,2,0,0,1.6666666666666667,0.25,-0.666666666666667,79.30000000000001,4,1,-0.14285714285714285,0.0588235294117647,-1,Lipid,3405140.627535,3159055.4621868534,0.9277312768353156,-0.10822111466319741,0.7969441193326474,0.9000155587663364,Downregulated
Feature0093,NA,C14 H27 N3 O5,317.19523,NA,NA,Feature0093,14,27,5,3,0,0,1.9285714285714288,0.35714285714285715,-0.5714285714285712,76.58571428571427,3,-2,-0.8333333333333334,-0.29411764705882354,-5,Protein,2643820.450582057,3044612.4192301733,1.1515957592959383,0.2036343813585627,0.5563460140138909,0.7562901141909594,Upregulated
Feature0092,NA,C14 H25 N3 O5,315.17946,NA,NA,Feature0092,14,25,5,3,0,0,1.7857142857142858,0.35714285714285715,-0.4285714285714288,72.51428571428572,4,-1,-0.6666666666666666,-0.17647058823529413,-4,Protein,2453660.2733540265,3240062.1295819334,1.3205015236901303,0.4010859661918113,0.027173495805171168,0.30484703241033084,Upregulated
Feature0091,Methyl N-{[(2R)-1-(methoxyacetyl)-4-(3-pyridinylcarbonyl)-2-piperazinyl]carbonyl}-O-methyl-L-tyrosinate,C25 H30 N4 O7,498.21169,NA,NA,Methyl N-{[(2R)-1-(methoxyacetyl)-4-(3-pyridinylcarbonyl)-2-piperazinyl]carbonyl}-O-methyl-L-tyrosinate,25,30,7,4,0,0,1.2,0.28,-0.16000000000000014,64.86,13,6,0.14285714285714285,0.3142857142857143,2,Lignin,103158.63051051783,118077.44393620067,1.1446201190521015,0.1948688705541237,0.20161503306259562,0.4974607521671786,Upregulated
Feature0090,NA,C19 H34 N4 O8,446.2376,NA,NA,Feature0090,19,34,8,4,0,0,1.7894736842105263,0.42105263157894735,-0.3157894736842106,69.3,5,-3,-1,-0.2727272727272727,-7,Protein,240221.92914735607,234022.11250672932,0.9741912960959377,-0.03772300139830778,0.9644077571816561,0.9788536492904287,Downregulated
Feature0089,HC blue 2,C12 H19 N3 O5,285.13253,NA,NA,HC blue 2-peak1,12,19,5,3,0,0,1.5833333333333333,0.4166666666666667,0,60.3,5,0,-0.75,-0.07692307692307693,-3,Protein,84176.59013995511,131283.1312956355,1.5596156969219035,0.6411905800824941,0.37165784530571117,0.6242377295699064,Upregulated
Feature0088,NA,C10 H15 N O5,229.09499,NA,NA,Feature0088,10,15,5,1,0,0,1.5,0.5,-0.20000000000000015,66,4,-1,-0.5,0.07692307692307693,-2,Protein,465029.5178915927,420990.6693378417,0.9052988103778451,-0.14353403628541328,0.5925417963827454,0.7816283742544378,Downregulated
Feature0087,NA,C14 H27 N3 O4,301.20021,NA,NA,Feature0087,14,27,4,3,0,0,1.9285714285714288,0.2857142857142857,-0.7142857142857144,80.65714285714286,3,-1,-0.5714285714285714,-0.2222222222222222,-4,Lipid,1994998.4297828334,1714738.9033839232,0.8595189238171892,-0.21839869137173007,0.7017701439658213,0.8470526718656479,Downregulated
Feature0086,NA,C15 H27 N3 O7,361.18494,NA,NA,Feature0086,15,27,7,3,0,0,1.8,0.4666666666666667,-0.2666666666666666,67.89999999999999,4,-3,-1.2,-0.29411764705882354,-6,Protein,366952.05720196967,523113.783894404,1.4255643853945836,0.511533199845345,0.2868711678809058,0.5646020478032001,Upregulated
Feature0085,NA,C19 H29 N3 O6,395.20574,NA,NA,Feature0085,19,29,6,3,0,0,1.5263157894736843,0.3157894736842105,-0.4210526315789478,72.30000000000001,7,1,-0.2,0.07692307692307693,-2,Protein,172340.41142800936,227417.7147062593,1.3195843785092565,0.40008360421840244,0.36374647902061136,0.6192829502119754,Upregulated
Feature0084,(+)-sesamin monocatechol,C19 H18 O6,342.11027,Biosynthesis of secondary metabolites;Other,NA,(+)-sesamin monocatechol-peak1,19,18,6,0,0,0,0.9473684210526316,0.3157894736842105,-0.3157894736842106,69.3,11,5,0.38461538461538464,0.5,5,Lignin,3246532.494112977,3252854.249851743,1.0019472331634536,0.002806532028184809,0.9906318176245635,0.9952747121088282,Upregulated
Feature0083,S-methyl D-thioglycerate,C4 H8 O3 S,136.0194,NA,NA,S-methyl D-thioglycerate,4,8,3,0,1,0,2,0.75,0,60.3,1,-2,-Inf,-1,-3,Carbohydrate,2857497.8556775767,2572423.5385184567,0.9002363845723613,-0.15162422003134624,0.40011996393712224,0.6461271991059953,Downregulated
Feature0082,NA,C15 H25 N3 O6,343.17444,NA,NA,Feature0082,15,25,6,3,0,0,1.6666666666666667,0.4,-0.2666666666666666,67.89999999999999,5,-1,-0.6666666666666666,-0.1111111111111111,-4,Protein,2132609.0273096864,3197069.60809385,1.4991353629066244,0.5841306558522859,0.1218880217234777,0.45317690246982556,Upregulated
Feature0081,Deferiprone,C7 H9 N O2,139.06334,NA,NA,Deferiprone,7,9,2,1,0,0,1.2857142857142858,0.2857142857142857,-0.2857142857142856,68.44285714285714,4,2,0.25,0.4,1,Lignin,3346216.744354957,3331808.3090986134,0.995694111781417,-0.006225496364804429,0.9794325090957426,0.9893611630341015,Downregulated
Feature0080,5-Deoxy-5-aminoshikimic acid,C7 H11 N O4,173.06883,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Other,5-Deoxy-5-aminoshikimic acid-peak1,7,11,4,1,0,0,1.5714285714285714,0.5714285714285714,0,60.3,3,-1,-1,0,-2,Amino Sugar,3466386.569668567,2870657.86286237,0.8281412950249353,-0.27205115778955274,0.029726979569580897,0.31473439619293775,Downregulated
Feature0079,NA,C15 H21 N3 O7,355.13805,NA,NA,Feature0079,15,21,7,3,0,0,1.4,0.4666666666666667,0.1333333333333333,56.5,7,0,-0.6,0.0588235294117647,-3,Lignin,297056.107180166,398233.43713504623,1.3406000668200895,0.42287891086616036,0.7513443687720871,0.876484459563939,Upregulated
Feature0078,NA,C13 H23 N3 O6,317.15865,NA,NA,Feature0078,13,23,6,3,0,0,1.7692307692307692,0.4615384615384616,-0.1538461538461542,64.6846153846154,4,-2,-1.25,-0.2857142857142857,-5,Protein,705742.525654474,816265.2626401683,1.1566048990504014,0.20989611809410366,0.695727209842978,0.8442420440358199,Upregulated
Feature0077,Tiglic acid,C5 H8 O2,100.0524,NA,NA,Tiglic acid-peak1,5,8,2,0,0,0,1.6,0.4,-0.7999999999999998,83.1,2,0,0,0.25,0,Protein,499209.7953716317,816180.9472574324,1.63494577795661,0.7092427903592908,0.44806690288547024,0.6693345092486654,Upregulated
Feature0076,Anhydroecgonine,C9 H13 N O2,167.09465,Metabolic pathways;Biosynthesis of alkaloids derived from shikimate pathway;Tyrosine metabolism;Other,Other,Anhydroecgonine-peak1,9,13,2,1,0,0,1.4444444444444444,0.2222222222222222,-0.666666666666667,79.30000000000001,4,2,0.16666666666666666,0.2857142857142857,1,Lignin,79039.81035053893,224767.8266860705,2.8437293268953034,1.5077841522535411,0.37181574329163847,0.6242377295699064,Upregulated
Feature0075,NA,C17 H30 N4 O8,418.20647,NA,NA,Feature0075,17,30,8,4,0,0,1.7647058823529411,0.4705882352941176,-0.117647058823529,63.65294117647058,5,-3,-1.4,-0.3333333333333333,-7,Protein,1072378.3569378387,1647484.34731564,1.5362901877468027,0.6194507504870693,0.10417038290623516,0.4293543275989352,Upregulated
Feature0074,NA,C16 H30 N4 O5,358.22175,NA,NA,Feature0074,16,30,5,4,0,0,1.875,0.3125,-0.5,74.55,4,-1,-0.7142857142857143,-0.2631578947368421,-5,Protein,1703031.5141949968,1857289.2347994065,1.0905783124496822,0.1250933710114187,0.7146228682350263,0.8531156721565429,Upregulated
Feature0073,NA,C18 H27 N3 O5,365.19518,NA,NA,Feature0073,18,27,5,3,0,0,1.5,0.2777777777777778,-0.44444444444444464,72.96666666666667,7,2,-0.1,0.12,-1,Lipid,2190143.3014186765,2259025.4185899366,1.0314509635632707,0.044675235373007986,0.9316216571286479,0.9640605297348379,Upregulated
Feature0072,NP-016455,C11 H18 N2 O4,242.12667,NA,NA,NP-016455-peak1,11,18,4,2,0,0,1.6363636363636365,0.3636363636363637,-0.3636363636363633,70.66363636363636,4,0,-0.4,0,-2,Protein,4106963.6631157734,3329457.38734527,0.8106858644128729,-0.30278510726205876,0.009562760323166702,0.2324530359410441,Downregulated
Feature0071,Methionylphenylalanine,C14 H20 N2 O3 S,296.11937,NA,NA,Methionylphenylalanine-peak1,14,20,3,2,1,0,1.4285714285714286,0.21428571428571427,-0.4285714285714288,72.51428571428572,6,3,0,0.15789473684210523,0,Lignin,1317952.5819933047,595689.8886502387,0.45198127519072223,-1.1456650893908256,0.1420068231141689,0.46161586781018427,Downregulated
Feature0070,NA,C14 H25 N3 O5,315.17952,NA,NA,Feature0070,14,25,5,3,0,0,1.7857142857142858,0.35714285714285715,-0.4285714285714288,72.51428571428572,4,-1,-0.6666666666666666,-0.17647058823529413,-4,Protein,503218.9179195513,730432.7790394666,1.4515209047769535,0.5375653497812225,0.1626372003143441,0.4734778652324074,Upregulated
Feature0069,NA,C19 H29 N3 O5,379.21082,NA,NA,Feature0069,19,29,5,3,0,0,1.5263157894736843,0.2631578947368421,-0.5263157894736841,75.3,7,2,-0.09090909090909093,0.1111111111111111,-1,Lipid,206105.32499609733,284540.364228636,1.380558043485892,0.46525154514357464,0.3762127318362744,0.62821390206306,Upregulated
Feature0068,NA,C11 H13 N3 O3,235.09569,NA,NA,Feature0068,11,13,3,3,0,0,1.181818181818182,0.2727272727272727,0.18181818181818168,55.11818181818182,7,4,0.2,0.38461538461538464,1,Lignin,61967.88999928777,72069.87589163464,1.1630196847506504,0.2178755154283351,0.046062501703755955,0.35607946299980225,Upregulated
Feature0067,NA,C14 H25 N3 O6,331.17449,NA,NA,Feature0067,14,25,6,3,0,0,1.7857142857142858,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,-2,-1,-0.25,-5,Protein,2853319.5358958403,2874116.161822263,1.0072885723680063,0.01047705204749382,0.9490976052956895,0.9724293424211538,Upregulated
Feature0066,"1-[2-(Hydroxyamino)phenyl]-1,3-decanedione",C16 H23 N O3,277.16771,NA,NA,"1-[2-(Hydroxyamino)phenyl]-1,3-decanedione",16,23,3,1,0,0,1.4375,0.1875,-0.875,85.2375,6,3,0.16666666666666666,0.25925925925925924,2,Lignin,240588.29932005034,325535.99829420965,1.3530832514059834,0.43625060701258705,0.35561282881935774,0.6145703098895281,Upregulated
Feature0065,allobarbital,C10 H12 N2 O3,208.08478,Metabolic pathways;Biosynthesis of cofactors;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,allobarbital,10,12,3,2,0,0,1.2,0.3,0,60.3,6,3,0.2,0.38461538461538464,1,Lignin,3624506.2985055363,1383028.8210323313,0.38157716034390243,-1.389953274814153,0.06806249702413034,0.3925920914282487,Downregulated
Feature0064,Ala-Tyr,C12 H16 N2 O4,252.11102,NA,NA,Ala-Tyr,12,16,4,2,0,0,1.3333333333333333,0.3333333333333333,-0.16666666666666696,65.05000000000001,6,2,0,0.25,0,Lignin,93631.65065722067,120371.65140284033,1.2855871978965003,0.3624274675861352,0.207135496738602,0.5026064024853513,Upregulated
Feature0063,N-Phenyl-beta-D-glucopyranosylamine,C12 H17 N O5,255.11067,NA,NA,N-Phenyl-beta-D-glucopyranosylamine-peak1,12,17,5,1,0,0,1.4166666666666667,0.4166666666666667,-0.33333333333333304,69.79999999999998,5,0,-0.16666666666666666,0.17647058823529413,-1,Lignin,175058.1145700531,156512.95838051834,0.894062858867856,-0.16155182836811946,0.8175679852648052,0.9127191231804745,Downregulated
Feature0062,Glu-Lys,C11 H21 N3 O5,275.14821,Metabolic pathways;Other,NA,Glu-Lys,11,21,5,3,0,0,1.9090909090909092,0.4545454545454546,-0.18181818181818168,65.48181818181817,3,-2,-1.6666666666666667,-0.4545454545454546,-5,Protein,1557692.02579259,1913086.59355247,1.228154578617071,0.29649215335418355,0.016516650035314513,0.2637533176745511,Upregulated
Feature0061,N-(2-Hydroxy-7-octenoyl)glycine,C10 H17 N O4,215.11577,NA,NA,N-(2-Hydroxy-7-octenoyl)glycine-peak1,10,17,4,1,0,0,1.7,0.4,-0.5999999999999996,77.39999999999999,3,-1,-0.4,0,-2,Protein,4871352.235891053,2925354.25366625,0.6005220136028929,-0.7357109624724925,0.14258861269680256,0.46161586781018427,Downregulated
Feature0060,NA,C16 H31 N3 O5,345.22649,NA,NA,Feature0060,16,31,5,3,0,0,1.9375,0.3125,-0.75,81.675,3,-2,-0.625,-0.23809523809523808,-5,Protein,3709602.820167413,3943190.186542077,1.0629682954478998,0.0880985670644906,0.8227604745345063,0.9136000023320247,Upregulated
Feature0059,Acetyl-L-methionine,C7 H13 N O3 S,191.0617,NA,NA,Acetyl-L-methionine-peak1,7,13,3,1,1,0,1.8571428571428572,0.42857142857142855,-0.2857142857142856,68.44285714285714,2,-1,-1.5,-0.42857142857142855,-3,Protein,192810.891734948,159345.22300067535,0.8264326852433367,-0.27503078126282926,0.20165923071752842,0.4974607521671786,Downregulated
Feature0058,Ajmaline,C20 H26 N2 O2,326.19951,Biosynthesis of secondary metabolites;Other,NA,Ajmaline,20,26,2,2,0,0,1.3,0.1,-0.7999999999999998,83.1,9,7,0.3125,0.35294117647058826,5,Unsaturated HC,98042.31458566284,138070.22996356233,1.408271831882608,0.49392583728286127,0.12271857878662093,0.45317690246982556,Upregulated
Feature0057,NA,C12 H22 N4 O3,270.16923,NA,NA,Feature0057,12,22,3,4,0,0,1.8333333333333333,0.25,-0.33333333333333304,69.79999999999998,4,1,-0.6,-0.2307692307692308,-3,Lipid,70373.50422949954,82927.52373715333,1.1783912801430645,0.23681865987463552,0.22049264317664297,0.5089827335113032,Upregulated
Feature0056,Uric acid,C5 H4 N4 O3,168.02837,Metabolic pathways;Microbial metabolism in diverse environments;Other,Other,Uric acid,5,4,3,4,0,0,0.8,0.6,2.8,-19.5,6,3,0.5,-1,-1,Condensed HC,96534.2855111671,84750.6891203827,0.8779335618595191,-0.1878163277946764,0.40880299722566205,0.6571680721141803,Downregulated
Feature0055,NA,C21 H33 N3 O4,391.24697,NA,NA,Feature0055,21,33,4,3,0,0,1.5714285714285714,0.1904761904761905,-0.7619047619047619,82.0142857142857,7,3,0,0.125,0,Lipid,601092.4377405196,472911.38490150264,0.7867531767312794,-0.34601699607582037,0.756564860527932,0.87699965252227,Downregulated
Feature0054,NA,C16 H30 N4 O5,358.22173,NA,NA,Feature0054,16,30,5,4,0,0,1.875,0.3125,-0.5,74.55,4,-1,-0.7142857142857143,-0.2631578947368421,-5,Protein,1070040.460957244,1099319.539324798,1.0273625899541792,0.03894544592791699,0.9633508734935783,0.9788536492904287,Upregulated
Feature0053,NA,C25 H54 N2 O5 P2 S,556.32268,NA,NA,Feature0053,25,54,5,2,1,2,2.16,0.2,-1.84,112.74,1,-4,-0.6,-0.37142857142857144,-9,Lipid,128746.17349318501,176868.779350971,1.3737789213621427,0.4581498537070146,0.07075679547699251,0.39590936857023457,Upregulated
Feature0052,NA,C19 H30 N4 O6,410.21666,NA,NA,Feature0052,19,30,6,4,0,0,1.5789473684210529,0.3157894736842105,-0.3157894736842106,69.3,7,1,-0.3333333333333333,0,-3,Protein,106512.4594996438,138298.26312854968,1.2984233373093048,0.37676083561915297,0.010461609872128732,0.2427666729230969,Upregulated
Feature0051,NA,C15 H33 N O,243.2562,NA,NA,Feature0051,15,33,1,1,0,0,2.2,0.06666666666666667,-1.8666666666666665,113.5,0,-1,-0.15384615384615383,-0.1111111111111111,-2,Lipid,3545700.8290606723,1237097.0585955372,0.34890057515745604,-1.5191121190916022,0.32128375668975007,0.5861484461709393,Downregulated
Feature0050,N-feruloylglycine,C12 H13 N O5,251.07936,NA,NA,N-feruloylglycine,12,13,5,1,0,0,1.0833333333333333,0.4166666666666667,0,60.3,7,2,0.16666666666666666,0.4117647058823529,1,Lignin,614577.6263327317,155024.58946261246,0.2522457421492307,-1.9870981777144368,0.018177931348869664,0.2637533176745511,Downregulated
Feature0049,"(1R)-6-Hydroxy-7-methoxy-1-methyl-1,2,3,4-tetrahydro-1-isoquinoliniumcarboxylate",C12 H15 N O4,237.10007,NA,NA,"(1R)-6-Hydroxy-7-methoxy-1-methyl-1,2,3,4-tetrahydro-1-isoquinoliniumcarboxylate-peak1",12,15,4,1,0,0,1.25,0.3333333333333333,-0.33333333333333304,69.79999999999998,6,2,0.14285714285714285,0.3333333333333333,1,Lignin,376847.6358919473,276330.31857646536,0.7332680167209459,-0.44758748081152916,0.5710278187078678,0.7634736581619005,Downregulated
Feature0048,NA,C27 H42 N2 O2,426.32469,NA,NA,Feature0048,27,42,2,2,0,0,1.5555555555555556,0.07407407407407407,-1.1851851851851851,94.07777777777778,8,6,0.17391304347826086,0.20833333333333337,4,Lipid,146995.30867730099,183299.636639821,1.2469760993680346,0.3184338134806078,0.16473403546674198,0.4734778652324074,Upregulated
Feature0047,NA,C14 H27 N3 O5,317.19516,NA,NA,Feature0047,14,27,5,3,0,0,1.9285714285714288,0.35714285714285715,-0.5714285714285712,76.58571428571427,3,-2,-0.8333333333333334,-0.29411764705882354,-5,Protein,937439.9709973333,973404.009692779,1.0383640977642377,0.054312407023529956,0.7058285498090876,0.8478072560935465,Upregulated
Feature0046,asn-tyr,C13 H17 N3 O5,295.11678,NA,NA,asn-tyr-peak1,13,17,5,3,0,0,1.3076923076923077,0.38461538461538464,0.15384615384615374,55.91538461538462,7,2,-0.2,0.2,-1,Lignin,2993305.6551122367,3274848.5216960898,1.0940575066575673,0.129688572124281,0.7005452229881697,0.8470526718656479,Upregulated
Feature0045,NA,C7 H9 N O3 S,187.03034,NA,NA,Feature0045,7,9,3,1,1,0,1.2857142857142858,0.42857142857142855,0.2857142857142856,52.15714285714286,4,1,-0.5,0.14285714285714285,-1,Lignin,2970497.5475562466,2064431.8982272968,0.6949784893529546,-0.524959769977948,0.06634870614488236,0.3871937356331548,Downregulated
Feature0044,Vinylbital,C11 H16 N2 O3,224.11608,NA,NA,Vinylbital,11,16,3,2,0,0,1.4545454545454546,0.2727272727272727,-0.3636363636363633,70.66363636363636,5,2,0,0.2,0,Lignin,1312868.54547949,1365507.6557662066,1.0400947303276975,0.05671493293375842,0.8425437902983903,0.9218399058025261,Upregulated
Feature0043,NA,C12 H17 N O4,239.11576,NA,NA,Feature0043,12,17,4,1,0,0,1.4166666666666667,0.3333333333333333,-0.5,74.55,5,1,0,0.2222222222222222,0,Lignin,720842.69377165,591960.802947008,0.8212066350422504,-0.2841828109577979,0.18523292016521464,0.4854964193043512,Downregulated
Feature0042,2-[(2Z)-2-({4-[(3-Aminopropyl)amino]butyl}imino)-2-hydroxyethyl]-2-hydroxysuccinic acid,C13 H25 N3 O6,319.17436,Other,NA,2-[(2Z)-2-({4-[(3-Aminopropyl)amino]butyl}imino)-2-hydroxyethyl]-2-hydroxysuccinic acid-peak1,13,25,6,3,0,0,1.9230769230769231,0.4615384615384616,-0.3076923076923075,69.06923076923076,3,-3,-1.5,-0.42857142857142855,-6,Protein,946775.291520838,1256270.5727041601,1.3268941257287874,0.40805326115295387,0.006255424008933117,0.23030609530252863,Upregulated
Feature0041,NA,C13 H23 N3 O6,317.15865,NA,NA,Feature0041,13,23,6,3,0,0,1.7692307692307692,0.4615384615384616,-0.1538461538461542,64.6846153846154,4,-2,-1.25,-0.2857142857142857,-5,Protein,1619136.44144895,2123211.682045833,1.3113235102940375,0.3910236498008605,0.1858266678635818,0.4854964193043512,Upregulated
Feature0040,NA,C19 H27 N3 O6,393.19014,NA,NA,Feature0040,19,27,6,3,0,0,1.4210526315789471,0.3157894736842105,-0.3157894736842106,69.3,8,2,-0.1,0.15384615384615383,-1,Lignin,731166.045582988,736583.1942211777,1.0074089171275322,0.010649406248436428,0.988871130872784,0.994743287231886,Upregulated
Feature0039,NA,C26 H48 N2 O6,484.35117,NA,NA,Feature0039,26,48,6,2,0,0,1.8461538461538465,0.2307692307692308,-1.1538461538461542,93.1846153846154,4,-2,-0.2222222222222222,-0.04761904761904761,-4,Lipid,361515.433687069,506461.7731470417,1.4009409445723402,0.4863961415158111,0.4700755631040777,0.6900415978321557,Upregulated
Feature0038,NA,C14 H25 N3 O6,331.17447,NA,NA,Feature0038,14,25,6,3,0,0,1.7857142857142858,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,-2,-1,-0.25,-5,Protein,2029010.67035216,2889364.5119831967,1.4240262775363874,0.5099757685807503,0.21235880673487512,0.5042851084128842,Upregulated
Feature0037,Anhalamine,C11 H15 N O3,209.10523,Biosynthesis of alkaloids derived from shikimate pathway;Other,NA,Anhalamine-peak1,11,15,3,1,0,0,1.3636363636363635,0.2727272727272727,-0.5454545454545459,75.84545454545456,5,2,0.14285714285714285,0.29411764705882354,1,Lignin,199163.80413907534,275795.0646257473,1.384764996922637,0.4696411628874106,0.023116427185158966,0.2919627558710051,Upregulated
Feature0036,Hypoxanthine,C5 H4 N4 O,136.03851,Metabolic pathways;Other,Superpathway of purine nucleotide salvage;Other,Hypoxanthine-peak1,5,4,1,4,0,0,0.8,0.2,2,3.299999999999997,6,5,Inf,3,1,Condensed HC,85873.25416798833,75938.9808107805,0.8843146978246097,-0.17736822730980656,0.5562415378460179,0.7562901141909594,Downregulated
Feature0035,NA,C8 H9 N5 O3,223.07052,NA,NA,Feature0035,8,9,3,5,0,0,1.125,0.375,1.5,17.549999999999997,7,4,-Inf,0.3333333333333333,-1,Lignin,3131115.3717609434,2288880.0677442267,0.731011092209278,-0.452034797391036,0.0308284829622812,0.32236697616113796,Downregulated
Feature0034,NA,C12 H23 N3 O5,289.16377,NA,NA,Feature0034,12,23,5,3,0,0,1.9166666666666667,0.4166666666666667,-0.33333333333333304,69.79999999999998,3,-2,-1.25,-0.38461538461538464,-5,Protein,3257085.8260644865,3906672.879545827,1.199438113752818,0.2623587222122622,0.6809974892798181,0.8353437703403417,Upregulated
Feature0033,Isoquinoline,C9 H7 N,129.05782,NA,NA,Isoquinoline,9,7,0,1,0,0,0.7777777777777778,0,-0.44444444444444464,72.96666666666667,7,7,0.75,0.75,6,Condensed HC,3538611.5245083035,2480942.0210676435,0.7011060705264546,-0.5122953684173174,0.02028904335401138,0.28009922407994764,Downregulated
Feature0032,"(2Z)-8-Hydroxy-2-octene-4,6-diynoic acid",C8 H6 O3,150.03174,Metabolic pathways;Microbial metabolism in diverse environments;Phenylalanine metabolism;Aminobenzoate degradation;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of aromatic compound degradation via 3-oxoadipate;Other,"(2Z)-8-Hydroxy-2-octene-4,6-diynoic acid-peak1",8,6,3,0,0,0,0.75,0.375,0,60.3,6,3,0.6,0.6923076923076923,3,Condensed HC,4082841.3953979933,3689165.6619814564,0.9035779999046077,-0.14627895011354772,0.3177117192590345,0.5843687865633056,Downregulated
Feature0031,NA,C14 H27 N3 O5,317.19507,NA,NA,Feature0031,14,27,5,3,0,0,1.9285714285714288,0.35714285714285715,-0.5714285714285712,76.58571428571427,3,-2,-0.8333333333333334,-0.29411764705882354,-5,Protein,3818533.380342143,5103924.013201347,1.336618933194721,0.41858821520624634,0.12961423172394446,0.45384777576550756,Upregulated
Feature0030,NA,C15 H19 N3 O3 S,321.11473,NA,NA,Feature0030,15,19,3,3,1,0,1.2666666666666666,0.2,-0.13333333333333375,64.10000000000001,8,5,0.125,0.2631578947368421,1,Lignin,100943.67443519634,143044.55452654258,1.4170729897332406,0.5029140696280004,0.4531152497034601,0.675089914685718,Upregulated
Feature0029,MFCD08277025,C12 H19 N O4,241.13144,Other,NA,MFCD08277025,12,19,4,1,0,0,1.5833333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,4,0,-0.14285714285714285,0.1111111111111111,-1,Protein,254723.471189018,419134.686968608,1.6454498088147849,0.7184820205805449,0.13849396438706013,0.45798070948295916,Upregulated
Feature0028,NA,C12 H23 N3 O5,289.16387,NA,NA,Feature0028,12,23,5,3,0,0,1.9166666666666667,0.4166666666666667,-0.33333333333333304,69.79999999999998,3,-2,-1.25,-0.38461538461538464,-5,Protein,1666098.44235096,1759128.10506868,1.0558368343388218,0.0783869024254012,0.6805412518489945,0.8353437703403417,Upregulated
Feature0027,asn-val,C9 H17 N3 O4,231.12192,NA,NA,asn-val-peak1,9,17,4,3,0,0,1.8888888888888888,0.4444444444444444,0,60.3,3,-1,-2,-0.5,-4,Protein,4038920.131518553,2524077.1112640565,0.6249386046450625,-0.6782136317123988,0.2872685769711855,0.5646020478032001,Downregulated
Feature0026,NA,C16 H21 N5 O9,427.13396,NA,NA,Feature0026,16,21,9,5,0,0,1.3125,0.5625,0.75,38.925,9,0,-2.5,-0.07692307692307693,-5,Lignin,2927686.2059017066,2794194.8321069633,0.9544037972629553,-0.06732831182746486,0.7093580393978636,0.849869386554764,Downregulated
Feature0025,NA,C17 H32 N6 O6,416.23845,NA,NA,Feature0025,17,32,6,6,0,0,1.8823529411764703,0.35294117647058826,-0.117647058823529,63.65294117647058,5,-1,-1.4,-0.5,-7,Protein,2484126.4675959935,3300087.1520939935,1.3284698646150828,0.40976550169858555,0.09555069678168678,0.41723968591020827,Upregulated
Feature0024,NA,C11 H19 N3 O5,273.13255,Biosynthesis of secondary metabolites;Other,NA,Feature0024,11,19,5,3,0,0,1.7272727272727273,0.4545454545454546,0,60.3,4,-1,-1.3333333333333333,-0.2727272727272727,-4,Protein,3258773.3757356033,2148080.5863432502,0.6591684473481878,-0.601280908712955,0.01821672855249261,0.2637533176745511,Downregulated
Feature0023,4-Hydroxyprolyllysine,C11 H21 N3 O4,259.15322,NA,NA,4-Hydroxyprolyllysine-peak1,11,21,4,3,0,0,1.9090909090909092,0.3636363636363637,-0.3636363636363633,70.66363636363636,3,-1,-1,-0.3333333333333333,-4,Protein,1209311.3497813046,1308802.5373759866,1.0822709450404764,0.11406172109878095,0.5670244494071071,0.7624035936741783,Upregulated
Feature0022,NA,C20 H38 N4 O6,430.27919,NA,NA,Feature0022,20,38,6,4,0,0,1.9,0.3,-0.7000000000000002,80.25,4,-2,-0.6,-0.2307692307692308,-6,Lipid,302110.942394926,224209.22334085932,0.7421420143324969,-0.43023281131755353,0.49056139611406807,0.7066420110690742,Downregulated
Feature0021,NA,C16 H30 N4 O5,358.22177,NA,NA,Feature0021,16,30,5,4,0,0,1.875,0.3125,-0.5,74.55,4,-1,-0.7142857142857143,-0.2631578947368421,-5,Protein,1762995.1703297934,2060469.34416052,1.1687322681519767,0.22494447679213,0.3236386392385674,0.586357064032228,Upregulated
Feature0020,"2-(4-Hydroxyphenyl)-5,6,7,8-tetramethoxy-2,3-dihydro-4H-chromen-4-one",C19 H20 O7,360.12104,NA,NA,"2-(4-Hydroxyphenyl)-5,6,7,8-tetramethoxy-2,3-dihydro-4H-chromen-4-one",19,20,7,0,0,0,1.0526315789473684,0.3684210526315789,-0.3157894736842106,69.3,10,3,0.25,0.41935483870967744,3,Lignin,4610988.73552233,2755001.7574763736,0.5974861175114731,-0.7430229021789587,0.14031404263379918,0.45798070948295916,Downregulated
Feature0019,Crotanecine,C8 H13 N O3,171.08956,Other,NA,Crotanecine-peak1,8,13,3,1,0,0,1.625,0.375,-0.5,74.55,3,0,-0.25,0.09090909090909093,-1,Protein,189972.15499311447,293204.31338518136,1.543406787146298,0.626118355137981,0.2281843823110689,0.5170330973050352,Upregulated
Feature0018,NA,C14 H27 N3 O4,301.20015,NA,NA,Feature0018,14,27,4,3,0,0,1.9285714285714288,0.2857142857142857,-0.7142857142857144,80.65714285714286,3,-1,-0.5714285714285714,-0.2222222222222222,-4,Lipid,1052625.324159847,1144466.0866369947,1.0872492427924916,0.12068270404695915,0.8009927426426533,0.9033832929671469,Upregulated
Feature0017,?-Ribazole,C14 H18 N2 O4,278.12676,Metabolic pathways;Biosynthesis of cofactors;Other,NA,?-Ribazole-peak1,14,18,4,2,0,0,1.2857142857142858,0.2857142857142857,-0.2857142857142856,68.44285714285714,7,3,0.125,0.3,1,Lignin,405220.07314353634,914687.290143509,2.257260562261214,1.1745729626967634,0.1715009097122207,0.4760067902771642,Upregulated
Feature0016,NA,C15 H21 N3 O7,355.1381,NA,NA,Feature0016,15,21,7,3,0,0,1.4,0.4666666666666667,0.1333333333333333,56.5,7,0,-0.6,0.0588235294117647,-3,Lignin,210308.51393715266,197768.89309767433,0.9403751155636733,-0.0886917323403728,0.49673662225095755,0.7099241665400493,Downregulated
Feature0015,NA,C17 H31 N3 O6,373.22133,NA,NA,Feature0015,17,31,6,3,0,0,1.8235294117647056,0.35294117647058826,-0.5882352941176467,77.06470588235292,4,-2,-0.625,-0.18181818181818185,-5,Protein,1630417.403396987,1544240.2737861366,0.9471441304347589,-0.078344112233354593,0.9192597365085948,0.9559061905453898,Downregulated
Feature0014,Marimastat,C15 H29 N3 O5,331.21086,NA,NA,Marimastat-peak1,15,29,5,3,0,0,1.9333333333333331,0.3333333333333333,-0.666666666666667,79.30000000000001,3,-2,-0.7142857142857143,-0.2631578947368421,-5,Protein,2906497.3653925667,3418312.344259427,1.1760933916407428,0.23400262676207506,0.29956878560196326,0.5734118901804811,Upregulated
Feature0013,1-(6-hydroxy-3-pyridyl)-4-(methylamino)butan-1-one,C10 H14 N2 O3,210.10041,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,1-(6-hydroxy-3-pyridyl)-4-(methylamino)butan-1-one,10,14,3,2,0,0,1.4,0.3,-0.20000000000000015,66,5,2,0,0.2307692307692308,0,Lignin,550333.1881227783,553982.3112957127,1.0066307525180915,0.009534577880535538,0.9697660530257248,0.9819388486703993,Upregulated
Feature0012,Pentoxifylline,C13 H18 N4 O3,278.13793,NA,NA,Pentoxifylline,13,18,3,4,0,0,1.3846153846153846,0.2307692307692308,0,60.3,7,4,0,0.2,0,Lignin,71255.27864756563,93575.94467160797,1.3132492981248751,0.39314081343454005,0.07165696931433903,0.39590936857023457,Upregulated
Feature0011,NA,C16 H30 N4 O5,358.22167,NA,NA,Feature0011,16,30,5,4,0,0,1.875,0.3125,-0.5,74.55,4,-1,-0.7142857142857143,-0.2631578947368421,-5,Protein,4131557.131462503,4348884.088297893,1.0526017067948568,0.07395963927685976,0.814253199687762,0.9122651589094372,Upregulated
Feature0010,NA,C16 H30 N6 O6,402.22286,NA,NA,Feature0010,16,30,6,6,0,0,1.875,0.375,0,60.3,5,-1,-1.75,-0.5714285714285714,-7,Protein,891441.3179684334,995641.37844086,1.116889422076481,0.1594863584991173,0.6404984476277178,0.8131443267876828,Upregulated
Feature0009,APM,C7 H13 N O4,175.08446,NA,NA,APM-peak1,7,13,4,1,0,0,1.8571428571428572,0.5714285714285714,-0.2857142857142856,68.44285714285714,2,-2,-1.5,-0.25,-3,Amino Sugar,180526.00073432634,201529.62885130613,1.1163468311021307,0.15878531907956211,0.7660937094770877,0.8822316409613777,Upregulated
Feature0008,NA,C15 H27 N3 O7,361.18502,NA,NA,Feature0008,15,27,7,3,0,0,1.8,0.4666666666666667,-0.2666666666666666,67.89999999999999,4,-3,-1.2,-0.29411764705882354,-6,Protein,550173.7644770497,1126489.1975031237,2.047515294688529,1.0338742286618292,0.20558636092084723,0.5018203103745176,Upregulated
Feature0007,(Z)-dehydrobutyrine,C4 H7 N O2,101.04765,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,(Z)-dehydrobutyrine-peak1,4,7,2,1,0,0,1.75,0.5,0,60.3,2,0,-1,0,-1,Protein,2453098.2932700533,3071211.18474694,1.2519723295118859,0.3242026768734665,0.10635358976100227,0.43283090716191397,Upregulated
Feature0006,N~2~-Acetyl-L-ornithine,C7 H14 N2 O3,174.10045,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Other,N~2~-Acetyl-L-ornithine-peak1,7,14,3,2,0,0,2,0.42857142857142855,-0.2857142857142856,68.44285714285714,2,-1,-1.5,-0.42857142857142855,-3,Protein,90522.70818000633,65833.4106854436,0.7272585189843466,-0.45945980397499936,0.41655437679236984,0.6580333694263849,Downregulated
Feature0005,NA,C14 H27 N3 O6,333.19005,NA,NA,Feature0005,14,27,6,3,0,0,1.9285714285714288,0.42857142857142855,-0.4285714285714288,72.51428571428572,3,-3,-1.2,-0.375,-6,Protein,746802.235716649,828495.539858297,1.1093908135709492,0.14976768423508122,0.4252382313571382,0.6594697741371865,Upregulated
Feature0004,"3,4-Dihydroxy-7-methoxy-2,2,6-trimethyl-2,3,4,6-tetrahydro-5H-pyrano[3,2-c]quinolin-5-one",C16 H19 N O5,305.12642,NA,NA,"3,4-Dihydroxy-7-methoxy-2,2,6-trimethyl-2,3,4,6-tetrahydro-5H-pyrano[3,2-c]quinolin-5-one",16,19,5,1,0,0,1.1875,0.3125,-0.375,70.9875,8,3,0.2,0.36,2,Lignin,93094.58822885767,69348.46200539496,0.7449247407906593,-0.42483341638987093,0.42949355966396524,0.6614200818825064,Downregulated
Feature0003,NA,C15 H28 N4 O5,344.20604,NA,NA,Feature0003,15,28,5,4,0,0,1.8666666666666667,0.3333333333333333,-0.4000000000000003,71.7,4,-1,-0.8333333333333334,-0.29411764705882354,-5,Protein,732391.1882994233,781409.3342410696,1.066928912751482,0.09346405560243322,0.8395386844120151,0.92084847293433425,Upregulated
Feature0002,NA,C21 H21 O6 P S,432.07976,NA,NA,Feature0002,21,21,6,0,1,1,1,0.2857142857142857,-0.5714285714285712,76.58571428571427,12,6,0.3076923076923077,0.4375,4,Lignin,65068.5080796928,71131.20858477587,1.0931741127006902,0.128523201124011,0.6451638422255781,0.8162117615609629,Upregulated
Feature0001,N-(1-{[Methyl(2-methyl-2-propanyl)carbamoyl]amino}ethyl)-alpha-asparagine,C12 H24 N4 O4,288.17983,NA,NA,N-(1-{[Methyl(2-methyl-2-propanyl)carbamoyl]amino}ethyl)-alpha-asparagine,12,24,4,4,0,0,2,0.3333333333333333,-0.33333333333333304,69.79999999999998,3,-1,-1.25,-0.5,-5,Protein,2558979.084674527,2885330.387834723,1.1275318368620837,0.1731681698306251,0.6046907460826225,0.7867481750107239,Upregulated
